cui,rxnorm_tty,rxnorm_name,atc_code,atc_name,L1_code,L1_name,L2_code,L2_name,L3_code,L3_name,L4_code,L4_name,L5_code,L5_name,unique_pub_count
C0000378,IN,droxidopa,C01CA27,droxidopa,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA27,droxidopa,8
C0000402,,,C10AX05,meglutol,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AX,Other lipid modifying agents in ATC,C10AX05,meglutol,42
C0000473,IN,4-aminobenzoic acid,D02BA01,aminobenzoic acid,D,DERMATOLOGICALS,D02,EMOLLIENTS AND PROTECTIVES,D02B,PROTECTIVES AGAINST UV-RADIATION,D02BA,Protectives against UV-radiation for topical use,D02BA01,aminobenzoic acid,56
C0000477,IN,dalfampridine,N07XX07,fampridine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07X,OTHER NERVOUS SYSTEM DRUGS in ATC,N07XX,Other nervous system drugs in ATC,N07XX07,fampridine,18
C0000578,IN,5-hydroxytryptophan,N06AX01,oxitriptan,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX01,oxitriptan,21
C0000608,IN,6-aminocaproic acid,B02AA01,aminocaproic acid,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02A,ANTIFIBRINOLYTICS,B02AA,Antifibrinolytic amino acids,B02AA01,aminocaproic acid,143
C0000618,IN,mercaptopurine,L01BB02,mercaptopurine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BB,"Purine analogs, antimetabolites antineoplastic",L01BB02,mercaptopurine,1352
C0000665,IN,oxyquinoline,A01AB07,oxyquinoline,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB07,oxyquinoline,55
C0000665,IN,oxyquinoline,D08AH03,oxyquinoline,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AH,"Quinoline derivatives, antiseptics and disinfectants",D08AH03,oxyquinoline,55
C0000665,IN,oxyquinoline,G01AC30,oxyquinoline,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AC,Quinoline gynecological antiinfectives,G01AC30,oxyquinoline,55
C0000665,IN,oxyquinoline,R02AA14,oxyquinoline,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AA,Antiseptic throat preparations,R02AA14,oxyquinoline,55
C0000946,IN,acebutolol,C07AB04,acebutolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AB,"Beta blocking agents, selective",C07AB04,acebutolol,25
C0000956,IN,acenocoumarol,B01AA07,acenocoumarol,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AA,Vitamin K antagonists,B01AA07,acenocoumarol,56
C0000959,IN,acepromazine,N05AA04,acepromazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AA,"Phenothiazines with aliphatic side-chain, antipsychotics",N05AA04,acepromazine,5
C0000970,IN,acetaminophen,N02BE01,paracetamol,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BE,Anilide analgesics and antipyretics,N02BE01,paracetamol,2815
C0000981,IN,acetazolamide,S01EC01,acetazolamide,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EC,"Carbonic anhydrase inhibitors, antiglaucoma drugs and miotics",S01EC01,acetazolamide,416
C0000983,IN,acetic acid,G01AD02,acetic acid,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AD,"Organic acids, Gynecological",G01AD02,acetic acid,345
C0000983,IN,acetic acid,S02AA10,acetic acid,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA10,acetic acid,345
C0001017,,,V08AA07,acetrizoic acid,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AA,"Watersoluble, nephrotropic, high osmolar X-ray contrast media",V08AA07,acetrizoic acid,1
C0001040,IN,acetylcarnitine,N06BX12,acetylcarnitine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BX,Other psychostimulants and nootropics in ATC,N06BX12,acetylcarnitine,114
C0001041,IN,acetylcholine,S01EB09,acetylcholine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EB,"Parasympathomimetics, antiglaucoma preparations and miotics",S01EB09,acetylcholine,315
C0001047,IN,acetylcysteine,R05CB01,acetylcysteine,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CB,Mucolytics,R05CB01,acetylcysteine,475
C0001047,IN,acetylcysteine,S01XA08,acetylcysteine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA08,acetylcysteine,475
C0001047,IN,acetylcysteine,V03AB23,acetylcysteine,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB23,acetylcysteine,475
C0001050,IN,acetyldigoxins,C01AA02,acetyldigoxin,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01A,CARDIAC GLYCOSIDES,C01AA,Digitalis glycosides,C01AA02,acetyldigoxin,3
C0001143,IN,aclarubicin,L01DB04,aclarubicin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01D,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,L01DB,Anthracyclines and related substances,L01DB04,aclarubicin,30
C0001187,IN,acriflavine,D08AA03,euflavine,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AA,"Acridine derivatives, antiseptics and disinfectants",D08AA03,euflavine,1
C0001268,IN,spectinomycin,J01XX04,spectinomycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XX,Other antibacterials in ATC,J01XX04,spectinomycin,25
C0001275,IN,activated charcoal,A07BA01,medicinal charcoal,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07B,INTESTINAL ADSORBENTS,A07BA,"Charcoal preparations, intestinal absorbents",A07BA01,medicinal charcoal,1756
C0001367,IN,acyclovir,D06BB03,aciclovir,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,D06BB,"Antivirals, topical",D06BB03,aciclovir,1394
C0001367,IN,acyclovir,J05AB01,aciclovir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,J05AB01,aciclovir,1394
C0001367,IN,acyclovir,S01AD03,aciclovir,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AD,"Antivirals, ophthalmologic",S01AD03,aciclovir,1394
C0001443,IN,adenosine,C01EB10,adenosine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01E,OTHER CARDIAC PREPARATIONS in ATC,C01EB,Other plain cardiac preparations in ATC,C01EB10,adenosine,939
C0001655,IN,corticotropin,H01AA01,corticotropin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AA,ACTH and synthetic analog preparations,H01AA01,corticotropin,2606
C0001888,IN,ajmaline,C01BA05,ajmaline,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BA,"Antiarrhythmics, class Ia",C01BA05,ajmaline,34
C0001911,IN,albendazole,P02CA03,albendazole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02C,ANTINEMATODAL AGENTS,P02CA,"Benzimidazole derivatives, antinematodal",P02CA03,albendazole,1170
C0001927,IN,albuterol,R03AC02,salbutamol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC02,salbutamol,2369
C0001927,IN,albuterol,R03CC02,salbutamol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CC,"Selective beta-2-adrenoreceptor agonists, systemic",R03CC02,salbutamol,2369
C0001962,IN,ethanol,D08AX08,ethanol,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AX,Other antiseptics and disinfectants in ATC,D08AX08,ethanol,10900
C0001962,IN,ethanol,V03AB16,ethanol,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB16,ethanol,10900
C0001962,IN,ethanol,V03AZ01,ethanol,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AZ,Nerve depressant drugs,V03AZ01,ethanol,10900
C0001964,IN,1-propanol,D08AX03,propanol,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AX,Other antiseptics and disinfectants in ATC,D08AX03,propanol,54
C0001981,IN,alcuronium,M03AA01,alcuronium,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AA,"Curare alkaloid muscle relaxants, peripherally acting",M03AA01,alcuronium,29
C0002006,IN,aldosterone,H02AA01,aldosterone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AA,"Mineralocorticoids for systemic use, plain",H02AA01,aldosterone,1323
C0002026,IN,alfentanil,N01AH02,alfentanil,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AH,Opioid anesthetics,N01AH02,alfentanil,235
C0002132,IN,allobarbital,N05CA21,allobarbital,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CA,"Barbiturates, hypnotics and sedatives, plain",N05CA21,allobarbital,1
C0002144,IN,allopurinol,M04AA01,allopurinol,M,MUSCULO-SKELETAL SYSTEM DRUGS,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AA,Preparations inhibiting uric acid production,M04AA01,allopurinol,385
C0002158,IN,allylestrenol,G03DC01,allylestrenol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03D,PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03DC,"Estren derivatives, sex hormones and modulators of the genital system",G03DC01,allylestrenol,11
C0002164,IN,almitrine,R07AB07,almitrine,R,RESPIRATORY SYSTEM DRUGS,R07,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07A,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07AB,Respiratory stimulants,R07AB07,almitrine,4
C0002191,IN,alpha 1-antitrypsin,B02AB02,alfa1 antitrypsin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02A,ANTIFIBRINOLYTICS,B02AB,"Proteinase inhibitors, antifibrinolytic",B02AB02,alfa1 antitrypsin,1273
C0002199,,,L03AB01,interferon alfa natural,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AB,Interferons,L03AB01,interferon alfa natural,224
C0002260,IN,eflornithine,D11AX16,eflornithine,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AX,OTHER DERMATOLOGICAL PREPARATIONS IN ATC,D11AX16,eflornithine,47
C0002260,IN,eflornithine,L01XX79,eflornithine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX79,eflornithine,47
C0002260,IN,eflornithine,P01CX03,eflornithine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01C,AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS,P01CX,Other agents against leishmaniasis and trypanosomiasis in ATC,P01CX03,eflornithine,47
C0002333,IN,alprazolam,N05BA12,alprazolam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA12,alprazolam,73
C0002334,IN,alprenolol,C07AA01,alprenolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AA,"Beta blocking agents, non-selective",C07AA01,alprenolol,4
C0002335,IN,alprostadil,C01EA01,alprostadil,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01E,OTHER CARDIAC PREPARATIONS in ATC,C01EA,Prostaglandin cardiac therapy preparations,C01EA01,alprostadil,546
C0002335,IN,alprostadil,G04BE01,alprostadil,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BE,Drugs used in erectile dysfunction,G04BE01,alprostadil,546
C0002371,IN,aluminum hydroxide,A02AB01,aluminium hydroxide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AB,antacids containing aluminium compounds,A02AB01,aluminium hydroxide,210
C0002374,IN,aluminum oxide,D10AX04,aluminium oxide,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AX,Other anti-acne preparations for topical use in ATC,D10AX04,aluminium oxide,8
C0002403,IN,amantadine,N04BB01,amantadine,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04B,DOPAMINERGIC AGENTS,N04BB,"Adamantane derivatives, dopaminergic",N04BB01,amantadine,139
C0002412,IN,ambenonium,N07AA30,ambenonium,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07A,PARASYMPATHOMIMETICS,N07AA,Anticholinesterase parasympathomimetics,N07AA30,ambenonium,1
C0002421,IN,ambroxol,R02AD05,ambroxol,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AD,local anesthetic throat preparations,R02AD05,ambroxol,89
C0002421,IN,ambroxol,R05CB06,ambroxol,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CB,Mucolytics,R05CB06,ambroxol,89
C0002435,IN,amdinocillin,J01CA11,mecillinam,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA11,mecillinam,32
C0002436,IN,amdinocillin pivoxil,J01CA08,pivmecillinam,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA08,pivmecillinam,54
C0002475,IN,mitomycin,L01DC03,mitomycin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01D,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,L01DC,Other cytotoxic antibiotics in ATC,L01DC03,mitomycin,385
C0002499,IN,amikacin,D06AX12,amikacin,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AX,Other antibiotics for topical use in ATC,D06AX12,amikacin,1034
C0002499,IN,amikacin,J01GB06,amikacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides in ATC,J01GB06,amikacin,1034
C0002499,IN,amikacin,S01AA21,amikacin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA21,amikacin,1034
C0002502,IN,amiloride,C03DB01,amiloride,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03D,ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS,C03DB,Other potassium-sparing agents in ATC,C03DB01,amiloride,83
C0002503,IN,aminacrine,D08AA02,aminoacridine,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AA,"Acridine derivatives, antiseptics and disinfectants",D08AA02,aminoacridine,16
C0002520,,,B05BA01,amino acids,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05B,"IV solutions used in parenteral administration of fluids, electrolytes and nutrients",B05BA,Solutions for parenteral nutrition,B05BA01,amino acids,3715
C0002555,IN,aminoglutethimide,L02BG01,aminoglutethimide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02B,HORMONE ANTAGONISTS AND RELATED AGENTS,L02BG,Aromatase inhibitors,L02BG01,aminoglutethimide,9
C0002563,IN,aminolevulinic acid,L01XD04,aminolevulinic acid,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XD,Sensitizers used in photodynamic/radiation therapy,L01XD04,aminolevulinic acid,157
C0002575,IN,aminophylline,R03DA05,aminophylline,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DA,"Xanthines, systemic for obstructive airway disease",R03DA05,aminophylline,471
C0002586,IN,aminopyrine,N02BB03,aminophenazone,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BB,"Pyrazolones, analgesics and antipyretics",N02BB03,aminophenazone,85
C0002598,IN,amiodarone,C01BD01,amiodarone,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BD,"Antiarrhythmics, class III",C01BD01,amiodarone,424
C0002600,IN,amitriptyline,N06AA09,amitriptyline,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AA,Non-selective monoamine reuptake inhibitors,N06AA09,amitriptyline,261
C0002615,IN,ammonium chloride,B05XA04,ammonium chloride,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA04,ammonium chloride,68
C0002615,IN,ammonium chloride,G04BA01,ammonium chloride,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BA,Acidifiers,G04BA01,ammonium chloride,68
C0002640,IN,amobarbital,N05CA02,amobarbital,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CA,"Barbiturates, hypnotics and sedatives, plain",N05CA02,amobarbital,77
C0002641,IN,amodiaquine,P01BA06,amodiaquine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BA,Aminoquinoline antimalarials,P01BA06,amodiaquine,641
C0002644,IN,amoxapine,N06AA17,amoxapine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AA,Non-selective monoamine reuptake inhibitors,N06AA17,amoxapine,9
C0002645,IN,amoxicillin,J01CA04,amoxicillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA04,amoxicillin,2854
C0002658,IN,amphetamine,N06BA01,amfetamine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BA,Centrally acting sympathomimetics,N06BA01,amfetamine,919
C0002679,IN,amphotericin B,A01AB04,amphotericin B,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB04,amphotericin B,1837
C0002679,IN,amphotericin B,A07AA07,amphotericin B,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,"antibiotics, intestinal",A07AA07,amphotericin B,1837
C0002679,IN,amphotericin B,G01AA03,amphotericin B,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AA,"Antibiotics, Gynecological",G01AA03,amphotericin B,1837
C0002679,IN,amphotericin B,J02AA01,amphotericin B,J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AA,Antibiotics for systemic use,J02AA01,amphotericin B,1837
C0002680,IN,ampicillin,J01CA01,ampicillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA01,ampicillin,3007
C0002680,IN,ampicillin,S01AA19,ampicillin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA19,ampicillin,3007
C0002697,IN,inamrinone,C01CE01,amrinone,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CE,"Phosphodiesterase inhibitors, cardiac stimulant",C01CE01,amrinone,29
C0002699,IN,amsacrine,L01XX01,amsacrine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX01,amsacrine,70
C0002711,IN,amyl nitrite,V03AB22,amyl nitrite,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB22,amyl nitrite,14
C0002823,IN,ancrod,B01AD09,ancrod,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AD,"Enzymes, antithrombotic",B01AD09,ancrod,2
C0003001,,,C01CX06,angiotensinamide,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CX,Other cardiac stimulants in ATC,C01CX06,angiotensinamide,3
C0003009,IN,angiotensin II,C01CX09,angiotensin II,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CX,Other cardiac stimulants in ATC,C01CX09,angiotensin II,1035
C0003143,IN,antazoline,R01AC04,antazoline,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AC,"Antiallergic nasal preparations for topical use, excl. corticosteroids",R01AC04,antazoline,4
C0003143,IN,antazoline,R06AX05,antazoline,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX05,antazoline,4
C0003166,IN,anthralin,D05AC01,dithranol,D,DERMATOLOGICALS,D05,ANTIPSORIATICS,D05A,ANTIPSORIATICS FOR TOPICAL USE,D05AC,"Antracen derivatives, topical antipsoriatics",D05AC01,dithranol,29
C0003420,IN,antipyrine,N02BB01,phenazone,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BB,"Pyrazolones, analgesics and antipyretics",N02BB01,phenazone,160
C0003420,IN,antipyrine,S02DA03,phenazone,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02D,OTHER OTOLOGICALS in ATC,S02DA,Analgesics and anesthetics,S02DA03,phenazone,160
C0003524,IN,apazone,M01AX04,azapropazone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids in ATC",M01AX04,azapropazone,2
C0003596,IN,apomorphine,G04BE07,apomorphine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BE,Drugs used in erectile dysfunction,G04BE07,apomorphine,14
C0003596,IN,apomorphine,N04BC07,apomorphine,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04B,DOPAMINERGIC AGENTS,N04BC,Dopamine agonists,N04BC07,apomorphine,14
C0003639,IN,aprindine,C01BB04,aprindine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BB,"Antiarrhythmics, class Ib",C01BB04,aprindine,5
C0003641,IN,aprotinin,B02AB01,aprotinin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02A,ANTIFIBRINOLYTICS,B02AB,"Proteinase inhibitors, antifibrinolytic",B02AB01,aprotinin,199
C0003968,IN,ascorbic acid,A11GA01,ascorbic acid,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11G,"ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS",A11GA,"vitamin C products, plain",A11GA01,ascorbic acid,2171
C0003968,IN,ascorbic acid,G01AD03,ascorbic acid,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AD,"Organic acids, Gynecological",G01AD03,ascorbic acid,2171
C0003968,IN,ascorbic acid,S01XA15,ascorbic acid,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA15,ascorbic acid,2171
C0003993,IN,asparaginase,L01XX02,asparaginase,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX02,asparaginase,1528
C0004057,IN,aspirin,A01AD05,acetylsalicylic acid,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AD,Other agents for local oral treatment in ATC,A01AD05,acetylsalicylic acid,2580
C0004057,IN,aspirin,B01AC06,acetylsalicylic acid,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC06,acetylsalicylic acid,2580
C0004057,IN,aspirin,N02BA01,acetylsalicylic acid,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BA,"Salicylic acid and derivatives, analgesics and antipyretics",N02BA01,acetylsalicylic acid,2580
C0004147,IN,atenolol,C07AB03,atenolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AB,"Beta blocking agents, selective",C07AB03,atenolol,176
C0004234,IN,atracurium,M03AC04,atracurium,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,"Other quaternary ammonium compounds in ATC, muscle relaxants, peripherally acting",M03AC04,atracurium,246
C0004259,IN,atropine,A03BA01,atropine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03B,"BELLADONNA AND DERIVATIVES CONTAINING DRUGS, PLAIN FOR FUNCTIONAL GASTROINTESTINAL DISORDERS",A03BA,"Belladonna alkaloids, tertiary amines for functional gastrointestinal disorders",A03BA01,atropine,1316
C0004259,IN,atropine,S01FA01,atropine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01F,MYDRIATICS AND CYCLOPLEGICS,S01FA,Anticholinergic mydriatics and cycloplegics,S01FA01,atropine,1316
C0004320,IN,auranofin,M01CB03,auranofin,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01C,SPECIFIC ANTIRHEUMATIC AGENTS,M01CB,Gold preparations,M01CB03,auranofin,20
C0004475,IN,azacitidine,L01BC07,azacitidine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BC,"Pyrimidine analogues, antineoplastic antimetabolites",L01BC07,azacitidine,114
C0004482,IN,azathioprine,L04AX01,azathioprine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AX,Other immunosuppressants in ATC,L04AX01,azathioprine,2236
C0004499,IN,azlocillin,J01CA09,azlocillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA09,azlocillin,75
C0004521,IN,aztreonam,J01DF01,aztreonam,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DF,Monobactams,J01DF01,aztreonam,199
C0004599,IN,bacitracin,D06AX05,bacitracin,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AX,Other antibiotics for topical use in ATC,D06AX05,bacitracin,127
C0004599,IN,bacitracin,J01XX10,bacitracin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XX,Other antibacterials in ATC,J01XX10,bacitracin,127
C0004599,IN,bacitracin,R02AB04,bacitracin,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AB,Antibiotic throat preparations,R02AB04,bacitracin,127
C0004599,IN,bacitracin,S01AA32,bacitracin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA32,bacitracin,127
C0004609,IN,baclofen,M03BX01,baclofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents in ATC,M03BX01,baclofen,399
C0004743,IN,barbital,N05CA04,barbital,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CA,"Barbiturates, hypnotics and sedatives, plain",N05CA04,barbital,8
C0004886,,,L03AX03,BCG vaccine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AX,Other immunostimulants in ATC,L03AX03,BCG vaccine,1989
C0004960,,,R07AB05,bemegride,R,RESPIRATORY SYSTEM DRUGS,R07,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07A,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07AB,Respiratory stimulants,R07AB05,bemegride,3
C0004969,IN,bencyclane,C04AX11,bencyclane,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AX,Other peripheral vasodilators in ATC,C04AX11,bencyclane,1
C0004975,IN,bendroflumethiazide,C03AA01,bendroflumethiazide,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03A,"LOW-CEILING DIURETICS, THIAZIDES",C03AA,"Thiazides, plain",C03AA01,bendroflumethiazide,6
C0005013,IN,benperidol,N05AD07,benperidol,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AD,"Butyrophenone derivatives, antipsychotics",N05AD07,benperidol,1
C0005025,IN,benzalkonium,D08AJ01,benzalkonium,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AJ,"Quaternary ammonium compounds, antiseptics and disinfectants",D08AJ01,benzalkonium,63
C0005025,IN,benzalkonium,D09AA11,benzalkonium,D,DERMATOLOGICALS,D09,MEDICATED DRESSINGS,D09A,MEDICATED DRESSINGS,D09AA,Medicated dressings with antiinfectives,D09AA11,benzalkonium,63
C0005025,IN,benzalkonium,R02AA16,benzalkonium,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AA,Antiseptic throat preparations,R02AA16,benzalkonium,63
C0005035,IN,benzbromarone,M04AB03,benzbromarone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AB,Preparations increasing uric acid excretion,M04AB03,benzbromarone,5
C0005038,IN,lindane,P03AB02,lindane,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03A,"ECTOPARASITICIDES, INCL. SCABICIDES",P03AB,Chlorine containing product ectoparasiticides,P03AB02,lindane,177
C0005041,IN,benzethonium,R02AA09,benzethonium,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AA,Antiseptic throat preparations,R02AA09,benzethonium,10
C0005059,IN,benzocaine,C05AD03,benzocaine,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AD,Local anesthetics for treatment of hemorrhoids and anal fissures for topical use,C05AD03,benzocaine,83
C0005059,IN,benzocaine,D04AB04,benzocaine,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AB,Anesthetics for topical use,D04AB04,benzocaine,83
C0005059,IN,benzocaine,N01BA05,benzocaine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BA,Esters of aminobenzoic acid for local anesthesia,N01BA05,benzocaine,83
C0005059,IN,benzocaine,R02AD01,benzocaine,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AD,local anesthetic throat preparations,R02AD01,benzocaine,83
C0005088,IN,benzoyl peroxide,D10AE01,benzoyl peroxide,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AE,Peroxide anti-acne preparations for topical use,D10AE01,benzoyl peroxide,118
C0005098,IN,benztropine,N04AC01,benzatropine,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04A,ANTICHOLINERGIC AGENTS,N04AC,"Ethers of tropine or tropine derivatives, anticholinergic",N04AC01,benzatropine,25
C0005099,IN,benzydamine,A01AD02,benzydamine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AD,Other agents for local oral treatment in ATC,A01AD02,benzydamine,21
C0005099,IN,benzydamine,G02CC03,benzydamine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02C,OTHER GYNECOLOGICALS in ATC,G02CC,Antiinflammatory products for vaginal administration,G02CC03,benzydamine,21
C0005099,IN,benzydamine,M01AX07,benzydamine,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids in ATC",M01AX07,benzydamine,21
C0005099,IN,benzydamine,M02AA05,benzydamine,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA05,benzydamine,21
C0005099,IN,benzydamine,R02AX03,benzydamine,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AX,Other throat preparations in ATC,R02AX03,benzydamine,21
C0005100,IN,benzyl alcohol,P03AX06,benzyl alcohol,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03A,"ECTOPARASITICIDES, INCL. SCABICIDES",P03AX,"Other ectoparasiticides, incl. scabicides in ATC",P03AX06,benzyl alcohol,63
C0005116,IN,bepridil,C08EA02,bepridil,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08E,NON-SELECTIVE CALCIUM CHANNEL BLOCKERS,C08EA,"Phenylalkylamine derivatives, non-selective calcium channel blockers",C08EA02,bepridil,3
C0005301,IN,betahistine,N07CA01,betahistine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07C,ANTIVERTIGO PREPARATIONS,N07CA,Antivertigo preparations,N07CA01,betahistine,10
C0005304,IN,betaine,A16AA06,betaine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AA,Amino acids and derivatives,A16AA06,betaine,261
C0005308,IN,betamethasone,A07EA04,betamethasone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EA,Corticosteroids acting locally,A07EA04,betamethasone,1332
C0005308,IN,betamethasone,C05AA05,betamethasone,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AA,"Corticosteroids, topical for treatment of hemorrhoids and anal fissures",C05AA05,betamethasone,1332
C0005308,IN,betamethasone,D07AC01,betamethasone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC01,betamethasone,1332
C0005308,IN,betamethasone,D07XC01,betamethasone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07X,"CORTICOSTEROIDS, OTHER COMBINATIONS",D07XC,"Corticosteroids, potent, other combinations",D07XC01,betamethasone,1332
C0005308,IN,betamethasone,H02AB01,betamethasone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,"Glucocorticoids, Systemic",H02AB01,betamethasone,1332
C0005308,IN,betamethasone,R01AD06,betamethasone,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AD,Corticosteroid nasal preparations for topical use,R01AD06,betamethasone,1332
C0005308,IN,betamethasone,R03BA04,betamethasone,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03B,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS in ATC",R03BA,Glucocorticoid inhalants for obstructive airway disease,R03BA04,betamethasone,1332
C0005308,IN,betamethasone,S01BA06,betamethasone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BA,"Corticosteroid ophthalmologic antiinflammatory agents, plain",S01BA06,betamethasone,1332
C0005308,IN,betamethasone,S01CB04,betamethasone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01C,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION,S01CB,Corticosteroids/antiinfectives/mydriatics in combination,S01CB04,betamethasone,1332
C0005308,IN,betamethasone,S02BA07,betamethasone,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02B,Corticosteroid otologicals,S02BA,Corticosteroids,S02BA07,betamethasone,1332
C0005308,IN,betamethasone,S03BA03,betamethasone,S,SENSORY ORGAN DRUGS,S03,OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,S03B,Corticosteroid ophthalmologic and otologic preparations,S03BA,Corticosteroids,S03BA03,betamethasone,1332
C0005320,IN,betaxolol,C07AB05,betaxolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AB,"Beta blocking agents, selective",C07AB05,betaxolol,24
C0005320,IN,betaxolol,S01ED02,betaxolol,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01ED,"Beta blocking agents, antiglaucoma preparations and miotics",S01ED02,betaxolol,24
C0005321,,,V04CG02,betazole,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CG,gastric secretion test diagnostic agents,V04CG02,betazole,3
C0005330,IN,bezafibrate,C10AB02,bezafibrate,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AB,"Fibrates, lipid modifying drugs, plain",C10AB02,bezafibrate,22
C0005575,IN,biotin,A11HA05,biotin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS in ATC,A11HA,Other plain vitamin preparations in ATC,A11HA05,biotin,772
C0005578,IN,biperiden,N04AA02,biperiden,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04A,ANTICHOLINERGIC AGENTS,N04AA,"Tertiary amines, anticholinergic",N04AA02,biperiden,43
C0005632,IN,bisacodyl,A06AB02,bisacodyl,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,A06AB02,bisacodyl,47
C0005632,IN,bisacodyl,A06AG02,bisacodyl,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AG,Enema for Constipation,A06AG02,bisacodyl,47
C0005640,IN,dicumarol,B01AA01,dicoumarol,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AA,Vitamin K antagonists,B01AA01,dicoumarol,12
C0005661,,,D10AB01,bithionol,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AB,"Preparations containing sulfur, anti-acne preparations for topical use",D10AB01,bithionol,14
C0005661,,,P02BX01,bithionol,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02B,ANTITREMATODALS,P02BX,Other antitrematodal agents in ATC,P02BX01,bithionol,14
C0005740,IN,bleomycin,L01DC01,bleomycin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01D,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,L01DC,Other cytotoxic antibiotics in ATC,L01DC01,bleomycin,1377
C0006020,IN,boric acid,S02AA03,boric acid,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA03,boric acid,40
C0006213,IN,bromazepam,N05BA08,bromazepam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA08,bromazepam,26
C0006217,IN,bromelains,D03BA03,bromelains,D,DERMATOLOGICALS,D03,PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS,D03B,ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS,D03BA,Proteolytic enzymes for treatment of wounds and ulcers,D03BA03,bromelains,27
C0006217,IN,bromelains,M09AB03,bromelains,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AB,Enzymes FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AB03,bromelains,27
C0006220,IN,bromhexine,R05CB02,bromhexine,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CB,Mucolytics,R05CB02,bromhexine,39
C0006226,,,N05CM03,bromisoval,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CM,Other hypnotics and sedatives in ATC,N05CM03,bromisoval,1
C0006230,IN,bromocriptine,G02CB01,bromocriptine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02C,OTHER GYNECOLOGICALS in ATC,G02CB,Prolactine inhibitors,G02CB01,bromocriptine,495
C0006230,IN,bromocriptine,N04BC01,bromocriptine,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04B,DOPAMINERGIC AGENTS,N04BC,Dopamine agonists,N04BC01,bromocriptine,495
C0006246,IN,brompheniramine,R06AB01,brompheniramine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AB,"Substituted alkylamines, systemic antihistamines",R06AB01,brompheniramine,37
C0006351,IN,bufexamac,M01AB17,bufexamac,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,M01AB17,bufexamac,9
C0006351,IN,bufexamac,M02AA09,bufexamac,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA09,bufexamac,9
C0006359,,,A10BA03,buformin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BA,biguanide blood glucose lower drugs,A10BA03,buformin,1
C0006376,IN,bumetanide,C03CA02,bumetanide,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03C,HIGH-CEILING DIURETICS,C03CA,"sulfonamides, high-ceiling diuretics, plain",C03CA02,bumetanide,55
C0006388,IN,levobunolol,S01ED03,levobunolol,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01ED,"Beta blocking agents, antiglaucoma preparations and miotics",S01ED03,levobunolol,4
C0006400,IN,bupivacaine,N01BB01,bupivacaine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BB,Amide local anesthetics,N01BB01,bupivacaine,2217
C0006403,IN,bupranolol,C07AA19,bupranolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AA,"Beta blocking agents, non-selective",C07AA19,bupranolol,1
C0006405,IN,buprenorphine,N02AE01,buprenorphine,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AE,Oripavine derivatives analgesics,N02AE01,buprenorphine,526
C0006405,IN,buprenorphine,N07BC01,buprenorphine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07B,DRUGS USED IN ADDICTIVE DISORDERS,N07BC,Drugs used in opioid dependence,N07BC01,buprenorphine,526
C0006456,IN,buserelin,L02AE01,buserelin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02A,HORMONES AND RELATED AGENTS,L02AE,"Gonadotropin releasing hormone analogues, endocrine therapy drugs",L02AE01,buserelin,189
C0006462,IN,buspirone,N05BE01,buspirone,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BE,"Azaspirodecanedione derivatives, anxiolytics",N05BE01,buspirone,40
C0006463,IN,busulfan,L01AB01,busulfan,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AB,Alkyl sulfonate alkylating agents,L01AB01,busulfan,1568
C0006491,IN,butorphanol,N02AF01,butorphanol,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AF,"Morphinan derivatives, opiod analgesics",N02AF01,butorphanol,60
C0006639,,,V04CC04,ceruletide,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CC,Diagnostic agents for bile duct patency testing,V04CC04,ceruletide,11
C0006644,IN,caffeine,D11AX26,caffeine,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AX,OTHER DERMATOLOGICAL PREPARATIONS IN ATC,D11AX26,caffeine,1306
C0006644,IN,caffeine,N06BC01,caffeine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BC,"Xanthine derivatives, psychostimulants, agents used for ADHD and nootropics",N06BC01,caffeine,1306
C0006657,IN,calcifediol,A11CC06,calcifediol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CC,Vitamin D and analogues,A11CC06,calcifediol,977
C0006657,IN,calcifediol,H05BX05,calcifediol,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BX,Other anti-parathyroid agents in ATC,H05BX05,calcifediol,977
C0006674,IN,calcitriol,A11CC04,calcitriol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CC,Vitamin D and analogues,A11CC04,calcitriol,922
C0006674,IN,calcitriol,D05AX03,calcitriol,D,DERMATOLOGICALS,D05,ANTIPSORIATICS,D05A,ANTIPSORIATICS FOR TOPICAL USE,D05AX,Other antipsoriatics for topical use in ATC,D05AX03,calcitriol,922
C0006681,IN,calcium carbonate,A02AC01,calcium carbonate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AC,antacids containing calcium compounds,A02AC01,calcium carbonate,241
C0006681,IN,calcium carbonate,A12AA04,calcium carbonate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM SUPPLEMENTS,A12AA,Calcium,A12AA04,calcium carbonate,241
C0006686,IN,calcium chloride,A12AA07,calcium chloride,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM SUPPLEMENTS,A12AA,Calcium,A12AA07,calcium chloride,101
C0006686,IN,calcium chloride,B05XA07,calcium chloride,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA07,calcium chloride,101
C0006686,IN,calcium chloride,G04BA03,calcium chloride,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BA,Acidifiers,G04BA03,calcium chloride,101
C0006699,IN,calcium gluconate,A12AA03,calcium gluconate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM SUPPLEMENTS,A12AA,Calcium,A12AA03,calcium gluconate,236
C0006699,IN,calcium gluconate,B05XA19,calcium gluconate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA19,calcium gluconate,236
C0006699,IN,calcium gluconate,D11AX03,calcium gluconate,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AX,OTHER DERMATOLOGICAL PREPARATIONS IN ATC,D11AX03,calcium gluconate,236
C0006711,IN,calcium phosphate,A12AA01,calcium phosphate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM SUPPLEMENTS,A12AA,Calcium,A12AA01,calcium phosphate,564
C0006834,,,G01AA04,candicidin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AA,"Antibiotics, Gynecological",G01AA04,candicidin,1
C0006863,IN,cannabidiol,N03AX24,cannabidiol,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX24,cannabidiol,194
C0006882,IN,canrenone,C03DA03,canrenone,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03D,ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS,C03DA,Aldosterone antagonists,C03DA03,canrenone,10
C0006931,IN,capsaicin,M02AB01,capsaicin,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AB,Capsaicin and similar agents,M02AB01,capsaicin,54
C0006931,IN,capsaicin,N01BX04,capsaicin,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BX,Other local anesthetics in ATC,N01BX04,capsaicin,54
C0006938,IN,captopril,C09AA01,captopril,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09A,"ACE INHIBITORS, PLAIN",C09AA,"ACE inhibitors, plain",C09AA01,captopril,301
C0006945,IN,carbachol,N07AB01,carbachol,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07A,PARASYMPATHOMIMETICS,N07AB,"Choline esters, parasympathomimetics",N07AB01,carbachol,3
C0006945,IN,carbachol,S01EB02,carbachol,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EB,"Parasympathomimetics, antiglaucoma preparations and miotics",S01EB02,carbachol,3
C0006949,IN,carbamazepine,N03AF01,carbamazepine,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AF,"Carboxamide derivatives, antiepileptics",N03AF01,carbamazepine,2272
C0006971,,,L01AC03,carboquone,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AC,"Ethylene imines, antineoplastic alkylating drugs",L01AC03,carboquone,2
C0006972,IN,carbazochrome,B02BX02,carbazochrome,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BX,Other systemic hemostatics in ATC,B02BX02,carbazochrome,4
C0006976,IN,carbenicillin,J01CA03,carbenicillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA03,carbenicillin,127
C0006979,IN,carbenoxolone,A02BX01,carbenoxolone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC,A02BX01,carbenoxolone,8
C0006983,IN,carbimazole,H03BB01,carbimazole,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY DRUGS,H03B,ANTITHYROID PREPARATIONS,H03BB,"Sulfur-containing imidazole derivatives, antithyroid preparations",H03BB01,carbimazole,153
C0006992,IN,carbocysteine,R05CB03,carbocisteine,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CB,Mucolytics,R05CB03,carbocisteine,14
C0007012,IN,carbon dioxide,V03AN02,carbon dioxide,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AN,Medical gases,V03AN02,carbon dioxide,2432
C0007018,IN,carbon monoxide,V04CX08,carbon monoxide,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CX,Other diagnostic agents in ATC,V04CX08,carbon monoxide,1357
C0007072,IN,glucarpidase,V03AF09,glucarpidase,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AF,Detoxifying agents for antineoplastic treatment,V03AF09,glucarpidase,33
C0007077,IN,carbromal,N05CM04,carbromal,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CM,Other hypnotics and sedatives in ATC,N05CM04,carbromal,2
C0007248,IN,carisoprodol,M03BA02,carisoprodol,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BA,"Carbamic acid esters, centrally acting muscle relaxants",M03BA02,carisoprodol,8
C0007257,IN,carmustine,L01AD01,carmustine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AD,"Nitrosoureas, antineoplastic alkylating agents",L01AD01,carmustine,222
C0007299,IN,carteolol,C07AA15,carteolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AA,"Beta blocking agents, non-selective",C07AA15,carteolol,6
C0007299,IN,carteolol,S01ED05,carteolol,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01ED,"Beta blocking agents, antiglaucoma preparations and miotics",S01ED05,carteolol,6
C0007343,IN,castor oil,A06AB05,castor oil,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,A06AB05,castor oil,23
C0007537,IN,cefaclor,J01DC04,cefaclor,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DC,Second-generation cephalosporins,J01DC04,cefaclor,357
C0007538,IN,cefadroxil,J01DB05,cefadroxil,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DB,First-generation cephalosporins,J01DB05,cefadroxil,81
C0007541,IN,cefamandole,J01DC03,cefamandole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DC,Second-generation cephalosporins,J01DC03,cefamandole,93
C0007545,IN,cefatrizine,J01DB07,cefatrizine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DB,First-generation cephalosporins,J01DB07,cefatrizine,11
C0007546,IN,cefazolin,J01DB04,cefazolin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DB,First-generation cephalosporins,J01DB04,cefazolin,526
C0007549,,,J01DD05,cefmenoxime,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD05,cefmenoxime,69
C0007549,,,S01AA31,cefmenoxime,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA31,cefmenoxime,69
C0007549,,,S02AA18,cefmenoxime,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA18,cefmenoxime,69
C0007550,IN,cefmetazole,J01DC09,cefmetazole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DC,Second-generation cephalosporins,J01DC09,cefmetazole,74
C0007551,IN,cefonicid,J01DC06,cefonicid,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DC,Second-generation cephalosporins,J01DC06,cefonicid,14
C0007552,IN,cefoperazone,J01DD12,cefoperazone,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD12,cefoperazone,202
C0007554,IN,cefotaxime,J01DD01,cefotaxime,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD01,cefotaxime,1483
C0007555,IN,cefotetan,J01DC05,cefotetan,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DC,Second-generation cephalosporins,J01DC05,cefotetan,40
C0007556,IN,cefotiam,J01DC07,cefotiam,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DC,Second-generation cephalosporins,J01DC07,cefotiam,88
C0007557,IN,cefoxitin,J01DC01,cefoxitin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DC,Second-generation cephalosporins,J01DC01,cefoxitin,218
C0007558,IN,cefsulodin,J01DD03,cefsulodin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD03,cefsulodin,35
C0007559,IN,ceftazidime,J01DD02,ceftazidime,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD02,ceftazidime,830
C0007560,IN,ceftizoxime,J01DD07,ceftizoxime,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD07,ceftizoxime,191
C0007561,IN,ceftriaxone,J01DD04,ceftriaxone,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD04,ceftriaxone,1974
C0007562,IN,cefuroxime,J01DC02,cefuroxime,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DC,Second-generation cephalosporins,J01DC02,cefuroxime,576
C0007562,IN,cefuroxime,S01AA27,cefuroxime,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA27,cefuroxime,576
C0007649,PIN,"cellulose, oxidized",B02BC02,oxidized cellulose,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BC,Local hemostatics,B02BC02,oxidized cellulose,22
C0007665,,,G03XC04,ormeloxifene,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03X,OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC,G03XC,Selective estrogen receptor modulators,G03XC04,ormeloxifene,2
C0007710,IN,meclofenoxate,N06BX01,meclofenoxate,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BX,Other psychostimulants and nootropics in ATC,N06BX01,meclofenoxate,2
C0007714,,,J01DB10,cefacetrile,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DB,First-generation cephalosporins,J01DB10,cefacetrile,8
C0007716,IN,cephalexin,J01DB01,cefalexin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DB,First-generation cephalosporins,J01DB01,cefalexin,381
C0007727,IN,cephaloridine,J01DB02,cefaloridine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DB,First-generation cephalosporins,J01DB02,cefaloridine,22
C0007735,IN,cephalothin,J01DB03,cefalotin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DB,First-generation cephalosporins,J01DB03,cefalotin,165
C0007737,IN,cephapirin,J01DB08,cefapirin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DB,First-generation cephalosporins,J01DB08,cefapirin,9
C0007738,IN,cephradine,J01DB09,cefradine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DB,First-generation cephalosporins,J01DB09,cefradine,74
C0007906,IN,cetylpyridinium,B05CA01,cetylpyridinium,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05C,"IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION",B05CA,Antiinfective irrigating solutions,B05CA01,cetylpyridinium,41
C0007906,IN,cetylpyridinium,D08AJ03,cetylpyridinium,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AJ,"Quaternary ammonium compounds, antiseptics and disinfectants",D08AJ03,cetylpyridinium,41
C0007906,IN,cetylpyridinium,D09AA07,cetylpyridinium,D,DERMATOLOGICALS,D09,MEDICATED DRESSINGS,D09A,MEDICATED DRESSINGS,D09AA,Medicated dressings with antiinfectives,D09AA07,cetylpyridinium,41
C0007906,IN,cetylpyridinium,R02AA06,cetylpyridinium,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AA,Antiseptic throat preparations,R02AA06,cetylpyridinium,41
C0008024,PIN,chenodeoxycholic acid,A05AA01,chenodeoxycholic acid,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A05,BILE AND LIVER THERAPY DRUGS,A05A,BILE THERAPY DRUGS,A05AA,Bile acids and derivatives for bile therapy,A05AA01,chenodeoxycholic acid,185
C0008161,PIN,chloral hydrate,N05CC01,chloral hydrate,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CC,Aldehydes and derivatives,N05CC01,chloral hydrate,396
C0008163,IN,chlorambucil,L01AA02,chlorambucil,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AA,Nitrogen mustard analogues,L01AA02,chlorambucil,203
C0008168,IN,chloramphenicol,D06AX02,chloramphenicol,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AX,Other antibiotics for topical use in ATC,D06AX02,chloramphenicol,1376
C0008168,IN,chloramphenicol,D10AF03,chloramphenicol,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AF,Antiinfectives for treatment of acne,D10AF03,chloramphenicol,1376
C0008168,IN,chloramphenicol,G01AA05,chloramphenicol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AA,"Antibiotics, Gynecological",G01AA05,chloramphenicol,1376
C0008168,IN,chloramphenicol,J01BA01,chloramphenicol,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01B,AMPHENICOLS,J01BA,"Amphenicol antibacterials, systemic",J01BA01,chloramphenicol,1376
C0008168,IN,chloramphenicol,S01AA01,chloramphenicol,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA01,chloramphenicol,1376
C0008168,IN,chloramphenicol,S02AA01,chloramphenicol,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA01,chloramphenicol,1376
C0008168,IN,chloramphenicol,S03AA08,chloramphenicol,S,SENSORY ORGAN DRUGS,S03,OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,S03A,"ANTIINFECTIVES, OPHTHALMOLOGIC AND OTOLOGIC",S03AA,Antiinfectives,S03AA08,chloramphenicol,1376
C0008183,IN,chlorcyclizine,R06AE04,chlorcyclizine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AE,"Piperazine derivatives, systemic antihistamines",R06AE04,chlorcyclizine,1
C0008188,IN,chlordiazepoxide,N05BA02,chlordiazepoxide,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA02,chlordiazepoxide,20
C0008196,IN,chlorhexidine,A01AB03,chlorhexidine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB03,chlorhexidine,773
C0008196,IN,chlorhexidine,B05CA02,chlorhexidine,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05C,"IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION",B05CA,Antiinfective irrigating solutions,B05CA02,chlorhexidine,773
C0008196,IN,chlorhexidine,D08AC02,chlorhexidine,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AC,Biguanides and amidines as antiseptics and disinfectants,D08AC02,chlorhexidine,773
C0008196,IN,chlorhexidine,D09AA12,chlorhexidine,D,DERMATOLOGICALS,D09,MEDICATED DRESSINGS,D09A,MEDICATED DRESSINGS,D09AA,Medicated dressings with antiinfectives,D09AA12,chlorhexidine,773
C0008196,IN,chlorhexidine,R02AA05,chlorhexidine,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AA,Antiseptic throat preparations,R02AA05,chlorhexidine,773
C0008196,IN,chlorhexidine,S01AX09,chlorhexidine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AX,Other antiinfectives in ATC,S01AX09,chlorhexidine,773
C0008196,IN,chlorhexidine,S02AA09,chlorhexidine,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA09,chlorhexidine,773
C0008196,IN,chlorhexidine,S03AA04,chlorhexidine,S,SENSORY ORGAN DRUGS,S03,OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,S03A,"ANTIINFECTIVES, OPHTHALMOLOGIC AND OTOLOGIC",S03AA,Antiinfectives,S03AA04,chlorhexidine,773
C0008221,IN,chlormethiazole,N05CM02,clomethiazole,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CM,Other hypnotics and sedatives in ATC,N05CM02,clomethiazole,4
C0008223,IN,chlormezanone,M03BB02,chlormezanone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BB,"Oxazol, thiazine, and triazine derivatives centrally acting muscle relaxants",M03BB02,chlormezanone,7
C0008232,IN,chlorobutanol,A04AD04,chlorobutanol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics in ATC,A04AD04,chlorobutanol,7
C0008238,IN,chloroform,N01AB02,chloroform,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AB,"Halogenated hydrocarbons, general anesthetics",N01AB02,chloroform,187
C0008241,IN,proguanil,P01BB01,proguanil,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BB,biguanide antimalarials,P01BB01,proguanil,158
C0008269,IN,chloroquine,P01BA01,chloroquine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BA,Aminoquinoline antimalarials,P01BA01,chloroquine,1721
C0008273,IN,chlorothiazide,C03AA04,chlorothiazide,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03A,"LOW-CEILING DIURETICS, THIAZIDES",C03AA,"Thiazides, plain",C03AA04,chlorothiazide,61
C0008275,IN,chlorotrianisene,G03CA06,chlorotrianisene,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03C,"ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",G03CA,"Natural and semisynthetic estrogens, plain",G03CA06,chlorotrianisene,1
C0008281,IN,chlorpheniramine,R06AB04,chlorphenamine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AB,"Substituted alkylamines, systemic antihistamines",R06AB04,chlorphenamine,138
C0008286,IN,chlorpromazine,N05AA01,chlorpromazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AA,"Phenothiazines with aliphatic side-chain, antipsychotics",N05AA01,chlorpromazine,272
C0008287,IN,chlorpropamide,A10BB02,chlorpropamide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas for blood glucose lowering,A10BB02,chlorpropamide,32
C0008290,IN,chlorprothixene,N05AF03,chlorprothixene,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AF,"Thioxanthene derivatives, antipsychotic",N05AF03,chlorprothixene,22
C0008292,IN,chlorquinaldol,D08AH02,chlorquinaldol,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AH,"Quinoline derivatives, antiseptics and disinfectants",D08AH02,chlorquinaldol,1
C0008292,IN,chlorquinaldol,G01AC03,chlorquinaldol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AC,Quinoline gynecological antiinfectives,G01AC03,chlorquinaldol,1
C0008292,IN,chlorquinaldol,P01AA04,chlorquinaldol,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AA,Hydroxyquinoline derivatives for amoebiasis and other protozoal diseases,P01AA04,chlorquinaldol,1
C0008292,IN,chlorquinaldol,R02AA11,chlorquinaldol,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AA,Antiseptic throat preparations,R02AA11,chlorquinaldol,1
C0008293,IN,chlortetracycline,A01AB21,chlortetracycline,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB21,chlortetracycline,19
C0008293,IN,chlortetracycline,D06AA02,chlortetracycline,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AA,"Tetracycline and derivatives, topical antibiotics",D06AA02,chlortetracycline,19
C0008293,IN,chlortetracycline,J01AA03,chlortetracycline,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,Tetracycline antibiotics,J01AA,Tetracyclines,J01AA03,chlortetracycline,19
C0008293,IN,chlortetracycline,S01AA02,chlortetracycline,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA02,chlortetracycline,19
C0008294,IN,chlorthalidone,C03BA04,chlortalidone,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03B,"LOW-CEILING DIURETICS, EXCL. THIAZIDES",C03BA,"sulfonamides, low-ceiling diuretics, plain",C03BA04,chlortalidone,15
C0008296,IN,chlorzoxazone,M03BB03,chlorzoxazone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BB,"Oxazol, thiazine, and triazine derivatives centrally acting muscle relaxants",M03BB03,chlorzoxazone,8
C0008318,IN,cholecalciferol,A11CC05,colecalciferol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CC,Vitamin D and analogues,A11CC05,colecalciferol,1149
C0008328,IN,cholecystokinin,V04CK02,pancreozymin (cholecystokinin),V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CK,pancreatic function test diagnostic agents,V04CK02,pancreozymin (cholecystokinin),141
C0008359,,,J07AE,Cholera vaccines,J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AE,Cholera vaccines,,,207
C0008402,IN,cholestyramine resin,C10AC01,colestyramine,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AC,Bile acid sequestrants,C10AC01,colestyramine,198
C0008466,IN,chondroitin sulfates,M01AX25,chondroitin sulfate,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids in ATC",M01AX25,chondroitin sulfate,201
C0008736,IN,chymopapain,M09AB01,chymopapain,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AB,Enzymes FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AB01,chymopapain,5
C0008742,IN,chymotrypsin,B06AA04,chymotrypsin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B06,OTHER HEMATOLOGICAL AGENTS in ATC,B06A,OTHER HEMATOLOGICAL AGENTS in ATC,B06AA,"Enzymes, hematological",B06AA04,chymotrypsin,172
C0008742,IN,chymotrypsin,S01KX01,chymotrypsin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01K,"SURGICAL AIDS, OPHTHALMOLOGIC",S01KX,Other ophthalmologic surgical aids in ATC,S01KX01,chymotrypsin,172
C0008783,IN,cimetidine,A02BA01,cimetidine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BA,H2-receptor antagonists,A02BA01,cimetidine,253
C0008803,IN,cinnarizine,N07CA02,cinnarizine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07C,ANTIVERTIGO PREPARATIONS,N07CA,Antivertigo preparations,N07CA02,cinnarizine,19
C0008806,IN,cinoxacin,J01MB06,cinoxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MB,Other quinolones in ATC,J01MB06,cinoxacin,3
C0008809,IN,ciprofloxacin,J01MA02,ciprofloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA02,ciprofloxacin,1507
C0008809,IN,ciprofloxacin,S01AE03,ciprofloxacin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AE,"Fluoroquinolone antiinfectives, ophthalmologic",S01AE03,ciprofloxacin,1507
C0008809,IN,ciprofloxacin,S02AA15,ciprofloxacin,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA15,ciprofloxacin,1507
C0008809,IN,ciprofloxacin,S03AA07,ciprofloxacin,S,SENSORY ORGAN DRUGS,S03,OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,S03A,"ANTIINFECTIVES, OPHTHALMOLOGIC AND OTOLOGIC",S03AA,Antiinfectives,S03AA07,ciprofloxacin,1507
C0008838,IN,cisplatin,L01XA01,cisplatin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XA,"Platinum compounds, antineoplastic drugs",L01XA01,cisplatin,2706
C0008845,IN,citalopram,N06AB04,citalopram,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AB,Selective serotonin reuptake inhibitors,N06AB04,citalopram,247
C0008929,IN,clemastine,D04AA14,clemastine,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AA,Antihistamines for topical use,D04AA14,clemastine,28
C0008929,IN,clemastine,R06AA04,clemastine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AA,"Aminoalkyl ethers, systemic antihistamines",R06AA04,clemastine,28
C0008932,IN,clenbuterol,R03AC14,clenbuterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC14,clenbuterol,37
C0008932,IN,clenbuterol,R03CC13,clenbuterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CC,"Selective beta-2-adrenoreceptor agonists, systemic",R03CC13,clenbuterol,37
C0008947,IN,clindamycin,D10AF01,clindamycin,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AF,Antiinfectives for treatment of acne,D10AF01,clindamycin,1307
C0008947,IN,clindamycin,G01AA10,clindamycin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AA,"Antibiotics, Gynecological",G01AA10,clindamycin,1307
C0008947,IN,clindamycin,J01FF01,clindamycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FF,Lincosamides,J01FF01,clindamycin,1307
C0008992,IN,clobetasol,D07AD01,clobetasol,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AD,"Corticosteroids, very potent (group IV)",D07AD01,clobetasol,120
C0008996,IN,clofazimine,J04BA01,clofazimine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04B,DRUGS FOR TREATMENT OF LEPRA,J04BA,Drugs for treatment of lepra,J04BA01,clofazimine,92
C0009002,IN,clofibrate,C10AB01,clofibrate,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AB,"Fibrates, lipid modifying drugs, plain",C10AB01,clofibrate,47
C0009008,IN,clomiphene,G03GB02,clomifene,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03G,GONADOTROPINS AND OTHER OVULATION STIMULANTS,G03GB,"Ovulation stimulants, synthetic",G03GB02,clomifene,562
C0009010,IN,clomipramine,N06AA04,clomipramine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AA,Non-selective monoamine reuptake inhibitors,N06AA04,clomipramine,131
C0009011,IN,clonazepam,N03AE01,clonazepam,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AE,Benzodiazepine derivative antiepileptics,N03AE01,clonazepam,481
C0009014,IN,clonidine,C02AC01,clonidine,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02A,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",C02AC,Imidazoline receptor agonists,C02AC01,clonidine,1062
C0009014,IN,clonidine,N02CX02,clonidine,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CX,Other antimigraine preparations in ATC,N02CX02,clonidine,1062
C0009014,IN,clonidine,S01EA04,clonidine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EA,Sympathomimetics in glaucoma therapy,S01EA04,clonidine,1062
C0009025,IN,clopamide,C03BA03,clopamide,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03B,"LOW-CEILING DIURETICS, EXCL. THIAZIDES",C03BA,"sulfonamides, low-ceiling diuretics, plain",C03BA03,clopamide,2
C0009026,,,N05AF02,clopenthixol,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AF,"Thioxanthene derivatives, antipsychotic",N05AF02,clopenthixol,12
C0009053,IN,collagenase Clostridium histolyticum,M09AB02,collagenase clostridium histolyticum,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AB,Enzymes FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,M09AB02,collagenase clostridium histolyticum,165
C0009071,IN,clothiapine,N05AH06,clotiapine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AH,"Diazepines, oxazepines, thiazepines and oxepines antipsychotic drugs",N05AH06,clotiapine,5
C0009073,IN,clotiazepam,N05BA21,clotiazepam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA21,clotiazepam,1
C0009074,IN,clotrimazole,A01AB18,clotrimazole,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB18,clotrimazole,147
C0009074,IN,clotrimazole,D01AC01,clotrimazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC01,clotrimazole,147
C0009074,IN,clotrimazole,G01AF02,clotrimazole,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AF,"Imidazole derivatives, gyncological antiinfectives",G01AF02,clotrimazole,147
C0009077,IN,cloxacillin,J01CF02,cloxacillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CF,Beta-lactamase resistant penicillins,J01CF02,cloxacillin,240
C0009079,IN,clozapine,N05AH02,clozapine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AH,"Diazepines, oxazepines, thiazepines and oxepines antipsychotic drugs",N05AH02,clozapine,246
C0009170,IN,cocaine,N01BC01,cocaine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BC,Esters of benzoic acid for local anesthesia,N01BC01,cocaine,1879
C0009170,IN,cocaine,R02AD03,cocaine,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AD,local anesthetic throat preparations,R02AD03,cocaine,1879
C0009170,IN,cocaine,S01HA01,cocaine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01H,"Local anesthetics, ophthalmologic",S01HA,Local anesthetics,S01HA01,cocaine,1879
C0009170,IN,cocaine,S02DA02,cocaine,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02D,OTHER OTOLOGICALS in ATC,S02DA,Analgesics and anesthetics,S02DA02,cocaine,1879
C0009214,IN,codeine,R05DA04,codeine,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DA,"Opium alkaloids and derivatives, cough suppressants",R05DA04,codeine,364
C0009262,IN,colchicine,M04AC01,colchicine,M,MUSCULO-SKELETAL SYSTEM DRUGS,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AC,Preparations with no effect on uric acid metabolism,M04AC01,colchicine,549
C0009279,IN,colestipol,C10AC02,colestipol,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AC,Bile acid sequestrants,C10AC02,colestipol,18
C0009316,IN,colistin,A07AA10,colistin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,"antibiotics, intestinal",A07AA10,colistin,320
C0009316,IN,colistin,J01XB01,colistin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XB,Polymyxins,J01XB01,colistin,320
C0009325,IN,collagen,B02BC07,collagen,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BC,Local hemostatics,B02BC07,collagen,2
C0009325,IN,collagen,G04BX11,collagen,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BX,Other urologicals in ATC,G04BX11,collagen,2
C0010137,IN,cortisone,H02AB10,cortisone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,"Glucocorticoids, Systemic",H02AB10,cortisone,639
C0010137,IN,cortisone,S01BA03,cortisone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BA,"Corticosteroid ophthalmologic antiinflammatory agents, plain",S01BA03,cortisone,639
C0010192,IN,cosyntropin,H01AA02,tetracosactide,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AA,ACTH and synthetic analog preparations,H01AA02,tetracosactide,273
C0010303,IN,creosote,R05CA08,creosote,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CA,Expectorants,R05CA08,creosote,9
C0010525,IN,cyclandelate,C04AX01,cyclandelate,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AX,Other peripheral vasodilators in ATC,C04AX01,cyclandelate,1
C0010547,IN,cyclizine,R06AE03,cyclizine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AE,"Piperazine derivatives, systemic antihistamines",R06AE03,cyclizine,10
C0010560,IN,cyclofenil,G03GB01,cyclofenil,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03G,GONADOTROPINS AND OTHER OVULATION STIMULANTS,G03GB,"Ovulation stimulants, synthetic",G03GB01,cyclofenil,7
C0010581,IN,cyclopenthiazide,C03AA07,cyclopenthiazide,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03A,"LOW-CEILING DIURETICS, THIAZIDES",C03AA,"Thiazides, plain",C03AA07,cyclopenthiazide,1
C0010582,IN,cyclopentolate,S01FA04,cyclopentolate,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01F,MYDRIATICS AND CYCLOPLEGICS,S01FA,Anticholinergic mydriatics and cycloplegics,S01FA04,cyclopentolate,203
C0010583,IN,cyclophosphamide,L01AA01,cyclophosphamide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AA,Nitrogen mustard analogues,L01AA01,cyclophosphamide,7114
C0010590,IN,cycloserine,J04AB01,cycloserine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AB,"Antibiotics, Antitubercular",J04AB01,cycloserine,63
C0010592,IN,cyclosporine,L04AD01,ciclosporin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AD,Calcineurin inhibitors,L04AD01,ciclosporin,5017
C0010592,IN,cyclosporine,S01XA18,ciclosporin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA18,ciclosporin,5017
C0010620,IN,cyproheptadine,R06AX02,cyproheptadine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX02,cyproheptadine,143
C0010648,IN,cysteamine,A16AA04,mercaptamine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AA,Amino acids and derivatives,A16AA04,mercaptamine,149
C0010648,IN,cysteamine,S01XA21,mercaptamine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA21,mercaptamine,149
C0010711,IN,cytarabine,L01BC01,cytarabine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BC,"Pyrimidine analogues, antineoplastic antimetabolites",L01BC01,cytarabine,2163
C0010725,IN,citicoline,N06BX06,citicoline,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BX,Other psychostimulants and nootropics in ATC,N06BX06,citicoline,35
C0010927,IN,dacarbazine,L01AX04,dacarbazine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AX,Other alkylating agents in ATC,L01AX04,dacarbazine,520
C0010934,IN,dactinomycin,L01DA01,dactinomycin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01D,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,L01DA,Actinomycines,L01DA01,dactinomycin,1271
C0010961,IN,danazol,G03XA01,danazol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03X,OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC,G03XA,Antigonadotropins and similar agents,G03XA01,danazol,167
C0010976,IN,dantrolene,M03CA01,dantrolene,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03C,"MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS",M03CA,"Dantrolene and derivatives, muscle relaxants, direct acting",M03CA01,dantrolene,167
C0010980,IN,dapsone,D10AX05,dapsone,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AX,Other anti-acne preparations for topical use in ATC,D10AX05,dapsone,567
C0010980,IN,dapsone,J04BA02,dapsone,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04B,DRUGS FOR TREATMENT OF LEPRA,J04BA,Drugs for treatment of lepra,J04BA02,dapsone,567
C0011015,IN,daunorubicin,L01DB02,daunorubicin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01D,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,L01DB,Anthracyclines and related substances,L01DB02,daunorubicin,1050
C0011064,IN,deanol,N06BX04,deanol,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BX,Other psychostimulants and nootropics in ATC,N06BX04,deanol,8
C0011082,IN,debrisoquin,C02CC04,debrisoquine,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02C,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",C02CC,"Guanine derivatives, peripherally acting antiadrenergic agents",C02CC04,debrisoquine,18
C0011134,IN,diethyltoluamide,P03BX01,diethyltoluamide,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03B,INSECTICIDES AND REPELLENTS,P03BX,Other insecticides and repellents in ATC,P03BX01,diethyltoluamide,17
C0011145,IN,deferoxamine,V03AC01,deferoxamine,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AC,Iron chelating agents,V03AC01,deferoxamine,696
C0011185,IN,prasterone,A14AA07,prasterone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,A14AA07,prasterone,1243
C0011185,IN,prasterone,G03XX01,prasterone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03X,OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC,G03XX,Other sex hormones and modulators of the genital system in ATC,G03XX01,prasterone,1243
C0011259,,,L01CC01,demecolcine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01C,"PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, ANTINEOPLASTIC DRUGS",L01CC,"Colchicine derivatives, antineooplastic",L01CC01,demecolcine,1
C0011276,IN,demeclocycline,D06AA01,demeclocycline,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AA,"Tetracycline and derivatives, topical antibiotics",D06AA01,demeclocycline,12
C0011276,IN,demeclocycline,J01AA01,demeclocycline,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,Tetracycline antibiotics,J01AA,Tetracyclines,J01AA01,demeclocycline,12
C0011279,IN,nordazepam,N05BA16,nordazepam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA16,nordazepam,42
C0011479,PIN,deoxycholic acid,D11AX24,deoxycholic acid,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AX,OTHER DERMATOLOGICAL PREPARATIONS IN ATC,D11AX24,deoxycholic acid,96
C0011522,IN,deoxyribonucleases,B06AA10,desoxyribonuclease,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B06,OTHER HEMATOLOGICAL AGENTS in ATC,B06A,OTHER HEMATOLOGICAL AGENTS in ATC,B06AA,"Enzymes, hematological",B06AA10,desoxyribonuclease,4
C0011588,IN,dequalinium,D08AH01,dequalinium,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AH,"Quinoline derivatives, antiseptics and disinfectants",D08AH01,dequalinium,8
C0011588,IN,dequalinium,G01AC05,dequalinium,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AC,Quinoline gynecological antiinfectives,G01AC05,dequalinium,8
C0011588,IN,dequalinium,R02AA02,dequalinium,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AA,Antiseptic throat preparations,R02AA02,dequalinium,8
C0011602,,,B01AX04,dermatan sulfate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AX,Other antithrombotic agents in ATC,B01AX04,dermatan sulfate,188
C0011685,IN,desipramine,N06AA01,desipramine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AA,Non-selective monoamine reuptake inhibitors,N06AA01,desipramine,125
C0011689,IN,deslanoside,C01AA07,deslanoside,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01A,CARDIAC GLYCOSIDES,C01AA,Digitalis glycosides,C01AA07,deslanoside,1
C0011701,IN,desmopressin,H01BA02,desmopressin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BA,Vasopressin and analogues,H01BA02,desmopressin,823
C0011705,IN,desonide,D07AB08,desonide,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AB,"Corticosteroids, moderately potent (group II)",D07AB08,desonide,25
C0011705,IN,desonide,S01BA11,desonide,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BA,"Corticosteroid ophthalmologic antiinflammatory agents, plain",S01BA11,desonide,25
C0011707,IN,desoximetasone,D07AC03,desoximetasone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC03,desoximetasone,9
C0011707,IN,desoximetasone,D07XC02,desoximetasone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07X,"CORTICOSTEROIDS, OTHER COMBINATIONS",D07XC,"Corticosteroids, potent, other combinations",D07XC02,desoximetasone,9
C0011710,IN,desoxycorticosterone,H02AA03,desoxycortone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AA,"Mineralocorticoids for systemic use, plain",H02AA03,desoxycortone,171
C0011777,IN,dexamethasone,A01AC02,dexamethasone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AC,Corticosteroids for local oral treatment,A01AC02,dexamethasone,4322
C0011777,IN,dexamethasone,C05AA09,dexamethasone,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AA,"Corticosteroids, topical for treatment of hemorrhoids and anal fissures",C05AA09,dexamethasone,4322
C0011777,IN,dexamethasone,D07AB19,dexamethasone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AB,"Corticosteroids, moderately potent (group II)",D07AB19,dexamethasone,4322
C0011777,IN,dexamethasone,D07XB05,dexamethasone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07X,"CORTICOSTEROIDS, OTHER COMBINATIONS",D07XB,"Corticosteroids, moderately potent, other combinations",D07XB05,dexamethasone,4322
C0011777,IN,dexamethasone,D10AA03,dexamethasone,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AA,"Corticosteroids, combinations for treatment of acne",D10AA03,dexamethasone,4322
C0011777,IN,dexamethasone,H02AB02,dexamethasone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,"Glucocorticoids, Systemic",H02AB02,dexamethasone,4322
C0011777,IN,dexamethasone,R01AD03,dexamethasone,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AD,Corticosteroid nasal preparations for topical use,R01AD03,dexamethasone,4322
C0011777,IN,dexamethasone,S01BA01,dexamethasone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BA,"Corticosteroid ophthalmologic antiinflammatory agents, plain",S01BA01,dexamethasone,4322
C0011777,IN,dexamethasone,S01CB01,dexamethasone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01C,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION,S01CB,Corticosteroids/antiinfectives/mydriatics in combination,S01CB01,dexamethasone,4322
C0011777,IN,dexamethasone,S02BA06,dexamethasone,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02B,Corticosteroid otologicals,S02BA,Corticosteroids,S02BA06,dexamethasone,4322
C0011777,IN,dexamethasone,S03BA01,dexamethasone,S,SENSORY ORGAN DRUGS,S03,OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,S03B,Corticosteroid ophthalmologic and otologic preparations,S03BA,Corticosteroids,S03BA01,dexamethasone,4322
C0011786,IN,dexfenfluramine,A08AA04,dexfenfluramine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,A08AA04,dexfenfluramine,109
C0011812,IN,dextroamphetamine,N06BA02,dexamfetamine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BA,Centrally acting sympathomimetics,N06BA02,dexamfetamine,1166
C0011816,IN,dextromethorphan,R05DA09,dextromethorphan,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DA,"Opium alkaloids and derivatives, cough suppressants",R05DA09,dextromethorphan,157
C0011817,IN,dextromoramide,N02AC01,dextromoramide,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AC,Diphenylpropylamine derivative analgesics,N02AC01,dextromoramide,9
C0011824,IN,dextrothyroxine,C10AX01,dextrothyroxine,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AX,Other lipid modifying agents in ATC,C10AX01,dextrothyroxine,14
C0011892,IN,heroin,N07BC06,diamorphine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07B,DRUGS USED IN ADDICTIVE DISORDERS,N07BC,Drugs used in opioid dependence,N07BC06,diamorphine,791
C0012010,IN,diazepam,N05BA01,diazepam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA01,diazepam,1180
C0012022,IN,diazoxide,C02DA01,diazoxide,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02D,"ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",C02DA,Thiazide derivatives acting on arteriolar smooth muscle,C02DA01,diazoxide,399
C0012022,IN,diazoxide,V03AH01,diazoxide,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AH,Drugs for treatment of hypoglycemia,V03AH01,diazoxide,399
C0012024,IN,dibekacin,J01GB09,dibekacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides in ATC,J01GB09,dibekacin,25
C0012024,IN,dibekacin,S01AA29,dibekacin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA29,dibekacin,25
C0012050,IN,dibucaine,C05AD04,cinchocaine,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AD,Local anesthetics for treatment of hemorrhoids and anal fissures for topical use,C05AD04,cinchocaine,48
C0012050,IN,dibucaine,D04AB02,cinchocaine,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AB,Anesthetics for topical use,D04AB02,cinchocaine,48
C0012050,IN,dibucaine,N01BB06,cinchocaine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BB,Amide local anesthetics,N01BB06,cinchocaine,48
C0012050,IN,dibucaine,S01HA06,cinchocaine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01H,"Local anesthetics, ophthalmologic",S01HA,Local anesthetics,S01HA06,cinchocaine,48
C0012050,IN,dibucaine,S02DA04,cinchocaine,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02D,OTHER OTOLOGICALS in ATC,S02DA,Analgesics and anesthetics,S02DA04,cinchocaine,48
C0012052,IN,dibutyl phthalate,P03BX03,dibutylphthalate,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03B,INSECTICIDES AND REPELLENTS,P03BX,Other insecticides and repellents in ATC,P03BX03,dibutylphthalate,147
C0012054,,,C01CE04,bucladesine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CE,"Phosphodiesterase inhibitors, cardiac stimulant",C01CE04,bucladesine,13
C0012081,IN,clodronic acid,M05BA02,clodronic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonate drugs affecting bone structure and mineralization,M05BA02,clodronic acid,14
C0012082,IN,dichlorophen,P02DX02,dichlorophen,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02D,ANTICESTODALS,P02DX,Other anticestodals in ATC,P02DX02,dichlorophen,4
C0012086,IN,dichlorphenamide,S01EC02,diclofenamide,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EC,"Carbonic anhydrase inhibitors, antiglaucoma drugs and miotics",S01EC02,diclofenamide,5
C0012091,IN,diclofenac,D11AX18,diclofenac,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AX,OTHER DERMATOLOGICAL PREPARATIONS IN ATC,D11AX18,diclofenac,301
C0012091,IN,diclofenac,M01AB05,diclofenac,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,M01AB05,diclofenac,301
C0012091,IN,diclofenac,M02AA15,diclofenac,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA15,diclofenac,301
C0012091,IN,diclofenac,S01BC03,diclofenac,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BC,"Antiinflammatory agents, non-steroidal, ophthalmologic",S01BC03,diclofenac,301
C0012093,IN,dicloxacillin,J01CF01,dicloxacillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CF,Beta-lactamase resistant penicillins,J01CF01,dicloxacillin,54
C0012125,IN,dicyclomine,A03AA07,dicycloverine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AA,"Synthetic anticholinergics, esters with tertiary amino group for functional gastrointestinal disorders",A03AA07,dicycloverine,56
C0012132,IN,zalcitabine,J05AF03,zalcitabine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,J05AF03,zalcitabine,25
C0012133,IN,didanosine,J05AF02,didanosine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,J05AF02,didanosine,191
C0012145,IN,dienestrol,G03CB01,dienestrol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03C,"ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",G03CB,"Synthetic estrogens, plain",G03CB01,dienestrol,6
C0012145,IN,dienestrol,G03CC02,dienestrol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03C,"ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",G03CC,"Estrogens, combinations with other drugs",G03CC02,dienestrol,6
C0012191,IN,diethylcarbamazine,P02CB02,diethylcarbamazine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02C,ANTINEMATODAL AGENTS,P02CB,"Piperazine and derivatives, antinematodal agents",P02CB02,diethylcarbamazine,260
C0012201,IN,diethylpropion,A08AA03,amfepramone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,A08AA03,amfepramone,6
C0012203,IN,diethylstilbestrol,G03CB02,diethylstilbestrol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03C,"ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",G03CB,"Synthetic estrogens, plain",G03CB02,diethylstilbestrol,404
C0012203,IN,diethylstilbestrol,G03CC05,diethylstilbestrol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03C,"ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",G03CC,"Estrogens, combinations with other drugs",G03CC05,diethylstilbestrol,404
C0012203,IN,diethylstilbestrol,L02AA01,diethylstilbestrol,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02A,HORMONES AND RELATED AGENTS,L02AA,"Estrogens, endocrine therapy drugs",L02AA01,diethylstilbestrol,404
C0012227,IN,diflucortolone,D07AC06,diflucortolone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC06,diflucortolone,22
C0012227,IN,diflucortolone,D07XC04,diflucortolone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07X,"CORTICOSTEROIDS, OTHER COMBINATIONS",D07XC,"Corticosteroids, potent, other combinations",D07XC04,diflucortolone,22
C0012228,IN,diflunisal,N02BA11,diflunisal,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BA,"Salicylic acid and derivatives, analgesics and antipyretics",N02BA11,diflunisal,5
C0012258,IN,digitoxin,C01AA04,digitoxin,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01A,CARDIAC GLYCOSIDES,C01AA,Digitalis glycosides,C01AA04,digitoxin,30
C0012265,IN,digoxin,C01AA05,digoxin,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01A,CARDIAC GLYCOSIDES,C01AA,Digitalis glycosides,C01AA05,digoxin,911
C0012271,IN,dihydralazine,C02DB01,dihydralazine,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02D,"ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",C02DB,Hydrazinophthalazine derivatives acting on arteriolar smooth muscle,C02DB01,dihydralazine,45
C0012289,IN,dihydroergocristine,C04AE04,dihydroergocristine,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AE,Ergot alkaloid peripheral vasodilators,C04AE04,dihydroergocristine,1
C0012291,IN,dihydroergotamine,N02CA01,dihydroergotamine,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CA,"Ergot alkaloids, antimigraine",N02CA01,dihydroergotamine,38
C0012306,IN,hydromorphone,N02AA03,hydromorphone,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AA,Natural opium alkaloid analgesics,N02AA03,hydromorphone,137
C0012319,IN,dihydrotachysterol,A11CC02,dihydrotachysterol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CC,Vitamin D and analogues,A11CC02,dihydrotachysterol,34
C0012341,IN,iodoquinol,G01AC01,diiodohydroxyquinoline,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AC,Quinoline gynecological antiinfectives,G01AC01,diiodohydroxyquinoline,15
C0012367,,,C01DX10,dilazep,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01D,VASODILATORS USED IN CARDIAC DISEASES,C01DX,Other vasodilators used in cardiac diseases in ATC,C01DX10,dilazep,7
C0012373,IN,diltiazem,C05AE03,diltiazem,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AE,Muscle relaxants FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AE03,diltiazem,79
C0012373,IN,diltiazem,C08DB01,diltiazem,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08D,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,C08DB,Benzothiazepine derivative selective calcium channel blockers with direct cardiac effects,C08DB01,diltiazem,79
C0012381,IN,dimenhydrinate,R06AA11,dimenhydrinate,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AA,"Aminoalkyl ethers, systemic antihistamines",R06AA11,dimenhydrinate,42
C0012383,IN,dimercaprol,V03AB09,dimercaprol,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB09,dimercaprol,60
C0012390,IN,dimethindene,D04AA13,dimetindene,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AA,Antihistamines for topical use,D04AA13,dimetindene,5
C0012390,IN,dimethindene,R06AB03,dimetindene,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AB,"Substituted alkylamines, systemic antihistamines",R06AB03,dimetindene,5
C0012403,IN,dimethyl sulfoxide,G04BX13,dimethyl sulfoxide,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BX,Other urologicals in ATC,G04BX13,dimethyl sulfoxide,128
C0012403,IN,dimethyl sulfoxide,M02AX03,dimethyl sulfoxide,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AX,Other topical products for joint and muscular pain in ATC,M02AX03,dimethyl sulfoxide,128
C0012471,IN,dinoprost,G02AD01,dinoprost,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02A,UTEROTONICS,G02AD,"Prostaglandins, oxytocics",G02AD01,dinoprost,490
C0012472,IN,dinoprostone,G02AD02,dinoprostone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02A,UTEROTONICS,G02AD,"Prostaglandins, oxytocics",G02AD02,dinoprostone,1551
C0012498,IN,diosmin,C05CA03,diosmin,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05C,CAPILLARY STABILIZING AGENTS,C05CA,Bioflavonoid drugs for capillary stabilizing,C05CA03,diosmin,12
C0012522,IN,diphenhydramine,D04AA32,diphenhydramine,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AA,Antihistamines for topical use,D04AA32,diphenhydramine,291
C0012522,IN,diphenhydramine,R06AA02,diphenhydramine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AA,"Aminoalkyl ethers, systemic antihistamines",R06AA02,diphenhydramine,291
C0012525,IN,diphenoxylate,A07DA01,diphenoxylate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07D,ANTIPROPULSIVES,A07DA,Antipropulsives,A07DA01,diphenoxylate,28
C0012551,IN,"diphtheria toxoid vaccine, inactivated",J07AF,Diphtheria vaccines,J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AF,Diphtheria vaccines,,,959
C0012551,IN,"diphtheria toxoid vaccine, inactivated",J07AF01,diphtheria toxoid,J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AF,Diphtheria vaccines,J07AF01,diphtheria toxoid,959
C0012582,IN,dipyridamole,B01AC07,dipyridamole,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC07,dipyridamole,288
C0012702,IN,disopyramide,C01BA03,disopyramide,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BA,"Antiarrhythmics, class Ia",C01BA03,disopyramide,52
C0012757,IN,distigmine,N07AA03,distigmine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07A,PARASYMPATHOMIMETICS,N07AA,Anticholinesterase parasympathomimetics,N07AA03,distigmine,1
C0012772,IN,disulfiram,N07BB01,disulfiram,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07B,DRUGS USED IN ADDICTIVE DISORDERS,N07BB,Drugs used in alcohol dependence,N07BB01,disulfiram,20
C0012772,IN,disulfiram,P03AA04,disulfiram,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03A,"ECTOPARASITICIDES, INCL. SCABICIDES",P03AA,Sulfur containing product ectoparasiticides,P03AA04,disulfiram,20
C0012963,IN,dobutamine,C01CA07,dobutamine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA07,dobutamine,383
C0013015,IN,domperidone,A03FA03,domperidone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,A03FA03,domperidone,140
C0013030,IN,dopamine,C01CA04,dopamine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA04,dopamine,2253
C0013065,IN,dothiepin,N06AA16,dosulepin,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AA,Non-selective monoamine reuptake inhibitors,N06AA16,dosulepin,18
C0013084,IN,doxapram,R07AB01,doxapram,R,RESPIRATORY SYSTEM DRUGS,R07,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07A,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07AB,Respiratory stimulants,R07AB01,doxapram,69
C0013085,IN,doxepin,D04AX01,doxepin,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AX,Other antipruritics in ATC,D04AX01,doxepin,27
C0013085,IN,doxepin,N06AA12,doxepin,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AA,Non-selective monoamine reuptake inhibitors,N06AA12,doxepin,27
C0013089,IN,doxorubicin,L01DB01,doxorubicin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01D,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,L01DB,Anthracyclines and related substances,L01DB01,doxorubicin,3181
C0013090,IN,doxycycline,A01AB22,doxycycline,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB22,doxycycline,755
C0013090,IN,doxycycline,J01AA02,doxycycline,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,Tetracycline antibiotics,J01AA,Tetracyclines,J01AA02,doxycycline,755
C0013092,IN,doxylamine,R06AA09,doxylamine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AA,"Aminoalkyl ethers, systemic antihistamines",R06AA09,doxylamine,61
C0013136,IN,droperidol,N05AD08,droperidol,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AD,"Butyrophenone derivatives, antipsychotics",N05AD08,droperidol,201
C0013340,IN,dydrogesterone,G03DB01,dydrogesterone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03D,PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03DB,"Pregnadien derivatives, progestogens",G03DB01,dydrogesterone,76
C0013360,IN,dyphylline,R03DA01,diprophylline,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DA,"Xanthines, systemic for obstructive airway disease",R03DA01,diprophylline,2
C0013547,IN,econazole,D01AC03,econazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC03,econazole,25
C0013547,IN,econazole,G01AF05,econazole,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AF,"Imidazole derivatives, gyncological antiinfectives",G01AF05,econazole,25
C0013615,IN,edrophonium,V04CX07,edrophonium,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CX,Other diagnostic agents in ATC,V04CX07,edrophonium,53
C0013954,IN,emepronium,G04BD01,emepronium,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BD,Drugs for urinary frequency and incontinence,G04BD01,emepronium,6
C0013974,IN,emetine,P01AX02,emetine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AX,Other agents against amoebiasis and other protozoal diseases in ATC,P01AX02,emetine,19
C0014025,IN,enalapril,C09AA02,enalapril,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09A,"ACE INHIBITORS, PLAIN",C09AA,"ACE inhibitors, plain",C09AA02,enalapril,262
C0014277,IN,enflurane,N01AB04,enflurane,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AB,"Halogenated hydrocarbons, general anesthetics",N01AB04,enflurane,188
C0014310,IN,enoxacin,J01MA04,enoxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA04,enoxacin,9
C0014448,IN,eosine yellowish,D08AX02,eosin,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AX,Other antiseptics and disinfectants in ATC,D08AX02,eosin,630
C0014479,IN,ephedrine,C01CA26,ephedrine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA26,ephedrine,476
C0014479,IN,ephedrine,R01AA03,ephedrine,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AA,"Sympathomimetics, plain",R01AA03,ephedrine,476
C0014479,IN,ephedrine,R01AB05,ephedrine,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AB,"Sympathomimetics, combinations excl. corticosteroids",R01AB05,ephedrine,476
C0014479,IN,ephedrine,R03CA02,ephedrine,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CA,"Alpha- and beta-adrenoreceptor agonist, systemic drugs",R03CA02,ephedrine,476
C0014479,IN,ephedrine,S01FB02,ephedrine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01F,MYDRIATICS AND CYCLOPLEGICS,S01FB,Sympathomimetics excl. antiglaucoma preparations,S01FB02,ephedrine,476
C0014561,,,G03GB03,epimestrol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03G,GONADOTROPINS AND OTHER OVULATION STIMULANTS,G03GB,"Ovulation stimulants, synthetic",G03GB03,epimestrol,7
C0014563,IN,epinephrine,A01AD01,epinephrine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AD,Other agents for local oral treatment in ATC,A01AD01,epinephrine,3105
C0014563,IN,epinephrine,B02BC09,epinephrine,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BC,Local hemostatics,B02BC09,epinephrine,3105
C0014563,IN,epinephrine,C01CA24,epinephrine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA24,epinephrine,3105
C0014563,IN,epinephrine,R01AA14,epinephrine,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AA,"Sympathomimetics, plain",R01AA14,epinephrine,3105
C0014563,IN,epinephrine,R03AA01,epinephrine,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AA,Alpha- and beta-adrenoreceptor agonist inhalants,R03AA01,epinephrine,3105
C0014563,IN,epinephrine,S01EA01,epinephrine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EA,Sympathomimetics in glaucoma therapy,S01EA01,epinephrine,3105
C0014582,IN,epirubicin,L01DB03,epirubicin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01D,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,L01DB,Anthracyclines and related substances,L01DB03,epirubicin,198
C0014695,IN,ergocalciferol,A11CC01,ergocalciferol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CC,Vitamin D and analogues,A11CC01,ergocalciferol,183
C0014704,IN,ergonovine,G02AB03,ergometrine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02A,UTEROTONICS,G02AB,Ergot alkaloid oxytocics,G02AB03,ergometrine,58
C0014708,IN,"ergoloid mesylates, USP",C04AE01,ergoloid mesylates,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AE,Ergot alkaloid peripheral vasodilators,C04AE01,ergoloid mesylates,1
C0014710,IN,ergotamine,N02CA02,ergotamine,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CA,"Ergot alkaloids, antimigraine",N02CA02,ergotamine,43
C0014806,IN,erythromycin,D10AF02,erythromycin,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AF,Antiinfectives for treatment of acne,D10AF02,erythromycin,1980
C0014806,IN,erythromycin,J01FA01,erythromycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,J01FA01,erythromycin,1980
C0014806,IN,erythromycin,S01AA17,erythromycin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA17,erythromycin,1980
C0014892,IN,estazolam,N05CD04,estazolam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CD,Benzodiazepine derivative hypnotics and sedatives,N05CD04,estazolam,1
C0014912,IN,estradiol,G03CA03,estradiol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03C,"ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",G03CA,"Natural and semisynthetic estrogens, plain",G03CA03,estradiol,4428
C0014927,IN,estriol,G03CA04,estriol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03C,"ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",G03CA,"Natural and semisynthetic estrogens, plain",G03CA04,estriol,1089
C0014927,IN,estriol,G03CC06,estriol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03C,"ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",G03CC,"Estrogens, combinations with other drugs",G03CC06,estriol,1089
C0014938,IN,"estrogens, conjugated (USP)",G03CA57,conjugated estrogens,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03C,"ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",G03CA,"Natural and semisynthetic estrogens, plain",G03CA57,conjugated estrogens,43
C0014942,IN,estrone,G03CA07,estrone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03C,"ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",G03CA,"Natural and semisynthetic estrogens, plain",G03CA07,estrone,486
C0014942,IN,estrone,G03CC04,estrone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03C,"ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",G03CC,"Estrogens, combinations with other drugs",G03CC04,estrone,486
C0014963,PIN,ethacrynic acid,C03CC01,etacrynic acid,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03C,HIGH-CEILING DIURETICS,C03CC,"Aryloxyacetic acid derivatives, high-ceiling diuretics",C03CC01,etacrynic acid,20
C0014964,IN,ethambutol,J04AK02,ethambutol,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AK,Other drugs for treatment of tuberculosis in ATC,J04AK02,ethambutol,447
C0014968,IN,ethamsylate,B02BX01,etamsylate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BX,Other systemic hemostatics in ATC,B02BX01,etamsylate,17
C0014987,IN,ethchlorvynol,N05CM08,ethchlorvynol,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CM,Other hypnotics and sedatives in ATC,N05CM08,ethchlorvynol,2
C0015011,IN,ethinyl estradiol,G03CA01,ethinylestradiol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03C,"ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",G03CA,"Natural and semisynthetic estrogens, plain",G03CA01,ethinylestradiol,1419
C0015011,IN,ethinyl estradiol,L02AA03,ethinylestradiol,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02A,HORMONES AND RELATED AGENTS,L02AA,"Estrogens, endocrine therapy drugs",L02AA03,ethinylestradiol,1419
C0015020,IN,amifostine,V03AF05,amifostine,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AF,Detoxifying agents for antineoplastic treatment,V03AF05,amifostine,41
C0015021,IN,ethionamide,J04AD03,ethionamide,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AD,Thiocarbamide derivatives for treatment of tuberculosis,J04AD03,ethionamide,63
C0015042,IN,profenamine,N04AA05,profenamine,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04A,ANTICHOLINERGIC AGENTS,N04AA,"Tertiary amines, anticholinergic",N04AA05,profenamine,5
C0015043,IN,ethosuximide,N03AD01,ethosuximide,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AD,"Succinimide derivatives, antiepileptics",N03AD01,ethosuximide,221
C0015046,IN,ethotoin,N03AB01,ethotoin,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AB,"Hydantoin derivatives, antiepileptics",N03AB01,ethotoin,3
C0015058,IN,ethyl chloride,N01BX01,ethyl chloride,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BX,Other local anesthetics in ATC,N01BX01,ethyl chloride,17
C0015099,IN,ethylestrenol,A14AB02,ethylestrenol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AB,"Estren derivatives, systemic",A14AB02,ethylestrenol,1
C0015109,IN,ethylmorphine,R05DA01,ethylmorphine,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DA,"Opium alkaloids and derivatives, cough suppressants",R05DA01,ethylmorphine,2
C0015109,IN,ethylmorphine,S01XA06,ethylmorphine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA06,ethylmorphine,2
C0015116,IN,etilefrine,C01CA01,etilefrine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA01,etilefrine,14
C0015120,IN,etidocaine,N01BB07,etidocaine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BB,Amide local anesthetics,N01BB07,etidocaine,24
C0015121,PIN,etidronic acid,M05BA01,etidronic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonate drugs affecting bone structure and mineralization,M05BA01,etidronic acid,69
C0015131,IN,etomidate,N01AX07,etomidate,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AX,Other general anesthetics in ATC,N01AX07,etomidate,144
C0015133,IN,etoposide,L01CB01,etoposide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01C,"PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, ANTINEOPLASTIC DRUGS",L01CB,"Podophyllotoxin derivatives, antineoplastic drugs",L01CB01,etoposide,3142
C0015137,IN,etretinate,D05BB01,etretinate,D,DERMATOLOGICALS,D05,ANTIPSORIATICS,D05B,ANTIPSORIATICS FOR SYSTEMIC USE,D05BB,Retinoids for treatment of psoriasis,D05BB01,etretinate,109
C0015505,IN,factor VIIa,B02BD08,coagulation factor VIIa,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BD,Blood coagulation factors,B02BD08,coagulation factor VIIa,317
C0015528,IN,factor XIII,B02BD07,coagulation factor XIII,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BD,Blood coagulation factors,B02BD07,coagulation factor XIII,229
C0015620,IN,famotidine,A02BA03,famotidine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BA,H2-receptor antagonists,A02BA03,famotidine,59
C0015707,,,M03AC08,fazadinium bromide,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,"Other quaternary ammonium compounds in ATC, muscle relaxants, peripherally acting",M03AC08,fazadinium bromide,1
C0015772,IN,felodipine,C08CA02,felodipine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,C08CA,Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects,C08CA02,felodipine,7
C0015821,IN,fenbendazole,P02CA06,fenbendazole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02C,ANTINEMATODAL AGENTS,P02CA,"Benzimidazole derivatives, antinematodal",P02CA06,fenbendazole,3
C0015827,IN,fenfluramine,A08AA02,fenfluramine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,A08AA02,fenfluramine,109
C0015827,IN,fenfluramine,N03AX26,fenfluramine,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX26,fenfluramine,109
C0015837,IN,fenoprofen,M01AE04,fenoprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,"Propionic acid derivatives, antiinflammatory and antirheumatic products",M01AE04,fenoprofen,4
C0015840,IN,fenoterol,G02CA03,fenoterol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02C,OTHER GYNECOLOGICALS in ATC,G02CA,"Sympathomimetics, labour repressants",G02CA03,fenoterol,337
C0015840,IN,fenoterol,R03AC04,fenoterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC04,fenoterol,337
C0015840,IN,fenoterol,R03CC04,fenoterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CC,"Selective beta-2-adrenoreceptor agonists, systemic",R03CC04,fenoterol,337
C0015843,IN,fenspiride,R03BX01,fenspiride,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03B,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS in ATC",R03BX,"Other drugs for obstructive airway diseases, inhalants in ATC",R03BX01,fenspiride,4
C0015843,IN,fenspiride,R03DX03,fenspiride,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DX,Other systemic drugs for obstructive airway diseases in ATC,R03DX03,fenspiride,4
C0015846,IN,fentanyl,N01AH01,fentanyl,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AH,Opioid anesthetics,N01AH01,fentanyl,2701
C0015846,IN,fentanyl,N02AB03,fentanyl,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AB,"Phenylpiperidine derivatives, opioid analgesics",N02AB03,fentanyl,2701
C0015888,IN,ferrous ascorbate,B03AA10,ferrous ascorbate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03A,IRON ANTIANEMIC PREPARATIONS,B03AA,"Iron bivalent, oral antianemic preparations",B03AA10,ferrous ascorbate,8
C0015980,IN,interferon-beta,L03AB02,interferon beta natural,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AB,Interferons,L03AB02,interferon beta natural,215
C0016016,IN,plasmin,B01AD05,fibrinolysin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AD,"Enzymes, antithrombotic",B01AD05,fibrinolysin,112
C0016225,IN,flavoxate,G04BD02,flavoxate,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BD,Drugs for urinary frequency and incontinence,G04BD02,flavoxate,6
C0016229,IN,flecainide,C01BC04,flecainide,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BC,"Antiarrhythmics, class Ic",C01BC04,flecainide,227
C0016245,IN,floctafenine,N02BG04,floctafenine,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BG,Other analgesics and antipyretics in ATC,N02BG04,floctafenine,3
C0016267,IN,floxacillin,J01CF05,flucloxacillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CF,Beta-lactamase resistant penicillins,J01CF05,flucloxacillin,184
C0016277,IN,fluconazole,D01AC15,fluconazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC15,fluconazole,954
C0016277,IN,fluconazole,J02AC01,fluconazole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AC,Triazole and tetrazole derivatives,J02AC01,fluconazole,954
C0016278,IN,flucytosine,D01AE21,flucytosine,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AE,Other antifungals for topical use in ATC,D01AE21,flucytosine,253
C0016278,IN,flucytosine,J02AX01,flucytosine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AX,Other antimycotics for systemic use in ATC,J02AX01,flucytosine,253
C0016280,IN,fludrocortisone,H02AA02,fludrocortisone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AA,"Mineralocorticoids for systemic use, plain",H02AA02,fludrocortisone,265
C0016282,IN,flufenamic acid,M01AG03,flufenamic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AG,"Fenamates, antiinflammatory and antirheumatic drugs",M01AG03,flufenamic acid,10
C0016293,IN,flumazenil,V03AB25,flumazenil,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB25,flumazenil,108
C0016294,IN,flumethasone,D07AB03,flumetasone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AB,"Corticosteroids, moderately potent (group II)",D07AB03,flumetasone,9
C0016294,IN,flumethasone,D07XB01,flumetasone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07X,"CORTICOSTEROIDS, OTHER COMBINATIONS",D07XB,"Corticosteroids, moderately potent, other combinations",D07XB01,flumetasone,9
C0016295,IN,flunarizine,N07CA03,flunarizine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07C,ANTIVERTIGO PREPARATIONS,N07CA,Antivertigo preparations,N07CA03,flunarizine,97
C0016296,IN,flunitrazepam,N05CD03,flunitrazepam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CD,Benzodiazepine derivative hypnotics and sedatives,N05CD03,flunitrazepam,69
C0016298,PIN,fluocinolone acetonide,C05AA10,fluocinolone acetonide,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AA,"Corticosteroids, topical for treatment of hemorrhoids and anal fissures",C05AA10,fluocinolone acetonide,104
C0016298,PIN,fluocinolone acetonide,D07AC04,fluocinolone acetonide,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC04,fluocinolone acetonide,104
C0016298,PIN,fluocinolone acetonide,S01BA15,fluocinolone acetonide,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BA,"Corticosteroid ophthalmologic antiinflammatory agents, plain",S01BA15,fluocinolone acetonide,104
C0016298,PIN,fluocinolone acetonide,S02BA08,fluocinolone acetonide,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02B,Corticosteroid otologicals,S02BA,Corticosteroids,S02BA08,fluocinolone acetonide,104
C0016299,IN,fluocinonide,C05AA11,fluocinonide,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AA,"Corticosteroids, topical for treatment of hemorrhoids and anal fissures",C05AA11,fluocinonide,21
C0016299,IN,fluocinonide,D07AC08,fluocinonide,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC08,fluocinonide,21
C0016301,IN,fluocortolone,C05AA08,fluocortolone,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AA,"Corticosteroids, topical for treatment of hemorrhoids and anal fissures",C05AA08,fluocortolone,43
C0016301,IN,fluocortolone,D07AC05,fluocortolone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC05,fluocortolone,43
C0016301,IN,fluocortolone,D07XC05,fluocortolone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07X,"CORTICOSTEROIDS, OTHER COMBINATIONS",D07XC,"Corticosteroids, potent, other combinations",D07XC05,fluocortolone,43
C0016301,IN,fluocortolone,H02AB03,fluocortolone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,"Glucocorticoids, Systemic",H02AB03,fluocortolone,43
C0016343,IN,floxuridine,L01BC09,floxuridine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BC,"Pyrimidine analogues, antineoplastic antimetabolites",L01BC09,floxuridine,23
C0016351,IN,fluorometholone,C05AA06,fluorometholone,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AA,"Corticosteroids, topical for treatment of hemorrhoids and anal fissures",C05AA06,fluorometholone,37
C0016351,IN,fluorometholone,D07AB06,fluorometholone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AB,"Corticosteroids, moderately potent (group II)",D07AB06,fluorometholone,37
C0016351,IN,fluorometholone,D07XB04,fluorometholone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07X,"CORTICOSTEROIDS, OTHER COMBINATIONS",D07XB,"Corticosteroids, moderately potent, other combinations",D07XB04,fluorometholone,37
C0016351,IN,fluorometholone,D10AA01,fluorometholone,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AA,"Corticosteroids, combinations for treatment of acne",D10AA01,fluorometholone,37
C0016351,IN,fluorometholone,S01BA07,fluorometholone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BA,"Corticosteroid ophthalmologic antiinflammatory agents, plain",S01BA07,fluorometholone,37
C0016351,IN,fluorometholone,S01CB05,fluorometholone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01C,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION,S01CB,Corticosteroids/antiinfectives/mydriatics in combination,S01CB05,fluorometholone,37
C0016360,IN,fluorouracil,L01BC02,fluorouracil,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BC,"Pyrimidine analogues, antineoplastic antimetabolites",L01BC02,fluorouracil,464
C0016365,IN,fluoxetine,N06AB03,fluoxetine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AB,Selective serotonin reuptake inhibitors,N06AB03,fluoxetine,588
C0016366,IN,fluoxymesterone,G03BA01,fluoxymesterone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03B,ANDROGENS,G03BA,3-oxoandrosten (4) derivatives,G03BA01,fluoxymesterone,30
C0016367,IN,flupenthixol,N05AF01,flupentixol,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AF,"Thioxanthene derivatives, antipsychotic",N05AF01,flupentixol,13
C0016368,IN,fluphenazine,N05AB02,fluphenazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AB,"Phenothiazines with piperazine structure, antipsychotics",N05AB02,fluphenazine,24
C0016374,IN,flurandrenolide,D07AC07,fludroxycortide,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC07,fludroxycortide,4
C0016375,IN,flurazepam,N05CD01,flurazepam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CD,Benzodiazepine derivative hypnotics and sedatives,N05CD01,flurazepam,5
C0016377,IN,flurbiprofen,M01AE09,flurbiprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,"Propionic acid derivatives, antiinflammatory and antirheumatic products",M01AE09,flurbiprofen,37
C0016377,IN,flurbiprofen,M02AA19,flurbiprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA19,flurbiprofen,37
C0016377,IN,flurbiprofen,R02AX01,flurbiprofen,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AX,Other throat preparations in ATC,R02AX01,flurbiprofen,37
C0016377,IN,flurbiprofen,S01BC04,flurbiprofen,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BC,"Antiinflammatory agents, non-steroidal, ophthalmologic",S01BC04,flurbiprofen,37
C0016383,IN,fluspirilene,N05AG01,fluspirilene,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AG,"Diphenylbutylpiperidine derivatives, antipsychotics",N05AG01,fluspirilene,3
C0016384,IN,flutamide,L02BB01,flutamide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02B,HORMONE ANTAGONISTS AND RELATED AGENTS,L02BB,Anti-androgen hormone antagonists and related agents,L02BB01,flutamide,59
C0016410,IN,folic acid,B03BB01,folic acid,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03B,VITAMIN B12 AND FOLIC ACID,B03BB,Folic acid and derivatives as antianemics,B03BB01,folic acid,5728
C0016410,IN,folic acid,V04CX02,folic acid,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CX,Other diagnostic agents in ATC,V04CX02,folic acid,5728
C0016610,IN,fosfomycin,J01XX01,fosfomycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XX,Other antibacterials in ATC,J01XX01,fosfomycin,194
C0016610,IN,fosfomycin,S02AA17,fosfomycin,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA17,fosfomycin,194
C0016673,IN,framycetin,D09AA01,framycetin,D,DERMATOLOGICALS,D09,MEDICATED DRESSINGS,D09A,MEDICATED DRESSINGS,D09AA,Medicated dressings with antiinfectives,D09AA01,framycetin,17
C0016673,IN,framycetin,R01AX08,framycetin,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AX,Other nasal preparations in ATC,R01AX08,framycetin,17
C0016673,IN,framycetin,S01AA07,framycetin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA07,framycetin,17
C0016745,IN,fructose,V06DC02,fructose,V,VARIOUS DRUG CLASSES IN ATC,V06,GENERAL NUTRIENTS,V06D,OTHER NUTRIENTS in ATC,V06DC,Carbohydrate nutrients,V06DC02,fructose,829
C0016778,IN,tegafur,L01BC03,tegafur,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BC,"Pyrimidine analogues, antineoplastic antimetabolites",L01BC03,tegafur,16
C0016855,IN,furazolidone,G01AX06,furazolidone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AX,Other gynecological antiinfectives and antiseptics in ATC,G01AX06,furazolidone,71
C0016860,IN,furosemide,C03CA01,furosemide,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03C,HIGH-CEILING DIURETICS,C03CA,"sulfonamides, high-ceiling diuretics, plain",C03CA01,furosemide,1023
C0016875,PIN,fusidic acid,D06AX01,fusidic acid,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AX,Other antibiotics for topical use in ATC,D06AX01,fusidic acid,147
C0016875,PIN,fusidic acid,D09AA02,fusidic acid,D,DERMATOLOGICALS,D09,MEDICATED DRESSINGS,D09A,MEDICATED DRESSINGS,D09AA,Medicated dressings with antiinfectives,D09AA02,fusidic acid,147
C0016875,PIN,fusidic acid,J01XC01,fusidic acid,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XC,Steroid antibacterials,J01XC01,fusidic acid,147
C0016875,PIN,fusidic acid,S01AA13,fusidic acid,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA13,fusidic acid,147
C0016945,IN,galactose,V04CE01,galactose,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CE,liver functional capacity test diagnostic agents,V04CE01,galactose,723
C0016967,IN,galantamine,N06DA04,galantamine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06D,ANTI-DEMENTIA DRUGS,N06DA,Anticholinesterase anti-dementia drugs,N06DA04,galantamine,10
C0016971,IN,gallamine,M03AC02,gallamine,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,"Other quaternary ammonium compounds in ATC, muscle relaxants, peripherally acting",M03AC02,gallamine,12
C0016986,IN,gallopamil,C08DA02,gallopamil,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08D,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,C08DA,"Phenylalkylamine derivatives, selective calcium channel blockers with direct cardiac effects",C08DA02,gallopamil,3
C0017066,IN,ganciclovir,J05AB06,ganciclovir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,J05AB06,ganciclovir,788
C0017066,IN,ganciclovir,S01AD09,ganciclovir,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AD,"Antivirals, ophthalmologic",S01AD09,ganciclovir,788
C0017226,,,A02BX07,gefarnate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC,A02BX07,gefarnate,1
C0017245,IN,gemfibrozil,C10AB04,gemfibrozil,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AB,"Fibrates, lipid modifying drugs, plain",C10AB04,gemfibrozil,21
C0017507,IN,gestrinone,G03XA02,gestrinone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03X,OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC,G03XA,Antigonadotropins and similar agents,G03XA02,gestrinone,6
C0017592,,,N02BG03,glafenine,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BG,Other analgesics and antipyretics in ATC,N02BG03,glafenine,4
C0017628,IN,glyburide,A10BB01,glibenclamide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas for blood glucose lowering,A10BB01,glibenclamide,199
C0017631,IN,gliclazide,A10BB09,gliclazide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas for blood glucose lowering,A10BB09,gliclazide,15
C0017642,IN,glipizide,A10BB07,glipizide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas for blood glucose lowering,A10BB07,glipizide,19
C0017687,IN,glucagon,H04AA01,glucagon,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H04,PANCREATIC HORMONES,H04A,GLYCOGENOLYTIC HORMONES,H04AA,Glycogenolytic hormones,H04AA01,glucagon,1150
C0017718,IN,glucosamine,M01AX05,glucosamine,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids in ATC",M01AX05,glucosamine,84
C0017725,IN,glucose,B05CX01,glucose,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05C,"IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION",B05CX,Other irrigating solutions in ATC,B05CX01,glucose,19300
C0017725,IN,glucose,V04CA02,glucose,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CA,Diagnostic agents for diabetes testing,V04CA02,glucose,19300
C0017725,IN,glucose,V06DC01,glucose,V,VARIOUS DRUG CLASSES IN ATC,V06,GENERAL NUTRIENTS,V06D,OTHER NUTRIENTS in ATC,V06DC,Carbohydrate nutrients,V06DC01,glucose,19300
C0017797,IN,glutamine,A16AA03,glutamine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AA,Amino acids and derivatives,A16AA03,glutamine,1026
C0017817,IN,glutathione,V03AB32,glutathione,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB32,glutathione,1303
C0017845,IN,glutethimide,N05CE01,glutethimide,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CE,"Piperidinedione derivatives, hypnotics and sedatives",N05CE01,glutethimide,8
C0017861,IN,glycerin,A06AG04,glycerol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AG,Enema for Constipation,A06AG04,glycerol,596
C0017861,IN,glycerin,A06AX01,glycerol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AX,Other drugs for constipation in ATC,A06AX01,glycerol,596
C0017887,IN,nitroglycerin,C01DA02,glyceryl trinitrate,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01D,VASODILATORS USED IN CARDIAC DISEASES,C01DA,Organic nitrates used in cardiac disease,C01DA02,glyceryl trinitrate,368
C0017887,IN,nitroglycerin,C05AE01,glyceryl trinitrate,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AE,Muscle relaxants FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AE01,glyceryl trinitrate,368
C0017889,PIN,glycerylphosphorylcholine,N07AX02,choline alfoscerate,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07A,PARASYMPATHOMIMETICS,N07AX,Other parasympathomimetics in ATC,N07AX02,choline alfoscerate,75
C0017890,IN,glycine,B05CX03,glycine,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05C,"IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION",B05CX,Other irrigating solutions in ATC,B05CX03,glycine,1368
C0018033,IN,aurothioglucose,M01CB04,aurothioglucose,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01C,SPECIFIC ANTIRHEUMATIC AGENTS,M01CB,Gold preparations,M01CB04,aurothioglucose,16
C0018034,PIN,gold sodium thiomalate,M01CB01,sodium aurothiomalate,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01C,SPECIFIC ANTIRHEUMATIC AGENTS,M01CB,Gold preparations,M01CB01,sodium aurothiomalate,29
C0018165,IN,gramicidin,R02AB30,gramicidin,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AB,Antibiotic throat preparations,R02AB30,gramicidin,23
C0018242,IN,griseofulvin,D01AA08,griseofulvin,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AA,"Antifungal Antibiotics, Topical",D01AA08,griseofulvin,182
C0018242,IN,griseofulvin,D01BA01,griseofulvin,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01B,ANTIFUNGALS FOR SYSTEMIC USE,D01BA,Antifungals for systemic use,D01BA01,griseofulvin,182
C0018305,IN,guaifenesin,R05CA03,guaifenesin,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CA,Expectorants,R05CA03,guaifenesin,19
C0018318,IN,guanethidine,C02CC02,guanethidine,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02C,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",C02CC,"Guanine derivatives, peripherally acting antiadrenergic agents",C02CC02,guanethidine,12
C0018318,IN,guanethidine,S01EX01,guanethidine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EX,Other antiglaucoma preparations in ATC,S01EX01,guanethidine,12
C0018513,IN,halcinonide,D07AD02,halcinonide,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AD,"Corticosteroids, very potent (group IV)",D07AD02,halcinonide,15
C0018546,IN,haloperidol,N05AD01,haloperidol,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AD,"Butyrophenone derivatives, antipsychotics",N05AD01,haloperidol,437
C0018549,IN,halothane,N01AB01,halothane,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AB,"Halogenated hydrocarbons, general anesthetics",N01AB01,halothane,1209
C0018880,IN,helium,V03AN03,helium,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AN,Medical gases,V03AN03,helium,170
C0018988,IN,hemin,B06AB01,hemin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B06,OTHER HEMATOLOGICAL AGENTS in ATC,B06A,OTHER HEMATOLOGICAL AGENTS in ATC,B06AB,Heme products,B06AB01,hemin,29
C0019134,IN,heparin,B01AB01,heparin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AB,Heparin group antithrombotic drugs,B01AB01,heparin,2863
C0019134,IN,heparin,C05BA03,heparin,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05B,ANTIVARICOSE THERAPY DRUGS,C05BA,Heparins or heparinoids for topical use,C05BA03,heparin,2863
C0019134,IN,heparin,S01XA14,heparin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA14,heparin,2863
C0019217,,,N05CA11,heptabarbital,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CA,"Barbiturates, hypnotics and sedatives, plain",N05CA11,heptabarbital,1
C0019223,IN,heptaminol,C01DX08,heptaminol,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01D,VASODILATORS USED IN CARDIAC DISEASES,C01DX,Other vasodilators used in cardiac diseases in ATC,C01DX08,heptaminol,1
C0019435,IN,hexachlorophene,D08AE01,hexachlorophene,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AE,"Phenol and derivatives, antiseptics and disinfectants",D08AE01,hexachlorophene,41
C0019453,IN,altretamine,L01XX03,altretamine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX03,altretamine,2
C0019468,IN,hexetidine,A01AB12,hexetidine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB12,hexetidine,4
C0019468,IN,hexetidine,G01AX16,hexetidine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AX,Other gynecological antiinfectives and antiseptics in ATC,G01AX16,hexetidine,4
C0019469,IN,hexobarbital,N01AF02,hexobarbital,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AF,"Barbiturates for general anesthesia, plain",N01AF02,hexobarbital,11
C0019469,IN,hexobarbital,N05CA16,hexobarbital,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CA,"Barbiturates, hypnotics and sedatives, plain",N05CA16,hexobarbital,11
C0019471,IN,hexobendine,C01DX06,hexobendine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01D,VASODILATORS USED IN CARDIAC DISEASES,C01DX,Other vasodilators used in cardiac diseases in ATC,C01DX06,hexobendine,1
C0019476,IN,hexoprenaline,R03AC06,hexoprenaline,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC06,hexoprenaline,55
C0019476,IN,hexoprenaline,R03CC05,hexoprenaline,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CC,"Selective beta-2-adrenoreceptor agonists, systemic",R03CC05,hexoprenaline,55
C0019497,IN,hexylresorcinol,R02AA12,hexylresorcinol,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AA,Antiseptic throat preparations,R02AA12,hexylresorcinol,1
C0020196,PIN,hyaluronic acid,D03AX05,hyaluronic acid,D,DERMATOLOGICALS,D03,PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS,D03A,CICATRIZANTS,D03AX,Other cicatrizants in ATC,D03AX05,hyaluronic acid,834
C0020196,PIN,hyaluronic acid,M09AX01,hyaluronic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AX,Other drugs for disorders of the musculo-skeletal system in ATC,M09AX01,hyaluronic acid,834
C0020196,PIN,hyaluronic acid,R01AX09,hyaluronic acid,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AX,Other nasal preparations in ATC,R01AX09,hyaluronic acid,834
C0020196,PIN,hyaluronic acid,S01KA01,hyaluronic acid,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01K,"SURGICAL AIDS, OPHTHALMOLOGIC",S01KA,Viscoelastic substances,S01KA01,hyaluronic acid,834
C0020223,IN,hydralazine,C02DB02,hydralazine,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02D,"ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",C02DB,Hydrazinophthalazine derivatives acting on arteriolar smooth muscle,C02DB02,hydralazine,200
C0020259,IN,hydrochloric acid,A09AB03,hydrochloric acid,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A09,"DIGESTIVES, INCL. ENZYMES",A09A,"DIGESTIVES, INCL. ENZYMES",A09AB,"Acid preparations, digestives",A09AB03,hydrochloric acid,104
C0020259,IN,hydrochloric acid,B05XA13,hydrochloric acid,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA13,hydrochloric acid,104
C0020261,IN,hydrochlorothiazide,C03AA03,hydrochlorothiazide,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03A,"LOW-CEILING DIURETICS, THIAZIDES",C03AA,"Thiazides, plain",C03AA03,hydrochlorothiazide,177
C0020264,IN,hydrocodone,R05DA03,hydrocodone,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DA,"Opium alkaloids and derivatives, cough suppressants",R05DA03,hydrocodone,101
C0020268,IN,hydrocortisone,A01AC03,hydrocortisone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AC,Corticosteroids for local oral treatment,A01AC03,hydrocortisone,8898
C0020268,IN,hydrocortisone,A07EA02,hydrocortisone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EA,Corticosteroids acting locally,A07EA02,hydrocortisone,8898
C0020268,IN,hydrocortisone,C05AA01,hydrocortisone,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AA,"Corticosteroids, topical for treatment of hemorrhoids and anal fissures",C05AA01,hydrocortisone,8898
C0020268,IN,hydrocortisone,D07AA02,hydrocortisone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AA,"Corticosteroids, weak (group I)",D07AA02,hydrocortisone,8898
C0020268,IN,hydrocortisone,D07XA01,hydrocortisone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07X,"CORTICOSTEROIDS, OTHER COMBINATIONS",D07XA,"Corticosteroids, weak, other combinations",D07XA01,hydrocortisone,8898
C0020268,IN,hydrocortisone,H02AB09,hydrocortisone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,"Glucocorticoids, Systemic",H02AB09,hydrocortisone,8898
C0020268,IN,hydrocortisone,S01BA02,hydrocortisone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BA,"Corticosteroid ophthalmologic antiinflammatory agents, plain",S01BA02,hydrocortisone,8898
C0020268,IN,hydrocortisone,S01CB03,hydrocortisone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01C,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION,S01CB,Corticosteroids/antiinfectives/mydriatics in combination,S01CB03,hydrocortisone,8898
C0020268,IN,hydrocortisone,S02BA01,hydrocortisone,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02B,Corticosteroid otologicals,S02BA,Corticosteroids,S02BA01,hydrocortisone,8898
C0020273,IN,hydroflumethiazide,C03AA02,hydroflumethiazide,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03A,"LOW-CEILING DIURETICS, THIAZIDES",C03AA,"Thiazides, plain",C03AA02,hydroflumethiazide,1
C0020281,IN,hydrogen peroxide,A01AB02,hydrogen peroxide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB02,hydrogen peroxide,419
C0020281,IN,hydrogen peroxide,D08AX01,hydrogen peroxide,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AX,Other antiseptics and disinfectants in ATC,D08AX01,hydrogen peroxide,419
C0020281,IN,hydrogen peroxide,D11AX25,hydrogen peroxide,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AX,OTHER DERMATOLOGICAL PREPARATIONS IN ATC,D11AX25,hydrogen peroxide,419
C0020281,IN,hydrogen peroxide,S02AA06,hydrogen peroxide,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA06,hydrogen peroxide,419
C0020306,IN,hydroquinone,D11AX11,hydroquinone,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AX,OTHER DERMATOLOGICAL PREPARATIONS IN ATC,D11AX11,hydroquinone,22
C0020316,IN,hydroxocobalamin,B03BA03,hydroxocobalamin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03B,VITAMIN B12 AND FOLIC ACID,B03BA,Vitamin B12 (cyanocobalamin and analogues),B03BA03,hydroxocobalamin,139
C0020316,IN,hydroxocobalamin,V03AB33,hydroxocobalamin,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB33,hydroxocobalamin,139
C0020336,IN,hydroxychloroquine,P01BA02,hydroxychloroquine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BA,Aminoquinoline antimalarials,P01BA02,hydroxychloroquine,545
C0020352,IN,hetastarch,B05AA07,hydroxyethylstarch,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05A,BLOOD AND RELATED PRODUCTS,B05AA,Blood substitutes and plasma protein fractions,B05AA07,hydroxyethylstarch,142
C0020402,IN,hydroxyurea,L01XX05,hydroxycarbamide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX05,hydroxycarbamide,1021
C0020404,IN,hydroxyzine,N05BB01,hydroxyzine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BB,"Diphenylmethane derivatives, anxiolytics",N05BB01,hydroxyzine,190
C0020411,IN,hymecromone,A05AX02,hymecromone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A05,BILE AND LIVER THERAPY DRUGS,A05A,BILE THERAPY DRUGS,A05AX,Other drugs for bile therapy in ATC,A05AX02,hymecromone,48
C0020740,IN,ibuprofen,C01EB16,ibuprofen,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01E,OTHER CARDIAC PREPARATIONS in ATC,C01EB,Other plain cardiac preparations in ATC,C01EB16,ibuprofen,1286
C0020740,IN,ibuprofen,G02CC01,ibuprofen,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02C,OTHER GYNECOLOGICALS in ATC,G02CC,Antiinflammatory products for vaginal administration,G02CC01,ibuprofen,1286
C0020740,IN,ibuprofen,M01AE01,ibuprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,"Propionic acid derivatives, antiinflammatory and antirheumatic products",M01AE01,ibuprofen,1286
C0020740,IN,ibuprofen,M02AA13,ibuprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA13,ibuprofen,1286
C0020740,IN,ibuprofen,R02AX02,ibuprofen,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AX,Other throat preparations in ATC,R02AX02,ibuprofen,1286
C0020789,IN,idarubicin,L01DB06,idarubicin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01D,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,L01DB,Anthracyclines and related substances,L01DB06,idarubicin,230
C0020811,IN,idoxuridine,D06BB01,idoxuridine,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,D06BB,"Antivirals, topical",D06BB01,idoxuridine,48
C0020811,IN,idoxuridine,J05AB02,idoxuridine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,J05AB02,idoxuridine,48
C0020811,IN,idoxuridine,S01AD01,idoxuridine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AD,"Antivirals, ophthalmologic",S01AD01,idoxuridine,48
C0020823,IN,ifosfamide,L01AA06,ifosfamide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AA,Nitrogen mustard analogues,L01AA06,ifosfamide,1288
C0020934,IN,imipramine,N06AA02,imipramine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AA,Non-selective monoamine reuptake inhibitors,N06AA02,imipramine,294
C0021186,IN,indapamide,C03BA11,indapamide,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03B,"LOW-CEILING DIURETICS, EXCL. THIAZIDES",C03BA,"sulfonamides, low-ceiling diuretics, plain",C03BA11,indapamide,1
C0021219,PIN,indigo carmine,V04CH02,indigo carmine,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CH,renal function and ureteral injuries test diagnostic agents,V04CH02,indigo carmine,24
C0021234,IN,indocyanine green,V04CX01,indocyanine green,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CX,Other diagnostic agents in ATC,V04CX01,indocyanine green,324
C0021246,IN,indomethacin,C01EB03,indometacin,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01E,OTHER CARDIAC PREPARATIONS in ATC,C01EB,Other plain cardiac preparations in ATC,C01EB03,indometacin,1525
C0021246,IN,indomethacin,M01AB01,indometacin,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,M01AB01,indometacin,1525
C0021246,IN,indomethacin,M02AA23,indometacin,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA23,indometacin,1525
C0021246,IN,indomethacin,S01BC01,indometacin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BC,"Antiinflammatory agents, non-steroidal, ophthalmologic",S01BC01,indometacin,1525
C0021251,,,M01AE10,indoprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,"Propionic acid derivatives, antiinflammatory and antirheumatic products",M01AE10,indoprofen,3
C0021252,IN,indoramin,C02CA02,indoramin,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02C,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",C02CA,"Alpha-adrenoreceptor antagonists, peripherally acting",C02CA02,indoramin,2
C0021528,IN,inosine,D06BB05,inosine,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,D06BB,"Antivirals, topical",D06BB05,inosine,156
C0021528,IN,inosine,G01AX02,inosine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AX,Other gynecological antiinfectives and antiseptics in ATC,G01AX02,inosine,156
C0021528,IN,inosine,S01XA10,inosine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA10,inosine,156
C0021547,IN,inositol,A11HA07,inositol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS in ATC,A11HA,Other plain vitamin preparations in ATC,A11HA07,inositol,493
C0021734,IN,interferon alfa-2a,L03AB04,interferon alfa-2a,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AB,Interferons,L03AB04,interferon alfa-2a,78
C0021735,IN,interferon alfa-2b,L03AB05,interferon alfa-2b,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AB,Interferons,L03AB05,interferon alfa-2b,115
C0021764,,,L03AC,Interleukins,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AC,Interleukins,,,122
C0021961,IN,iodamide,V08AA03,iodamide,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AA,"Watersoluble, nephrotropic, high osmolar X-ray contrast media",V08AA03,iodamide,3
C0021968,IN,iodine,D08AG03,iodine,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AG,"Iodine products, antiseptics and disinfectants",D08AG03,iodine,5147
C0021971,IN,iodipamide,V08AC04,adipiodone,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AC,"Watersoluble, hepatotropic X-ray contrast media",V08AC04,adipiodone,5
C0021978,IN,clioquinol,D08AH30,clioquinol,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AH,"Quinoline derivatives, antiseptics and disinfectants",D08AH30,clioquinol,26
C0021978,IN,clioquinol,D09AA10,clioquinol,D,DERMATOLOGICALS,D09,MEDICATED DRESSINGS,D09A,MEDICATED DRESSINGS,D09AA,Medicated dressings with antiinfectives,D09AA10,clioquinol,26
C0021978,IN,clioquinol,G01AC02,clioquinol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AC,Quinoline gynecological antiinfectives,G01AC02,clioquinol,26
C0021978,IN,clioquinol,P01AA02,clioquinol,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AA,Hydroxyquinoline derivatives for amoebiasis and other protozoal diseases,P01AA02,clioquinol,26
C0021978,IN,clioquinol,S02AA05,clioquinol,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA05,clioquinol,26
C0022003,,,V08AC03,ioglycamic acid,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AC,"Watersoluble, hepatotropic X-ray contrast media",V08AC03,ioglycamic acid,5
C0022005,IN,iohexol,V08AB02,iohexol,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AB,"Watersoluble, nephrotropic, low osmolar X-ray contrast media",V08AB02,iohexol,253
C0022026,IN,iopamidol,V08AB04,iopamidol,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AB,"Watersoluble, nephrotropic, low osmolar X-ray contrast media",V08AB04,iopamidol,99
C0022028,IN,iopanoic acid,V08AC06,iopanoic acid,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AC,"Watersoluble, hepatotropic X-ray contrast media",V08AC06,iopanoic acid,8
C0022029,IN,iophendylate,V08AD04,iofendylate,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AD,Non-watersoluble X-ray contrast media,V08AD04,iofendylate,7
C0022034,IN,iothalamic acid,V08AA04,iotalamic acid,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AA,"Watersoluble, nephrotropic, high osmolar X-ray contrast media",V08AA04,iotalamic acid,273
C0022041,PIN,ioxaglic acid,V08AB03,ioxaglic acid,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AB,"Watersoluble, nephrotropic, low osmolar X-ray contrast media",V08AB03,ioxaglic acid,23
C0022046,IN,ipecac,R05CA04,ipecacuanha,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CA,Expectorants,R05CA04,ipecacuanha,107
C0022046,IN,ipecac,V03AB01,ipecacuanha,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB01,ipecacuanha,107
C0022059,IN,iproniazid,N06AF05,iproniazide,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AF,"Monoamine oxidase inhibitors, non-selective",N06AF05,iproniazide,1
C0022154,IN,isocarboxazid,N06AF01,isocarboxazid,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AF,"Monoamine oxidase inhibitors, non-selective",N06AF01,isocarboxazid,4
C0022176,IN,isoetharine,R03AC07,isoetarine,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC07,isoetarine,21
C0022176,IN,isoetharine,R03CC06,isoetarine,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CC,"Selective beta-2-adrenoreceptor agonists, systemic",R03CC06,isoetarine,21
C0022180,IN,isoflurane,N01AB06,isoflurane,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AB,"Halogenated hydrocarbons, general anesthetics",N01AB06,isoflurane,672
C0022181,IN,isoflurophate,S01EB07,fluostigmine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EB,"Parasympathomimetics, antiglaucoma preparations and miotics",S01EB07,fluostigmine,10
C0022209,IN,isoniazid,J04AC01,isoniazid,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AC,Hydrazides for tuberculosis treatment,J04AC01,isoniazid,1485
C0022230,IN,inosine pranobex,J05AX05,inosine pranobex,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX05,inosine pranobex,80
C0022237,IN,isopropyl alcohol,D08AX05,isopropanol,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AX,Other antiseptics and disinfectants in ATC,D08AX05,isopropanol,137
C0022245,IN,isoproterenol,C01CA02,isoprenaline,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA02,isoprenaline,378
C0022245,IN,isoproterenol,R03AB02,isoprenaline,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AB,Non-selective beta-adrenoreceptor agonist inhalants,R03AB02,isoprenaline,378
C0022245,IN,isoproterenol,R03CB01,isoprenaline,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CB,Non-selective beta-adrenoreceptor agonists for systemic use,R03CB01,isoprenaline,378
C0022252,IN,isosorbide dinitrate,C01DA08,isosorbide dinitrate,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01D,VASODILATORS USED IN CARDIAC DISEASES,C01DA,Organic nitrates used in cardiac disease,C01DA08,isosorbide dinitrate,60
C0022252,IN,isosorbide dinitrate,C05AE02,isosorbide dinitrate,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AE,Muscle relaxants FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AE02,isosorbide dinitrate,60
C0022265,IN,isotretinoin,D10AD04,isotretinoin,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AD,Retinoids for topical use in acne,D10AD04,isotretinoin,456
C0022265,IN,isotretinoin,D10BA01,isotretinoin,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10B,ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,D10BA,Retinoids for treatment of acne,D10BA01,isotretinoin,456
C0022267,IN,isoxsuprine,C04AA01,isoxsuprine,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AA,2-amino-1-phenylethanol derivatives,C04AA01,isoxsuprine,59
C0022322,IN,ivermectin,D11AX22,ivermectin,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AX,OTHER DERMATOLOGICAL PREPARATIONS IN ATC,D11AX22,ivermectin,556
C0022322,IN,ivermectin,P02CF01,ivermectin,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02C,ANTINEMATODAL AGENTS,P02CF,Avermectines,P02CF01,ivermectin,556
C0022419,IN,josamycin,J01FA07,josamycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,J01FA07,josamycin,51
C0022487,IN,kanamycin,A07AA08,kanamycin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,"antibiotics, intestinal",A07AA08,kanamycin,231
C0022487,IN,kanamycin,J01GB04,kanamycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides in ATC,J01GB04,kanamycin,231
C0022487,IN,kanamycin,S01AA24,kanamycin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA24,kanamycin,231
C0022499,IN,kaolin,A07BC02,kaolin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07B,INTESTINAL ADSORBENTS,A07BC,Other intestinal adsorbents in ATC,A07BC02,kaolin,103
C0022614,IN,ketamine,N01AX03,ketamine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AX,Other general anesthetics in ATC,N01AX03,ketamine,1640
C0022616,IN,ketanserin,C02KD01,ketanserin,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02K,OTHER ANTIHYPERTENSIVES in ATC,C02KD,"Serotonin antagonists, antihypertensives",C02KD01,ketanserin,20
C0022625,IN,ketoconazole,D01AC08,ketoconazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC08,ketoconazole,406
C0022625,IN,ketoconazole,G01AF11,ketoconazole,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AF,"Imidazole derivatives, gyncological antiinfectives",G01AF11,ketoconazole,406
C0022625,IN,ketoconazole,H02CA03,ketoconazole,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02C,ANTIADRENAL PREPARATIONS,H02CA,Anticorticosteroids,H02CA03,ketoconazole,406
C0022625,IN,ketoconazole,J02AB02,ketoconazole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AB,"Imidazole derivatives, antimycotic for systemic use",J02AB02,ketoconazole,406
C0022635,IN,ketoprofen,M01AE03,ketoprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,"Propionic acid derivatives, antiinflammatory and antirheumatic products",M01AE03,ketoprofen,114
C0022635,IN,ketoprofen,M02AA10,ketoprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA10,ketoprofen,114
C0022642,IN,ketotifen,R06AX17,ketotifen,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX17,ketotifen,211
C0022642,IN,ketotifen,S01GX08,ketotifen,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GX,Other antiallergics in ATC,S01GX08,ketotifen,211
C0022860,IN,labetalol,C07AG01,labetalol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AG,Alpha and beta blocking agents,C07AG01,labetalol,223
C0022957,IN,lactulose,A06AD11,lactulose,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,A06AD11,lactulose,497
C0023556,IN,levamisole,P02CE01,levamisole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02C,ANTINEMATODAL AGENTS,P02CE,"Imidazothiazole derivatives, antinematodal",P02CE01,levamisole,270
C0023566,IN,levonorgestrel,G03AC03,levonorgestrel,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03A,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,G03AC,Progestogen systemic hormonal contraceptives,G03AC03,levonorgestrel,1076
C0023566,IN,levonorgestrel,G03AD01,levonorgestrel,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03A,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,G03AD,Emergency contraceptive drugs,G03AD01,levonorgestrel,1076
C0023570,IN,levodopa,N04BA01,levodopa,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04B,DOPAMINERGIC AGENTS,N04BA,Dopa and dopa derivatives,N04BA01,levodopa,748
C0023610,IN,gonadorelin,H01CA,Gonadotropin-releasing hormones,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CA,Gonadotropin-releasing hormones,,,2410
C0023610,IN,gonadorelin,H01CA01,gonadorelin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CA,Gonadotropin-releasing hormones,H01CA01,gonadorelin,2410
C0023610,IN,gonadorelin,V04CM01,gonadorelin,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CM,fertility disturbances test diagnostic agents,V04CM01,gonadorelin,2410
C0023660,IN,lidocaine,C01BB01,lidocaine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BB,"Antiarrhythmics, class Ib",C01BB01,lidocaine,1884
C0023660,IN,lidocaine,C05AD01,lidocaine,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AD,Local anesthetics for treatment of hemorrhoids and anal fissures for topical use,C05AD01,lidocaine,1884
C0023660,IN,lidocaine,D04AB01,lidocaine,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AB,Anesthetics for topical use,D04AB01,lidocaine,1884
C0023660,IN,lidocaine,N01BB02,lidocaine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BB,Amide local anesthetics,N01BB02,lidocaine,1884
C0023660,IN,lidocaine,R02AD02,lidocaine,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AD,local anesthetic throat preparations,R02AD02,lidocaine,1884
C0023660,IN,lidocaine,S01HA07,lidocaine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01H,"Local anesthetics, ophthalmologic",S01HA,Local anesthetics,S01HA07,lidocaine,1884
C0023660,IN,lidocaine,S02DA01,lidocaine,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02D,OTHER OTOLOGICALS in ATC,S02DA,Analgesics and anesthetics,S02DA01,lidocaine,1884
C0023665,IN,lidoflazine,C08EX01,lidoflazine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08E,NON-SELECTIVE CALCIUM CHANNEL BLOCKERS,C08EX,Other non-selective calcium channel blockers in ATC,C08EX01,lidoflazine,1
C0023726,IN,lincomycin,J01FF02,lincomycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FF,Lincosamides,J01FF02,lincomycin,85
C0023754,IN,linseed oil,A06AC05,linseed,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AC,Bulk-forming laxatives,A06AC05,linseed,17
C0023791,PIN,thioctic acid,A16AX01,thioctic acid,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX01,thioctic acid,53
C0023863,IN,lisuride,G02CB02,lisuride,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02C,OTHER GYNECOLOGICALS in ATC,G02CB,Prolactine inhibitors,G02CB02,lisuride,15
C0023863,IN,lisuride,N02CA07,lisuride,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CA,"Ergot alkaloids, antimigraine",N02CA07,lisuride,15
C0023961,IN,lofepramine,N06AA07,lofepramine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AA,Non-selective monoamine reuptake inhibitors,N06AA07,lofepramine,2
C0023972,IN,lomustine,L01AD02,lomustine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AD,"Nitrosoureas, antineoplastic alkylating agents",L01AD02,lomustine,189
C0023992,IN,loperamide,A07DA03,loperamide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07D,ANTIPROPULSIVES,A07DA,Antipropulsives,A07DA03,loperamide,73
C0024001,,,C01BA12,lorajmine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BA,"Antiarrhythmics, class Ia",C01BA12,lorajmine,1
C0024002,IN,lorazepam,N05BA06,lorazepam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA06,lorazepam,320
C0024027,IN,lovastatin,C10AA02,lovastatin,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AA,"HMG CoA reductase inhibitors, plain lipid modifying drugs",C10AA02,lovastatin,74
C0024056,IN,loxapine,N05AH01,loxapine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AH,"Diazepines, oxazepines, thiazepines and oxepines antipsychotic drugs",N05AH01,loxapine,11
C0024200,IN,lymecycline,J01AA04,lymecycline,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,Tetracycline antibiotics,J01AA,Tetracyclines,J01AA04,lymecycline,10
C0024321,IN,lynestrenol,G03AC02,lynestrenol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03A,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,G03AC,Progestogen systemic hormonal contraceptives,G03AC02,lynestrenol,89
C0024321,IN,lynestrenol,G03DC03,lynestrenol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03D,PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03DC,"Estren derivatives, sex hormones and modulators of the genital system",G03DC03,lynestrenol,89
C0024328,IN,lypressin,H01BA03,lypressin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BA,Vasopressin and analogues,H01BA03,lypressin,68
C0024337,IN,lysine,B05XB03,lysine,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XB,"Amino Acids, I.V. solution additive",B05XB03,lysine,897
C0024452,IN,mafenide,D06BA03,mafenide,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,D06BA,"Sulfonamides, topical",D06BA03,mafenide,10
C0024472,IN,magnesium chloride,A12CC01,magnesium chloride,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS in ATC,A12CC,"Magnesium supplements, alimentary tract and metabolism",A12CC01,magnesium chloride,27
C0024472,IN,magnesium chloride,B05XA11,magnesium chloride,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA11,magnesium chloride,27
C0024476,IN,magnesium hydroxide,A02AA04,magnesium hydroxide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AA,antacids containing magnesium compounds,A02AA04,magnesium hydroxide,38
C0024476,IN,magnesium hydroxide,G04BX01,magnesium hydroxide,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BX,Other urologicals in ATC,G04BX01,magnesium hydroxide,38
C0024477,IN,magnesium oxide,A02AA02,magnesium oxide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AA,antacids containing magnesium compounds,A02AA02,magnesium oxide,60
C0024477,IN,magnesium oxide,A06AD02,magnesium oxide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,A06AD02,magnesium oxide,60
C0024477,IN,magnesium oxide,A12CC10,magnesium oxide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS in ATC,A12CC,"Magnesium supplements, alimentary tract and metabolism",A12CC10,magnesium oxide,60
C0024480,IN,magnesium sulfate,A06AD04,magnesium sulfate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,A06AD04,magnesium sulfate,1327
C0024480,IN,magnesium sulfate,A12CC02,magnesium sulfate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS in ATC,A12CC,"Magnesium supplements, alimentary tract and metabolism",A12CC02,magnesium sulfate,1327
C0024480,IN,magnesium sulfate,B05XA05,magnesium sulfate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA05,magnesium sulfate,1327
C0024480,IN,magnesium sulfate,D11AX05,magnesium sulfate,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AX,OTHER DERMATOLOGICAL PREPARATIONS IN ATC,D11AX05,magnesium sulfate,1327
C0024480,IN,magnesium sulfate,V04CC02,magnesium sulfate,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CC,Diagnostic agents for bile duct patency testing,V04CC02,magnesium sulfate,1327
C0024547,IN,malathion,P03AX03,malathion,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03A,"ECTOPARASITICIDES, INCL. SCABICIDES",P03AX,"Other ectoparasiticides, incl. scabicides in ATC",P03AX03,malathion,128
C0024730,IN,mannitol,A06AD16,mannitol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,A06AD16,mannitol,687
C0024730,IN,mannitol,B05BC01,mannitol,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05B,"IV solutions used in parenteral administration of fluids, electrolytes and nutrients",B05BC,Solutions producing osmotic diuresis,B05BC01,mannitol,687
C0024730,IN,mannitol,B05CX04,mannitol,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05C,"IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION",B05CX,Other irrigating solutions in ATC,B05CX04,mannitol,687
C0024730,IN,mannitol,R05CB16,mannitol,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CB,Mucolytics,R05CB16,mannitol,687
C0024730,IN,mannitol,V04CX04,mannitol,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CX,Other diagnostic agents in ATC,V04CX04,mannitol,687
C0024778,IN,maprotiline,N06AA21,maprotiline,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AA,Non-selective monoamine reuptake inhibitors,N06AA21,maprotiline,11
C0024977,IN,mazindol,A08AA05,mazindol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,A08AA05,mazindol,12
C0025023,IN,mebendazole,P02CA01,mebendazole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02C,ANTINEMATODAL AGENTS,P02CA,"Benzimidazole derivatives, antinematodal",P02CA01,mebendazole,422
C0025029,IN,mecamylamine,C02BB01,mecamylamine,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02B,"ANTIADRENERGIC AGENTS, GANGLION-BLOCKING",C02BB,"Secondary and tertiary amines, ganglion-blocking antiadrenergic",C02BB01,mecamylamine,3
C0025033,IN,mechlorethamine,L01AA05,chlormethine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AA,Nitrogen mustard analogues,L01AA05,chlormethine,321
C0025039,IN,meclizine,R06AE05,meclozine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AE,"Piperazine derivatives, systemic antihistamines",R06AE05,meclozine,19
C0025042,IN,meclofenamic acid,M01AG04,meclofenamic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AG,"Fenamates, antiinflammatory and antirheumatic drugs",M01AG04,meclofenamic acid,7
C0025042,IN,meclofenamic acid,M02AA18,meclofenamic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA18,meclofenamic acid,7
C0025051,IN,medazepam,N05BA03,medazepam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA03,medazepam,3
C0025132,IN,medigoxin,C01AA08,metildigoxin,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01A,CARDIAC GLYCOSIDES,C01AA,Digitalis glycosides,C01AA08,metildigoxin,2
C0025145,IN,medrogestone,G03DB03,medrogestone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03D,PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03DB,"Pregnadien derivatives, progestogens",G03DB03,medrogestone,3
C0025152,PIN,mefenamic acid,M01AG01,mefenamic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AG,"Fenamates, antiinflammatory and antirheumatic drugs",M01AG01,mefenamic acid,55
C0025153,IN,mefloquine,P01BC02,mefloquine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BC,"Methanolquinolines, antimalarial",P01BC02,mefloquine,397
C0025156,IN,mefruside,C03BA05,mefruside,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03B,"LOW-CEILING DIURETICS, EXCL. THIAZIDES",C03BA,"sulfonamides, low-ceiling diuretics, plain",C03BA05,mefruside,1
C0025217,,,P01CD01,melarsoprol,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01C,AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS,P01CD,"Arsenic compounds, for leishmaniasis and trypanosomiasis",P01CD01,melarsoprol,42
C0025219,IN,melatonin,N05CH01,melatonin,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CH,"Melatonin receptor agonists, hypnotics and sedatives",N05CH01,melatonin,824
C0025241,IN,melphalan,L01AA03,melphalan,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AA,Nitrogen mustard analogues,L01AA03,melphalan,949
C0025242,IN,memantine,N06DX01,memantine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06D,ANTI-DEMENTIA DRUGS,N06DX,Other anti-dementia drugs in ATC,N06DX01,memantine,35
C0025270,IN,vitamin K3,B02BA02,menadione,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BA,Vitamin K containing hemostatics,B02BA02,menadione,15
C0025326,,,G03GA02,human menopausal gonadotrophin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03G,GONADOTROPINS AND OTHER OVULATION STIMULANTS,G03GA,Gonadotropins,G03GA02,human menopausal gonadotrophin,3697
C0025373,,,A01AB16,mepartricin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB16,mepartricin,2
C0025373,,,D01AA06,mepartricin,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AA,"Antifungal Antibiotics, Topical",D01AA06,mepartricin,2
C0025373,,,G01AA09,mepartricin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AA,"Antibiotics, Gynecological",G01AA09,mepartricin,2
C0025373,,,G04CX03,mepartricin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04C,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,G04CX,Other drugs used in benign prostatic hypertrophy in ATC,G04CX03,mepartricin,2
C0025376,IN,meperidine,N02AB02,pethidine,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AB,"Phenylpiperidine derivatives, opioid analgesics",N02AB02,pethidine,743
C0025380,IN,mephentermine,C01CA11,mephentermine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA11,mephentermine,7
C0025381,IN,mephenytoin,N03AB04,mephenytoin,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AB,"Hydantoin derivatives, antiepileptics",N03AB04,mephenytoin,22
C0025382,IN,mephobarbital,N03AA01,methylphenobarbital,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AA,Barbiturates and derivatives,N03AA01,methylphenobarbital,19
C0025384,IN,mepivacaine,N01BB03,mepivacaine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BB,Amide local anesthetics,N01BB03,mepivacaine,124
C0025386,IN,meprobamate,N05BC01,meprobamate,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BC,Carbamate anxiolytics,N05BC01,meprobamate,16
C0025387,IN,meptazinol,N02AX05,meptazinol,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AX,Other opioids in ATC,N02AX05,meptazinol,12
C0025397,IN,merbromin,D08AK04,merbromin,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AK,Mercurial antiseptic and disinfectant products,D08AK04,merbromin,25
C0025405,IN,tiopronin,G04BX16,tiopronin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BX,Other urologicals in ATC,G04BX16,tiopronin,25
C0025417,IN,mercuric chloride,D08AK03,mercuric chloride,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AK,Mercurial antiseptic and disinfectant products,D08AK03,mercuric chloride,20
C0025497,IN,mesoridazine,N05AC03,mesoridazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AC,"Phenothiazines with piperidine structure, antipsychotics",N05AC03,mesoridazine,4
C0025503,IN,mesterolone,G03BB01,mesterolone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03B,ANDROGENS,G03BB,5-androstanon (3) derivatives,G03BB01,mesterolone,6
C0025575,IN,metaraminol,C01CA09,metaraminol,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA09,metaraminol,19
C0025598,IN,metformin,A10BA02,metformin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BA,biguanide blood glucose lower drugs,A10BA02,metformin,939
C0025603,IN,methacycline,J01AA05,metacycline,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,Tetracycline antibiotics,J01AA,Tetracyclines,J01AA05,metacycline,3
C0025605,IN,methadone,N07BC02,methadone,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07B,DRUGS USED IN ADDICTIVE DISORDERS,N07BC,Drugs used in opioid dependence,N07BC02,methadone,1139
C0025611,IN,methamphetamine,N06BA03,metamfetamine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BA,Centrally acting sympathomimetics,N06BA03,metamfetamine,420
C0025616,IN,methandrostenolone,A14AA03,metandienone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,A14AA03,metandienone,14
C0025616,IN,methandrostenolone,D11AE01,metandienone,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AE,Androgens for topical use,D11AE01,metandienone,14
C0025624,IN,methantheline,A03AB07,methantheline,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds for functional gastrointestinal disorders",A03AB07,methantheline,1
C0025625,IN,methapyrilene,R06AC05,methapyrilene,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AC,"Substituted ethylene diamines, systemic antihistamines",R06AC05,methapyrilene,2
C0025627,IN,methaqualone,N05CM01,methaqualone,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CM,Other hypnotics and sedatives in ATC,N05CM01,methaqualone,9
C0025629,IN,metharbital,N03AA30,metharbital,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AA,Barbiturates and derivatives,N03AA30,metharbital,1
C0025631,IN,methazolamide,S01EC05,methazolamide,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EC,"Carbonic anhydrase inhibitors, antiglaucoma drugs and miotics",S01EC05,methazolamide,1
C0025638,IN,methenamine,J01XX05,methenamine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XX,Other antibacterials in ATC,J01XX05,methenamine,26
C0025639,IN,methenolone,A14AA04,metenolone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,A14AA04,metenolone,3
C0025641,IN,metergoline,G02CB05,metergoline,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02C,OTHER GYNECOLOGICALS in ATC,G02CB,Prolactine inhibitors,G02CB05,metergoline,13
C0025643,IN,methicillin,J01CF03,meticillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CF,Beta-lactamase resistant penicillins,J01CF03,meticillin,1745
C0025644,IN,methimazole,H03BB02,thiamazole,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY DRUGS,H03B,ANTITHYROID PREPARATIONS,H03BB,"Sulfur-containing imidazole derivatives, antithyroid preparations",H03BB02,thiamazole,404
C0025646,IN,methionine,V03AB26,methionine,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB26,methionine,1169
C0025656,,,J05AA01,metisazone,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AA,"Thiosemicarbazones, direct acting antivirals",J05AA01,metisazone,1
C0025659,IN,methocarbamol,M03BA03,methocarbamol,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BA,"Carbamic acid esters, centrally acting muscle relaxants",M03BA03,methocarbamol,7
C0025668,IN,methohexital,N01AF01,methohexital,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AF,"Barbiturates for general anesthesia, plain",N01AF01,methohexital,141
C0025668,IN,methohexital,N05CA15,methohexital,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CA,"Barbiturates, hypnotics and sedatives, plain",N05CA15,methohexital,141
C0025677,IN,methotrexate,L01BA01,methotrexate,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BA,"Folic acid analogs, antimetabolites",L01BA01,methotrexate,6476
C0025677,IN,methotrexate,L04AX03,methotrexate,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AX,Other immunosuppressants in ATC,L04AX03,methotrexate,6476
C0025678,IN,methotrimeprazine,N05AA02,levomepromazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AA,"Phenothiazines with aliphatic side-chain, antipsychotics",N05AA02,levomepromazine,22
C0025681,IN,methoxamine,C01CA10,methoxamine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA10,methoxamine,15
C0025684,IN,methoxsalen,D05AD02,methoxsalen,D,DERMATOLOGICALS,D05,ANTIPSORIATICS,D05A,ANTIPSORIATICS FOR TOPICAL USE,D05AD,Psoralens for topical use,D05AD02,methoxsalen,68
C0025684,IN,methoxsalen,D05BA02,methoxsalen,D,DERMATOLOGICALS,D05,ANTIPSORIATICS,D05B,ANTIPSORIATICS FOR SYSTEMIC USE,D05BA,Psoralens for systemic use,D05BA02,methoxsalen,68
C0025688,IN,methoxyflurane,N02BG09,methoxyflurane,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BG,Other analgesics and antipyretics in ATC,N02BG09,methoxyflurane,46
C0025696,IN,methyclothiazide,C03AA08,methyclothiazide,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03A,"LOW-CEILING DIURETICS, THIAZIDES",C03AA,"Thiazides, plain",C03AA08,methyclothiazide,1
C0025729,IN,methylcellulose,A06AC06,methylcellulose,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AC,Bulk-forming laxatives,A06AC06,methylcellulose,101
C0025741,IN,methyldopa,C02AB01,methyldopa (levorotatory),C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02A,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",C02AB,"Methyldopa, centrally acting adntiadrenergic agents",C02AB01,methyldopa (levorotatory),182
C0025746,IN,methylene blue,V03AB17,methylthioninium chloride,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB17,methylthioninium chloride,279
C0025746,IN,methylene blue,V04CG05,methylthioninium chloride,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CG,gastric secretion test diagnostic agents,V04CG05,methylthioninium chloride,279
C0025760,IN,methylergonovine,G02AB01,methylergometrine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02A,UTEROTONICS,G02AB,Ergot alkaloid oxytocics,G02AB01,methylergometrine,49
C0025810,IN,methylphenidate,N06BA04,methylphenidate,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BA,Centrally acting sympathomimetics,N06BA04,methylphenidate,2553
C0025815,IN,methylprednisolone,D07AA01,methylprednisolone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AA,"Corticosteroids, weak (group I)",D07AA01,methylprednisolone,3335
C0025815,IN,methylprednisolone,D10AA02,methylprednisolone,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AA,"Corticosteroids, combinations for treatment of acne",D10AA02,methylprednisolone,3335
C0025815,IN,methylprednisolone,H02AB04,methylprednisolone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,"Glucocorticoids, Systemic",H02AB04,methylprednisolone,3335
C0025826,IN,methyltestosterone,G03BA02,methyltestosterone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03B,ANDROGENS,G03BA,3-oxoandrosten (4) derivatives,G03BA02,methyltestosterone,20
C0025826,IN,methyltestosterone,G03EK01,methyltestosterone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03E,ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION,G03EK,Androgens and female sex hormones in combination with other drugs,G03EK01,methyltestosterone,20
C0025830,,,H03BA01,methylthiouracil,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY DRUGS,H03B,ANTITHYROID PREPARATIONS,H03BA,Thiouracil antithyroid preparations,H03BA01,methylthiouracil,1
C0025840,IN,methyprylon,N05CE02,methyprylon,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CE,"Piperidinedione derivatives, hypnotics and sedatives",N05CE02,methyprylon,2
C0025842,IN,methysergide,N02CA04,methysergide,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CA,"Ergot alkaloids, antimigraine",N02CA04,methysergide,9
C0025853,IN,metoclopramide,A03FA01,metoclopramide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,A03FA01,metoclopramide,452
C0025854,IN,metolazone,C03BA08,metolazone,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03B,"LOW-CEILING DIURETICS, EXCL. THIAZIDES",C03BA,"sulfonamides, low-ceiling diuretics, plain",C03BA08,metolazone,8
C0025859,IN,metoprolol,C07AB02,metoprolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AB,"Beta blocking agents, selective",C07AB02,metoprolol,187
C0025869,IN,metrizamide,V08AB01,metrizamide,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AB,"Watersoluble, nephrotropic, low osmolar X-ray contrast media",V08AB01,metrizamide,160
C0025872,IN,metronidazole,A01AB17,metronidazole,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB17,metronidazole,1523
C0025872,IN,metronidazole,D06BX01,metronidazole,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,D06BX,Other chemotherapeutics in ATC,D06BX01,metronidazole,1523
C0025872,IN,metronidazole,G01AF01,metronidazole,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AF,"Imidazole derivatives, gyncological antiinfectives",G01AF01,metronidazole,1523
C0025872,IN,metronidazole,J01XD01,metronidazole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XD,"Imidazole derivatives, antibacterial for systemic use",J01XD01,metronidazole,1523
C0025872,IN,metronidazole,P01AB01,metronidazole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AB,"Nitroimidazole derivatives, antiprotozoal agents against amoebiasis and other protozoal diseases",P01AB01,metronidazole,1523
C0025876,IN,metyrapone,V04CD01,metyrapone,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CD,pituitary function test diagnostic agents,V04CD01,metyrapone,157
C0025887,IN,mexiletine,C01BB02,mexiletine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BB,"Antiarrhythmics, class Ib",C01BB02,mexiletine,71
C0025893,IN,mezlocillin,J01CA10,mezlocillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA10,mezlocillin,55
C0025912,IN,mianserin,N06AX03,mianserin,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX03,mianserin,43
C0025942,IN,miconazole,A01AB09,miconazole,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB09,miconazole,141
C0025942,IN,miconazole,A07AC01,miconazole,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AC,"Imidazole derivatives, intestinal antiinfectives",A07AC01,miconazole,141
C0025942,IN,miconazole,D01AC02,miconazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC02,miconazole,141
C0025942,IN,miconazole,G01AF04,miconazole,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AF,"Imidazole derivatives, gyncological antiinfectives",G01AF04,miconazole,141
C0025942,IN,miconazole,J02AB01,miconazole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AB,"Imidazole derivatives, antimycotic for systemic use",J02AB01,miconazole,141
C0025942,IN,miconazole,S02AA13,miconazole,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA13,miconazole,141
C0026056,IN,midazolam,N05CD08,midazolam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CD,Benzodiazepine derivative hypnotics and sedatives,N05CD08,midazolam,2320
C0026078,IN,midodrine,C01CA17,midodrine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA17,midodrine,39
C0026088,IN,mifepristone,G03XB01,mifepristone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03X,OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC,G03XB,"Progesterone receptor modulators, sex hormones and modulators of the genital system",G03XB01,mifepristone,438
C0026156,IN,mineral oil,A06AA01,liquid paraffin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AA,"Softeners, emollients",A06AA01,liquid paraffin,87
C0026187,IN,minocycline,A01AB23,minocycline,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB23,minocycline,353
C0026187,IN,minocycline,D10AF07,minocycline,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AF,Antiinfectives for treatment of acne,D10AF07,minocycline,353
C0026187,IN,minocycline,J01AA08,minocycline,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,Tetracycline antibiotics,J01AA,Tetracyclines,J01AA08,minocycline,353
C0026196,IN,minoxidil,C02DC01,minoxidil,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02D,"ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",C02DC,Pyrimidine derivatives acting on arteriolar smooth muscle,C02DC01,minoxidil,77
C0026196,IN,minoxidil,D11AX01,minoxidil,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AX,OTHER DERMATOLOGICAL PREPARATIONS IN ATC,D11AX01,minoxidil,77
C0026202,IN,miocamycin,J01FA11,miocamycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,J01FA11,miocamycin,58
C0026234,IN,plicamycin,L01DC02,plicamycin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01D,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,L01DC,Other cytotoxic antibiotics in ATC,L01DC02,plicamycin,6
C0026236,IN,mitobronitol,L01AX01,mitobronitol,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AX,Other alkylating agents in ATC,L01AX01,mitobronitol,3
C0026251,,,L01XX16,mitoguazone,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX16,mitoguazone,9
C0026256,IN,mitotane,L01XX23,mitotane,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX23,mitotane,72
C0026259,IN,mitoxantrone,L01DB07,mitoxantrone,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01D,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,L01DB,Anthracyclines and related substances,L01DB07,mitoxantrone,241
C0026388,IN,molindone,N05AE02,molindone,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AE,"Indole derivatives, antipsychotic",N05AE02,molindone,16
C0026400,IN,molsidomine,C01DX12,molsidomine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01D,VASODILATORS USED IN CARDIAC DISEASES,C01DX,Other vasodilators used in cardiac diseases in ATC,C01DX12,molsidomine,2
C0026549,IN,morphine,N02AA01,morphine,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AA,Natural opium alkaloid analgesics,N02AA01,morphine,2524
C0026651,IN,moxalactam,J01DD06,latamoxef,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD06,latamoxef,146
C0026933,IN,mycophenolic acid,L04AA06,mycophenolic acid,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AA,Selective immunosuppressants,L04AA06,mycophenolic acid,1031
C0027302,IN,nadolol,C07AA12,nadolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AA,"Beta blocking agents, non-selective",C07AA12,nadolol,67
C0027324,IN,nafcillin,J01CF06,nafcillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CF,Beta-lactamase resistant penicillins,J01CF06,nafcillin,78
C0027329,IN,nafronyl,C04AX21,naftidrofuryl,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AX,Other peripheral vasodilators in ATC,C04AX21,naftidrofuryl,6
C0027348,IN,nalbuphine,N02AF02,nalbuphine,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AF,"Morphinan derivatives, opiod analgesics",N02AF02,nalbuphine,137
C0027353,PIN,nalidixic acid,J01MB02,nalidixic acid,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MB,Other quinolones in ATC,J01MB02,nalidixic acid,211
C0027355,,,V03AB02,nalorphine,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB02,nalorphine,5
C0027358,IN,naloxone,A06AH04,naloxone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AH,Peripheral opioid receptor antagonists,A06AH04,naloxone,435
C0027358,IN,naloxone,V03AB15,naloxone,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB15,naloxone,435
C0027360,IN,naltrexone,N07BB04,naltrexone,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07B,DRUGS USED IN ADDICTIVE DISORDERS,N07BB,Drugs used in alcohol dependence,N07BB04,naltrexone,127
C0027368,IN,nandrolone,A14AB01,nandrolone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AB,"Estren derivatives, systemic",A14AB01,nandrolone,78
C0027368,IN,nandrolone,S01XA11,nandrolone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA11,nandrolone,78
C0027373,IN,naphazoline,R01AA08,naphazoline,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AA,"Sympathomimetics, plain",R01AA08,naphazoline,16
C0027373,IN,naphazoline,R01AB02,naphazoline,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AB,"Sympathomimetics, combinations excl. corticosteroids",R01AB02,naphazoline,16
C0027373,IN,naphazoline,S01GA01,naphazoline,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GA,Sympathomimetics used as decongestants,S01GA01,naphazoline,16
C0027396,IN,naproxen,G02CC02,naproxen,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02C,OTHER GYNECOLOGICALS in ATC,G02CC,Antiinflammatory products for vaginal administration,G02CC02,naproxen,204
C0027396,IN,naproxen,M01AE02,naproxen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,"Propionic acid derivatives, antiinflammatory and antirheumatic products",M01AE02,naproxen,204
C0027396,IN,naproxen,M02AA12,naproxen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA12,naproxen,204
C0027444,IN,natamycin,A01AB10,natamycin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB10,natamycin,44
C0027444,IN,natamycin,A07AA03,natamycin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,"antibiotics, intestinal",A07AA03,natamycin,44
C0027444,IN,natamycin,D01AA02,natamycin,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AA,"Antifungal Antibiotics, Topical",D01AA02,natamycin,44
C0027444,IN,natamycin,G01AA02,natamycin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AA,"Antibiotics, Gynecological",G01AA02,natamycin,44
C0027444,IN,natamycin,S01AA10,natamycin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA10,natamycin,44
C0027556,IN,nefopam,N02BG06,nefopam,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BG,Other analgesics and antipyretics in ATC,N02BG06,nefopam,12
C0027603,IN,neomycin,A01AB08,neomycin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB08,neomycin,246
C0027603,IN,neomycin,A07AA01,neomycin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,"antibiotics, intestinal",A07AA01,neomycin,246
C0027603,IN,neomycin,B05CA09,neomycin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05C,"IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION",B05CA,Antiinfective irrigating solutions,B05CA09,neomycin,246
C0027603,IN,neomycin,D06AX04,neomycin,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AX,Other antibiotics for topical use in ATC,D06AX04,neomycin,246
C0027603,IN,neomycin,J01GB05,neomycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides in ATC,J01GB05,neomycin,246
C0027603,IN,neomycin,R02AB01,neomycin,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AB,Antibiotic throat preparations,R02AB01,neomycin,246
C0027603,IN,neomycin,S01AA03,neomycin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA03,neomycin,246
C0027603,IN,neomycin,S02AA07,neomycin,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA07,neomycin,246
C0027603,IN,neomycin,S03AA01,neomycin,S,SENSORY ORGAN DRUGS,S03,OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,S03A,"ANTIINFECTIVES, OPHTHALMOLOGIC AND OTOLOGIC",S03AA,Antiinfectives,S03AA01,neomycin,246
C0027679,IN,neostigmine,N07AA01,neostigmine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07A,PARASYMPATHOMIMETICS,N07AA,Anticholinesterase parasympathomimetics,N07AA01,neostigmine,226
C0027679,IN,neostigmine,S01EB06,neostigmine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EB,"Parasympathomimetics, antiglaucoma preparations and miotics",S01EB06,neostigmine,226
C0027780,IN,netilmicin,J01GB07,netilmicin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides in ATC,J01GB07,netilmicin,200
C0027780,IN,netilmicin,S01AA23,netilmicin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA23,netilmicin,200
C0027996,IN,niacin,C04AC01,nicotinic acid,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AC,"Nicotinic acid and derivatives, peripheral vasodilators",C04AC01,nicotinic acid,461
C0027996,IN,niacin,C10AD02,nicotinic acid,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AD,"Nicotinic acid and derivatives, lipid modifying, plain",C10AD02,nicotinic acid,461
C0027999,IN,nialamide,N06AF02,nialamide,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AF,"Monoamine oxidase inhibitors, non-selective",N06AF02,nialamide,2
C0028005,IN,nicardipine,C08CA04,nicardipine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,C08CA,Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects,C08CA04,nicardipine,114
C0028008,IN,nicergoline,C04AE02,nicergoline,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AE,Ergot alkaloid peripheral vasodilators,C04AE02,nicergoline,2
C0028009,,,C10AD01,niceritrol,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AD,"Nicotinic acid and derivatives, lipid modifying, plain",C10AD01,niceritrol,1
C0028017,IN,niclosamide,P02DA01,niclosamide,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02D,ANTICESTODALS,P02DA,Salicylic acid derivative anticestodals,P02DA01,niclosamide,45
C0028027,IN,niacinamide,A11HA01,nicotinamide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS in ATC,A11HA,Other plain vitamin preparations in ATC,A11HA01,nicotinamide,356
C0028040,IN,nicotine,N07BA01,nicotine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07B,DRUGS USED IN ADDICTIVE DISORDERS,N07BA,Drugs used in nicotine dependence,N07BA01,nicotine,2619
C0028053,IN,nicotinyl alcohol,C04AC02,nicotinyl alcohol,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AC,"Nicotinic acid and derivatives, peripheral vasodilators",C04AC02,nicotinyl alcohol,1
C0028053,IN,nicotinyl alcohol,C10AD05,nicotinyl alcohol,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AD,"Nicotinic acid and derivatives, lipid modifying, plain",C10AD05,nicotinyl alcohol,1
C0028066,IN,nifedipine,C08CA05,nifedipine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,C08CA,Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects,C08CA05,nifedipine,580
C0028067,IN,niflumic acid,M01AX02,niflumic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids in ATC",M01AX02,niflumic acid,14
C0028067,IN,niflumic acid,M02AA17,niflumic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA17,niflumic acid,14
C0028070,IN,nifuratel,G01AX05,nifuratel,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AX,Other gynecological antiinfectives and antiseptics in ATC,G01AX05,nifuratel,6
C0028073,IN,nifurtimox,P01CC01,nifurtimox,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01C,AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS,P01CC,"Nitrofuran derivatives, antiprotozoal drugs",P01CC01,nifurtimox,63
C0028089,IN,nikethamide,R07AB02,nikethamide,R,RESPIRATORY SYSTEM DRUGS,R07,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07A,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07AB,Respiratory stimulants,R07AB02,nikethamide,2
C0028094,IN,nimodipine,C08CA06,nimodipine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,C08CA,Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects,C08CA06,nimodipine,43
C0028095,IN,nimorazole,P01AB06,nimorazole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AB,"Nitroimidazole derivatives, antiprotozoal agents against amoebiasis and other protozoal diseases",P01AB06,nimorazole,3
C0028096,,,L01AD06,nimustine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AD,"Nitrosoureas, antineoplastic alkylating agents",L01AD06,nimustine,66
C0028113,,,P02BX02,niridazole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02B,ANTITREMATODALS,P02BX,Other antitrematodal agents in ATC,P02BX02,niridazole,29
C0028116,IN,nisoldipine,C08CA07,nisoldipine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,C08CA,Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects,C08CA07,nisoldipine,2
C0028126,IN,nitrazepam,N05CD02,nitrazepam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CD,Benzodiazepine derivative hypnotics and sedatives,N05CD02,nitrazepam,68
C0028127,IN,nitrendipine,C08CA08,nitrendipine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,C08CA,Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects,C08CA08,nitrendipine,8
C0028128,IN,nitric oxide,R07AX01,nitric oxide,R,RESPIRATORY SYSTEM DRUGS,R07,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07A,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07AX,Other respiratory system products in ATC,R07AX01,nitric oxide,4044
C0028156,IN,nitrofurantoin,J01XE01,nitrofurantoin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XE,"Nitrofuran derivatives, antibacterials for systemic use",J01XE01,nitrofurantoin,291
C0028157,IN,nitrofurazone,B05CA03,nitrofural,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05C,"IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION",B05CA,Antiinfective irrigating solutions,B05CA03,nitrofural,15
C0028157,IN,nitrofurazone,D08AF01,nitrofural,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AF,"Nitrofuran derivatives, antiseptics and disinfectants",D08AF01,nitrofural,15
C0028157,IN,nitrofurazone,D09AA03,nitrofural,D,DERMATOLOGICALS,D09,MEDICATED DRESSINGS,D09A,MEDICATED DRESSINGS,D09AA,Medicated dressings with antiinfectives,D09AA03,nitrofural,15
C0028157,IN,nitrofurazone,P01CC02,nitrofural,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01C,AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS,P01CC,"Nitrofuran derivatives, antiprotozoal drugs",P01CC02,nitrofural,15
C0028157,IN,nitrofurazone,S01AX04,nitrofural,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AX,Other antiinfectives in ATC,S01AX04,nitrofural,15
C0028157,IN,nitrofurazone,S02AA02,nitrofural,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA02,nitrofural,15
C0028158,IN,nitrogen,V03AN04,nitrogen,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AN,Medical gases,V03AN04,nitrogen,1708
C0028193,IN,nitroprusside,C02DD01,nitroprusside,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02D,"ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",C02DD,Nitroferricyanide derivatives acting on arteriolar smooth muscle,C02DD01,nitroprusside,248
C0028215,IN,nitrous oxide,N01AX13,nitrous oxide,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AX,Other general anesthetics in ATC,N01AX13,nitrous oxide,1773
C0028277,IN,nomifensine,N06AX04,nomifensine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX04,nomifensine,6
C0028351,IN,norepinephrine,C01CA03,norepinephrine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA03,norepinephrine,1635
C0028355,IN,norethandrolone,A14AA09,norethandrolone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,A14AA09,norethandrolone,9
C0028356,IN,norethindrone,G03AC01,norethisterone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03A,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,G03AC,Progestogen systemic hormonal contraceptives,G03AC01,norethisterone,405
C0028356,IN,norethindrone,G03DC02,norethisterone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03D,PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03DC,"Estren derivatives, sex hormones and modulators of the genital system",G03DC02,norethisterone,405
C0028365,IN,norfloxacin,J01MA06,norfloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA06,norfloxacin,135
C0028365,IN,norfloxacin,S01AE02,norfloxacin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AE,"Fluoroquinolone antiinfectives, ophthalmologic",S01AE02,norfloxacin,135
C0028369,IN,norgestrienone,G03AC07,norgestrienone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03A,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,G03AC,Progestogen systemic hormonal contraceptives,G03AC07,norgestrienone,9
C0028403,IN,octopamine,C01CA18,octopamine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA18,octopamine,10
C0028420,IN,nortriptyline,N06AA10,nortriptyline,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AA,Non-selective monoamine reuptake inhibitors,N06AA10,nortriptyline,85
C0028426,IN,noscapine,R05DA07,noscapine,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DA,"Opium alkaloids and derivatives, cough suppressants",R05DA07,noscapine,4
C0028735,IN,nylidrin,C04AA02,buphenine,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AA,2-amino-1-phenylethanol derivatives,C04AA02,buphenine,26
C0028735,IN,nylidrin,G02CA02,buphenine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02C,OTHER GYNECOLOGICALS in ATC,G02CA,"Sympathomimetics, labour repressants",G02CA02,buphenine,26
C0028741,IN,nystatin,A07AA02,nystatin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,"antibiotics, intestinal",A07AA02,nystatin,169
C0028741,IN,nystatin,D01AA01,nystatin,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AA,"Antifungal Antibiotics, Topical",D01AA01,nystatin,169
C0028741,IN,nystatin,G01AA01,nystatin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AA,"Antibiotics, Gynecological",G01AA01,nystatin,169
C0028833,IN,octreotide,H01CB02,octreotide,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CB,Somatostatin and analogues,H01CB02,octreotide,564
C0028902,IN,ofloxacin,J01MA01,ofloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA01,ofloxacin,397
C0028902,IN,ofloxacin,S01AE01,ofloxacin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AE,"Fluoroquinolone antiinfectives, ophthalmologic",S01AE01,ofloxacin,397
C0028902,IN,ofloxacin,S02AA16,ofloxacin,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA16,ofloxacin,397
C0028923,IN,oleandomycin,J01FA05,oleandomycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,J01FA05,oleandomycin,6
C0028978,IN,omeprazole,A02BC01,omeprazole,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors for peptic ulcer and GORD,A02BC01,omeprazole,425
C0029105,IN,opipramol,N06AA05,opipramol,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AA,Non-selective monoamine reuptake inhibitors,N06AA05,opipramol,2
C0029112,IN,opium,A07DA02,opium,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07D,ANTIPROPULSIVES,A07DA,Antipropulsives,A07DA02,opium,110
C0029112,IN,opium,N02AA02,opium,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AA,Natural opium alkaloid analgesics,N02AA02,opium,110
C0029193,IN,metaproterenol,R03AB03,orciprenaline,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AB,Non-selective beta-adrenoreceptor agonist inhalants,R03AB03,orciprenaline,102
C0029193,IN,metaproterenol,R03CB03,orciprenaline,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CB,Non-selective beta-adrenoreceptor agonists for systemic use,R03CB03,orciprenaline,102
C0029274,IN,ornidazole,G01AF06,ornidazole,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AF,"Imidazole derivatives, gyncological antiinfectives",G01AF06,ornidazole,39
C0029274,IN,ornidazole,J01XD03,ornidazole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XD,"Imidazole derivatives, antibacterial for systemic use",J01XD03,ornidazole,39
C0029274,IN,ornidazole,P01AB03,ornidazole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AB,"Nitroimidazole derivatives, antiprotozoal agents against amoebiasis and other protozoal diseases",P01AB03,ornidazole,39
C0029276,IN,ornipressin,H01BA05,ornipressin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BA,Vasopressin and analogues,H01BA05,ornipressin,10
C0029904,IN,ouabain,C01AC01,g-strophanthin,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01A,CARDIAC GLYCOSIDES,C01AC,Strophanthus glycosides used in cardiac therapy,C01AC01,g-strophanthin,84
C0029983,IN,oxacillin,J01CF04,oxacillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CF,Beta-lactamase resistant penicillins,J01CF04,oxacillin,294
C0029994,IN,oxamniquine,P02BA02,oxamniquine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02B,ANTITREMATODALS,P02BA,"Quinoline derivatives and related substances, antitrematodals",P02BA02,oxamniquine,76
C0029995,IN,oxandrolone,A14AA08,oxandrolone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,A14AA08,oxandrolone,159
C0029997,IN,oxazepam,N05BA04,oxazepam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA04,oxazepam,43
C0030031,IN,oxolinic acid,J01MB05,oxolinic acid,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MB,Other quinolones in ATC,J01MB05,oxolinic acid,6
C0030040,IN,oxprenolol,C07AA02,oxprenolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AA,"Beta blocking agents, non-selective",C07AA02,oxprenolol,16
C0030049,IN,oxycodone,N02AA05,oxycodone,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AA,Natural opium alkaloid analgesics,N02AA05,oxycodone,285
C0030054,IN,oxygen,V03AN01,oxygen,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AN,Medical gases,V03AN01,oxygen,12963
C0030071,IN,oxymetazoline,D11AX27,oxymetazoline,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AX,OTHER DERMATOLOGICAL PREPARATIONS IN ATC,D11AX27,oxymetazoline,43
C0030071,IN,oxymetazoline,R01AA05,oxymetazoline,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AA,"Sympathomimetics, plain",R01AA05,oxymetazoline,43
C0030071,IN,oxymetazoline,R01AB07,oxymetazoline,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AB,"Sympathomimetics, combinations excl. corticosteroids",R01AB07,oxymetazoline,43
C0030071,IN,oxymetazoline,S01GA04,oxymetazoline,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GA,Sympathomimetics used as decongestants,S01GA04,oxymetazoline,43
C0030072,IN,oxymetholone,A14AA05,oxymetholone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,A14AA05,oxymetholone,53
C0030073,IN,oxymorphone,N02AA11,oxymorphone,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AA,Natural opium alkaloid analgesics,N02AA11,oxymorphone,17
C0030078,IN,oxyphenbutazone,M01AA03,oxyphenbutazone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AA,"Butylpyrazolidines, antiinflammatory and antirheumatic drugs",M01AA03,oxyphenbutazone,14
C0030078,IN,oxyphenbutazone,M02AA04,oxyphenbutazone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA04,oxyphenbutazone,14
C0030078,IN,oxyphenbutazone,S01BC02,oxyphenbutazone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BC,"Antiinflammatory agents, non-steroidal, ophthalmologic",S01BC02,oxyphenbutazone,14
C0030082,IN,oxyphenonium,A03AB03,oxyphenonium,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds for functional gastrointestinal disorders",A03AB03,oxyphenonium,3
C0030092,IN,oxytetracycline,A01AB25,oxytetracycline,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB25,oxytetracycline,66
C0030092,IN,oxytetracycline,D06AA03,oxytetracycline,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AA,"Tetracycline and derivatives, topical antibiotics",D06AA03,oxytetracycline,66
C0030092,IN,oxytetracycline,G01AA07,oxytetracycline,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AA,"Antibiotics, Gynecological",G01AA07,oxytetracycline,66
C0030092,IN,oxytetracycline,J01AA06,oxytetracycline,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,Tetracycline antibiotics,J01AA,Tetracyclines,J01AA06,oxytetracycline,66
C0030092,IN,oxytetracycline,S01AA04,oxytetracycline,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA04,oxytetracycline,66
C0030095,IN,oxytocin,H01BB02,oxytocin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BB,Oxytocin and analogues,H01BB02,oxytocin,2956
C0030123,IN,4-aminohippuric acid,V04CH30,aminohippuric acid,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CH,renal function and ureteral injuries test diagnostic agents,V04CH30,aminohippuric acid,95
C0030125,IN,aminosalicylic acid,J04AA01,4-aminosalicylic acid,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AA,Aminosalicylic acid and derivatives,J04AA01,4-aminosalicylic acid,64
C0030310,IN,pancuronium,M03AC01,pancuronium,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,"Other quaternary ammonium compounds in ATC, muscle relaxants, peripherally acting",M03AC01,pancuronium,277
C0030350,IN,papaverine,A03AD01,papaverine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AD,Papaverine and derivatives containing drugs for functional gastrointestinal disorders,A03AD01,papaverine,42
C0030350,IN,papaverine,G04BE02,papaverine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BE,Drugs used in erectile dysfunction,G04BE02,papaverine,42
C0030438,IN,paraldehyde,N05CC05,paraldehyde,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CC,Aldehydes and derivatives,N05CC05,paraldehyde,28
C0030454,IN,paramethasone,H02AB05,paramethasone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,"Glucocorticoids, Systemic",H02AB05,paramethasone,5
C0030480,,,S01EB10,paraoxon,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EB,"Parasympathomimetics, antiglaucoma preparations and miotics",S01EB10,paraoxon,22
C0030520,IN,parathyroid hormone,H05AA03,parathyroid hormone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05A,PARATHYROID HORMONES AND ANALOGUES,H05AA,Parathyroid hormones and analogues,H05AA03,parathyroid hormone,2884
C0030557,IN,pargyline,C02KC01,pargyline,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02K,OTHER ANTIHYPERTENSIVES in ATC,C02KC,"MAO inhibitors, antihypertensives",C02KC01,pargyline,3
C0030576,IN,paromomycin,A07AA06,paromomycin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,"antibiotics, intestinal",A07AA06,paromomycin,91
C0030771,IN,pefloxacin,J01MA03,pefloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA03,pefloxacin,56
C0030800,IN,pemoline,N06BA05,pemoline,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BA,Centrally acting sympathomimetics,N06BA05,pemoline,60
C0030815,IN,penfluridol,N05AG03,penfluridol,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AG,"Diphenylbutylpiperidine derivatives, antipsychotics",N05AG03,penfluridol,5
C0030817,IN,penicillamine,M01CC01,penicillamine,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01C,SPECIFIC ANTIRHEUMATIC AGENTS,M01CC,Penicillamine and similar antirheumatic agents,M01CC01,penicillamine,450
C0030827,IN,penicillin G,J01CE01,benzylpenicillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,J01CE01,benzylpenicillin,783
C0030827,IN,penicillin G,S01AA14,benzylpenicillin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA14,benzylpenicillin,783
C0030830,PIN,penicillin G procaine,J01CE09,procaine benzylpenicillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,J01CE09,procaine benzylpenicillin,64
C0030840,IN,penicillin V,J01CE02,phenoxymethylpenicillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,J01CE02,phenoxymethylpenicillin,393
C0030858,PIN,pentaerythritol tetranitrate,C01DA05,pentaerithrityl tetranitrate,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01D,VASODILATORS USED IN CARDIAC DISEASES,C01DA,Organic nitrates used in cardiac disease,C01DA05,pentaerithrityl tetranitrate,187
C0030859,IN,pentagastrin,V04CG04,pentagastrin,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CG,gastric secretion test diagnostic agents,V04CG04,pentagastrin,139
C0030873,IN,pentazocine,N02AD01,pentazocine,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AD,Benzomorphan derivative analgesics,N02AD01,pentazocine,82
C0030883,IN,pentobarbital,N05CA01,pentobarbital,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CA,"Barbiturates, hypnotics and sedatives, plain",N05CA01,pentobarbital,221
C0030895,IN,sodium stibogluconate,P01CB02,sodium stibogluconate,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01C,AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS,P01CB,Antimony compounds for treatment of leishmaniasis and trypanosomiasis,P01CB02,sodium stibogluconate,223
C0030896,IN,pentostatin,L01XX08,pentostatin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX08,pentostatin,28
C0030899,IN,pentoxifylline,C04AD03,pentoxifylline,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AD,"Purine derivatives, peripheral vasodilators",C04AD03,pentoxifylline,142
C0030903,IN,pentylenetetrazole,R07AB03,pentetrazol,R,RESPIRATORY SYSTEM DRUGS,R07,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07A,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07AB,Respiratory stimulants,R07AB03,pentetrazol,3
C0030909,IN,pepsin A,A09AA03,pepsin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A09,"DIGESTIVES, INCL. ENZYMES",A09A,"DIGESTIVES, INCL. ENZYMES",A09AA,"Enzyme preparations, digestives",A09AA03,pepsin,180
C0030969,IN,perazine,N05AB10,perazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AB,"Phenothiazines with piperazine structure, antipsychotics",N05AB10,perazine,3
C0031007,IN,pergolide,N04BC02,pergolide,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04B,DOPAMINERGIC AGENTS,N04BC,Dopamine agonists,N04BC02,pergolide,17
C0031013,IN,perhexiline,C08EX02,perhexiline,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08E,NON-SELECTIVE CALCIUM CHANNEL BLOCKERS,C08EX,Other non-selective calcium channel blockers in ATC,C08EX02,perhexiline,2
C0031184,IN,perphenazine,N05AB03,perphenazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AB,"Phenothiazines with piperazine structure, antipsychotics",N05AB03,perphenazine,32
C0031237,IN,pertussis vaccine,J07AJ,Pertussis vaccines,J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AJ,Pertussis vaccines,,,1861
C0031364,IN,phenacetin,N02BE03,phenacetin,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BE,Anilide analgesics and antipyretics,N02BE03,phenacetin,21
C0031379,IN,phenazopyridine,G04BX06,phenazopyridine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BX,Other urologicals in ATC,G04BX06,phenazopyridine,7
C0031392,IN,phenelzine,N06AF03,phenelzine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AF,"Monoamine oxidase inhibitors, non-selective",N06AF03,phenelzine,11
C0031404,IN,phenformin,A10BA01,phenformin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BA,biguanide blood glucose lower drugs,A10BA01,phenformin,7
C0031406,IN,phenindione,B01AA02,phenindione,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AA,Vitamin K antagonists,B01AA02,phenindione,13
C0031408,IN,pheniramine,D04AA16,pheniramine,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AA,Antihistamines for topical use,D04AA16,pheniramine,11
C0031408,IN,pheniramine,R06AB05,pheniramine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AB,"Substituted alkylamines, systemic antihistamines",R06AB05,pheniramine,11
C0031412,IN,phenobarbital,N03AA02,phenobarbital,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AA,Barbiturates and derivatives,N03AA02,phenobarbital,2032
C0031422,IN,oxyphenisatin,A06AB01,oxyphenisatine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,A06AB01,oxyphenisatine,2
C0031430,IN,phenolsulfonphthalein,V04CH03,phenolsulfonphthalein,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CH,renal function and ureteral injuries test diagnostic agents,V04CH03,phenolsulfonphthalein,15
C0031432,IN,phenoperidine,N01AH04,phenoperidine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AH,Opioid anesthetics,N01AH04,phenoperidine,7
C0031441,IN,phenoxybenzamine,C04AX02,phenoxybenzamine,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AX,Other peripheral vasodilators in ATC,C04AX02,phenoxybenzamine,95
C0031444,IN,phenprocoumon,B01AA04,phenprocoumon,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AA,Vitamin K antagonists,B01AA04,phenprocoumon,45
C0031447,IN,phentermine,A08AA01,phentermine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,A08AA01,phentermine,18
C0031448,IN,phentolamine,C04AB01,phentolamine,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AB,"Imidazoline derivatives, peripheral vasodilators",C04AB01,phentolamine,75
C0031448,IN,phentolamine,V03AB36,phentolamine,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB36,phentolamine,75
C0031463,IN,phenylbutazone,M01AA01,phenylbutazone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AA,"Butylpyrazolidines, antiinflammatory and antirheumatic drugs",M01AA01,phenylbutazone,30
C0031463,IN,phenylbutazone,M02AA01,phenylbutazone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA01,phenylbutazone,30
C0031469,IN,phenylephrine,C01CA06,phenylephrine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA06,phenylephrine,452
C0031469,IN,phenylephrine,C05AX06,phenylephrine,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AX,Other agents for treatment of hemorrhoids and anal fissures for topical use in ATC,C05AX06,phenylephrine,452
C0031469,IN,phenylephrine,R01AA04,phenylephrine,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AA,"Sympathomimetics, plain",R01AA04,phenylephrine,452
C0031469,IN,phenylephrine,R01AB01,phenylephrine,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AB,"Sympathomimetics, combinations excl. corticosteroids",R01AB01,phenylephrine,452
C0031469,IN,phenylephrine,R01BA03,phenylephrine,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01B,NASAL DECONGESTANTS FOR SYSTEMIC USE,R01BA,Sympathomimetics,R01BA03,phenylephrine,452
C0031469,IN,phenylephrine,S01FB01,phenylephrine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01F,MYDRIATICS AND CYCLOPLEGICS,S01FB,Sympathomimetics excl. antiglaucoma preparations,S01FB01,phenylephrine,452
C0031469,IN,phenylephrine,S01GA05,phenylephrine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GA,Sympathomimetics used as decongestants,S01GA05,phenylephrine,452
C0031495,IN,phenylpropanolamine,R01BA01,phenylpropanolamine,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01B,NASAL DECONGESTANTS FOR SYSTEMIC USE,R01BA,Sympathomimetics,R01BA01,phenylpropanolamine,92
C0031507,IN,phenytoin,N03AB02,phenytoin,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AB,"Hydantoin derivatives, antiepileptics",N03AB02,phenytoin,1898
C0031566,IN,phloroglucinol,A03AX12,phloroglucinol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders in ATC,A03AX12,phloroglucinol,13
C0031634,,,C01EB06,fosfocreatine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01E,OTHER CARDIAC PREPARATIONS in ATC,C01EB,Other plain cardiac preparations in ATC,C01EB06,fosfocreatine,351
C0031676,,,A05BA10,phospholipids,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A05,BILE AND LIVER THERAPY DRUGS,A05B,"LIVER THERAPY, LIPOTROPICS",A05BA,Liver therapy drugs,A05BA10,phospholipids,3409
C0031681,,,J05AD02,fosfonet,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AD,"Phosphonic acid derivatives, direct acting antivirals",J05AD02,fosfonet,8
C0031849,IN,physostigmine,S01EB05,physostigmine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EB,"Parasympathomimetics, antiglaucoma preparations and miotics",S01EB05,physostigmine,87
C0031849,IN,physostigmine,V03AB19,physostigmine,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB19,physostigmine,87
C0031862,IN,vitamin K1,B02BA01,phytomenadione,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BA,Vitamin K containing hemostatics,B02BA01,phytomenadione,1072
C0031923,IN,pilocarpine,N07AX01,pilocarpine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07A,PARASYMPATHOMIMETICS,N07AX,Other parasympathomimetics in ATC,N07AX01,pilocarpine,110
C0031923,IN,pilocarpine,S01EB01,pilocarpine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EB,"Parasympathomimetics, antiglaucoma preparations and miotics",S01EB01,pilocarpine,110
C0031935,IN,pimozide,N05AG02,pimozide,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AG,"Diphenylbutylpiperidine derivatives, antipsychotics",N05AG02,pimozide,72
C0031937,IN,pindolol,C07AA03,pindolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AA,"Beta blocking agents, non-selective",C07AA03,pindolol,46
C0031953,PIN,pipemidic acid,J01MB04,pipemidic acid,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MB,Other quinolones in ATC,J01MB04,pipemidic acid,6
C0031955,IN,piperacillin,J01CA12,piperacillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA12,piperacillin,465
C0031957,IN,piperazine,P02CB01,piperazine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02C,ANTINEMATODAL AGENTS,P02CB,"Piperazine and derivatives, antinematodal agents",P02CB01,piperazine,940
C0031965,IN,pipobroman,L01AX02,pipobroman,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AX,Other alkylating agents in ATC,L01AX02,pipobroman,2
C0031968,IN,pipothiazine,N05AC04,pipotiazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AC,"Phenothiazines with piperidine structure, antipsychotics",N05AC04,pipotiazine,1
C0031977,IN,piracetam,N06BX03,piracetam,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BX,Other psychostimulants and nootropics in ATC,N06BX03,piracetam,442
C0031978,IN,pirenzepine,A02BX03,pirenzepine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC,A02BX03,pirenzepine,79
C0031979,IN,piribedil,N04BC08,piribedil,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04B,DOPAMINERGIC AGENTS,N04BC,Dopamine agonists,N04BC08,piribedil,3
C0031982,IN,pirinitramide,N02AC03,piritramide,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AC,Diphenylpropylamine derivative analgesics,N02AC03,piritramide,34
C0031990,IN,piroxicam,M01AC01,piroxicam,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AC,"Oxicams, antiinflammatory and antirheumatic drugs",M01AC01,piroxicam,46
C0031990,IN,piroxicam,M02AA07,piroxicam,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA07,piroxicam,46
C0031990,IN,piroxicam,S01BC06,piroxicam,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BC,"Antiinflammatory agents, non-steroidal, ophthalmologic",S01BC06,piroxicam,46
C0032032,IN,pivampicillin,J01CA02,pivampicillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA02,pivampicillin,45
C0032036,IN,pizotyline,N02CX01,pizotifen,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CX,Other antimigraine preparations in ATC,N02CX01,pizotifen,24
C0032066,,,J07AK,Plague vaccines,J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AK,Plague vaccines,,,2
C0032143,IN,alteplase,B01AD02,alteplase,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AD,"Enzymes, antithrombotic",B01AD02,alteplase,716
C0032143,IN,alteplase,S01XA13,alteplase,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA13,alteplase,716
C0032334,IN,podofilox,D06BB04,podophyllotoxin,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,D06BB,"Antivirals, topical",D06BB04,podophyllotoxin,117
C0032483,IN,polyethylene glycols,A06AD15,macrogol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,A06AD15,macrogol,1145
C0032535,IN,polymyxin B,A07AA05,polymyxin B,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,"antibiotics, intestinal",A07AA05,polymyxin B,134
C0032535,IN,polymyxin B,J01XB02,polymyxin B,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XB,Polymyxins,J01XB02,polymyxin B,134
C0032535,IN,polymyxin B,S01AA18,polymyxin B,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA18,polymyxin B,134
C0032535,IN,polymyxin B,S02AA11,polymyxin B,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA11,polymyxin B,134
C0032535,IN,polymyxin B,S03AA03,polymyxin B,S,SENSORY ORGAN DRUGS,S03,OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,S03A,"ANTIINFECTIVES, OPHTHALMOLOGIC AND OTOLOGIC",S03AA,Antiinfectives,S03AA03,polymyxin B,134
C0032613,IN,polythiazide,C03AA05,polythiazide,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03A,"LOW-CEILING DIURETICS, THIAZIDES",C03AA,"Thiazides, plain",C03AA05,polythiazide,1
C0032825,IN,potassium chloride,A12BA01,potassium chloride,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12B,POTASSIUM SUPPLEMENTS,A12BA,Potassium,A12BA01,potassium chloride,349
C0032825,IN,potassium chloride,B05XA01,potassium chloride,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA01,potassium chloride,349
C0032831,IN,potassium iodide,R05CA02,potassium iodide,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CA,Expectorants,R05CA02,potassium iodide,166
C0032831,IN,potassium iodide,S01XA04,potassium iodide,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA04,potassium iodide,166
C0032831,IN,potassium iodide,V03AB21,potassium iodide,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB21,potassium iodide,166
C0032838,IN,potassium permanganate,D08AX06,potassium permanganate,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AX,Other antiseptics and disinfectants in ATC,D08AX06,potassium permanganate,21
C0032838,IN,potassium permanganate,V03AB18,potassium permanganate,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB18,potassium permanganate,21
C0032857,IN,povidone-iodine,D08AG02,povidone-iodine,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AG,"Iodine products, antiseptics and disinfectants",D08AG02,povidone-iodine,339
C0032857,IN,povidone-iodine,D09AA09,povidone-iodine,D,DERMATOLOGICALS,D09,MEDICATED DRESSINGS,D09A,MEDICATED DRESSINGS,D09AA,Medicated dressings with antiinfectives,D09AA09,povidone-iodine,339
C0032857,IN,povidone-iodine,D11AC06,povidone-iodine,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AC,Medicated shampoos,D11AC06,povidone-iodine,339
C0032857,IN,povidone-iodine,G01AX11,povidone-iodine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AX,Other gynecological antiinfectives and antiseptics in ATC,G01AX11,povidone-iodine,339
C0032857,IN,povidone-iodine,R02AA15,povidone-iodine,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AA,Antiseptic throat preparations,R02AA15,povidone-iodine,339
C0032857,IN,povidone-iodine,S01AX18,povidone-iodine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AX,Other antiinfectives in ATC,S01AX18,povidone-iodine,339
C0032896,IN,practolol,C07AB01,practolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AB,"Beta blocking agents, selective",C07AB01,practolol,10
C0032899,IN,prajmaline,C01BA08,prajmaline,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BA,"Antiarrhythmics, class Ia",C01BA08,prajmaline,3
C0032910,IN,prazepam,N05BA11,prazepam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA11,prazepam,8
C0032911,IN,praziquantel,P02BA01,praziquantel,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02B,ANTITREMATODALS,P02BA,"Quinoline derivatives and related substances, antitrematodals",P02BA01,praziquantel,1143
C0032912,IN,prazosin,C02CA01,prazosin,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02C,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",C02CA,"Alpha-adrenoreceptor antagonists, peripherally acting",C02CA01,prazosin,92
C0032949,IN,prednimustine,L01AA08,prednimustine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AA,Nitrogen mustard analogues,L01AA08,prednimustine,3
C0032950,IN,prednisolone,A01AC04,prednisolone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AC,Corticosteroids for local oral treatment,A01AC04,prednisolone,4670
C0032950,IN,prednisolone,A07EA01,prednisolone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EA,Corticosteroids acting locally,A07EA01,prednisolone,4670
C0032950,IN,prednisolone,C05AA04,prednisolone,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AA,"Corticosteroids, topical for treatment of hemorrhoids and anal fissures",C05AA04,prednisolone,4670
C0032950,IN,prednisolone,D07AA03,prednisolone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AA,"Corticosteroids, weak (group I)",D07AA03,prednisolone,4670
C0032950,IN,prednisolone,D07XA02,prednisolone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07X,"CORTICOSTEROIDS, OTHER COMBINATIONS",D07XA,"Corticosteroids, weak, other combinations",D07XA02,prednisolone,4670
C0032950,IN,prednisolone,H02AB06,prednisolone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,"Glucocorticoids, Systemic",H02AB06,prednisolone,4670
C0032950,IN,prednisolone,R01AD02,prednisolone,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AD,Corticosteroid nasal preparations for topical use,R01AD02,prednisolone,4670
C0032950,IN,prednisolone,S01BA04,prednisolone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BA,"Corticosteroid ophthalmologic antiinflammatory agents, plain",S01BA04,prednisolone,4670
C0032950,IN,prednisolone,S01CB02,prednisolone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01C,ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION,S01CB,Corticosteroids/antiinfectives/mydriatics in combination,S01CB02,prednisolone,4670
C0032950,IN,prednisolone,S02BA03,prednisolone,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02B,Corticosteroid otologicals,S02BA,Corticosteroids,S02BA03,prednisolone,4670
C0032950,IN,prednisolone,S03BA02,prednisolone,S,SENSORY ORGAN DRUGS,S03,OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,S03B,Corticosteroid ophthalmologic and otologic preparations,S03BA,Corticosteroids,S03BA02,prednisolone,4670
C0032952,IN,prednisone,A07EA03,prednisone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EA,Corticosteroids acting locally,A07EA03,prednisone,6403
C0032952,IN,prednisone,H02AB07,prednisone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,"Glucocorticoids, Systemic",H02AB07,prednisone,6403
C0033056,IN,feprazone,M01AX18,feprazone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids in ATC",M01AX18,feprazone,4
C0033056,IN,feprazone,M02AA16,feprazone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA16,feprazone,4
C0033059,IN,prenylamine,C01DX02,prenylamine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01D,VASODILATORS USED IN CARDIAC DISEASES,C01DX,Other vasodilators used in cardiac diseases in ATC,C01DX02,prenylamine,1
C0033124,IN,prilocaine,N01BB04,prilocaine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BB,Amide local anesthetics,N01BB04,prilocaine,327
C0033126,IN,primaquine,P01BA03,primaquine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BA,Aminoquinoline antimalarials,P01BA03,primaquine,305
C0033148,IN,primidone,N03AA03,primidone,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AA,Barbiturates and derivatives,N03AA03,primidone,188
C0033209,IN,probenecid,M04AB01,probenecid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AB,Preparations increasing uric acid excretion,M04AB01,probenecid,96
C0033215,IN,probucol,C10AX02,probucol,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AX,Other lipid modifying agents in ATC,C10AX02,probucol,17
C0033216,IN,procainamide,C01BA02,procainamide,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BA,"Antiarrhythmics, class Ia",C01BA02,procainamide,86
C0033218,IN,procaine,C05AD05,procaine,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AD,Local anesthetics for treatment of hemorrhoids and anal fissures for topical use,C05AD05,procaine,138
C0033218,IN,procaine,N01BA02,procaine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BA,Esters of aminobenzoic acid for local anesthesia,N01BA02,procaine,138
C0033218,IN,procaine,S01HA05,procaine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01H,"Local anesthetics, ophthalmologic",S01HA,Local anesthetics,S01HA05,procaine,138
C0033223,IN,procarbazine,L01XB01,procarbazine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XB,"Methylhydrazines, antineoplastics",L01XB01,procarbazine,568
C0033228,IN,fenofibrate,C10AB05,fenofibrate,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AB,"Fibrates, lipid modifying drugs, plain",C10AB05,fenofibrate,40
C0033229,IN,prochlorperazine,N05AB04,prochlorperazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AB,"Phenothiazines with piperazine structure, antipsychotics",N05AB04,prochlorperazine,60
C0033254,IN,procyclidine,N04AA04,procyclidine,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04A,ANTICHOLINERGIC AGENTS,N04AA,"Tertiary amines, anticholinergic",N04AA04,procyclidine,5
C0033308,IN,progesterone,G03DA04,progesterone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03D,PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03DA,"Pregnen (4) derivatives, progestogens",G03DA04,progesterone,4125
C0033399,IN,promazine,N05AA03,promazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AA,"Phenothiazines with aliphatic side-chain, antipsychotics",N05AA03,promazine,23
C0033401,IN,promegestone,G03DB07,promegestone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03D,PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03DB,"Pregnadien derivatives, progestogens",G03DB07,promegestone,2
C0033405,IN,promethazine,D04AA10,promethazine,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AA,Antihistamines for topical use,D04AA10,promethazine,182
C0033405,IN,promethazine,R06AD02,promethazine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AD,"Phenothiazine derivatives, systemic antihistamines",R06AD02,promethazine,182
C0033429,IN,propafenone,C01BC03,propafenone,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BC,"Antiarrhythmics, class Ic",C01BC03,propafenone,95
C0033439,IN,propanidid,N01AX04,propanidid,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AX,Other general anesthetics in ATC,N01AX04,propanidid,25
C0033447,IN,propantheline,A03AB05,propantheline,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds for functional gastrointestinal disorders",A03AB05,propantheline,20
C0033459,IN,periciazine,N05AC01,periciazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AC,"Phenothiazines with piperidine structure, antipsychotics",N05AC01,periciazine,7
C0033473,IN,propiomazine,N05CM06,propiomazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CM,Other hypnotics and sedatives in ATC,N05CM06,propiomazine,2
C0033487,IN,propofol,N01AX10,propofol,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AX,Other general anesthetics in ATC,N01AX10,propofol,2199
C0033493,IN,propoxyphene,N02AC04,dextropropoxyphene,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AC,Diphenylpropylamine derivative analgesics,N02AC04,dextropropoxyphene,64
C0033497,IN,propranolol,C07AA05,propranolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AA,"Beta blocking agents, non-selective",C07AA05,propranolol,1707
C0033509,IN,propyliodone,V08AD03,propyliodone,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AD,Non-watersoluble X-ray contrast media,V08AD03,propyliodone,3
C0033511,IN,propylthiouracil,H03BA02,propylthiouracil,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY DRUGS,H03B,ANTITHYROID PREPARATIONS,H03BA,Thiouracil antithyroid preparations,H03BA02,propylthiouracil,385
C0033567,IN,epoprostenol,B01AC09,epoprostenol,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC09,epoprostenol,653
C0033603,IN,protamines,V03AB14,protamine,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB14,protamine,210
C0033631,,,B05BA04,protein hydrolysates,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05B,"IV solutions used in parenteral administration of fluids, electrolytes and nutrients",B05BA,Solutions for parenteral nutrition,B05BA04,protein hydrolysates,244
C0033705,IN,prothionamide,J04AD01,protionamide,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AD,Thiocarbamide derivatives for treatment of tuberculosis,J04AD01,protionamide,11
C0033743,IN,protriptyline,N06AA11,protriptyline,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AA,Non-selective monoamine reuptake inhibitors,N06AA11,protriptyline,6
C0033798,IN,pseudoephedrine,R01BA02,pseudoephedrine,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01B,NASAL DECONGESTANTS FOR SYSTEMIC USE,R01BA,Sympathomimetics,R01BA02,pseudoephedrine,120
C0034235,IN,pyrantel,P02CC01,pyrantel,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02C,ANTINEMATODAL AGENTS,P02CC,"Tetrahydropyrimidine derivatives, antinematodal",P02CC01,pyrantel,104
C0034239,IN,pyrazinamide,J04AK01,pyrazinamide,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AK,Other drugs for treatment of tuberculosis in ATC,J04AK01,pyrazinamide,440
C0034261,IN,pyridostigmine,N07AA02,pyridostigmine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07A,PARASYMPATHOMIMETICS,N07AA,Anticholinesterase parasympathomimetics,N07AA02,pyridostigmine,228
C0034266,PIN,pyridoxal phosphate,A11HA06,pyridoxal phosphate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS in ATC,A11HA,Other plain vitamin preparations in ATC,A11HA06,pyridoxal phosphate,258
C0034272,IN,pyridoxine,A11HA02,pyridoxine (vit B6),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS in ATC,A11HA,Other plain vitamin preparations in ATC,A11HA02,pyridoxine (vit B6),1176
C0034282,IN,pyrilamine,D04AA02,mepyramine,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AA,Antihistamines for topical use,D04AA02,mepyramine,6
C0034282,IN,pyrilamine,R06AC01,mepyramine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AC,"Substituted ethylene diamines, systemic antihistamines",R06AC01,mepyramine,6
C0034283,IN,pyrimethamine,P01BD01,pyrimethamine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BD,"Diaminopyrimidines, antimalarials",P01BD01,pyrimethamine,1063
C0034295,IN,pyrithioxin,N06BX02,pyritinol,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BX,Other psychostimulants and nootropics in ATC,N06BX02,pyritinol,4
C0034403,IN,quinacrine,P01AX05,mepacrine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AX,Other agents against amoebiasis and other protozoal diseases in ATC,P01AX05,mepacrine,51
C0034414,IN,quinidine,C01BA01,quinidine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BA,"Antiarrhythmics, class Ia",C01BA01,quinidine,135
C0034417,IN,quinine,P01BC01,quinine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BC,"Methanolquinolines, antimalarial",P01BC01,quinine,647
C0034665,IN,ranitidine,A02BA02,ranitidine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BA,H2-receptor antagonists,A02BA02,ranitidine,302
C0035158,,,B02BX03,batroxobin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BX,Other systemic hemostatics in ATC,B02BX03,batroxobin,14
C0035179,IN,reserpine,C02AA02,reserpine,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02A,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",C02AA,Rauwolfia alkaloids,C02AA02,reserpine,30
C0035525,IN,ribavirin,J05AP01,ribavirin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,J05AP01,ribavirin,660
C0035527,IN,riboflavin,A11HA04,riboflavin (vit B2),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS in ATC,A11HA,Other plain vitamin preparations in ATC,A11HA04,riboflavin (vit B2),1019
C0035527,IN,riboflavin,S01XA26,riboflavin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA26,riboflavin,1019
C0035554,,,J01GB10,ribostamycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides in ATC,J01GB10,ribostamycin,4
C0035608,IN,rifampin,J04AB02,rifampicin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AB,"Antibiotics, Antitubercular",J04AB02,rifampicin,1980
C0035629,IN,rimantadine,J05AC02,rimantadine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AC,"Cyclic amines, direct acting antivirals",J05AC02,rimantadine,37
C0035633,IN,rimiterol,R03AC05,rimiterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC05,rimiterol,2
C0035661,IN,ritodrine,G02CA01,ritodrine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02C,OTHER GYNECOLOGICALS in ATC,G02CA,"Sympathomimetics, labour repressants",G02CA01,ritodrine,516
C0035823,IN,rolitetracycline,J01AA09,rolitetracycline,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,Tetracycline antibiotics,J01AA,Tetracyclines,J01AA09,rolitetracycline,3
C0035891,IN,roxithromycin,J01FA06,roxithromycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,J01FA06,roxithromycin,77
C0035976,IN,rutin,C05CA01,rutoside,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05C,CAPILLARY STABILIZING AGENTS,C05CA,Bioflavonoid drugs for capillary stabilizing,C05CA01,rutoside,36
C0036002,IN,S-adenosylmethionine,A16AA02,ademetionine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AA,Amino acids and derivatives,A16AA02,ademetionine,147
C0036071,IN,salicylamide,N02BA05,salicylamide,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BA,"Salicylic acid and derivatives, analgesics and antipyretics",N02BA05,salicylamide,6
C0036078,IN,sulfasalazine,A07EC01,sulfasalazine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EC,Aminosalicylic acid and similar agents,A07EC01,sulfasalazine,270
C0036079,IN,salicylic acid,D01AE12,salicylic acid,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AE,Other antifungals for topical use in ATC,D01AE12,salicylic acid,229
C0036079,IN,salicylic acid,S01BC08,salicylic acid,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BC,"Antiinflammatory agents, non-steroidal, ophthalmologic",S01BC08,salicylic acid,229
C0036442,IN,scopolamine,A04AD01,scopolamine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics in ATC,A04AD01,scopolamine,173
C0036442,IN,scopolamine,N05CM05,scopolamine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CM,Other hypnotics and sedatives in ATC,N05CM05,scopolamine,173
C0036442,IN,scopolamine,S01FA02,scopolamine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01F,MYDRIATICS AND CYCLOPLEGICS,S01FA,Anticholinergic mydriatics and cycloplegics,S01FA02,scopolamine,173
C0036516,IN,secobarbital,N05CA06,secobarbital,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CA,"Barbiturates, hypnotics and sedatives, plain",N05CA06,secobarbital,21
C0036534,IN,secretin,V04CK01,secretin,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CK,pancreatic function test diagnostic agents,V04CK01,secretin,8
C0036579,IN,selegiline,N04BD01,selegiline,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04B,DOPAMINERGIC AGENTS,N04BD,"MAO B Inhibitors, dopaminergic anti-parkinson drugs",N04BD01,selegiline,21
C0036637,,,L01AD03,semustine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AD,"Nitrosoureas, antineoplastic alkylating agents",L01AD03,semustine,11
C0037125,IN,silver,D08AL30,silver,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AL,"Silver compounds, antiseptics and disinfectants",D08AL30,silver,518
C0037129,IN,silver nitrate,D08AL01,silver nitrate,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AL,"Silver compounds, antiseptics and disinfectants",D08AL01,silver nitrate,141
C0037134,IN,silver sulfadiazine,D06BA01,silver sulfadiazine,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,D06BA,"Sulfonamides, topical",D06BA01,silver sulfadiazine,156
C0037167,IN,sincalide,V04CC03,sincalide,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CC,Diagnostic agents for bile duct patency testing,V04CC03,sincalide,48
C0037209,IN,sisomicin,J01GB08,sisomicin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides in ATC,J01GB08,sisomicin,32
C0037494,IN,sodium chloride,A12CA01,sodium chloride,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS in ATC,A12CA,Sodium supplements,A12CA01,sodium chloride,2039
C0037494,IN,sodium chloride,B05CB01,sodium chloride,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05C,"IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION",B05CB,Salt irrigating solutions,B05CB01,sodium chloride,2039
C0037494,IN,sodium chloride,B05XA03,sodium chloride,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA03,sodium chloride,2039
C0037508,IN,sodium fluoride,A01AA01,sodium fluoride,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AA,Caries prophylactic agents,A01AA01,sodium fluoride,463
C0037508,IN,sodium fluoride,A12CD01,sodium fluoride,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS in ATC,A12CD,Fluoride supplements,A12CD01,sodium fluoride,463
C0037512,PIN,gold sodium thiosulfate,M01CB02,sodium aurotiosulfate,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01C,SPECIFIC ANTIRHEUMATIC AGENTS,M01CB,Gold preparations,M01CB02,sodium aurotiosulfate,9
C0037537,PIN,sodium oxybate,N01AX11,sodium oxybate,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AX,Other general anesthetics in ATC,N01AX11,sodium oxybate,83
C0037537,PIN,sodium oxybate,N07XX04,sodium oxybate,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07X,OTHER NERVOUS SYSTEM DRUGS in ATC,N07XX,Other nervous system drugs in ATC,N07XX04,sodium oxybate,83
C0037556,IN,sodium tetradecyl sulfate,C05BB04,sodium tetradecyl sulfate,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05B,ANTIVARICOSE THERAPY DRUGS,C05BB,Sclerosing agents for local injection,C05BB04,sodium tetradecyl sulfate,69
C0037659,IN,somatostatin,H01CB01,somatostatin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CB,Somatostatin and analogues,H01CB01,somatostatin,677
C0037688,IN,sorbitol,A06AD18,sorbitol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,A06AD18,sorbitol,229
C0037688,IN,sorbitol,A06AG07,sorbitol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AG,Enema for Constipation,A06AG07,sorbitol,229
C0037688,IN,sorbitol,B05CX02,sorbitol,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05C,"IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION",B05CX,Other irrigating solutions in ATC,B05CX02,sorbitol,229
C0037688,IN,sorbitol,V04CC01,sorbitol,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CC,Diagnostic agents for bile duct patency testing,V04CC01,sorbitol,229
C0037707,IN,sotalol,C07AA07,sotalol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AA,"Beta blocking agents, non-selective",C07AA07,sotalol,127
C0037760,,,C01BA04,sparteine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BA,"Antiarrhythmics, class Ia",C01BA04,sparteine,2
C0037962,IN,spiramycin,J01FA02,spiramycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,J01FA02,spiramycin,132
C0037982,IN,spironolactone,C03DA01,spironolactone,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03D,ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS,C03DA,Aldosterone antagonists,C03DA01,spironolactone,287
C0038143,IN,stannous fluoride,A01AA04,stannous fluoride,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AA,Caries prophylactic agents,A01AA04,stannous fluoride,29
C0038148,,,A14AA01,androstanolone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,A14AA01,androstanolone,400
C0038148,,,G03BB02,androstanolone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03B,ANDROGENS,G03BB,5-androstanon (3) derivatives,G03BB02,androstanolone,400
C0038149,IN,stanozolol,A14AA02,stanozolol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A14,ANABOLIC AGENTS FOR SYSTEMIC USE,A14A,ANABOLIC STEROIDS,A14AA,Androstan derivatives,A14AA02,stanozolol,42
C0038418,IN,streptokinase,B01AD01,streptokinase,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AD,"Enzymes, antithrombotic",B01AD01,streptokinase,236
C0038425,IN,streptomycin,A07AA04,streptomycin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,"antibiotics, intestinal",A07AA04,streptomycin,556
C0038425,IN,streptomycin,J01GA01,streptomycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GA,Streptomycins,J01GA01,streptomycin,556
C0038432,IN,streptozocin,L01AD04,streptozocin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AD,"Nitrosoureas, antineoplastic alkylating agents",L01AD04,streptozocin,43
C0038627,IN,succinylcholine,M03AB01,suxamethonium,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AB,"Choline derivative muscle relaxants, peripherally acting",M03AB01,suxamethonium,572
C0038633,IN,sucralfate,A02BX02,sucralfate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC,A02BX02,sucralfate,56
C0038665,IN,sulbactam,J01CG01,sulbactam,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CG,"Beta-lactamase inhibitors, systemic penicillins",J01CG01,sulbactam,307
C0038666,IN,sulbenicillin,J01CA16,sulbenicillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA16,sulbenicillin,10
C0038670,IN,sulfacetamide,D10AF06,sulfacetamide,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AF,Antiinfectives for treatment of acne,D10AF06,sulfacetamide,23
C0038670,IN,sulfacetamide,S01AB04,sulfacetamide,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AB,"Sulfonamides, ophthalmologic antiinfectives",S01AB04,sulfacetamide,23
C0038675,IN,sulfadiazine,J01EC02,sulfadiazine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01EC,Intermediate-acting sulfonamides,J01EC02,sulfadiazine,220
C0038676,IN,sulfadimethoxine,J01ED01,sulfadimethoxine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01ED,Long-acting sulfonamides,J01ED01,sulfadimethoxine,3
C0038681,IN,sulfaguanidine,A07AB03,sulfaguanidine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AB,"Sulfonamides, intestinal antiinfectives",A07AB03,sulfaguanidine,1
C0038683,IN,sulfalene,J01ED02,sulfalene,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01ED,Long-acting sulfonamides,J01ED02,sulfalene,30
C0038684,IN,sulfamerazine,D06BA06,sulfamerazine,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,D06BA,"Sulfonamides, topical",D06BA06,sulfamerazine,6
C0038684,IN,sulfamerazine,J01ED07,sulfamerazine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01ED,Long-acting sulfonamides,J01ED07,sulfamerazine,6
C0038685,,,J01ED04,sulfametoxydiazine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01ED,Long-acting sulfonamides,J01ED04,sulfametoxydiazine,6
C0038686,IN,sulfamethazine,J01EB03,sulfadimidine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01EB,Short-acting sulfonamides,J01EB03,sulfadimidine,31
C0038687,IN,sulfamethizole,B05CA04,sulfamethizole,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05C,"IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION",B05CA,Antiinfective irrigating solutions,B05CA04,sulfamethizole,20
C0038687,IN,sulfamethizole,D06BA04,sulfamethizole,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,D06BA,"Sulfonamides, topical",D06BA04,sulfamethizole,20
C0038687,IN,sulfamethizole,J01EB02,sulfamethizole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01EB,Short-acting sulfonamides,J01EB02,sulfamethizole,20
C0038687,IN,sulfamethizole,S01AB01,sulfamethizole,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AB,"Sulfonamides, ophthalmologic antiinfectives",S01AB01,sulfamethizole,20
C0038689,IN,sulfamethoxazole,J01EC01,sulfamethoxazole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01EC,Intermediate-acting sulfonamides,J01EC01,sulfamethoxazole,1460
C0038693,IN,sulfamethoxypyridazine,J01ED05,sulfamethoxypyridazine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01ED,Long-acting sulfonamides,J01ED05,sulfamethoxypyridazine,3
C0038700,IN,sulfamoxole,J01EC03,sulfamoxole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01EC,Intermediate-acting sulfonamides,J01EC03,sulfamoxole,9
C0038702,IN,sulfanilamide,D06BA05,sulfanilamide,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,D06BA,"Sulfonamides, topical",D06BA05,sulfanilamide,90
C0038702,IN,sulfanilamide,J01EB06,sulfanilamide,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01EB,Short-acting sulfonamides,J01EB06,sulfanilamide,90
C0038706,,,J01ED08,sulfaphenazole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01ED,Long-acting sulfonamides,J01ED08,sulfaphenazole,5
C0038706,,,S01AB05,sulfafenazol,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AB,"Sulfonamides, ophthalmologic antiinfectives",S01AB05,sulfafenazol,5
C0038710,IN,sulfapyridine,J01EB04,sulfapyridine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01EB,Short-acting sulfonamides,J01EB04,sulfapyridine,35
C0038722,IN,sulfathiazole,D06BA02,sulfathiazole,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,D06BA,"Sulfonamides, topical",D06BA02,sulfathiazole,7
C0038722,IN,sulfathiazole,J01EB07,sulfathiazole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01EB,Short-acting sulfonamides,J01EB07,sulfathiazole,7
C0038742,IN,sulfinpyrazone,M04AB02,sulfinpyrazone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AB,Preparations increasing uric acid excretion,M04AB02,sulfinpyrazone,5
C0038744,IN,sulfisomidine,J01EB01,sulfaisodimidine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01EB,Short-acting sulfonamides,J01EB01,sulfaisodimidine,2
C0038745,IN,sulfisoxazole,J01EB05,sulfafurazole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01EB,Short-acting sulfonamides,J01EB05,sulfafurazole,75
C0038745,IN,sulfisoxazole,S01AB02,sulfafurazole,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AB,"Sulfonamides, ophthalmologic antiinfectives",S01AB02,sulfafurazole,75
C0038753,IN,sulfobromophthalein,V04CE02,sulfobromophthalein,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CE,liver functional capacity test diagnostic agents,V04CE02,sulfobromophthalein,20
C0038792,IN,sulindac,M01AB02,sulindac,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,M01AB02,sulindac,34
C0038803,IN,sulpiride,N05AL01,sulpiride,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AL,Benzamide antipsychotics,N05AL01,sulpiride,64
C0038807,IN,sulthiame,N03AX03,sultiame,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX03,sultiame,60
C0038878,IN,suprofen,M01AE07,suprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,"Propionic acid derivatives, antiinflammatory and antirheumatic products",M01AE07,suprofen,10
C0039245,IN,tacrine,N06DA01,tacrine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06D,ANTI-DEMENTIA DRUGS,N06DA,Anticholinesterase anti-dementia drugs,N06DA01,tacrine,1
C0039266,IN,talampicillin,J01CA15,talampicillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA15,talampicillin,2
C0039286,IN,tamoxifen,L02BA01,tamoxifen,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02B,HORMONE ANTAGONISTS AND RELATED AGENTS,L02BA,Anti-estrogens,L02BA01,tamoxifen,177
C0039419,PIN,technetium Tc-99m sulfur colloid,V09DB05,technetium (99mTc) sulfur colloid,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09D,HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,V09DB,"Technetium (99mTc), particles and colloids",V09DB05,technetium (99mTc) sulfur colloid,164
C0039468,IN,temazepam,N05CD07,temazepam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CD,Benzodiazepine derivative hypnotics and sedatives,N05CD07,temazepam,36
C0039512,IN,teniposide,L01CB02,teniposide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01C,"PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, ANTINEOPLASTIC DRUGS",L01CB,"Podophyllotoxin derivatives, antineoplastic drugs",L01CB02,teniposide,174
C0039542,IN,terbutaline,R03AC03,terbutaline,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC03,terbutaline,574
C0039542,IN,terbutaline,R03CC03,terbutaline,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CC,"Selective beta-2-adrenoreceptor agonists, systemic",R03CC03,terbutaline,574
C0039601,IN,testosterone,G03BA03,testosterone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03B,ANDROGENS,G03BA,3-oxoandrosten (4) derivatives,G03BA03,testosterone,5823
C0039623,IN,tetrabenazine,N07XX06,tetrabenazine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07X,OTHER NERVOUS SYSTEM DRUGS in ATC,N07XX,Other nervous system drugs in ATC,N07XX06,tetrabenazine,42
C0039629,IN,tetracaine,C05AD02,tetracaine,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AD,Local anesthetics for treatment of hemorrhoids and anal fissures for topical use,C05AD02,tetracaine,162
C0039629,IN,tetracaine,D04AB06,tetracaine,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AB,Anesthetics for topical use,D04AB06,tetracaine,162
C0039629,IN,tetracaine,N01BA03,tetracaine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BA,Esters of aminobenzoic acid for local anesthesia,N01BA03,tetracaine,162
C0039629,IN,tetracaine,S01HA03,tetracaine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01H,"Local anesthetics, ophthalmologic",S01HA,Local anesthetics,S01HA03,tetracaine,162
C0039644,IN,tetracycline,A01AB13,tetracycline,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB13,tetracycline,1280
C0039644,IN,tetracycline,D06AA04,tetracycline,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AA,"Tetracycline and derivatives, topical antibiotics",D06AA04,tetracycline,1280
C0039644,IN,tetracycline,J01AA07,tetracycline,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,Tetracycline antibiotics,J01AA,Tetracyclines,J01AA07,tetracycline,1280
C0039644,IN,tetracycline,S01AA09,tetracycline,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA09,tetracycline,1280
C0039644,IN,tetracycline,S02AA08,tetracycline,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA08,tetracycline,1280
C0039644,IN,tetracycline,S03AA02,tetracycline,S,SENSORY ORGAN DRUGS,S03,OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,S03A,"ANTIINFECTIVES, OPHTHALMOLOGIC AND OTOLOGIC",S03AA,Antiinfectives,S03AA02,tetracycline,1280
C0039663,IN,dronabinol,A04AD10,dronabinol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics in ATC,A04AD10,dronabinol,204
C0039736,IN,thalidomide,L04AX02,thalidomide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AX,Other immunosuppressants in ATC,L04AX02,thalidomide,300
C0039763,IN,theobromine,C03BD01,theobromine,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03B,"LOW-CEILING DIURETICS, EXCL. THIAZIDES",C03BD,"Xanthine derivatives, low-ceiling diuretics",C03BD01,theobromine,61
C0039763,IN,theobromine,R03DA07,theobromine,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DA,"Xanthines, systemic for obstructive airway disease",R03DA07,theobromine,61
C0039771,IN,theophylline,R03DA04,theophylline,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DA,"Xanthines, systemic for obstructive airway disease",R03DA04,theophylline,1319
C0039832,IN,thiabendazole,D01AC06,tiabendazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC06,tiabendazole,98
C0039832,IN,thiabendazole,P02CA02,tiabendazole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02C,ANTINEMATODAL AGENTS,P02CA,"Benzimidazole derivatives, antinematodal",P02CA02,tiabendazole,98
C0039834,,,J04AK07,thioacetazone,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AK,Other drugs for treatment of tuberculosis in ATC,J04AK07,thioacetazone,20
C0039840,IN,thiamine,A11DA01,thiamine (vit B1),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11D,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12",A11DA,"Vitamin B1, plain",A11DA01,thiamine (vit B1),948
C0039854,IN,thiamphenicol,J01BA02,thiamphenicol,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01B,AMPHENICOLS,J01BA,"Amphenicol antibacterials, systemic",J01BA02,thiamphenicol,25
C0039865,IN,thiethylperazine,R06AD03,thiethylperazine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AD,"Phenothiazine derivatives, systemic antihistamines",R06AD03,thiethylperazine,2
C0039867,IN,thimerosal,D08AK06,thiomersal,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AK,Mercurial antiseptic and disinfectant products,D08AK06,thiomersal,192
C0039871,IN,thiotepa,L01AC01,thiotepa,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AC,"Ethylene imines, antineoplastic alkylating drugs",L01AC01,thiotepa,404
C0039902,IN,thioguanine,L01BB03,tioguanine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BB,"Purine analogs, antimetabolites antineoplastic",L01BB03,tioguanine,551
C0039925,IN,thiopental,N01AF03,thiopental,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AF,"Barbiturates for general anesthesia, plain",N01AF03,thiopental,700
C0039925,IN,thiopental,N05CA19,thiopental,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CA,"Barbiturates, hypnotics and sedatives, plain",N05CA19,thiopental,700
C0039943,IN,thioridazine,N05AC02,thioridazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AC,"Phenothiazines with piperidine structure, antipsychotics",N05AC02,thioridazine,85
C0039955,IN,thiothixene,N05AF04,tiotixene,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AF,"Thioxanthene derivatives, antipsychotic",N05AF04,tiotixene,7
C0039962,IN,thiram,P03AA05,thiram,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03A,"ECTOPARASITICIDES, INCL. SCABICIDES",P03AA,Sulfur containing product ectoparasiticides,P03AA05,thiram,15
C0040018,IN,thrombin,B02BC06,thrombin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BC,Local hemostatics,B02BC06,thrombin,1189
C0040018,IN,thrombin,B02BD30,thrombin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BD,Blood coagulation factors,B02BD30,thrombin,1189
C0040108,IN,moxisylyte,C04AX10,moxisylyte,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AX,Other peripheral vasodilators in ATC,C04AX10,moxisylyte,1
C0040108,IN,moxisylyte,G04BE06,moxisylyte,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BE,Drugs used in erectile dysfunction,G04BE06,moxisylyte,1
C0040160,IN,thyrotropin,V04CJ01,thyrotropin,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CJ,thyreoidea function test diagnostic agents,V04CJ01,thyrotropin,4581
C0040162,IN,thyrotropin-releasing hormone,V04CJ02,protirelin,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CJ,thyreoidea function test diagnostic agents,V04CJ02,protirelin,741
C0040180,IN,tiapride,N05AL03,tiapride,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AL,Benzamide antipsychotics,N05AL03,tiapride,35
C0040193,IN,ticarcillin,J01CA13,ticarcillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA13,ticarcillin,133
C0040207,IN,ticlopidine,B01AC05,ticlopidine,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC05,ticlopidine,72
C0040209,,,C03CC02,tienilic acid,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03C,HIGH-CEILING DIURETICS,C03CC,"Aryloxyacetic acid derivatives, high-ceiling diuretics",C03CC02,tienilic acid,1
C0040219,IN,tilidine,N02AX01,tilidine,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AX,Other opioids in ATC,N02AX01,tilidine,4
C0040233,IN,timolol,C07AA06,timolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AA,"Beta blocking agents, non-selective",C07AA06,timolol,180
C0040233,IN,timolol,S01ED01,timolol,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01ED,"Beta blocking agents, antiglaucoma preparations and miotics",S01ED01,timolol,180
C0040263,IN,tinidazole,G01AF21,tinidazole,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AF,"Imidazole derivatives, gyncological antiinfectives",G01AF21,tinidazole,98
C0040263,IN,tinidazole,J01XD02,tinidazole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XD,"Imidazole derivatives, antibacterial for systemic use",J01XD02,tinidazole,98
C0040263,IN,tinidazole,P01AB02,tinidazole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AB,"Nitroimidazole derivatives, antiprotozoal agents against amoebiasis and other protozoal diseases",P01AB02,tinidazole,98
C0040341,IN,tobramycin,J01GB01,tobramycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides in ATC,J01GB01,tobramycin,728
C0040341,IN,tobramycin,S01AA12,tobramycin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA12,tobramycin,728
C0040372,IN,tolazamide,A10BB05,tolazamide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas for blood glucose lowering,A10BB05,tolazamide,3
C0040373,IN,tolazoline,C04AB02,tolazoline,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AB,"Imidazoline derivatives, peripheral vasodilators",C04AB02,tolazoline,116
C0040373,IN,tolazoline,M02AX02,tolazoline,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AX,Other topical products for joint and muscular pain in ATC,M02AX02,tolazoline,116
C0040374,IN,tolbutamide,A10BB03,tolbutamide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas for blood glucose lowering,A10BB03,tolbutamide,100
C0040374,IN,tolbutamide,V04CA01,tolbutamide,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CA,Diagnostic agents for diabetes testing,V04CA01,tolbutamide,100
C0040377,IN,tolmetin,M01AB03,tolmetin,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,M01AB03,tolmetin,75
C0040377,IN,tolmetin,M02AA21,tolmetin,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA21,tolmetin,75
C0040379,IN,tolnaftate,D01AE18,tolnaftate,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AE,Other antifungals for topical use in ATC,D01AE18,tolnaftate,6
C0040382,IN,tolperisone,M02AX06,tolperisone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AX,Other topical products for joint and muscular pain in ATC,M02AX06,tolperisone,6
C0040382,IN,tolperisone,M03BX04,tolperisone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents in ATC,M03BX04,tolperisone,6
C0040610,IN,tramadol,N02AX02,tramadol,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AX,Other opioids in ATC,N02AX02,tramadol,425
C0040613,IN,tranexamic acid,B02AA02,tranexamic acid,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02A,ANTIFIBRINOLYTICS,B02AA,Antifibrinolytic amino acids,B02AA02,tranexamic acid,444
C0040778,IN,tranylcypromine,N06AF04,tranylcypromine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AF,"Monoamine oxidase inhibitors, non-selective",N06AF04,tranylcypromine,16
C0040779,IN,trapidil,C01DX11,trapidil,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01D,VASODILATORS USED IN CARDIAC DISEASES,C01DX,Other vasodilators used in cardiac diseases in ATC,C01DX11,trapidil,2
C0040805,IN,trazodone,N06AX05,trazodone,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX05,trazodone,54
C0040845,IN,tretinoin,D10AD01,tretinoin,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AD,Retinoids for topical use in acne,D10AD01,tretinoin,774
C0040845,IN,tretinoin,L01XF01,tretinoin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XF,Retinoids for cancer treatment,L01XF01,tretinoin,774
C0040846,,,R03AC09,tretoquinol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC09,tretoquinol,2
C0040846,,,R03CC09,tretoquinol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CC,"Selective beta-2-adrenoreceptor agonists, systemic",R03CC09,tretoquinol,2
C0040864,IN,triamcinolone,A01AC01,triamcinolone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AC,Corticosteroids for local oral treatment,A01AC01,triamcinolone,634
C0040864,IN,triamcinolone,C05AA12,triamcinolone,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AA,"Corticosteroids, topical for treatment of hemorrhoids and anal fissures",C05AA12,triamcinolone,634
C0040864,IN,triamcinolone,D07AB09,triamcinolone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AB,"Corticosteroids, moderately potent (group II)",D07AB09,triamcinolone,634
C0040864,IN,triamcinolone,D07XB02,triamcinolone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07X,"CORTICOSTEROIDS, OTHER COMBINATIONS",D07XB,"Corticosteroids, moderately potent, other combinations",D07XB02,triamcinolone,634
C0040864,IN,triamcinolone,H02AB08,triamcinolone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,"Glucocorticoids, Systemic",H02AB08,triamcinolone,634
C0040864,IN,triamcinolone,R01AD11,triamcinolone,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AD,Corticosteroid nasal preparations for topical use,R01AD11,triamcinolone,634
C0040864,IN,triamcinolone,R03BA06,triamcinolone,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03B,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS in ATC",R03BA,Glucocorticoid inhalants for obstructive airway disease,R03BA06,triamcinolone,634
C0040864,IN,triamcinolone,S01BA05,triamcinolone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BA,"Corticosteroid ophthalmologic antiinflammatory agents, plain",S01BA05,triamcinolone,634
C0040869,IN,triamterene,C03DB02,triamterene,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03D,ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS,C03DB,Other potassium-sparing agents in ATC,C03DB02,triamterene,16
C0040878,,,L01AC02,triaziquone,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AC,"Ethylene imines, antineoplastic alkylating drugs",L01AC02,triaziquone,1
C0040879,IN,triazolam,N05CD05,triazolam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CD,Benzodiazepine derivative hypnotics and sedatives,N05CD05,triazolam,22
C0040898,IN,trichlorfon,P02BB01,metrifonate,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02B,ANTITREMATODALS,P02BB,"Organophosphorous compounds, antitrematodals",P02BB01,metrifonate,70
C0040899,IN,trichlormethiazide,C03AA06,trichlormethiazide,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03A,"LOW-CEILING DIURETICS, THIAZIDES",C03AA,"Thiazides, plain",C03AA06,trichlormethiazide,5
C0040905,IN,trichloroethylene,N01AB05,trichloroethylene,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AB,"Halogenated hydrocarbons, general anesthetics",N01AB05,trichloroethylene,63
C0040958,IN,triclosan,D08AE04,triclosan,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AE,"Phenol and derivatives, antiseptics and disinfectants",D08AE04,triclosan,231
C0040958,IN,triclosan,D09AA06,triclosan,D,DERMATOLOGICALS,D09,MEDICATED DRESSINGS,D09A,MEDICATED DRESSINGS,D09AA,Medicated dressings with antiinfectives,D09AA06,triclosan,231
C0040976,IN,trientine,A16AX12,trientine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX12,trientine,63
C0040979,IN,trifluoperazine,N05AB06,trifluoperazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AB,"Phenothiazines with piperazine structure, antipsychotics",N05AB06,trifluoperazine,20
C0040987,IN,trifluridine,S01AD02,trifluridine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AD,"Antivirals, ophthalmologic",S01AD02,trifluridine,17
C0040988,IN,trifluperidol,N05AD02,trifluperidol,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AD,"Butyrophenone derivatives, antipsychotics",N05AD02,trifluperidol,2
C0040989,IN,triflupromazine,N05AA05,triflupromazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AA,"Phenothiazines with aliphatic side-chain, antipsychotics",N05AA05,triflupromazine,3
C0041009,IN,trihexyphenidyl,N04AA01,trihexyphenidyl,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04A,ANTICHOLINERGIC AGENTS,N04AA,"Tertiary amines, anticholinergic",N04AA01,trihexyphenidyl,70
C0041023,IN,trimebutine,A03AA05,trimebutine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AA,"Synthetic anticholinergics, esters with tertiary amino group for functional gastrointestinal disorders",A03AA05,trimebutine,8
C0041030,IN,metipranolol,S01ED04,metipranolol,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01ED,"Beta blocking agents, antiglaucoma preparations and miotics",S01ED04,metipranolol,5
C0041031,IN,trimeprazine,R06AD01,alimemazine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AD,"Phenothiazine derivatives, systemic antihistamines",R06AD01,alimemazine,58
C0041037,IN,trimetazidine,C01EB15,trimetazidine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01E,OTHER CARDIAC PREPARATIONS in ATC,C01EB,Other plain cardiac preparations in ATC,C01EB15,trimetazidine,1
C0041038,IN,trimethadione,N03AC02,trimethadione,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AC,"Oxazolidine derivatives, antiepileptics",N03AC02,trimethadione,13
C0041040,IN,trimethaphan,C02BA01,trimetaphan,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02B,"ANTIADRENERGIC AGENTS, GANGLION-BLOCKING",C02BA,"Sulfonium derivatives, ganglion-blocking adreneregic",C02BA01,trimetaphan,13
C0041041,IN,trimethoprim,J01EA01,trimethoprim,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01EA,"Trimethoprim and derivatives, systemic antibacterials",J01EA01,trimethoprim,1636
C0041056,IN,trimipramine,N06AA06,trimipramine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AA,Non-selective monoamine reuptake inhibitors,N06AA06,trimipramine,5
C0041086,IN,trioxsalen,D05AD01,trioxysalen,D,DERMATOLOGICALS,D05,ANTIPSORIATICS,D05A,ANTIPSORIATICS FOR TOPICAL USE,D05AD,Psoralens for topical use,D05AD01,trioxysalen,5
C0041086,IN,trioxsalen,D05BA01,trioxysalen,D,DERMATOLOGICALS,D05,ANTIPSORIATICS,D05B,ANTIPSORIATICS FOR SYSTEMIC USE,D05BA,Psoralens for systemic use,D05BA01,trioxysalen,5
C0041090,IN,tripelennamine,D04AA04,tripelennamine,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AA,Antihistamines for topical use,D04AA04,tripelennamine,7
C0041090,IN,tripelennamine,R06AC04,tripelennamine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AC,"Substituted ethylene diamines, systemic antihistamines",R06AC04,tripelennamine,7
C0041098,IN,triprolidine,R06AX07,triprolidine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX07,triprolidine,14
C0041165,IN,troleandomycin,J01FA08,troleandomycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,J01FA08,troleandomycin,26
C0041175,IN,tromethamine,B05BB03,trometamol,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05B,"IV solutions used in parenteral administration of fluids, electrolytes and nutrients",B05BB,Solutions affecting the electrolyte balance,B05BB03,trometamol,60
C0041175,IN,tromethamine,B05XX02,trometamol,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XX,Other i.v. solution additives in ATC,B05XX02,trometamol,60
C0041190,IN,tropicamide,S01FA06,tropicamide,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01F,MYDRIATICS AND CYCLOPLEGICS,S01FA,Anticholinergic mydriatics and cycloplegics,S01FA06,tropicamide,141
C0041236,IN,trypsin,B06AA07,trypsin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B06,OTHER HEMATOLOGICAL AGENTS in ATC,B06A,OTHER HEMATOLOGICAL AGENTS in ATC,B06AA,"Enzymes, hematological",B06AA07,trypsin,531
C0041236,IN,trypsin,D03BA01,trypsin,D,DERMATOLOGICALS,D03,PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS,D03B,ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS,D03BA,Proteolytic enzymes for treatment of wounds and ulcers,D03BA01,trypsin,531
C0041249,IN,tryptophan,N06AX02,tryptophan,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX02,tryptophan,850
C0041345,IN,tubocurarine,M03AA02,tubocurarine,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AA,"Curare alkaloid muscle relaxants, peripherally acting",M03AA02,tubocurarine,94
C0041469,,,J07AP,Typhoid vaccines,J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AP,Typhoid vaccines,,,97
C0041499,IN,tyrothricin,D06AX08,tyrothricin,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AX,Other antibiotics for topical use in ATC,D06AX08,tyrothricin,2
C0041499,IN,tyrothricin,R02AB02,tyrothricin,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AB,Antibiotic throat preparations,R02AB02,tyrothricin,2
C0041499,IN,tyrothricin,S01AA05,tyrothricin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA05,tyrothricin,2
C0041536,IN,ubidecarenone,C01EB09,ubidecarenone,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01E,OTHER CARDIAC PREPARATIONS in ATC,C01EB,Other plain cardiac preparations in ATC,C01EB09,ubidecarenone,343
C0041660,PIN,undecylenic acid,D01AE04,undecylenic acid,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AE,Other antifungals for topical use in ATC,D01AE04,undecylenic acid,2
C0041942,IN,urea,B05BC02,carbamide,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05B,"IV solutions used in parenteral administration of fluids, electrolytes and nutrients",B05BC,Solutions producing osmotic diuresis,B05BC02,carbamide,10
C0041942,IN,urea,D02AE01,carbamide,D,DERMATOLOGICALS,D02,EMOLLIENTS AND PROTECTIVES,D02A,EMOLLIENTS AND PROTECTIVES,D02AE,"Carbamide products, emollients and protectives",D02AE01,carbamide,10
C0042071,IN,urokinase,B01AD04,urokinase,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AD,"Enzymes, antithrombotic",B01AD04,urokinase,297
C0042105,PIN,ursodiol,A05AA02,ursodeoxycholic acid,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A05,BILE AND LIVER THERAPY DRUGS,A05A,BILE THERAPY DRUGS,A05AA,Bile acids and derivatives for bile therapy,A05AA02,ursodeoxycholic acid,450
C0042291,PIN,valproic acid,N03AG01,valproic acid,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AG,"Fatty acid derivatives, antiepileptics",N03AG01,valproic acid,3146
C0042313,IN,vancomycin,A07AA09,vancomycin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,"antibiotics, intestinal",A07AA09,vancomycin,2495
C0042313,IN,vancomycin,J01XA01,vancomycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XA,Glycopeptide antibacterials,J01XA01,vancomycin,2495
C0042313,IN,vancomycin,S01AA28,vancomycin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA28,vancomycin,2495
C0042523,IN,verapamil,C08DA01,verapamil,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08D,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,C08DA,"Phenylalkylamine derivatives, selective calcium channel blockers with direct cardiac effects",C08DA01,verapamil,380
C0042646,IN,vidarabine,J05AB03,vidarabine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,J05AB03,vidarabine,501
C0042646,IN,vidarabine,S01AD06,vidarabine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AD,"Antivirals, ophthalmologic",S01AD06,vidarabine,501
C0042665,IN,viloxazine,N06AX09,viloxazine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX09,viloxazine,22
C0042670,IN,vinblastine,L01CA01,vinblastine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01C,"PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, ANTINEOPLASTIC DRUGS",L01CA,"Vinca alkaloids and analogues, antineoplastic",L01CA01,vinblastine,993
C0042674,IN,vincamine,C04AX07,vincamine,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AX,Other peripheral vasodilators in ATC,C04AX07,vincamine,1
C0042679,IN,vincristine,L01CA02,vincristine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01C,"PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, ANTINEOPLASTIC DRUGS",L01CA,"Vinca alkaloids and analogues, antineoplastic",L01CA02,vincristine,4941
C0042682,IN,vindesine,L01CA03,vindesine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01C,"PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, ANTINEOPLASTIC DRUGS",L01CA,"Vinca alkaloids and analogues, antineoplastic",L01CA03,vindesine,77
C0042754,IN,virginiamycin,D06AX10,virginiamycin,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AX,Other antibiotics for topical use in ATC,D06AX10,virginiamycin,13
C0042839,IN,vitamin A,A11CA01,retinol (vit A),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CA,"Vitamin A, plain",A11CA01,retinol (vit A),2834
C0042839,IN,vitamin A,D10AD02,retinol,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AD,Retinoids for topical use in acne,D10AD02,retinol,2834
C0042839,IN,vitamin A,R01AX02,retinol,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AX,Other nasal preparations in ATC,R01AX02,retinol,2834
C0042839,IN,vitamin A,S01XA02,retinol,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA02,retinol,2834
C0042845,IN,vitamin B12,B03BA01,cyanocobalamin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03B,VITAMIN B12 AND FOLIC ACID,B03BA,Vitamin B12 (cyanocobalamin and analogues),B03BA01,cyanocobalamin,1825
C0042874,IN,vitamin E,A11HA03,tocopherol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS in ATC,A11HA,Other plain vitamin preparations in ATC,A11HA03,tocopherol,2186
C0043031,IN,warfarin,B01AA03,warfarin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AA,Vitamin K antagonists,B01AA03,warfarin,905
C0043339,IN,xenon,N01AX15,xenon,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AX,Other general anesthetics in ATC,N01AX15,xenon,188
C0043339,IN,xenon,V04CX12,xenon,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CX,Other diagnostic agents in ATC,V04CX12,xenon,188
C0043355,IN,xipamide,C03BA10,xipamide,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03B,"LOW-CEILING DIURETICS, EXCL. THIAZIDES",C03BA,"sulfonamides, low-ceiling diuretics, plain",C03BA10,xipamide,1
C0043474,IN,zidovudine,J05AF01,zidovudine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,J05AF01,zidovudine,1387
C0043479,,,N06AB02,zimeldine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AB,Selective serotonin reuptake inhibitors,N06AB02,zimeldine,2
C0043606,,,M03BX09,eperisone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents in ATC,M03BX09,eperisone,1
C0043668,IN,doxercalciferol,H05BX03,doxercalciferol,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BX,Other anti-parathyroid agents in ATC,H05BX03,doxercalciferol,6
C0043822,IN,drospirenone,G03AC10,drospirenone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03A,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,G03AC,Progestogen systemic hormonal contraceptives,G03AC10,drospirenone,158
C0043832,IN,deferiprone,V03AC02,deferiprone,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AC,Iron chelating agents,V03AC02,deferiprone,196
C0044401,,,L01BC04,carmofur,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BC,"Pyrimidine analogues, antineoplastic antimetabolites",L01BC04,carmofur,2
C0044410,IN,alfacalcidol,A11CC03,alfacalcidol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CC,Vitamin D and analogues,A11CC03,alfacalcidol,60
C0044923,IN,gemeprost,G02AD03,gemeprost,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02A,UTEROTONICS,G02AD,"Prostaglandins, oxytocics",G02AD03,gemeprost,80
C0045093,IN,gemcitabine,L01BC05,gemcitabine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BC,"Pyrimidine analogues, antineoplastic antimetabolites",L01BC05,gemcitabine,128
C0046056,IN,fluorodeoxyglucose F18,V09IX04,fludeoxyglucose (18F),V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09I,TUMOUR DETECTION RADIOPHARMACEUTICALS,V09IX,Other diagnostic radiopharmaceuticals for tumour detection in ATC,V09IX04,fludeoxyglucose (18F),290
C0046100,IN,octinoxate,D02BA02,octinoxate,D,DERMATOLOGICALS,D02,EMOLLIENTS AND PROTECTIVES,D02B,PROTECTIVES AGAINST UV-RADIATION,D02BA,Protectives against UV-radiation for topical use,D02BA02,octinoxate,5
C0046882,IN,tiratricol,D11AX08,tiratricol,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AX,OTHER DERMATOLOGICAL PREPARATIONS IN ATC,D11AX08,tiratricol,15
C0046882,IN,tiratricol,H03AA04,tiratricol,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY DRUGS,H03A,THYROID PREPARATIONS,H03AA,Thyroid hormones,H03AA04,tiratricol,15
C0046948,IN,amifampridine,N07XX05,amifampridine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07X,OTHER NERVOUS SYSTEM DRUGS in ATC,N07XX,Other nervous system drugs in ATC,N07XX05,amifampridine,17
C0047683,IN,etonogestrel,G03AC08,etonogestrel,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03A,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,G03AC,Progestogen systemic hormonal contraceptives,G03AC08,etonogestrel,138
C0048007,,,N06BX22,phenibut,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BX,Other psychostimulants and nootropics in ATC,N06BX22,phenibut,2
C0048038,IN,apraclonidine,S01EA03,apraclonidine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EA,Sympathomimetics in glaucoma therapy,S01EA03,apraclonidine,13
C0048044,IN,vigabatrin,N03AG04,vigabatrin,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AG,"Fatty acid derivatives, antiepileptics",N03AG04,vigabatrin,465
C0048045,IN,4-aminomethylbenzoic acid,B02AA03,aminomethylbenzoic acid,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02A,ANTIFIBRINOLYTICS,B02AA,Antifibrinolytic amino acids,B02AA03,aminomethylbenzoic acid,1
C0048365,,,R05CB08,domiodol,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CB,Mucolytics,R05CB08,domiodol,1
C0048470,IN,argatroban,B01AE03,argatroban,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AE,Direct thrombin inhibitors,B01AE03,argatroban,40
C0048504,IN,fomepizole,V03AB34,fomepizole,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB34,fomepizole,24
C0048897,IN,sapropterin,A16AX07,sapropterin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX07,sapropterin,365
C0049065,IN,decitabine,L01BC08,decitabine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BC,"Pyrimidine analogues, antineoplastic antimetabolites",L01BC08,decitabine,56
C0049289,IN,5-methoxypsoralen,D05BA03,bergapten,D,DERMATOLOGICALS,D05,ANTIPSORIATICS,D05B,ANTIPSORIATICS FOR SYSTEMIC USE,D05BA,Psoralens for systemic use,D05BA03,bergapten,2
C0049506,IN,mirtazapine,N06AX11,mirtazapine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX11,mirtazapine,68
C0050393,IN,acarbose,A10BF01,acarbose,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BF,"Alpha glucosidase inhibitors, blood glucose lowering",A10BF01,acarbose,30
C0050403,IN,aceclofenac,M01AB16,aceclofenac,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,M01AB16,aceclofenac,3
C0050403,IN,aceclofenac,M02AA25,aceclofenac,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA25,aceclofenac,3
C0050409,IN,acemetacin,M01AB11,acemetacin,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,M01AB11,acemetacin,1
C0050451,IN,acetohydroxamic acid,G04BX03,acetohydroxamic acid,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BX,Other urologicals in ATC,G04BX03,acetohydroxamic acid,4
C0050461,IN,racecadotril,A07XA04,racecadotril,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07X,OTHER ANTIDIARRHEALS in ATC,A07XA,Other antidiarrheals in ATC,A07XA04,racecadotril,16
C0050558,IN,acipimox,C10AD06,acipimox,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AD,"Nicotinic acid and derivatives, lipid modifying, plain",C10AD06,acipimox,4
C0050559,IN,acitretin,D05BB02,acitretin,D,DERMATOLOGICALS,D05,ANTIPSORIATICS,D05B,ANTIPSORIATICS FOR SYSTEMIC USE,D05BB,Retinoids for treatment of psoriasis,D05BB02,acitretin,144
C0050940,IN,lansoprazole,A02BC03,lansoprazole,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors for peptic ulcer and GORD,A02BC03,lansoprazole,131
C0051027,,,C01EB13,acadesine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01E,OTHER CARDIAC PREPARATIONS in ATC,C01EB,Other plain cardiac preparations in ATC,C01EB13,acadesine,1
C0051080,IN,alanylglutamine,B05XB02,alanyl glutamine,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XB,"Amino Acids, I.V. solution additive",B05XB02,alanyl glutamine,7
C0051150,IN,alfuzosin,G04CA01,alfuzosin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04C,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,G04CA,"Alpha-adrenoreceptor antagonists, benign prostatic hypertrophy",G04CA01,alfuzosin,5
C0051156,IN,alginic acid,A02BX13,alginic acid,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC,A02BX13,alginic acid,81
C0051162,IN,alizapride,A03FA05,alizapride,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,A03FA05,alizapride,8
C0051254,IN,aloxiprin,B01AC15,aloxiprin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC15,aloxiprin,1
C0051254,IN,aloxiprin,N02BA02,aloxiprin,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BA,"Salicylic acid and derivatives, analgesics and antipyretics",N02BA02,aloxiprin,1
C0051482,IN,alfaxalone,N01AX05,alfaxalone,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AX,Other general anesthetics in ATC,N01AX05,alfaxalone,58
C0051515,IN,aluminum magnesium silicate,A02AD05,almasilate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AD,"antacids containing combinations and complexes of aluminium, calcium and magnesium compounds",A02AD05,almasilate,1
C0051519,IN,aluminum phosphate,A02AB03,aluminium phosphate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AB,antacids containing aluminium compounds,A02AB03,aluminium phosphate,30
C0051607,IN,amineptin,N06AA19,amineptine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AA,Non-selective monoamine reuptake inhibitors,N06AA19,amineptine,3
C0051696,IN,amlodipine,C08CA01,amlodipine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,C08CA,Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects,C08CA01,amlodipine,113
C0051736,IN,amorolfine,D01AE16,amorolfine,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AE,Other antifungals for topical use in ATC,D01AE16,amorolfine,6
C0051809,IN,anagrelide,L01XX35,anagrelide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX35,anagrelide,20
C0052416,IN,arsenic trioxide,L01XX27,arsenic trioxide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX27,arsenic trioxide,127
C0052427,,,P01BE04,artemotil,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BE,"Artemisinin and derivatives, plain",P01BE04,artemotil,6
C0052429,IN,artemether,P01BE02,artemether,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BE,"Artemisinin and derivatives, plain",P01BE02,artemether,614
C0052430,IN,artemisinin,P01BE01,artemisinin,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BE,"Artemisinin and derivatives, plain",P01BE01,artemisinin,1640
C0052432,IN,artesunate,P01BE03,artesunate,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BE,"Artemisinin and derivatives, plain",P01BE03,artesunate,850
C0052585,IN,sparfloxacin,J01MA09,sparfloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA09,sparfloxacin,9
C0052657,IN,attapulgite,A07BC04,attapulgite,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07B,INTESTINAL ADSORBENTS,A07BC,Other intestinal adsorbents in ATC,A07BC04,attapulgite,1
C0052759,IN,azatadine,R06AX09,azatadine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX09,azatadine,6
C0052761,PIN,azelaic acid,D10AX03,azelaic acid,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AX,Other anti-acne preparations for topical use in ATC,D10AX03,azelaic acid,21
C0052762,IN,azelastine,R01AC03,azelastine,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AC,"Antiallergic nasal preparations for topical use, excl. corticosteroids",R01AC03,azelastine,79
C0052762,IN,azelastine,R06AX19,azelastine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX19,azelastine,79
C0052762,IN,azelastine,S01GX07,azelastine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GX,Other antiallergics in ATC,S01GX07,azelastine,79
C0052772,IN,azidocillin,J01CE04,azidocillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,J01CE04,azidocillin,6
C0052796,IN,azithromycin,J01FA10,azithromycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,J01FA10,azithromycin,1603
C0052796,IN,azithromycin,S01AA26,azithromycin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA26,azithromycin,1603
C0052865,IN,bacampicillin,J01CA06,bacampicillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA06,bacampicillin,14
C0052940,IN,balsalazide,A07EC04,balsalazide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EC,Aminosalicylic acid and similar agents,A07EC04,balsalazide,4
C0052944,IN,bambuterol,R03CC12,bambuterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CC,"Selective beta-2-adrenoreceptor agonists, systemic",R03CC12,bambuterol,10
C0053071,,,S01ED06,befunolol,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01ED,"Beta blocking agents, antiglaucoma preparations and miotics",S01ED06,befunolol,1
C0053091,IN,benazepril,C09AA07,benazepril,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09A,"ACE INHIBITORS, PLAIN",C09AA,"ACE inhibitors, plain",C09AA07,benazepril,9
C0053105,IN,benfluorex,A10BX06,benfluorex,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins in ATC",A10BX06,benfluorex,1
C0053108,,,C08CA15,benidipine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,C08CA,Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects,C08CA15,benidipine,1
C0053111,,,M01AE06,benoxaprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,"Propionic acid derivatives, antiinflammatory and antirheumatic products",M01AE06,benoxaprofen,1
C0053114,IN,benoxinate,D04AB03,oxybuprocaine,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AB,Anesthetics for topical use,D04AB03,oxybuprocaine,8
C0053114,IN,benoxinate,S01HA02,oxybuprocaine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01H,"Local anesthetics, ophthalmologic",S01HA,Local anesthetics,S01HA02,oxybuprocaine,8
C0053116,IN,benphothiamine,A11DA03,benfotiamine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11D,"VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12",A11DA,"Vitamin B1, plain",A11DA03,benfotiamine,2
C0053122,IN,bentiromide,V04CK03,bentiromide,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CK,pancreatic function test diagnostic agents,V04CK03,bentiromide,9
C0053185,,,C01DX04,benziodarone,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01D,VASODILATORS USED IN CARDIAC DISEASES,C01DX,Other vasodilators used in cardiac diseases in ATC,C01DX04,benziodarone,1
C0053229,IN,benzonatate,R05DB01,benzonatate,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DB,Other cough suppressants in ATC,R05DB01,benzonatate,9
C0053230,IN,benznidazole,P01CA02,benznidazole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01C,AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS,P01CA,"Nitroimidazole derivatives, antiprotozoal agents against leishmaniasis and trypanosomiasis",P01CA02,benznidazole,105
C0053289,IN,benzyl benzoate,P03AX01,benzyl benzoate,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03A,"ECTOPARASITICIDES, INCL. SCABICIDES",P03AX,"Other ectoparasiticides, incl. scabicides in ATC",P03AX01,benzyl benzoate,31
C0053332,IN,benzylthiouracil,H03BA03,benzylthiouracil,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY DRUGS,H03B,ANTITHYROID PREPARATIONS,H03BA,Thiouracil antithyroid preparations,H03BA03,benzylthiouracil,4
C0053336,,,B01AC19,beraprost,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC19,beraprost,24
C0053396,IN,beta carotene,A11CA02,betacarotene,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11C,"VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",A11CA,"Vitamin A, plain",A11CA02,betacarotene,620
C0053396,IN,beta carotene,D02BB01,betacarotene,D,DERMATOLOGICALS,D02,EMOLLIENTS AND PROTECTIVES,D02B,PROTECTIVES AGAINST UV-RADIATION,D02BB,Protectives against UV-radiation for systemic use,D02BB01,betacarotene,620
C0053526,IN,bethanechol,N07AB02,bethanechol,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07A,PARASYMPATHOMIMETICS,N07AB,"Choline esters, parasympathomimetics",N07AB02,bethanechol,34
C0053570,IN,bifonazole,D01AC10,bifonazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC10,bifonazole,19
C0053618,IN,bioallethrin,P03AC02,bioallethrin,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03A,"ECTOPARASITICIDES, INCL. SCABICIDES",P03AC,"Pyrethrines, incl. synthetic compounds, ectoparasiticides, incl. scabicides",P03AC02,bioallethrin,9
C0053791,IN,bismuth subnitrate,A02BX12,bismuth subnitrate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC,A02BX12,bismuth subnitrate,1
C0053799,IN,bisoprolol,C07AB07,bisoprolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AB,"Beta blocking agents, selective",C07AB07,bisoprolol,34
C0053817,IN,bitolterol,R03AC17,bitolterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC17,bitolterol,6
C0053882,IN,cefprozil,J01DC10,cefprozil,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DC,Second-generation cephalosporins,J01DC10,cefprozil,86
C0054015,IN,nesiritide,C01DX19,nesiritide,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01D,VASODILATORS USED IN CARDIAC DISEASES,C01DX,Other vasodilators used in cardiac diseases in ATC,C01DX19,nesiritide,25
C0054084,IN,brodimoprim,J01EA02,brodimoprim,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01EA,"Trimethoprim and derivatives, systemic antibacterials",J01EA02,brodimoprim,8
C0054094,IN,bromfenac,S01BC11,bromfenac,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BC,"Antiinflammatory agents, non-steroidal, ophthalmologic",S01BC11,bromfenac,2
C0054129,IN,bromopride,A03FA04,bromopride,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,A03FA04,bromopride,2
C0054138,IN,bromperidol,N05AD06,bromperidol,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AD,"Butyrophenone derivatives, antipsychotics",N05AD06,bromperidol,1
C0054151,IN,brotizolam,N05CD09,brotizolam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CD,Benzodiazepine derivative hypnotics and sedatives,N05CD09,brotizolam,2
C0054201,IN,budesonide,A07EA06,budesonide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EA,Corticosteroids acting locally,A07EA06,budesonide,1190
C0054201,IN,budesonide,D07AC09,budesonide,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC09,budesonide,1190
C0054201,IN,budesonide,R01AD05,budesonide,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AD,Corticosteroid nasal preparations for topical use,R01AD05,budesonide,1190
C0054201,IN,budesonide,R03BA02,budesonide,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03B,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS in ATC",R03BA,Glucocorticoid inhalants for obstructive airway disease,R03BA02,budesonide,1190
C0054207,IN,buflomedil,C04AX20,buflomedil,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AX,Other peripheral vasodilators in ATC,C04AX20,buflomedil,2
C0054236,IN,butamirate,R05DB13,butamirate,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DB,Other cough suppressants in ATC,R05DB13,butamirate,3
C0054249,IN,butobarbital,N05CA03,butobarbital,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CA,"Barbiturates, hypnotics and sedatives, plain",N05CA03,butobarbital,1
C0054259,IN,butoconazole,G01AF15,butoconazole,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AF,"Imidazole derivatives, gyncological antiinfectives",G01AF15,butoconazole,1
C0054340,IN,acrivastine,R06AX18,acrivastine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX18,acrivastine,6
C0054409,IN,cadexomer iodine,D03AX01,cadexomer iodine,D,DERMATOLOGICALS,D03,PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS,D03A,CICATRIZANTS,D03AX,Other cicatrizants in ATC,D03AX01,cadexomer iodine,1
C0054422,,,C02DB04,cadralazine,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02D,"ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",C02DB,Hydrazinophthalazine derivatives acting on arteriolar smooth muscle,C02DB04,cadralazine,1
C0054480,IN,calcium polycarbophil,A06AC08,polycarbophil calcium,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AC,Bulk-forming laxatives,A06AC08,polycarbophil calcium,6
C0054483,IN,calcium silicate,A02AC02,calcium silicate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AC,antacids containing calcium compounds,A02AC02,calcium silicate,9
C0054568,IN,camylofine,A03AA03,camylofin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AA,"Synthetic anticholinergics, esters with tertiary amino group for functional gastrointestinal disorders",A03AA03,camylofin,1
C0054598,,,C01AX02,peruvoside,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01A,CARDIAC GLYCOSIDES,C01AX,Other cardiac glycosides in ATC,C01AX02,peruvoside,1
C0054667,,,J01CA05,carindacillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA05,carindacillin,1
C0054668,IN,carbetapentane,R05DB05,pentoxyverine,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DB,Other cough suppressants in ATC,R05DB05,pentoxyverine,2
C0054670,,,H01BB03,carbetocin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BB,Oxytocin and analogues,H01BB03,carbetocin,41
C0054672,IN,carbinoxamine,R06AA08,carbinoxamine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AA,"Aminoalkyl ethers, systemic antihistamines",R06AA08,carbinoxamine,6
C0054773,,,R03AC10,carbuterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC10,carbuterol,2
C0054773,,,R03CC10,carbuterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CC,"Selective beta-2-adrenoreceptor agonists, systemic",R03CC10,carbuterol,2
C0054836,IN,carvedilol,C07AG02,carvedilol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AG,Alpha and beta blocking agents,C07AG02,carvedilol,84
C0054999,,,J01DB06,cefazedone,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DB,First-generation cephalosporins,J01DB06,cefazedone,4
C0055000,,,J01DC13,cefbuperazone,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DC,Second-generation cephalosporins,J01DC13,cefbuperazone,21
C0055003,IN,cefepime,J01DE01,cefepime,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DE,Fourth-generation cephalosporins,J01DE01,cefepime,252
C0055004,IN,cefetamet,J01DD10,cefetamet,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD10,cefetamet,7
C0055006,,,J01DC12,cefminox,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DC,Second-generation cephalosporins,J01DC12,cefminox,25
C0055007,IN,cefodizime,J01DD09,cefodizime,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD09,cefodizime,24
C0055008,IN,ceforanide,J01DC11,ceforanide,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DC,Second-generation cephalosporins,J01DC11,ceforanide,5
C0055010,,,J01DD11,cefpiramide,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD11,cefpiramide,22
C0055011,IN,cefpodoxime,J01DD13,cefpodoxime,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD13,cefpodoxime,100
C0055013,,,J01DB12,ceftezole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DB,First-generation cephalosporins,J01DB12,ceftezole,4
C0055014,IN,ceftibuten,J01DD14,ceftibuten,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD14,ceftibuten,31
C0055021,IN,celiprolol,C07AB08,celiprolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AB,"Beta blocking agents, selective",C07AB08,celiprolol,3
C0055146,IN,cetiedil,C04AX26,cetiedil,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AX,Other peripheral vasodilators in ATC,C04AX26,cetiedil,1
C0055147,IN,cetirizine,R06AE07,cetirizine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AE,"Piperazine derivatives, systemic antihistamines",R06AE07,cetirizine,215
C0055147,IN,cetirizine,S01GX12,cetirizine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GX,Other antiallergics in ATC,S01GX12,cetirizine,215
C0055151,IN,cetrimonium,D08AJ02,cetrimonium,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AJ,"Quaternary ammonium compounds, antiseptics and disinfectants",D08AJ02,cetrimonium,17
C0055151,IN,cetrimonium,R02AA17,cetrimonium,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AA,Antiseptic throat preparations,R02AA17,cetrimonium,17
C0055332,IN,chloramine-T,D08AX04,tosylchloramide sodium,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AX,Other antiseptics and disinfectants in ATC,D08AX04,tosylchloramide sodium,6
C0055443,IN,chloroprocaine,N01BA04,chloroprocaine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BA,Esters of aminobenzoic acid for local anesthesia,N01BA04,chloroprocaine,70
C0055443,IN,chloroprocaine,S01HA08,chloroprocaine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01H,"Local anesthetics, ophthalmologic",S01HA,Local anesthetics,S01HA08,chloroprocaine,70
C0055445,IN,chloropyramine,D04AA09,chloropyramine,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AA,Antihistamines for topical use,D04AA09,chloropyramine,1
C0055445,IN,chloropyramine,R06AC03,chloropyramine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AC,"Substituted ethylene diamines, systemic antihistamines",R06AC03,chloropyramine,1
C0055463,IN,chloroxylenol,D08AE05,chloroxylenol,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AE,"Phenol and derivatives, antiseptics and disinfectants",D08AE05,chloroxylenol,4
C0055477,IN,lornoxicam,M01AC05,lornoxicam,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AC,"Oxicams, antiinflammatory and antirheumatic drugs",M01AC05,lornoxicam,2
C0055568,IN,cholic acid,A05AA03,cholic acid,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A05,BILE AND LIVER THERAPY DRUGS,A05A,BILE THERAPY DRUGS,A05AA,Bile acids and derivatives for bile therapy,A05AA03,cholic acid,168
C0055573,PIN,choline salicylate,N02BA03,choline salicylate,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BA,"Salicylic acid and derivatives, analgesics and antipyretics",N02BA03,choline salicylate,1
C0055578,IN,oxtriphylline,R03DA02,choline theophyllinate,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DA,"Xanthines, systemic for obstructive airway disease",R03DA02,choline theophyllinate,13
C0055709,,,P02CA04,ciclobendazole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02C,ANTINEMATODAL AGENTS,P02CA,"Benzimidazole derivatives, antinematodal",P02CA04,ciclobendazole,2
C0055711,IN,ciclopirox,D01AE14,ciclopirox,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AE,Other antifungals for topical use in ATC,D01AE14,ciclopirox,25
C0055711,IN,ciclopirox,G01AX12,ciclopirox,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AX,Other gynecological antiinfectives and antiseptics in ATC,G01AX12,ciclopirox,25
C0055720,IN,cifenline,C01BG07,cibenzoline,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BG,"Other antiarrhythmics, class I and III in ATC",C01BG07,cibenzoline,6
C0055723,IN,cilazapril,C09AA08,cilazapril,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09A,"ACE INHIBITORS, PLAIN",C09AA,"ACE inhibitors, plain",C09AA08,cilazapril,5
C0055729,IN,cilostazol,B01AC23,cilostazol,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC23,cilostazol,8
C0055738,IN,eucalyptol,R05CA13,cineole,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CA,Expectorants,R05CA13,cineole,7
C0055740,,,C04AX27,cinepazide,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AX,Other peripheral vasodilators in ATC,C04AX27,cinepazide,1
C0055775,IN,ciprofibrate,C10AB08,ciprofibrate,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AB,"Fibrates, lipid modifying drugs, plain",C10AB08,ciprofibrate,1
C0055819,IN,citric acid,A09AB04,citric acid,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A09,"DIGESTIVES, INCL. ENZYMES",A09A,"DIGESTIVES, INCL. ENZYMES",A09AB,"Acid preparations, digestives",A09AB04,citric acid,453
C0055856,IN,clarithromycin,J01FA09,clarithromycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,J01FA09,clarithromycin,836
C0055869,IN,clebopride,A03FA06,clebopride,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,A03FA06,clebopride,2
C0055891,IN,clobazam,N05BA09,clobazam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA09,clobazam,282
C0055894,IN,clobenzorex,A08AA08,clobenzorex,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,A08AA08,clobenzorex,1
C0055897,IN,clobutinol,R05DB03,clobutinol,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DB,Other cough suppressants in ATC,R05DB03,clobutinol,3
C0055899,IN,clocortolone,D07AB21,clocortolone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AB,"Corticosteroids, moderately potent (group II)",D07AB21,clocortolone,2
C0055915,IN,clofoctol,J01XX03,clofoctol,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XX,Other antibacterials in ATC,J01XX03,clofoctol,1
C0055930,IN,cloperastine,R05DB21,cloperastine,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DB,Other cough suppressants in ATC,R05DB21,cloperastine,3
C0055936,IN,cloprednol,H02AB14,cloprednol,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,"Glucocorticoids, Systemic",H02AB14,cloprednol,4
C0055964,IN,cloxazolam,N05BA22,cloxazolam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA22,cloxazolam,2
C0056039,IN,cobamamide,B03BA04,cobamamide,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03B,VITAMIN B12 AND FOLIC ACID,B03BA,Vitamin B12 (cyanocobalamin and analogues),B03BA04,cobamamide,21
C0056301,IN,copper sulfate,V03AB20,copper sulfate,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB20,copper sulfate,47
C0056396,IN,cortivazol,H02AB17,cortivazol,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,"Glucocorticoids, Systemic",H02AB17,cortivazol,2
C0056643,IN,cyamemazine,N05AA06,cyamemazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AA,"Phenothiazines with aliphatic side-chain, antipsychotics",N05AA06,cyamemazine,5
C0056732,IN,cyclobenzaprine,M03BX08,cyclobenzaprine,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents in ATC,M03BX08,cyclobenzaprine,11
C0056836,,,P03BA01,cyfluthrin,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03B,INSECTICIDES AND REPELLENTS,P03BA,Pyrethrines,P03BA01,cyfluthrin,22
C0056849,IN,cypermethrin,P03BA02,cypermethrin,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03B,INSECTICIDES AND REPELLENTS,P03BA,Pyrethrines,P03BA02,cypermethrin,49
C0056913,IN,cytisine,N07BA04,cytisinicline,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07B,DRUGS USED IN ADDICTIVE DISORDERS,N07BA,Drugs used in nicotine dependence,N07BA04,cytisinicline,4
C0057135,IN,danthron,A06AB03,dantron,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,A06AB03,dantron,1
C0057143,IN,dapiprazole,S01EX02,dapiprazole,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EX,Other antiglaucoma preparations in ATC,S01EX02,dapiprazole,1
C0057144,IN,daptomycin,J01XX09,daptomycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XX,Other antibacterials in ATC,J01XX09,daptomycin,100
C0057218,,,H01BB01,demoxytocin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BB,Oxytocin and analogues,H01BB01,demoxytocin,6
C0057232,,,D08AJ10,decamethoxine,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AJ,"Quaternary ammonium compounds, antiseptics and disinfectants",D08AJ10,decamethoxine,1
C0057233,IN,decamethrin,P03BA03,decamethrin,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03B,INSECTICIDES AND REPELLENTS,P03BA,Pyrethrines,P03BA03,decamethrin,69
C0057257,IN,defibrotide,B01AX01,defibrotide,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AX,Other antithrombotic agents in ATC,B01AX01,defibrotide,83
C0057258,IN,deflazacort,H02AB13,deflazacort,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,"Glucocorticoids, Systemic",H02AB13,deflazacort,106
C0057301,,,C09AA12,delapril,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09A,"ACE INHIBITORS, PLAIN",C09AA,"ACE inhibitors, plain",C09AA12,delapril,1
C0057362,IN,demegestone,G03DB05,demegestone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03D,PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03DB,"Pregnadien derivatives, progestogens",G03DB05,demegestone,1
C0057558,IN,desogestrel,G03AC09,desogestrel,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03A,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,G03AC,Progestogen systemic hormonal contraceptives,G03AC09,desogestrel,454
C0057605,IN,dexbrompheniramine,R06AB06,dexbrompheniramine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AB,"Substituted alkylamines, systemic antihistamines",R06AB06,dexbrompheniramine,2
C0057606,IN,dexchlorpheniramine,R06AB02,dexchlorpheniramine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AB,"Substituted alkylamines, systemic antihistamines",R06AB02,dexchlorpheniramine,14
C0057610,IN,dexpanthenol,A11HA30,dexpanthenol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS in ATC,A11HA,Other plain vitamin preparations in ATC,A11HA30,dexpanthenol,26
C0057610,IN,dexpanthenol,D03AX03,dexpanthenol,D,DERMATOLOGICALS,D03,PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS,D03A,CICATRIZANTS,D03AX,Other cicatrizants in ATC,D03AX03,dexpanthenol,26
C0057610,IN,dexpanthenol,S01XA12,dexpanthenol,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA12,dexpanthenol,26
C0057621,IN,dextranomer,D03AX02,dextranomer,D,DERMATOLOGICALS,D03,PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS,D03A,CICATRIZANTS,D03AX,Other cicatrizants in ATC,D03AX02,dextranomer,224
C0057626,IN,dezocine,N02AX03,dezocine,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AX,Other opioids in ATC,N02AX03,dezocine,6
C0057678,IN,diacetylrhein,M01AX21,diacerein,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids in ATC",M01AX21,diacerein,4
C0057763,,,R06AX16,deptropine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX16,deptropine,3
C0057831,IN,dichloralphenazone,N05CC04,dichloralphenazone,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CC,Aldehydes and derivatives,N05CC04,dichloralphenazone,1
C0057846,IN,dichlorobenzyl alcohol,R02AA03,dichlorobenzyl alcohol,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AA,Antiseptic throat preparations,R02AA03,dichlorobenzyl alcohol,1
C0057916,IN,dienogest,G03DB08,dienogest,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03D,PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03DB,"Pregnadien derivatives, progestogens",G03DB08,dienogest,62
C0057981,IN,difenoxin,A07DA04,difenoxin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07D,ANTIPROPULSIVES,A07DA,Antipropulsives,A07DA04,difenoxin,1
C0058004,IN,difluprednate,D07AC19,difluprednate,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC19,difluprednate,7
C0058004,IN,difluprednate,S01BA16,difluprednate,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BA,"Corticosteroid ophthalmologic antiinflammatory agents, plain",S01BA16,difluprednate,7
C0058056,IN,dihydrocodeine,N02AA08,dihydrocodeine,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AA,Natural opium alkaloid analgesics,N02AA08,dihydrocodeine,14
C0058192,,,R07AB08,dimefline,R,RESPIRATORY SYSTEM DRUGS,R07,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07A,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07AB,Respiratory stimulants,R07AB08,dimefline,1
C0058218,IN,dimethyl fumarate,L04AX07,dimethyl fumarate,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AX,Other immunosuppressants in ATC,L04AX07,dimethyl fumarate,26
C0058224,,,P03BX02,dimethylphthalate,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03B,INSECTICIDES AND REPELLENTS,P03BX,Other insecticides and repellents in ATC,P03BX02,dimethylphthalate,23
C0058389,IN,diphenylpyraline,R06AA07,diphenylpyraline,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AA,"Aminoalkyl ethers, systemic antihistamines",R06AA07,diphenylpyraline,3
C0058415,IN,dipivefrin,S01EA02,dipivefrine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EA,Sympathomimetics in glaucoma therapy,S01EA02,dipivefrine,4
C0058425,IN,dipropizine,R05DB19,dropropizine,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DB,Other cough suppressants in ATC,R05DB19,dropropizine,1
C0058426,IN,dipropylacetamide,N03AG02,valpromide,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AG,"Fatty acid derivatives, antiepileptics",N03AG02,valpromide,4
C0058445,IN,dirithromycin,J01FA13,dirithromycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,J01FA13,dirithromycin,7
C0058446,,,G02CB06,terguride,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02C,OTHER GYNECOLOGICALS in ATC,G02CB,Prolactine inhibitors,G02CB06,terguride,2
C0058518,,,N05AB01,dixyrazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AB,"Phenothiazines with piperazine structure, antipsychotics",N05AB01,dixyrazine,4
C0058677,IN,domiphen,A01AB06,domiphen,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB06,domiphen,1
C0058702,IN,dopexamine,C01CA14,dopexamine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA14,dopexamine,4
C0058721,,,R03DA11,doxofylline,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DA,"Xanthines, systemic for obstructive airway disease",R03DA11,doxofylline,7
C0058762,IN,drotaverin,A03AD02,drotaverine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AD,Papaverine and derivatives containing drugs for functional gastrointestinal disorders,A03AD02,drotaverine,11
C0058895,IN,ebastine,R06AX22,ebastine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX22,ebastine,26
C0059424,,,J01CA07,epicillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA07,epicillin,8
C0059459,IN,epomediol,A05BA05,epomediol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A05,BILE AND LIVER THERAPY DRUGS,A05B,"LIVER THERAPY, LIPOTROPICS",A05BA,Liver therapy drugs,A05BA05,epomediol,1
C0059469,IN,eprazinone,R05CB04,eprazinone,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CB,Mucolytics,R05CB04,eprazinone,1
C0059506,IN,erdosteine,R05CB15,erdosteine,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CB,Mucolytics,R05CB15,erdosteine,5
C0059678,IN,etifoxine,N05BX03,etifoxine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BX,Other anxiolytics in ATC,N05BX03,etifoxine,2
C0059680,,,R03DA06,etamiphylline,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DA,"Xanthines, systemic for obstructive airway disease",R03DA06,etamiphylline,1
C0059699,IN,ethanolamine oleate,C05BB01,monoethanolamine oleate,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05B,ANTIVARICOSE THERAPY DRUGS,C05BB,Sclerosing agents for local injection,C05BB01,monoethanolamine oleate,46
C0059752,IN,vinpocetine,N06BX18,vinpocetine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BX,Other psychostimulants and nootropics in ATC,N06BX18,vinpocetine,7
C0059772,IN,ethyl loflazepate,N05BA18,ethyl loflazepate,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA18,ethyl loflazepate,2
C0059862,,,N05BA19,etizolam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA19,etizolam,4
C0059865,IN,etodolac,M01AB08,etodolac,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,M01AB08,etodolac,5
C0059867,IN,etofamide,P01AC03,etofamide,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AC,Dichloroacetamide derivative drugs for amoebiasis and other protozoal diseases,P01AC03,etofamide,1
C0059868,IN,etofenamate,M02AA06,etofenamate,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA06,etofenamate,2
C0059985,IN,fludarabine,L01BB05,fludarabine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BB,"Purine analogs, antimetabolites antineoplastic",L01BB05,fludarabine,837
C0060135,IN,felbamate,N03AX10,felbamate,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX10,felbamate,58
C0060156,IN,fenbufen,M01AE05,fenbufen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,"Propionic acid derivatives, antiinflammatory and antirheumatic products",M01AE05,fenbufen,3
C0060180,IN,fenoldopam,C01CA19,fenoldopam,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA19,fenoldopam,16
C0060183,IN,fenoxazoline,R01AA12,fenoxazoline,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AA,"Sympathomimetics, plain",R01AA12,fenoxazoline,2
C0060201,,,M01AB10,fentiazac,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,M01AB10,fentiazac,2
C0060201,,,M02AA14,fentiazac,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA14,fentiazac,2
C0060203,IN,fenticonazole,D01AC12,fenticonazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC12,fenticonazole,7
C0060203,IN,fenticonazole,G01AF12,fenticonazole,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AF,"Imidazole derivatives, gyncological antiinfectives",G01AF12,fenticonazole,7
C0060228,IN,ferric ammonium citrate,V08CA07,ferric ammonium citrate,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08C,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,V08CA,Paramagnetic contrast media,V08CA07,ferric ammonium citrate,7
C0060231,IN,ferric citrate,V03AE08,ferric citrate,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AE,Drugs for treatment of hyperkalemia and hyperphosphatemia,V03AE08,ferric citrate,2
C0060234,IN,prussian blue insoluble,V03AB31,prussian blue,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB31,prussian blue,32
C0060236,IN,ferric hydroxide,B03AB04,ferric hydroxide,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03A,IRON ANTIANEMIC PREPARATIONS,B03AB,"Iron trivalent, oral antianemic preparations",B03AB04,ferric hydroxide,2
C0060237,IN,ferric maltol,B03AB10,ferric maltol,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03A,IRON ANTIANEMIC PREPARATIONS,B03AB,"Iron trivalent, oral antianemic preparations",B03AB10,ferric maltol,1
C0060241,IN,iron sucrose,B03AB02,saccharated iron oxide,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03A,IRON ANTIANEMIC PREPARATIONS,B03AB,"Iron trivalent, oral antianemic preparations",B03AB02,saccharated iron oxide,60
C0060275,IN,ferrous chloride,B03AA05,ferrous chloride,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03A,IRON ANTIANEMIC PREPARATIONS,B03AA,"Iron bivalent, oral antianemic preparations",B03AA05,ferrous chloride,1
C0060276,IN,ferrous fumarate,B03AA02,ferrous fumarate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03A,IRON ANTIANEMIC PREPARATIONS,B03AA,"Iron bivalent, oral antianemic preparations",B03AA02,ferrous fumarate,78
C0060277,IN,ferrous gluconate,B03AA03,ferrous gluconate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03A,IRON ANTIANEMIC PREPARATIONS,B03AA,"Iron bivalent, oral antianemic preparations",B03AA03,ferrous gluconate,20
C0060281,IN,ferrous succinate,B03AA06,ferrous succinate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03A,IRON ANTIANEMIC PREPARATIONS,B03AA,"Iron bivalent, oral antianemic preparations",B03AA06,ferrous succinate,4
C0060282,IN,ferrous sulfate,B03AA07,ferrous sulfate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03A,IRON ANTIANEMIC PREPARATIONS,B03AA,"Iron bivalent, oral antianemic preparations",B03AA07,ferrous sulfate,248
C0060304,IN,fexinidazole,P01CA03,fexinidazole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01C,AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS,P01CA,"Nitroimidazole derivatives, antiprotozoal agents against leishmaniasis and trypanosomiasis",P01CA03,fexinidazole,1
C0060389,IN,finasteride,D11AX10,finasteride,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AX,OTHER DERMATOLOGICAL PREPARATIONS IN ATC,D11AX10,finasteride,18
C0060389,IN,finasteride,G04CB01,finasteride,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04C,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,G04CB,Testosterone-5-alpha reductase inhibitors for benign prostatic hypertrophy,G04CB01,finasteride,18
C0060400,IN,cefixime,J01DD08,cefixime,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD08,cefixime,265
C0060405,IN,cefdinir,J01DD15,cefdinir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD15,cefdinir,113
C0060477,IN,flubendazole,P02CA05,flubendazole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02C,ANTINEMATODAL AGENTS,P02CA,"Benzimidazole derivatives, antinematodal",P02CA05,flubendazole,11
C0060485,,,N05BA17,fludiazepam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA17,fludiazepam,1
C0060493,IN,flumequine,J01MB07,flumequine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MB,Other quinolones in ATC,J01MB07,flumequine,2
C0060501,IN,flunisolide,R01AD04,flunisolide,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AD,Corticosteroid nasal preparations for topical use,R01AD04,flunisolide,61
C0060501,IN,flunisolide,R03BA03,flunisolide,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03B,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS in ATC",R03BA,Glucocorticoid inhalants for obstructive airway disease,R03BA03,flunisolide,61
C0060520,IN,fluorescein,S01JA01,fluorescein,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01J,"DIAGNOSTIC AGENTS, OPHTHAMOLOGIC",S01JA,"Diagnostic, opthalmologic coloring agents",S01JA01,fluorescein,1157
C0060583,IN,flupirtine,N02BG07,flupirtine,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BG,Other analgesics and antipyretics in ATC,N02BG07,flupirtine,4
C0060657,IN,formoterol,R03AC13,formoterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC13,formoterol,327
C0060657,IN,formoterol,R03CC15,formoterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CC,"Selective beta-2-adrenoreceptor agonists, systemic",R03CC15,formoterol,327
C0060696,,,L01AD05,fotemustine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AD,"Nitrosoureas, antineoplastic alkylating agents",L01AD05,fotemustine,3
C0060787,IN,follitropin beta,G03GA06,follitropin beta,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03G,GONADOTROPINS AND OTHER OVULATION STIMULANTS,G03GA,Gonadotropins,G03GA06,follitropin beta,4218
C0060819,IN,fumagillin,P01AX10,fumagillin,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AX,Other agents against amoebiasis and other protozoal diseases in ATC,P01AX10,fumagillin,4
C0060825,PIN,fumaric acid,D05AX01,fumaric acid,D,DERMATOLOGICALS,D05,ANTIPSORIATICS,D05A,ANTIPSORIATICS FOR TOPICAL USE,D05AX,Other antipsoriatics for topical use in ATC,D05AX01,fumaric acid,12
C0060879,IN,fusafungin,R02AB03,fusafungine,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AB,Antibiotic throat preparations,R02AB03,fusafungine,7
C0060926,IN,gabapentin,N02BF01,gabapentin,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BF,"Gabapentinoids, analgesics and antipyretics",N02BF01,gabapentin,326
C0060930,IN,gadoteridol,V08CA04,gadoteridol,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08C,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,V08CA,Paramagnetic contrast media,V08CA04,gadoteridol,17
C0060933,,,V08CA01,gadopentetic acid,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08C,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,V08CA,Paramagnetic contrast media,V08CA01,gadopentetic acid,558
C0061078,PIN,gamma-linolenic acid,D11AX02,gamolenic acid,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AX,OTHER DERMATOLOGICAL PREPARATIONS IN ATC,D11AX02,gamolenic acid,95
C0061231,IN,geranylgeranylacetone,A02BX15,teprenone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC,A02BX15,teprenone,1
C0061323,IN,glimepiride,A10BB12,glimepiride,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BB,Sulfonylureas for blood glucose lowering,A10BB12,glimepiride,8
C0061347,IN,calcium glubionate,A12AA02,calcium glubionate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM SUPPLEMENTS,A12AA,Calcium,A12AA02,calcium glubionate,1
C0061450,,,B01AB11,sulodexide,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AB,Heparin group antithrombotic drugs,B01AB11,sulodexide,1
C0061751,IN,glycyrrhizic acid,A05BA08,glycyrrhizic acid,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A05,BILE AND LIVER THERAPY DRUGS,A05B,"LIVER THERAPY, LIPOTROPICS",A05BA,Liver therapy drugs,A05BA08,glycyrrhizic acid,37
C0061851,IN,ondansetron,A04AA01,ondansetron,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AA,Serotonin (5HT3) antagonists,A04AA01,ondansetron,516
C0061863,IN,granisetron,A04AA02,granisetron,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AA,Serotonin (5HT3) antagonists,A04AA02,granisetron,100
C0061996,IN,guar gum,A10BX01,guar gum,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins in ATC",A10BX01,guar gum,14
C0062068,,,C04AX32,fasudil,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AX,Other peripheral vasodilators in ATC,C04AX32,fasudil,2
C0062097,IN,halometasone,D07AC12,halometasone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC12,halometasone,5
C0062106,IN,haloprogin,D01AE11,haloprogin,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AE,Other antifungals for topical use in ATC,D01AE11,haloprogin,2
C0062525,IN,hepatitis B immune globulin,J06BB04,hepatitis B immunoglobulin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,J06BB04,hepatitis B immunoglobulin,134
C0062619,IN,hexafluorenium,M03AC05,hexafluronium,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,"Other quaternary ammonium compounds in ATC, muscle relaxants, peripherally acting",M03AC05,hexafluronium,1
C0062648,IN,hexamidine,D08AC04,hexamidine,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AC,Biguanides and amidines as antiseptics and disinfectants,D08AC04,hexamidine,5
C0062648,IN,hexamidine,R01AX07,hexamidine,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AX,Other nasal preparations in ATC,R01AX07,hexamidine,5
C0062648,IN,hexamidine,R02AA18,hexamidine,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AA,Antiseptic throat preparations,R02AA18,hexamidine,5
C0062648,IN,hexamidine,S01AX08,hexamidine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AX,Other antiinfectives in ATC,S01AX08,hexamidine,5
C0062648,IN,hexamidine,S03AA05,hexamidine,S,SENSORY ORGAN DRUGS,S03,OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,S03A,"ANTIINFECTIVES, OPHTHALMOLOGIC AND OTOLOGIC",S03AA,Antiinfectives,S03AA05,hexamidine,5
C0062922,IN,homatropine,S01FA05,homatropine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01F,MYDRIATICS AND CYCLOPLEGICS,S01FA,Anticholinergic mydriatics and cycloplegics,S01FA05,homatropine,14
C0062923,PIN,homatropine methylbromide,A03BB06,homatropine methylbromide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03B,"BELLADONNA AND DERIVATIVES CONTAINING DRUGS, PLAIN FOR FUNCTIONAL GASTROINTESTINAL DISORDERS",A03BB,"Belladonna alkaloids, semisynthetic, quaternary ammonium compounds for functional gastrointestinal disorders",A03BB06,homatropine methylbromide,2
C0062941,IN,omacetaxine mepesuccinate,L01XX40,omacetaxine mepesuccinate,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX40,omacetaxine mepesuccinate,17
C0062986,IN,cefpirome,J01DE02,cefpirome,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DE,Fourth-generation cephalosporins,J01DE02,cefpirome,34
C0063041,IN,leflunomide,L04AK01,leflunomide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AK,Dihydroorotate dehydrogenase (DHODH) inhibitors,L04AK01,leflunomide,86
C0063103,IN,hydroquinidine,C01BA13,hydroquinidine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BA,"Antiarrhythmics, class Ia",C01BA13,hydroquinidine,7
C0063242,IN,hypromellose,S01KA02,hypromellose,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01K,"SURGICAL AIDS, OPHTHALMOLOGIC",S01KA,Viscoelastic substances,S01KA02,hypromellose,12
C0063252,IN,desflurane,N01AB07,desflurane,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AB,"Halogenated hydrocarbons, general anesthetics",N01AB07,desflurane,168
C0063322,IN,tropisetron,A04AA03,tropisetron,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AA,Serotonin (5HT3) antagonists,A04AA03,tropisetron,43
C0063340,IN,ifenprodil,C04AX28,ifenprodil,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AX,Other peripheral vasodilators in ATC,C04AX28,ifenprodil,2
C0063384,IN,imidazole-2-hydroxybenzoate,N02BA16,imidazole salicylate,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BA,"Salicylic acid and derivatives, analgesics and antipyretics",N02BA16,imidazole salicylate,2
C0063449,IN,indanazoline,R01AA15,indanazoline,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AA,"Sympathomimetics, plain",R01AA15,indanazoline,1
C0063479,IN,indobufen,B01AC10,indobufen,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC10,indobufen,1
C0063739,IN,invert sugar,C05BB03,invert sugar,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05B,ANTIVARICOSE THERAPY DRUGS,C05BB,Sclerosing agents for local injection,C05BB03,invert sugar,2
C0063757,IN,iodixanol,V08AB09,iodixanol,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AB,"Watersoluble, nephrotropic, low osmolar X-ray contrast media",V08AB09,iodixanol,15
C0063779,IN,iodoform,D09AA13,iodoform,D,DERMATOLOGICALS,D09,MEDICATED DRESSINGS,D09A,MEDICATED DRESSINGS,D09AA,Medicated dressings with antiinfectives,D09AA13,iodoform,33
C0063810,IN,iomeprol,V08AB10,iomeprol,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AB,"Watersoluble, nephrotropic, low osmolar X-ray contrast media",V08AB10,iomeprol,7
C0063815,IN,iopentol,V08AB08,iopentol,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AB,"Watersoluble, nephrotropic, low osmolar X-ray contrast media",V08AB08,iopentol,7
C0063817,IN,iopromide,V08AB05,iopromide,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AB,"Watersoluble, nephrotropic, low osmolar X-ray contrast media",V08AB05,iopromide,25
C0063828,IN,ioversol,V08AB07,ioversol,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AB,"Watersoluble, nephrotropic, low osmolar X-ray contrast media",V08AB07,ioversol,3
C0063830,,,V08AA05,ioxitalamic acid,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AA,"Watersoluble, nephrotropic, high osmolar X-ray contrast media",V08AA05,ioxitalamic acid,3
C0063953,IN,isoconazole,D01AC05,isoconazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC05,isoconazole,6
C0063953,IN,isoconazole,G01AF07,isoconazole,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AF,"Imidazole derivatives, gyncological antiinfectives",G01AF07,isoconazole,6
C0063986,IN,lanatoside C,C01AA06,lanatoside C,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01A,CARDIAC GLYCOSIDES,C01AA,Digitalis glycosides,C01AA06,lanatoside C,1
C0064079,PIN,isosorbide mononitrate,C01DA14,isosorbide mononitrate,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01D,VASODILATORS USED IN CARDIAC DISEASES,C01DA,Organic nitrates used in cardiac disease,C01DA14,isosorbide mononitrate,34
C0064113,IN,itraconazole,J02AC02,itraconazole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AC,Triazole and tetrazole derivatives,J02AC02,itraconazole,582
C0064263,IN,emedastine,S01GX06,emedastine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GX,Other antiallergics in ATC,S01GX06,emedastine,10
C0064311,,,N02AB01,ketobemidone,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AB,"Phenylpiperidine derivatives, opioid analgesics",N02AB01,ketobemidone,12
C0064568,IN,lacidipine,C08CA09,lacidipine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,C08CA,Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects,C08CA09,lacidipine,3
C0064582,PIN,lactic acid,G01AD01,lactic acid,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AD,"Organic acids, Gynecological",G01AD01,lactic acid,1625
C0064585,IN,lactitol,A06AD12,lactitol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,A06AD12,lactitol,10
C0064636,IN,lamotrigine,N03AX09,lamotrigine,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX09,lamotrigine,895
C0064694,IN,lavender oil,N05BX05,Lavandulae aetheroleum,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BX,Other anxiolytics in ATC,N05BX05,Lavandulae aetheroleum,16
C0064777,IN,letosteine,R05CB09,letosteine,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CB,Mucolytics,R05CB09,letosteine,1
C0064870,IN,levocabastine,R01AC02,levocabastine,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AC,"Antiallergic nasal preparations for topical use, excl. corticosteroids",R01AC02,levocabastine,38
C0064870,IN,levocabastine,S01GX02,levocabastine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GX,Other antiallergics in ATC,S01GX02,levocabastine,38
C0064906,IN,nafarelin,H01CA02,nafarelin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CA,Gonadotropin-releasing hormones,H01CA02,nafarelin,39
C0065023,IN,fidaxomicin,A07AA12,fidaxomicin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,"antibiotics, intestinal",A07AA12,fidaxomicin,8
C0065088,IN,lithium chloride,V04CX11,lithium chloride,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CX,Other diagnostic agents in ATC,V04CX11,lithium chloride,20
C0065152,IN,lofexidine,N07BC04,lofexidine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07B,DRUGS USED IN ADDICTIVE DISORDERS,N07BC,Drugs used in opioid dependence,N07BC04,lofexidine,2
C0065162,IN,lomefloxacin,J01MA07,lomefloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA07,lomefloxacin,14
C0065162,IN,lomefloxacin,S01AE04,lomefloxacin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AE,"Fluoroquinolone antiinfectives, ophthalmologic",S01AE04,lomefloxacin,14
C0065180,IN,loratadine,R06AX13,loratadine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX13,loratadine,177
C0065183,,,C01BC07,lorcainide,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BC,"Antiarrhythmics, class Ic",C01BC07,lorcainide,5
C0065185,IN,lormetazepam,N05CD06,lormetazepam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CD,Benzodiazepine derivative hypnotics and sedatives,N05CD06,lormetazepam,3
C0065199,IN,loxoprofen,M01AE19,loxoprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,"Propionic acid derivatives, antiinflammatory and antirheumatic products",M01AE19,loxoprofen,5
C0065199,IN,loxoprofen,M02AA31,loxoprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA31,loxoprofen,5
C0065295,IN,loracarbef,J01DC08,loracarbef,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DC,Second-generation cephalosporins,J01DC08,loracarbef,27
C0065374,IN,lisinopril,C09AA03,lisinopril,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09A,"ACE INHIBITORS, PLAIN",C09AA,"ACE inhibitors, plain",C09AA03,lisinopril,49
C0065517,IN,magnesium carbonate,A02AA01,magnesium carbonate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AA,antacids containing magnesium compounds,A02AA01,magnesium carbonate,1
C0065517,IN,magnesium carbonate,A06AD01,magnesium carbonate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,A06AD01,magnesium carbonate,1
C0065527,IN,magnesium phosphate,B05XA10,magnesium phosphate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA10,magnesium phosphate,13
C0065636,IN,mandelic acid,B05CA06,mandelic acid,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05C,"IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION",B05CA,Antiinfective irrigating solutions,B05CA06,mandelic acid,25
C0065636,IN,mandelic acid,J01XX06,mandelic acid,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XX,Other antibacterials in ATC,J01XX06,mandelic acid,25
C0065656,IN,manidipine,C08CA11,manidipine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,C08CA,Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects,C08CA11,manidipine,1
C0065760,,,N04AA10,mazaticol,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04A,ANTICHOLINERGIC AGENTS,N04AA,"Tertiary amines, anticholinergic",N04AA10,mazaticol,1
C0065767,IN,calcipotriene,D05AX02,calcipotriol,D,DERMATOLOGICALS,D05,ANTIPSORIATICS,D05A,ANTIPSORIATICS FOR TOPICAL USE,D05AX,Other antipsoriatics for topical use in ATC,D05AX02,calcipotriol,67
C0065832,IN,mebeverine,A03AA04,mebeverine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AA,"Synthetic anticholinergics, esters with tertiary amino group for functional gastrointestinal disorders",A03AA04,mebeverine,2
C0065841,IN,meclocycline,D10AF04,meclocycline,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AF,Antiinfectives for treatment of acne,D10AF04,meclocycline,1
C0065844,IN,mecobalamin,B03BA05,mecobalamin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03B,VITAMIN B12 AND FOLIC ACID,B03BA,Vitamin B12 (cyanocobalamin and analogues),B03BA05,mecobalamin,40
C0065865,IN,medrysone,S01BA08,medrysone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BA,"Corticosteroid ophthalmologic antiinflammatory agents, plain",S01BA08,medrysone,2
C0065936,IN,menatetrenone,M05BX08,menatetrenone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BX,Other drugs affecting bone structure and mineralization in ATC,M05BX08,menatetrenone,3
C0065961,IN,mepindolol,C07AA14,mepindolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AA,"Beta blocking agents, non-selective",C07AA14,mepindolol,1
C0065972,IN,mequitazine,R06AD07,mequitazine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AD,"Phenothiazine derivatives, systemic antihistamines",R06AD07,mequitazine,8
C0066005,IN,meropenem,J01DH02,meropenem,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DH,Carbapenems,J01DH02,meropenem,691
C0066469,IN,metopimazine,A04AD05,metopimazine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics in ATC,A04AD05,metopimazine,4
C0066477,IN,metylperon,N05AD03,melperone,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AD,"Butyrophenone derivatives, antipsychotics",N05AD03,melperone,4
C0066520,IN,micronomicin,S01AA22,micronomicin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA22,micronomicin,2
C0066522,IN,ocriplasmin,S01XA22,ocriplasmin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA22,ocriplasmin,2
C0066531,IN,midecamycin,J01FA03,midecamycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,J01FA03,midecamycin,11
C0066561,IN,minaprine,N06AX07,minaprine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX07,minaprine,2
C0066673,IN,moclobemide,N06AG02,moclobemide,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AG,"MAO A Inhibitors, antidepressant drugs",N06AG02,moclobemide,9
C0066677,IN,modafinil,N06BA07,modafinil,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BA,Centrally acting sympathomimetics,N06BA07,modafinil,57
C0066803,IN,morniflumate,M01AX22,morniflumate,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids in ATC",M01AX22,morniflumate,4
C0066805,IN,moroxydine,J05AX01,moroxydine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX01,moroxydine,1
C0066837,IN,moxonidine,C02AC05,moxonidine,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02A,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",C02AC,Imidazoline receptor agonists,C02AC05,moxonidine,2
C0068006,IN,miltefosine,P01CX04,miltefosine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01C,AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS,P01CX,Other agents against leishmaniasis and trypanosomiasis in ATC,P01CX04,miltefosine,82
C0068333,IN,nabilone,A04AD11,nabilone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics in ATC,A04AD11,nabilone,4
C0068334,IN,nabumetone,M01AX01,nabumetone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids in ATC",M01AX01,nabumetone,7
C0068367,IN,naftifine,D01AE22,naftifine,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AE,Other antifungals for topical use in ATC,D01AE22,naftifine,9
C0068377,IN,nalmefene,N07BB05,nalmefene,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07B,DRUGS USED IN ADDICTIVE DISORDERS,N07BB,Drugs used in alcohol dependence,N07BB05,nalmefene,4
C0068475,IN,nebivolol,C07AB12,nebivolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AB,"Beta blocking agents, selective",C07AB12,nebivolol,6
C0068483,IN,nedocromil,R01AC07,nedocromil,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AC,"Antiallergic nasal preparations for topical use, excl. corticosteroids",R01AC07,nedocromil,151
C0068483,IN,nedocromil,R03BC03,nedocromil,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03B,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS in ATC",R03BC,"Antiallergic inhalants for obstructive airway diseases, excl. corticosteroids",R03BC03,nedocromil,151
C0068483,IN,nedocromil,S01GX04,nedocromil,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GX,Other antiallergics in ATC,S01GX04,nedocromil,151
C0068485,IN,nefazodone,N06AX06,nefazodone,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX06,nefazodone,19
C0068673,IN,niaprazine,N05CM16,niaprazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CM,Other hypnotics and sedatives in ATC,N05CM16,niaprazine,8
C0068699,,,N02AA04,nicomorphine,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AA,Natural opium alkaloid analgesics,N02AA04,nicomorphine,2
C0068700,IN,nicorandil,C01DX16,nicorandil,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01D,VASODILATORS USED IN CARDIAC DISEASES,C01DX,Other vasodilators used in cardiac diseases in ATC,C01DX16,nicorandil,10
C0068742,IN,nifuroxazide,A07AX03,nifuroxazide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AX,Other intestinal antiinfectives in ATC,A07AX03,nifuroxazide,2
C0068788,IN,nitazoxanide,P01AX11,nitazoxanide,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AX,Other agents against amoebiasis and other protozoal diseases in ATC,P01AX11,nitazoxanide,65
C0068881,IN,nitroxoline,J01XX07,nitroxoline,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XX,Other antibacterials in ATC,J01XX07,nitroxoline,1
C0068897,IN,tiagabine,N03AG06,tiagabine,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AG,"Fatty acid derivatives, antiepileptics",N03AG06,tiagabine,46
C0068922,IN,nomegestrol,G03DB04,nomegestrol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03D,PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03DB,"Pregnadien derivatives, progestogens",G03DB04,nomegestrol,1
C0068955,IN,theodrenaline,C01CA23,theodrenaline,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA23,theodrenaline,9
C0068978,IN,cafedrine,C01CA21,cafedrine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA21,cafedrine,9
C0069008,IN,normethadone,R05DA06,normethadone,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DA,"Opium alkaloids and derivatives, cough suppressants",R05DA06,normethadone,1
C0069021,IN,cathine,A08AA07,cathine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,A08AA07,cathine,2
C0069351,IN,octenidine,A01AB24,octenidine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AB,Antiinfectives and antiseptics for local oral treatment,A01AB24,octenidine,8
C0069351,IN,octenidine,R02AA21,octenidine,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AA,Antiseptic throat preparations,R02AA21,octenidine,8
C0069454,IN,olsalazine,A07EC03,olsalazine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EC,Aminosalicylic acid and similar agents,A07EC03,olsalazine,5
C0069562,,,A02BX14,rebamipide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BX,Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC,A02BX14,rebamipide,1
C0069638,IN,orgotein,M01AX14,orgotein,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids in ATC",M01AX14,orgotein,1
C0069709,,,N06AX10,oxaflozane,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX10,oxaflozane,1
C0069717,IN,oxaliplatin,L01XA03,oxaliplatin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XA,"Platinum compounds, antineoplastic drugs",L01XA03,oxaliplatin,78
C0069734,IN,oxantel,P02CC02,oxantel,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02C,ANTINEMATODAL AGENTS,P02CC,"Tetrahydropyrimidine derivatives, antinematodal",P02CC02,oxantel,22
C0069751,IN,oxcarbazepine,N03AF02,oxcarbazepine,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AF,"Carboxamide derivatives, antiepileptics",N03AF02,oxcarbazepine,409
C0069760,IN,oxetorone,N02CX06,oxetorone,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CX,Other antimigraine preparations in ATC,N02CX06,oxetorone,1
C0069765,IN,oxiconazole,D01AC11,oxiconazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC11,oxiconazole,5
C0069765,IN,oxiconazole,G01AF17,oxiconazole,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AF,"Imidazole derivatives, gyncological antiinfectives",G01AF17,oxiconazole,5
C0069805,IN,oxybutynin,G04BD04,oxybutynin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BD,Drugs for urinary frequency and incontinence,G04BD04,oxybutynin,192
C0069833,IN,oxyphencyclimine,A03AA01,oxyphencyclimine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AA,"Synthetic anticholinergics, esters with tertiary amino group for functional gastrointestinal disorders",A03AA01,oxyphencyclimine,1
C0070034,IN,pantethine,A11HA32,pantethine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS in ATC,A11HA,Other plain vitamin preparations in ATC,A11HA32,pantethine,4
C0070072,IN,paramethadione,N03AC01,paramethadione,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AC,"Oxazolidine derivatives, antiepileptics",N03AC01,paramethadione,1
C0070093,IN,teriparatide,H05AA02,teriparatide,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05A,PARATHYROID HORMONES AND ANALOGUES,H05AA,Parathyroid hormones and analogues,H05AA02,teriparatide,52
C0070122,IN,paroxetine,N06AB05,paroxetine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AB,Selective serotonin reuptake inhibitors,N06AB05,paroxetine,254
C0070166,IN,clopidogrel,B01AC04,clopidogrel,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC04,clopidogrel,99
C0070203,IN,pectin,A07BC01,pectin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07B,INTESTINAL ADSORBENTS,A07BC,Other intestinal adsorbents in ATC,A07BC01,pectin,46
C0070217,,,J01CE06,penamecillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,J01CE06,penamecillin,1
C0070325,IN,peppermint oil,A03AX15,menthae piperitae aetheroleum,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders in ATC,A03AX15,menthae piperitae aetheroleum,7
C0070455,IN,permethrin,P03AC04,permethrin,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03A,"ECTOPARASITICIDES, INCL. SCABICIDES",P03AC,"Pyrethrines, incl. synthetic compounds, ectoparasiticides, incl. scabicides",P03AC04,permethrin,292
C0070525,IN,phenacemide,N03AX07,phenacemide,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX07,phenacemide,3
C0070557,IN,phenethicillin,J01CE05,pheneticillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,J01CE05,pheneticillin,2
C0070570,IN,phenol,C05BB05,phenol,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05B,ANTIVARICOSE THERAPY DRUGS,C05BB,Sclerosing agents for local injection,C05BB05,phenol,1054
C0070570,IN,phenol,D08AE03,phenol,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AE,"Phenol and derivatives, antiseptics and disinfectants",D08AE03,phenol,1054
C0070570,IN,phenol,N01BX03,phenol,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BX,Other local anesthetics in ATC,N01BX03,phenol,1054
C0070570,IN,phenol,R02AA19,phenol,R,RESPIRATORY SYSTEM DRUGS,R02,THROAT PREPARATIONS,R02A,THROAT PREPARATIONS,R02AA,Antiseptic throat preparations,R02AA19,phenol,1054
C0070585,IN,phenothrin,P03AC03,phenothrin,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03A,"ECTOPARASITICIDES, INCL. SCABICIDES",P03AC,"Pyrethrines, incl. synthetic compounds, ectoparasiticides, incl. scabicides",P03AC03,phenothrin,11
C0070694,IN,edaravone,N07XX14,edaravone,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07X,OTHER NERVOUS SYSTEM DRUGS in ATC,N07XX,Other nervous system drugs in ATC,N07XX14,edaravone,16
C0070742,IN,pholcodine,R05DA08,pholcodine,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DA,"Opium alkaloids and derivatives, cough suppressants",R05DA08,pholcodine,3
C0070895,IN,foscarnet,J05AD01,foscarnet,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AD,"Phosphonic acid derivatives, direct acting antivirals",J05AD01,foscarnet,141
C0071043,,,B01AC03,picotamide,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC03,picotamide,1
C0071082,,,N05BA14,pinazepam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA14,pinazepam,1
C0071097,IN,pioglitazone,A10BG03,pioglitazone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BG,"Thiazolidinediones, blood glucose lowering drugs",A10BG03,pioglitazone,51
C0071098,IN,pipamperone,N05AD05,pipamperone,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AD,"Butyrophenone derivatives, antipsychotics",N05AD05,pipamperone,15
C0071099,IN,pipazethate,R05DB11,pipazetate,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DB,Other cough suppressants in ATC,R05DB11,pipazetate,1
C0071103,IN,pipenzolate,A03AB14,pipenzolate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds for functional gastrointestinal disorders",A03AB14,pipenzolate,2
C0071126,IN,pirarubicin,L01DB08,pirarubicin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01D,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,L01DB,Anthracyclines and related substances,L01DB08,pirarubicin,50
C0071129,IN,pirbuterol,R03AC08,pirbuterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC08,pirbuterol,5
C0071129,IN,pirbuterol,R03CC07,pirbuterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CC,"Selective beta-2-adrenoreceptor agonists, systemic",R03CC07,pirbuterol,5
C0071132,IN,piretanide,C03CA03,piretanide,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03C,HIGH-CEILING DIURETICS,C03CA,"sulfonamides, high-ceiling diuretics, plain",C03CA03,piretanide,1
C0071152,,,M01AE08,pirprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,"Propionic acid derivatives, antiinflammatory and antirheumatic products",M01AE08,pirprofen,2
C0071304,IN,isradipine,C08CA03,isradipine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,C08CA,Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects,C08CA03,isradipine,20
C0071330,IN,polidocanol,C05BB02,polidocanol,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05B,ANTIVARICOSE THERAPY DRUGS,C05BB,Sclerosing agents for local injection,C05BB02,polidocanol,120
C0071359,,,L03AX08,poly ICLC,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AX,Other immunostimulants in ATC,L03AX08,poly ICLC,5
C0071568,IN,pegaspargase,L01XX24,pegaspargase,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX24,pegaspargase,158
C0071751,IN,potassium bicarbonate,A12BA04,potassium hydrogencarbonate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12B,POTASSIUM SUPPLEMENTS,A12BA,Potassium,A12BA04,potassium hydrogencarbonate,23
C0071774,IN,potassium perchlorate,H03BC01,potassium perchlorate,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H03,THYROID THERAPY DRUGS,H03B,ANTITHYROID PREPARATIONS,H03BC,Perchlorate antithyroid preparations,H03BC01,potassium perchlorate,12
C0071808,IN,pralidoxime,V03AB04,pralidoxime,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB04,pralidoxime,50
C0071810,IN,pramoxine,C05AD07,pramocaine,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AD,Local anesthetics for treatment of hemorrhoids and anal fissures for topical use,C05AD07,pramocaine,1
C0071810,IN,pramoxine,D04AB07,pramocaine,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AB,Anesthetics for topical use,D04AB07,pramocaine,1
C0071836,IN,prednicarbate,D07AC18,prednicarbate,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC18,prednicarbate,10
C0072032,IN,procaterol,R03AC16,procaterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC16,procaterol,43
C0072032,IN,procaterol,R03CC08,procaterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CC,"Selective beta-2-adrenoreceptor agonists, systemic",R03CC08,procaterol,43
C0072076,IN,progabide,N03AG05,progabide,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AG,"Fatty acid derivatives, antiepileptics",N03AG05,progabide,7
C0072151,IN,promestriene,G03CA09,promestriene,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03C,"ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",G03CA,"Natural and semisynthetic estrogens, plain",G03CA09,promestriene,1
C0072159,IN,propamidine,D08AC03,propamidine,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AC,Biguanides and amidines as antiseptics and disinfectants,D08AC03,propamidine,2
C0072159,IN,propamidine,S01AX15,propamidine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AX,Other antiinfectives in ATC,S01AX15,propamidine,2
C0072171,IN,propentofylline,N06BC02,propentofylline,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BC,"Xanthine derivatives, psychostimulants, agents used for ADHD and nootropics",N06BC02,propentofylline,1
C0072176,IN,propicillin,J01CE03,propicillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,J01CE03,propicillin,1
C0072245,IN,propyphenazone,N02BB04,propyphenazone,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BB,"Pyrazolones, analgesics and antipyretics",N02BB04,propyphenazone,5
C0072247,IN,proquazone,M01AX13,proquazone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids in ATC",M01AX13,proquazone,2
C0072315,IN,proglumetacin,M01AB14,proglumetacin,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,M01AB14,proglumetacin,2
C0072510,IN,proparacaine,S01HA04,proxymetacaine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01H,"Local anesthetics, ophthalmologic",S01HA,Local anesthetics,S01HA04,proxymetacaine,26
C0072511,IN,proxyphylline,R03DA03,proxyphylline,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DA,"Xanthines, systemic for obstructive airway disease",R03DA03,proxyphylline,2
C0072652,,,S01BC09,pranoprofen,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BC,"Antiinflammatory agents, non-steroidal, ophthalmologic",S01BC09,pranoprofen,1
C0072804,IN,pyrvinium,P02CX01,pyrvinium,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02C,ANTINEMATODAL AGENTS,P02CX,Other antinematodals in ATC,P02CX01,pyrvinium,6
C0072857,IN,quinapril,C09AA06,quinapril,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09A,"ACE INHIBITORS, PLAIN",C09AA,"ACE inhibitors, plain",C09AA06,quinapril,4
C0072916,IN,cisapride,A03FA02,cisapride,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,A03FA02,cisapride,180
C0072973,IN,ramipril,C09AA05,ramipril,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09A,"ACE INHIBITORS, PLAIN",C09AA,"ACE inhibitors, plain",C09AA05,ramipril,41
C0072980,IN,sirolimus,L01EG04,sirolimus,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EG,Mammalian target of rapamycin (mTOR) kinase inhibitors (L01EG),L01EG04,sirolimus,995
C0072980,IN,sirolimus,L04AH01,sirolimus,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AH,Mammalian target of rapamycin (mTOR) kinase inhibitors (L04AH),L04AH01,sirolimus,995
C0072980,IN,sirolimus,S01XA23,sirolimus,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA23,sirolimus,995
C0073047,IN,remoxipride,N05AL04,remoxipride,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AL,Benzamide antipsychotics,N05AL04,remoxipride,2
C0073076,IN,reproterol,R03AC15,reproterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC15,reproterol,8
C0073076,IN,reproterol,R03CC14,reproterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CC,"Selective beta-2-adrenoreceptor agonists, systemic",R03CC14,reproterol,8
C0073085,IN,resorcinol,D10AX02,resorcinol,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AX,Other anti-acne preparations for topical use in ATC,D10AX02,resorcinol,21
C0073085,IN,resorcinol,S01AX06,resorcinol,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AX,Other antiinfectives in ATC,S01AX06,resorcinol,21
C0073188,IN,Rho(D) immune globulin,J06BB01,anti-D (rh) immunoglobulin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,J06BB01,anti-D (rh) immunoglobulin,144
C0073371,IN,rifamycin SV,A07AA13,rifamycin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,"antibiotics, intestinal",A07AA13,rifamycin,76
C0073371,IN,rifamycin SV,D06AX15,rifamycin,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AX,Other antibiotics for topical use in ATC,D06AX15,rifamycin,76
C0073371,IN,rifamycin SV,J04AB03,rifamycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AB,"Antibiotics, Antitubercular",J04AB03,rifamycin,76
C0073371,IN,rifamycin SV,S01AA16,rifamycin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA16,rifamycin,76
C0073371,IN,rifamycin SV,S02AA12,rifamycin,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA12,rifamycin,76
C0073372,IN,rifapentine,J04AB05,rifapentine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AB,"Antibiotics, Antitubercular",J04AB05,rifapentine,38
C0073374,IN,rifaximin,A07AA11,rifaximin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07A,INTESTINAL ANTIINFECTIVES,A07AA,"antibiotics, intestinal",A07AA11,rifaximin,53
C0073374,IN,rifaximin,D06AX11,rifaximin,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AX,Other antibiotics for topical use in ATC,D06AX11,rifaximin,53
C0073379,IN,riluzole,N07XX02,riluzole,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07X,OTHER NERVOUS SYSTEM DRUGS in ATC,N07XX,Other nervous system drugs in ATC,N07XX02,riluzole,13
C0073393,IN,risperidone,N05AX08,risperidone,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AX,Other antipsychotics in ATC,N05AX08,risperidone,854
C0073560,,,J01FA12,rokitamycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,J01FA12,rokitamycin,33
C0073571,IN,ropivacaine,N01BB09,ropivacaine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BB,Amide local anesthetics,N01BB09,ropivacaine,675
C0073591,IN,rosoxacin,J01MB01,rosoxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MB,Other quinolones in ATC,J01MB01,rosoxacin,1
C0073629,IN,ganirelix,H01CC01,ganirelix,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CC,Anti-gonadotropin-releasing hormones,H01CC01,ganirelix,43
C0073631,IN,ketorolac,M01AB15,ketorolac,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,M01AB15,ketorolac,295
C0073631,IN,ketorolac,S01BC05,ketorolac,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BC,"Antiinflammatory agents, non-steroidal, ophthalmologic",S01BC05,ketorolac,295
C0073633,IN,ranolazine,C01EB18,ranolazine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01E,OTHER CARDIAC PREPARATIONS in ATC,C01EB,Other plain cardiac preparations in ATC,C01EB18,ranolazine,2
C0073704,,,J01MA10,rufloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA10,rufloxacin,2
C0073917,,,M01CC02,bucillamine,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01C,SPECIFIC ANTIRHEUMATIC AGENTS,M01CC,Penicillamine and similar antirheumatic agents,M01CC02,bucillamine,4
C0073983,IN,salsalate,N02BA06,salsalate,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BA,"Salicylic acid and derivatives, analgesics and antipyretics",N02BA06,salsalate,1
C0073992,IN,salmeterol,R03AC12,salmeterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC12,salmeterol,381
C0073994,IN,salmon calcitonin,H05BA01,calcitonin (salmon synthetic),H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BA,Calcitonin preparations,H05BA01,calcitonin (salmon synthetic),18
C0073999,IN,phenyl salicylate,G04BX12,phenyl salicylate,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BX,Other urologicals in ATC,G04BX12,phenyl salicylate,1
C0074246,IN,secnidazole,P01AB07,secnidazole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AB,"Nitroimidazole derivatives, antiprotozoal agents against amoebiasis and other protozoal diseases",P01AB07,secnidazole,19
C0074281,IN,selenium sulfide,D01AE13,selenium sulfide,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AE,Other antifungals for topical use in ATC,D01AE13,selenium sulfide,16
C0074391,IN,sertaconazole,D01AC14,sertaconazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC14,sertaconazole,12
C0074391,IN,sertaconazole,G01AF19,sertaconazole,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AF,"Imidazole derivatives, gyncological antiinfectives",G01AF19,sertaconazole,12
C0074393,IN,sertraline,N06AB06,sertraline,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AB,Selective serotonin reuptake inhibitors,N06AB06,sertraline,413
C0074414,IN,sevoflurane,N01AB08,sevoflurane,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AB,"Halogenated hydrocarbons, general anesthetics",N01AB08,sevoflurane,1773
C0074493,IN,sibutramine,A08AA10,sibutramine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,A08AA10,sibutramine,30
C0074554,IN,simvastatin,C10AA01,simvastatin,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AA,"HMG CoA reductase inhibitors, plain lipid modifying drugs",C10AA01,simvastatin,125
C0074710,IN,pramipexole,N04BC05,pramipexole,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04B,DOPAMINERGIC AGENTS,N04BC,Dopamine agonists,N04BC05,pramipexole,19
C0074714,IN,sobrerol,R05CB07,sobrerol,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CB,Mucolytics,R05CB07,sobrerol,2
C0074722,IN,sodium bicarbonate,B05CB04,sodium bicarbonate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05C,"IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION",B05CB,Salt irrigating solutions,B05CB04,sodium bicarbonate,491
C0074722,IN,sodium bicarbonate,B05XA02,sodium bicarbonate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA02,sodium bicarbonate,491
C0074727,PIN,sodium borate,S01AX07,sodium borate,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AX,Other antiinfectives in ATC,S01AX07,sodium borate,9
C0074757,IN,sodium phosphate,A06AD17,sodium phosphate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,A06AD17,sodium phosphate,2
C0074757,IN,sodium phosphate,A06AG01,sodium phosphate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AG,Enema for Constipation,A06AG01,sodium phosphate,2
C0074757,IN,sodium phosphate,B05XA09,sodium phosphate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA09,sodium phosphate,2
C0074757,IN,sodium phosphate,V03AG05,sodium phosphate,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AG,Drugs for treatment of hypercalcemia,V03AG05,sodium phosphate,2
C0074769,IN,sodium sulfate,A06AD13,sodium sulfate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,A06AD13,sodium sulfate,15
C0074769,IN,sodium sulfate,A12CA02,sodium sulfate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS in ATC,A12CA,Sodium supplements,A12CA02,sodium sulfate,15
C0075227,IN,stepronin,R05CB11,stepronin,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CB,Mucolytics,R05CB11,stepronin,1
C0075262,IN,stiripentol,N03AX17,stiripentol,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX17,stiripentol,66
C0075432,,,G04BX10,succinimide,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BX,Other urologicals in ATC,G04BX10,succinimide,24
C0075503,IN,sulconazole,D01AC09,sulconazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC09,sulconazole,1
C0075539,,,J01EB08,sulfathiourea,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE,J01EB,Short-acting sulfonamides,J01EB08,sulfathiourea,1
C0075628,,,G02AD05,sulprostone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02A,UTEROTONICS,G02AD,"Prostaglandins, oxytocics",G02AD05,sulprostone,83
C0075630,IN,sultopride,N05AL02,sultopride,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AL,Benzamide antipsychotics,N05AL02,sultopride,1
C0075632,IN,sumatriptan,N02CC01,sumatriptan,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CC,Selective serotonin (5HT1) agonists,N02CC01,sumatriptan,73
C0075783,IN,talinolol,C07AB13,talinolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AB,"Beta blocking agents, selective",C07AB13,talinolol,4
C0075857,IN,taurursodiol,A05AA05,ursodoxicoltaurine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A05,BILE AND LIVER THERAPY DRUGS,A05A,BILE THERAPY DRUGS,A05AA,Bile acids and derivatives for bile therapy,A05AA05,ursodoxicoltaurine,7
C0075870,IN,tazobactam,J01CG02,tazobactam,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CG,"Beta-lactamase inhibitors, systemic penicillins",J01CG02,tazobactam,243
C0075928,,,V09CA02,technetium (99mTc) succimer,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09C,RENAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,V09CA,Technetium (99mTc) compounds,V09CA02,technetium (99mTc) succimer,477
C0075932,PIN,technetium Tc 99m disofenin,V09DA01,technetium (99mTc) disofenin,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09D,HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,V09DA,Technetium (99mTc) compounds,V09DA01,technetium (99mTc) disofenin,49
C0076075,IN,temafloxacin,J01MA05,temafloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA05,temafloxacin,2
C0076079,IN,temocillin,J01CA17,temocillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA17,temocillin,7
C0076080,IN,temozolomide,L01AX03,temozolomide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AX,Other alkylating agents in ATC,L01AX03,temozolomide,344
C0076096,IN,tenoxicam,M01AC02,tenoxicam,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AC,"Oxicams, antiinflammatory and antirheumatic drugs",M01AC02,tenoxicam,12
C0076107,IN,terazosin,G04CA03,terazosin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04C,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,G04CA,"Alpha-adrenoreceptor antagonists, benign prostatic hypertrophy",G04CA03,terazosin,6
C0076110,IN,terbinafine,D01AE15,terbinafine,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AE,Other antifungals for topical use in ATC,D01AE15,terbinafine,169
C0076110,IN,terbinafine,D01BA02,terbinafine,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01B,ANTIFUNGALS FOR SYSTEMIC USE,D01BA,Antifungals for systemic use,D01BA02,terbinafine,169
C0076115,IN,terconazole,G01AG02,terconazole,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AG,"Triazole derivatives, gynecological antiinfectives and antiseptics",G01AG02,terconazole,5
C0076126,IN,terodiline,G04BD05,terodiline,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BD,Drugs for urinary frequency and incontinence,G04BD05,terodiline,5
C0076275,IN,orlistat,A08AB01,orlistat,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AB,Peripherally acting antiobesity products,A08AB01,orlistat,35
C0076286,IN,tetrahydrozoline,R01AA06,tetryzoline,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AA,"Sympathomimetics, plain",R01AA06,tetryzoline,9
C0076286,IN,tetrahydrozoline,R01AB03,tetryzoline,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AB,"Sympathomimetics, combinations excl. corticosteroids",R01AB03,tetryzoline,9
C0076286,IN,tetrahydrozoline,S01GA02,tetryzoline,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GA,Sympathomimetics used as decongestants,S01GA02,tetryzoline,9
C0076295,,,P03BA04,tetramethrin,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03B,INSECTICIDES AND REPELLENTS,P03BA,Pyrethrines,P03BA04,tetramethrin,4
C0076341,IN,tetrazepam,M03BX07,tetrazepam,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents in ATC,M03BX07,tetrazepam,2
C0076382,,,D04AA03,thenalidine,D,DERMATOLOGICALS,D04,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04A,"ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",D04AA,Antihistamines for topical use,D04AA03,thenalidine,1
C0076382,,,R06AX03,thenalidine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX03,thenalidine,1
C0076456,IN,thiocolchicoside,M03BX05,thiocolchicoside,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents in ATC,M03BX05,thiocolchicoside,3
C0076652,IN,tianeptine,N06AX14,tianeptine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX14,tianeptine,8
C0076653,PIN,tiaprofenic acid,M01AE11,tiaprofenic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,"Propionic acid derivatives, antiinflammatory and antirheumatic products",M01AE11,tiaprofenic acid,11
C0076660,IN,tibolone,G03CX01,tibolone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03C,"ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",G03CX,Other estrogens in ATC,G03CX01,tibolone,6
C0076705,IN,tioconazole,D01AC07,tioconazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC07,tioconazole,6
C0076705,IN,tioconazole,G01AF08,tioconazole,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AF,"Imidazole derivatives, gyncological antiinfectives",G01AF08,tioconazole,6
C0076714,,,R05DB24,tipepidine,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DB,Other cough suppressants in ATC,R05DB24,tipepidine,5
C0076772,,,C07AA27,cloranolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AA,"Beta blocking agents, non-selective",C07AA27,cloranolol,1
C0076784,IN,tofisopam,N05BA23,tofisopam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05B,ANXIOLYTICS,N05BA,Benzodiazepine derivative anxiolytics,N05BA23,tofisopam,2
C0076793,IN,tolciclate,D01AE19,tolciclate,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AE,Other antifungals for topical use in ATC,D01AE19,tolciclate,2
C0076799,IN,tolfenamic acid,M01AG02,tolfenamic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AG,"Fenamates, antiinflammatory and antirheumatic drugs",M01AG02,tolfenamic acid,7
C0076804,IN,toloxatone,N06AG03,toloxatone,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AG,"MAO A Inhibitors, antidepressant drugs",N06AG03,toloxatone,1
C0076823,IN,atomoxetine,N06BA09,atomoxetine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BA,Centrally acting sympathomimetics,N06BA09,atomoxetine,537
C0076829,IN,topiramate,N03AX11,topiramate,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX11,topiramate,698
C0076836,IN,toremifene,L02BA02,toremifene,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02B,HORMONE ANTAGONISTS AND RELATED AGENTS,L02BA,Anti-estrogens,L02BA02,toremifene,2
C0076840,IN,torsemide,C03CA04,torasemide,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03C,HIGH-CEILING DIURETICS,C03CA,"sulfonamides, high-ceiling diuretics, plain",C03CA04,torasemide,4
C0076843,,,J01MA22,tosufloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA22,tosufloxacin,25
C0076843,,,S01AE09,tosufloxacin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AE,"Fluoroquinolone antiinfectives, ophthalmologic",S01AE09,tosufloxacin,25
C0076890,IN,tramazoline,R01AA09,tramazoline,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AA,"Sympathomimetics, plain",R01AA09,tramazoline,3
C0076891,IN,trandolapril,C09AA10,trandolapril,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09A,"ACE INHIBITORS, PLAIN",C09AA,"ACE inhibitors, plain",C09AA10,trandolapril,3
C0076959,IN,treosulfan,L01AB02,treosulfan,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AB,Alkyl sulfonate alkylating agents,L01AB02,treosulfan,131
C0077015,IN,tribenoside,C05AX05,tribenoside,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05A,AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,C05AX,Other agents for treatment of hemorrhoids and anal fissures for topical use in ATC,C05AX05,tribenoside,1
C0077015,IN,tribenoside,C05CX01,tribenoside,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05C,CAPILLARY STABILIZING AGENTS,C05CX,Other capillary stabilizing agents in ATC,C05CX01,tribenoside,1
C0077071,IN,triclabendazole,P02BX04,triclabendazole,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02B,ANTITREMATODALS,P02BX,Other antitrematodal agents in ATC,P02BX04,triclabendazole,39
C0077073,IN,triclofos,N05CM07,triclofos,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CM,Other hypnotics and sedatives in ATC,N05CM07,triclofos,34
C0077089,IN,triethanolamine,D03AX12,trolamine,D,DERMATOLOGICALS,D03,PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS,D03A,CICATRIZANTS,D03AX,Other cicatrizants in ATC,D03AX12,trolamine,6
C0077144,IN,trilostane,H02CA01,trilostane,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02C,ANTIADRENAL PREPARATIONS,H02CA,Anticorticosteroids,H02CA01,trilostane,2
C0077163,IN,trimethobenzamide,R06AA10,trimethobenzamide,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AA,"Aminoalkyl ethers, systemic antihistamines",R06AA10,trimethobenzamide,1
C0077275,IN,triptorelin,L02AE04,triptorelin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02A,HORMONES AND RELATED AGENTS,L02AE,"Gonadotropin releasing hormone analogues, endocrine therapy drugs",L02AE04,triptorelin,376
C0077316,IN,tritoqualine,R06AX21,tritoqualine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX21,tritoqualine,1
C0077375,IN,trofosfamide,L01AA07,trofosfamide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AA,Nitrogen mustard analogues,L01AA07,trofosfamide,17
C0077410,IN,troxerutin,C05CA04,troxerutin,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05C,CAPILLARY STABILIZING AGENTS,C05CA,Bioflavonoid drugs for capillary stabilizing,C05CA04,troxerutin,2
C0077497,IN,tulobuterol,R03AC11,tulobuterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC11,tulobuterol,15
C0077497,IN,tulobuterol,R03CC11,tulobuterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03C,ADRENERGICS FOR SYSTEMIC USE,R03CC,"Selective beta-2-adrenoreceptor agonists, systemic",R03CC11,tulobuterol,15
C0077539,IN,tyloxapol,R05CA01,tyloxapol,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CA,Expectorants,R05CA01,tyloxapol,3
C0077857,IN,urapidil,C02CA06,urapidil,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02C,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",C02CA,"Alpha-adrenoreceptor antagonists, peripherally acting",C02CA06,urapidil,11
C0077906,,,B02AB05,ulinastatin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02A,ANTIFIBRINOLYTICS,B02AB,"Proteinase inhibitors, antifibrinolytic",B02AB05,ulinastatin,26
C0077981,,,A03AX14,valethamate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders in ATC,A03AX14,valethamate,5
C0077995,,,N05CM13,valnoctamide,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CM,Other hypnotics and sedatives in ATC,N05CM13,valnoctamide,1
C0078049,IN,varicella-zoster immune globulin,J06BB03,varicella/zoster immunoglobulin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,J06BB03,varicella/zoster immunoglobulin,16
C0078257,IN,vinorelbine,L01CA04,vinorelbine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01C,"PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, ANTINEOPLASTIC DRUGS",L01CA,"Vinca alkaloids and analogues, antineoplastic",L01CA04,vinorelbine,86
C0078264,,,N01AA02,vinyl ether,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AA,Ethers for general anesthesia,N01AA02,vinyl ether,2
C0078442,IN,epinastine,R06AX24,epinastine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX24,epinastine,8
C0078442,IN,epinastine,S01GX10,epinastine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GX,Other antiallergics in ATC,S01GX10,epinastine,8
C0078569,IN,venlafaxine,N06AX16,venlafaxine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX16,venlafaxine,169
C0078595,IN,xamoterol,C01CX07,xamoterol,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CX,Other cardiac stimulants in ATC,C01CX07,xamoterol,1
C0078643,IN,xylometazoline,R01AA07,xylometazoline,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AA,"Sympathomimetics, plain",R01AA07,xylometazoline,30
C0078643,IN,xylometazoline,R01AB06,xylometazoline,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AB,"Sympathomimetics, combinations excl. corticosteroids",R01AB06,xylometazoline,30
C0078643,IN,xylometazoline,S01GA03,xylometazoline,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GA,Sympathomimetics used as decongestants,S01GA03,xylometazoline,30
C0078703,IN,mepirodipine,C08CA12,barnidipine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,C08CA,Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects,C08CA12,barnidipine,1
C0078774,IN,zinc chloride,B05XA12,zinc chloride,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA12,zinc chloride,13
C0078794,IN,zinc sulfate,A12CB01,zinc sulfate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS in ATC,A12CB,Zinc Supplements,A12CB01,zinc sulfate,309
C0078794,IN,zinc sulfate,B05XA18,zinc sulfate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA18,zinc sulfate,309
C0078811,IN,zipeprol,R05DB15,zipeprol,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DB,Other cough suppressants in ATC,R05DB15,zipeprol,3
C0078839,IN,zolpidem,N05CF02,zolpidem,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CF,Benzodiazepine related hypnotics and sedatives,N05CF02,zolpidem,66
C0078840,IN,zomepirac,M01AB04,zomepirac,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AB,Acetic acid derivatives and related substances,M01AB04,zomepirac,1
C0078844,IN,zonisamide,N03AX15,zonisamide,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX15,zonisamide,211
C0078847,IN,zopiclone,N05CF01,zopiclone,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CF,Benzodiazepine related hypnotics and sedatives,N05CF01,zopiclone,20
C0078849,IN,zotepine,N05AX11,zotepine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AX,Other antipsychotics in ATC,N05AX11,zotepine,3
C0078956,IN,anistreplase,B01AD03,anistreplase,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AD,"Enzymes, antithrombotic",B01AD03,anistreplase,2
C0079083,IN,carboplatin,L01XA02,carboplatin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XA,"Platinum compounds, antineoplastic drugs",L01XA02,carboplatin,1412
C0079466,IN,guanfacine,C02AC02,guanfacine,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02A,"ANTIADRENERGIC AGENTS, CENTRALLY ACTING",C02AC,Imidazoline receptor agonists,C02AC02,guanfacine,122
C0079594,IN,iloprost,B01AC11,iloprost,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC11,iloprost,109
C0079856,IN,moricizine,C01BG01,moracizine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BG,"Other antiarrhythmics, class I and III in ATC",C01BG01,moracizine,3
C0080225,IN,thymopentin,L03AX09,thymopentin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AX,Other immunostimulants in ATC,L03AX09,thymopentin,23
C0081002,IN,pidotimod,L03AX05,pidotimod,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AX,Other immunostimulants in ATC,L03AX05,pidotimod,33
C0081876,IN,pantoprazole,A02BC02,pantoprazole,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors for peptic ulcer and GORD,A02BC02,pantoprazole,56
C0082286,IN,dehydroemetine,P01AX09,dehydroemetine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AX,Other agents against amoebiasis and other protozoal diseases in ATC,P01AX09,dehydroemetine,5
C0082607,IN,fluticasone,D07AC17,fluticasone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC17,fluticasone,847
C0082607,IN,fluticasone,R01AD08,fluticasone,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AD,Corticosteroid nasal preparations for topical use,R01AD08,fluticasone,847
C0082607,IN,fluticasone,R03BA05,fluticasone,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03B,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS in ATC",R03BA,Glucocorticoid inhalants for obstructive airway disease,R03BA05,fluticasone,847
C0082608,IN,fluvastatin,C10AA04,fluvastatin,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AA,"HMG CoA reductase inhibitors, plain lipid modifying drugs",C10AA04,fluvastatin,23
C0082646,IN,gadodiamide,V08CA03,gadodiamide,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08C,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,V08CA,Paramagnetic contrast media,V08CA03,gadodiamide,21
C0082787,IN,halobetasol,D07AC21,ulobetasol,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC21,ulobetasol,2
C0082944,PIN,hydrocortisone aceponate,D07AC16,hydrocortisone aceponate,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC16,hydrocortisone aceponate,1
C0082966,IN,ibutilide,C01BD05,ibutilide,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BD,"Antiarrhythmics, class III",C01BD05,ibutilide,7
C0083183,IN,lactase,A09AA04,tilactase,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A09,"DIGESTIVES, INCL. ENZYMES",A09A,"DIGESTIVES, INCL. ENZYMES",A09AA,"Enzyme preparations, digestives",A09AA04,tilactase,593
C0083256,,,A07DA05,loperamide oxide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07D,ANTIPROPULSIVES,A07DA,Antipropulsives,A07DA05,loperamide oxide,1
C0083381,IN,meloxicam,M01AC06,meloxicam,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AC,"Oxicams, antiinflammatory and antirheumatic drugs",M01AC06,meloxicam,33
C0084186,,,N02BE05,propacetamol,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BE,Anilide analgesics and antipyretics,N02BE05,propacetamol,25
C0084528,IN,sertindole,N05AE03,sertindole,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AE,"Indole derivatives, antipsychotic",N05AE03,sertindole,1
C0085149,IN,tacrolimus,D11AH01,tacrolimus,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AH,"Agents for dermatitis, excluding corticosteroids",D11AH01,tacrolimus,2497
C0085149,IN,tacrolimus,L04AD02,tacrolimus,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AD,Calcineurin inhibitors,L04AD02,tacrolimus,2497
C0085154,IN,nizatidine,A02BA04,nizatidine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BA,H2-receptor antagonists,A02BA04,nizatidine,10
C0085161,IN,fleroxacin,J01MA08,fleroxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA08,fleroxacin,8
C0085170,IN,astemizole,R06AX11,astemizole,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX11,astemizole,49
C0085173,IN,terfenadine,R06AX12,terfenadine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX12,terfenadine,136
C0085174,IN,misoprostol,A02BB01,misoprostol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BB,Prostaglandin drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),A02BB01,misoprostol,1261
C0085174,IN,misoprostol,G02AD06,misoprostol,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02A,UTEROTONICS,G02AD,"Prostaglandins, oxytocics",G02AD06,misoprostol,1261
C0085176,IN,trimetrexate,P01AX07,trimetrexate,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AX,Other agents against amoebiasis and other protozoal diseases in ATC,P01AX07,trimetrexate,11
C0085191,,,A02BB02,enprostil,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BB,Prostaglandin drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),A02BB02,enprostil,2
C0085208,IN,bupropion,N06AX12,bupropion,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX12,bupropion,155
C0085228,IN,fluvoxamine,N06AB08,fluvoxamine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AB,Selective serotonin reuptake inhibitors,N06AB08,fluvoxamine,116
C0085237,IN,tocainide,C01BB03,tocainide,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BB,"Antiarrhythmics, class Ib",C01BB03,tocainide,8
C0085251,IN,encainide,C01BC08,encainide,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BC,"Antiarrhythmics, class Ic",C01BC08,encainide,11
C0085259,IN,mupirocin,D06AX09,mupirocin,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AX,Other antibiotics for topical use in ATC,D06AX09,mupirocin,163
C0085259,IN,mupirocin,R01AX06,mupirocin,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AX,Other nasal preparations in ATC,R01AX06,mupirocin,163
C0085272,IN,leuprolide,L02AE02,leuprorelin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02A,HORMONES AND RELATED AGENTS,L02AE,"Gonadotropin releasing hormone analogues, endocrine therapy drugs",L02AE02,leuprorelin,403
C0085379,IN,muromonab-CD3,L04AG01,muromonab-CD3,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AG,Monoclonal antibodies,L04AG01,muromonab-CD3,287
C0085542,IN,pravastatin,C10AA03,pravastatin,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AA,"HMG CoA reductase inhibitors, plain lipid modifying drugs",C10AA03,pravastatin,94
C0086073,IN,cromolyn,A07EB01,cromoglicic acid,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EB,"Antiallergic intestinal antiinflammatory drugs, excl. corticosteroids",A07EB01,cromoglicic acid,183
C0086073,IN,cromolyn,D11AH03,cromoglicic acid,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AH,"Agents for dermatitis, excluding corticosteroids",D11AH03,cromoglicic acid,183
C0086073,IN,cromolyn,R01AC01,cromoglicic acid,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AC,"Antiallergic nasal preparations for topical use, excl. corticosteroids",R01AC01,cromoglicic acid,183
C0086073,IN,cromolyn,R03BC01,cromoglicic acid,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03B,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS in ATC",R03BC,"Antiallergic inhalants for obstructive airway diseases, excl. corticosteroids",R03BC01,cromoglicic acid,183
C0086073,IN,cromolyn,S01GX01,cromoglicic acid,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GX,Other antiallergics in ATC,S01GX01,cromoglicic acid,183
C0086140,IN,dextran,B05AA05,dextran,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05A,BLOOD AND RELATED PRODUCTS,B05AA,Blood substitutes and plasma protein fractions,B05AA05,dextran,555
C0086444,IN,dexrazoxane,V03AF02,dexrazoxane,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AF,Detoxifying agents for antineoplastic treatment,V03AF02,dexrazoxane,57
C0086728,IN,obidoxime,V03AB13,obidoxime,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB13,obidoxime,4
C0087163,IN,levocarnitine,A16AA01,levocarnitine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AA,Amino acids and derivatives,A16AA01,levocarnitine,1829
C0090306,IN,latanoprost,S01EE01,latanoprost,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EE,"Prostaglandin analogues, antiglaucoma drugs and miotics",S01EE01,latanoprost,49
C0092777,IN,clofarabine,L01BB06,clofarabine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BB,"Purine analogs, antimetabolites antineoplastic",L01BB06,clofarabine,97
C0092801,IN,cladribine,L01BB04,cladribine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BB,"Purine analogs, antimetabolites antineoplastic",L01BB04,cladribine,110
C0092801,IN,cladribine,L04AA40,cladribine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AA,Selective immunosuppressants,L04AA40,cladribine,110
C0100672,,,V09CA03,technetium (99mTc) mertiatide,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09C,RENAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,V09CA,Technetium (99mTc) compounds,V09CA03,technetium (99mTc) mertiatide,2
C0102139,IN,alglucerase,A16AB01,alglucerase,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB01,alglucerase,33
C0102840,IN,aluminum chloride,D10AX01,aluminium chloride,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AX,Other anti-acne preparations for topical use in ATC,D10AX01,aluminium chloride,22
C0103045,IN,amisulpride,N05AL05,amisulpride,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AL,Benzamide antipsychotics,N05AL05,amisulpride,27
C0104449,,,J01CA19,aspoxicillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,J01CA19,aspoxicillin,22
C0105205,IN,barbexaclone,N03AA04,barbexaclone,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AA,Barbiturates and derivatives,N03AA04,barbexaclone,8
C0107497,IN,butenafine,D01AE23,butenafine,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AE,Other antifungals for topical use in ATC,D01AE23,butenafine,3
C0107994,IN,cabergoline,G02CB03,cabergoline,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02C,OTHER GYNECOLOGICALS in ATC,G02CB,Prolactine inhibitors,G02CB03,cabergoline,146
C0107994,IN,cabergoline,N04BC06,cabergoline,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04B,DOPAMINERGIC AGENTS,N04BC,Dopamine agonists,N04BC06,cabergoline,146
C0108092,IN,calcium alginate,B02BC08,calcium alginate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BC,Local hemostatics,B02BC08,calcium alginate,18
C0108101,IN,calcium citrate,A12AA13,calcium citrate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM SUPPLEMENTS,A12AA,Calcium,A12AA13,calcium citrate,40
C0108121,IN,calcium lactate,A12AA05,calcium lactate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM SUPPLEMENTS,A12AA,Calcium,A12AA05,calcium lactate,21
C0108124,IN,calcium levulinate,A12AA30,calcium laevulate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12A,CALCIUM SUPPLEMENTS,A12AA,Calcium,A12AA30,calcium laevulate,3
C0108530,,,A03AX11,caroverine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AX,Other drugs for functional gastrointestinal disorders in ATC,A03AX11,caroverine,1
C0108941,,,J01DB11,cefroxadine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DB,First-generation cephalosporins,J01DB11,cefroxadine,27
C0109002,IN,methsuximide,N03AD03,mesuximide,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AD,"Succinimide derivatives, antiepileptics",N03AD03,mesuximide,13
C0113293,IN,dexmedetomidine,N05CM18,dexmedetomidine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CM,Other hypnotics and sedatives in ATC,N05CM18,dexmedetomidine,1080
C0114771,IN,dofetilide,C01BD04,dofetilide,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BD,"Antiarrhythmics, class III",C01BD04,dofetilide,1
C0114873,IN,doxazosin,C02CA04,doxazosin,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02C,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",C02CA,"Alpha-adrenoreceptor antagonists, peripherally acting",C02CA04,doxazosin,43
C0115656,,,H05BA04,elcatonin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BA,Calcitonin preparations,H05BA04,elcatonin,3
C0116190,IN,enoximone,C01CE03,enoximone,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CE,"Phosphodiesterase inhibitors, cardiac stimulant",C01CE03,enoximone,22
C0116569,IN,esmolol,C07AB09,esmolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AB,"Beta blocking agents, selective",C07AB09,esmolol,78
C0117881,,,J01DC14,flomoxef,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DC,Second-generation cephalosporins,J01DC14,flomoxef,59
C0117899,IN,fluindione,B01AA12,fluindione,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AA,Vitamin K antagonists,B01AA12,fluindione,7
C0118168,IN,fosinopril,C09AA09,fosinopril,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09A,"ACE INHIBITORS, PLAIN",C09AA,"ACE inhibitors, plain",C09AA09,fosinopril,8
C0120107,IN,goserelin,L02AE03,goserelin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02A,HORMONES AND RELATED AGENTS,L02AE,"Gonadotropin releasing hormone analogues, endocrine therapy drugs",L02AE03,goserelin,58
C0120436,,,N02BA14,guacetisal,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BA,"Salicylic acid and derivatives, analgesics and antipyretics",N02BA14,guacetisal,2
C0120726,IN,halofantrine,P01BX01,halofantrine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BX,Other antimalarials in ATC,P01BX01,halofantrine,78
C0121780,,,C05CA05,hidrosmin,C,CARDIOVASCULAR SYSTEM DRUGS,C05,VASOPROTECTIVES,C05C,CAPILLARY STABILIZING AGENTS,C05CA,Bioflavonoid drugs for capillary stabilizing,C05CA05,hidrosmin,1
C0121902,IN,histrelin,L02AE05,histrelin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02A,HORMONES AND RELATED AGENTS,L02AE,"Gonadotropin releasing hormone analogues, endocrine therapy drugs",L02AE05,histrelin,29
C0123043,IN,ibopamine,C01CA16,ibopamine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CA,Adrenergic and dopaminergic cardiac stimulants,C01CA16,ibopamine,3
C0123043,IN,ibopamine,S01FB03,ibopamine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01F,MYDRIATICS AND CYCLOPLEGICS,S01FB,Sympathomimetics excl. antiglaucoma preparations,S01FB03,ibopamine,3
C0123091,IN,quetiapine,N05AH04,quetiapine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AH,"Diazepines, oxazepines, thiazepines and oxepines antipsychotic drugs",N05AH04,quetiapine,304
C0123163,IN,idebenone,N06BX13,idebenone,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BX,Other psychostimulants and nootropics in ATC,N06BX13,idebenone,45
C0123677,IN,"insulin aspart, human",A10AB05,insulin aspart,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AB,"Insulins and analogues for injection, fast-acting",A10AB05,insulin aspart,115
C0123677,IN,"insulin aspart, human",A10AD05,insulin aspart,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AD,"Insulins and analogues for injection used in Diabetes, intermediate- or long-acting combined with fast-acting",A10AD05,insulin aspart,115
C0123865,IN,iotrolan,V08AB06,iotrolan,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AB,"Watersoluble, nephrotropic, low osmolar X-ray contrast media",V08AB06,iotrolan,3
C0123931,IN,irinotecan,L01CE02,irinotecan,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01C,"PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, ANTINEOPLASTIC DRUGS",L01CE,Topoisomerase 1 (TOP1) inhibitors,L01CE02,irinotecan,251
C0124008,,,J01GB11,isepamicin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides in ATC,J01GB11,isepamicin,6
C0125654,IN,"dipropizine, (S)-isomer",R05DB27,levodropropizine,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DB,Other cough suppressants in ATC,R05DB27,levodropropizine,7
C0126120,IN,lodoxamide,S01GX05,lodoxamide,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GX,Other antiallergics in ATC,S01GX05,lodoxamide,19
C0126174,IN,losartan,C09CA01,losartan,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09C,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",C09CA,"Angiotensin II receptor blockers (ARBs), plain",C09CA01,losartan,117
C0126774,IN,magnesium citrate,A06AD19,magnesium citrate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AD,Osmotically acting laxatives,A06AD19,magnesium citrate,26
C0126774,IN,magnesium citrate,A12CC04,magnesium citrate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS in ATC,A12CC,"Magnesium supplements, alimentary tract and metabolism",A12CC04,magnesium citrate,26
C0126774,IN,magnesium citrate,B05CB03,magnesium citrate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05C,"IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION",B05CB,Salt irrigating solutions,B05CB03,magnesium citrate,26
C0126777,IN,magnesium gluconate,A12CC03,magnesium gluconate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS in ATC,A12CC,"Magnesium supplements, alimentary tract and metabolism",A12CC03,magnesium gluconate,6
C0127615,IN,mesalamine,A07EC02,mesalazine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EC,Aminosalicylic acid and similar agents,A07EC02,mesalazine,318
C0128513,IN,milrinone,C01CE02,milrinone,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CE,"Phosphodiesterase inhibitors, cardiac stimulant",C01CE02,milrinone,223
C0129341,,,L03AX15,mifamurtide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AX,Other immunostimulants in ATC,L03AX15,mifamurtide,11
C0129975,,,B02AB04,camostat,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02A,ANTIFIBRINOLYTICS,B02AB,"Proteinase inhibitors, antifibrinolytic",B02AB04,camostat,1
C0132092,,,J06BC01,nebacumab,J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BC,Antibacterial monoclonal antibodies,J06BC01,nebacumab,1
C0132326,IN,nevirapine,J05AG01,nevirapine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AG,Non-nucleoside reverse transcriptase inhibitors,J05AG01,nevirapine,1083
C0132515,IN,nimesulide,M01AX17,nimesulide,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AX,"Other antiinflammatory and antirheumatic agents, non-steroids in ATC",M01AX17,nimesulide,73
C0132515,IN,nimesulide,M02AA26,nimesulide,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA26,nimesulide,73
C0134337,IN,oxatomide,R06AE06,oxatomide,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AE,"Piperazine derivatives, systemic antihistamines",R06AE06,oxatomide,25
C0136123,IN,perindopril,C09AA04,perindopril,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09A,"ACE INHIBITORS, PLAIN",C09AA,"ACE inhibitors, plain",C09AA04,perindopril,7
C0137904,IN,polystyrene sulfonate,V03AE01,polystyrene sulfonate,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AE,Drugs for treatment of hyperkalemia and hyperphosphatemia,V03AE01,polystyrene sulfonate,5
C0137984,IN,potassium acetate,B05XA17,potassium acetate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA17,potassium acetate,5
C0137988,IN,aluminum potassium sulfate,S01XA07,alum,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA07,alum,3
C0137996,IN,potassium citrate,A12BA02,potassium citrate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12B,POTASSIUM SUPPLEMENTS,A12BA,Potassium,A12BA02,potassium citrate,85
C0138305,,,R05DB18,prenoxdiazine,R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05D,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",R05DB,Other cough suppressants in ATC,R05DB18,prenoxdiazine,1
C0138666,IN,propiverine,G04BD06,propiverine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BD,Drugs for urinary frequency and incontinence,G04BD06,propiverine,19
C0139007,IN,prothipendyl,N05AX07,prothipendyl,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AX,Other antipsychotics in ATC,N05AX07,prothipendyl,1
C0140575,IN,rifabutin,J04AB04,rifabutin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AB,"Antibiotics, Antitubercular",J04AB04,rifabutin,51
C0140594,IN,rimexolone,H02AB12,rimexolone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,"Glucocorticoids, Systemic",H02AB12,rimexolone,5
C0140594,IN,rimexolone,S01BA13,rimexolone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BA,"Corticosteroid ophthalmologic antiinflammatory agents, plain",S01BA13,rimexolone,5
C0140610,IN,risedronic acid,M05BA07,risedronic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonate drugs affecting bone structure and mineralization,M05BA07,risedronic acid,22
C0142046,IN,sermorelin,H01AC04,sermorelin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,H01AC04,sermorelin,35
C0142046,IN,sermorelin,V04CD03,sermorelin,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CD,pituitary function test diagnostic agents,V04CD03,sermorelin,35
C0142785,IN,sodium acetate,B05XA08,sodium acetate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA08,sodium acetate,44
C0142822,IN,sodium chlorite,D03AX11,sodium chlorite,D,DERMATOLOGICALS,D03,PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS,D03A,CICATRIZANTS,D03AX,Other cicatrizants in ATC,D03AX11,sodium chlorite,4
C0142825,IN,sodium citrate,B05CB02,sodium citrate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05C,"IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION",B05CB,Salt irrigating solutions,B05CB02,sodium citrate,87
C0142890,PIN,sodium monofluorophosphate,A01AA02,sodium monofluorophosphate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AA,Caries prophylactic agents,A01AA02,sodium monofluorophosphate,45
C0142890,PIN,sodium monofluorophosphate,A12CD02,sodium monofluorophosphate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS in ATC,A12CD,Fluoride supplements,A12CD02,sodium monofluorophosphate,45
C0143083,IN,somatrem,H01AC02,somatrem,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,H01AC02,somatrem,23
C0143993,IN,sufentanil,N01AH03,sufentanil,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AH,Opioid anesthetics,N01AH03,sufentanil,442
C0144567,IN,taurolidine,B05CA05,taurolidine,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05C,"IRRIGATING SOLUTIONS, BLOOD SUBSTITUTES AND PERFUSION",B05CA,Antiinfective irrigating solutions,B05CA05,taurolidine,22
C0144576,IN,paclitaxel,L01CD01,paclitaxel,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01C,"PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, ANTINEOPLASTIC DRUGS",L01CD,"Taxanes, antineoplastic",L01CD01,paclitaxel,223
C0145055,PIN,technetium Tc 99m exametazime,V09AA01,technetium (99mTc) exametazime,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09A,CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,V09AA,Technetium (99mTc) compounds,V09AA01,technetium (99mTc) exametazime,302
C0145106,IN,teicoplanin,J01XA02,teicoplanin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XA,Glycopeptide antibacterials,J01XA02,teicoplanin,243
C0145184,IN,terizidone,J04AK03,terizidone,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AK,Other drugs for treatment of tuberculosis in ATC,J04AK03,terizidone,5
C0145185,IN,terlipressin,H01BA04,terlipressin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01B,POSTERIOR PITUITARY LOBE HORMONES,H01BA,Vasopressin and analogues,H01BA04,terlipressin,57
C0146010,IN,tixocortol,A07EA05,tixocortol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07E,INTESTINAL ANTIINFLAMMATORY AGENTS,A07EA,Corticosteroids acting locally,A07EA05,tixocortol,15
C0146010,IN,tixocortol,R01AD07,tixocortol,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AD,Corticosteroid nasal preparations for topical use,R01AD07,tixocortol,15
C0146011,IN,tizanidine,M03BX02,tizanidine,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03B,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",M03BX,Other centrally acting agents in ATC,M03BX02,tizanidine,19
C0146224,IN,topotecan,L01CE01,topotecan,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01C,"PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, ANTINEOPLASTIC DRUGS",L01CE,Topoisomerase 1 (TOP1) inhibitors,L01CE01,topotecan,295
C0147942,IN,diatrizoic acid,V08AA01,diatrizoic acid,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AA,"Watersoluble, nephrotropic, high osmolar X-ray contrast media",V08AA01,diatrizoic acid,168
C0149368,IN,zinc acetate,A16AX05,zinc acetate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX05,zinc acetate,38
C0149381,IN,zinc gluconate,A12CB02,zinc gluconate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS in ATC,A12CB,Zinc Supplements,A12CB02,zinc gluconate,34
C0162680,PIN,technetium Tc 99m sestamibi,V09GA01,technetium (99mTc) sestamibi,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09G,CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,V09GA,Technetium (99mTc) compounds,V09GA01,technetium (99mTc) sestamibi,156
C0162745,IN,collagenase,D03BA02,collagenase,D,DERMATOLOGICALS,D03,PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS,D03B,ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS,D03BA,Proteolytic enzymes for treatment of wounds and ulcers,D03BA02,collagenase,165
C0162922,,,V08CX01,perflubron,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08C,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,V08CX,Other magnetic resonance imaging contrast media in ATC,V08CX01,perflubron,18
C0163272,IN,brivudine,J05AB15,brivudine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,J05AB15,brivudine,1
C0163557,IN,moxidectin,P02CX03,moxidectin,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02C,ANTINEMATODAL AGENTS,P02CX,Other antinematodals in ATC,P02CX03,moxidectin,8
C0163748,,,A07BC05,diosmectite,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A07,"ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",A07B,INTESTINAL ADSORBENTS,A07BC,Other intestinal adsorbents in ATC,A07BC05,diosmectite,11
C0164398,IN,atosiban,G02CX01,atosiban,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02C,OTHER GYNECOLOGICALS in ATC,G02CX,Other gynecologicals in ATC,G02CX01,atosiban,115
C0164662,IN,stavudine,J05AF04,stavudine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,J05AF04,stavudine,266
C0164674,IN,pegademase bovine,L03AX04,pegademase,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AX,Other immunostimulants in ATC,L03AX04,pegademase,1
C0164815,IN,penciclovir,D06BB06,penciclovir,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,D06BB,"Antivirals, topical",D06BB06,penciclovir,6
C0164815,IN,penciclovir,J05AB13,penciclovir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,J05AB13,penciclovir,6
C0165032,IN,imiquimod,D06BB10,imiquimod,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,D06BB,"Antivirals, topical",D06BB10,imiquimod,128
C0165590,IN,dorzolamide,S01EC03,dorzolamide,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EC,"Carbonic anhydrase inhibitors, antiglaucoma drugs and miotics",S01EC03,dorzolamide,27
C0165603,IN,atovaquone,P01AX06,atovaquone,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AX,Other agents against amoebiasis and other protozoal diseases in ATC,P01AX06,atovaquone,87
C0165631,IN,adapalene,D10AD03,adapalene,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AD,Retinoids for topical use in acne,D10AD03,adapalene,84
C0165703,IN,imidapril,C09AA16,imidapril,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09A,"ACE INHIBITORS, PLAIN",C09AA,"ACE inhibitors, plain",C09AA16,imidapril,1
C0165921,IN,entacapone,N04BX02,entacapone,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04B,DOPAMINERGIC AGENTS,N04BX,Other dopaminergic agents in ATC,N04BX02,entacapone,4
C0167117,IN,exenatide,A10BJ01,exenatide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,A10BJ01,exenatide,29
C0168273,IN,bivalirudin,B01AE06,bivalirudin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AE,Direct thrombin inhibitors,B01AE06,bivalirudin,65
C0168388,IN,reboxetine,N06AX18,reboxetine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX18,reboxetine,18
C0169964,IN,somatropin,H01AC01,somatropin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,H01AC01,somatropin,9189
C0171023,IN,olanzapine,N05AH03,olanzapine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AH,"Diazepines, oxazepines, thiazepines and oxepines antipsychotic drugs",N05AH03,olanzapine,410
C0171302,IN,mizolastine,R06AX25,mizolastine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX25,mizolastine,4
C0171447,,,J01MA21,sitafloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA21,sitafloxacin,1
C0172907,IN,flutrimazole,D01AC16,flutrimazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC16,flutrimazole,2
C0172907,IN,flutrimazole,G01AF18,flutrimazole,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AF,"Imidazole derivatives, gyncological antiinfectives",G01AF18,flutrimazole,2
C0173083,IN,nitisinone,A16AX04,nitisinone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX04,nitisinone,57
C0174938,PIN,methylprednisolone aceponate,D07AC14,methylprednisolone aceponate,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC14,methylprednisolone aceponate,13
C0175022,,,J01MA18,pazufloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA18,pazufloxacin,3
C0205996,IN,pristinamycin,J01FG01,pristinamycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FG,Streptogramins,J01FG01,pristinamycin,21
C0206232,IN,nadroparin,B01AB06,nadroparin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AB,Heparin group antithrombotic drugs,B01AB06,nadroparin,37
C0206460,IN,enoxaparin,B01AB05,enoxaparin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AB,Heparin group antithrombotic drugs,B01AB05,enoxaparin,396
C0206461,IN,dalteparin,B01AB04,dalteparin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AB,Heparin group antithrombotic drugs,B01AB04,dalteparin,47
C0206788,,,L01DB05,zorubicin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01D,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,L01DB,Anthracyclines and related substances,L01DB05,zorubicin,4
C0206816,IN,diloxanide,P01AC01,diloxanide,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AC,Dichloroacetamide derivative drugs for amoebiasis and other protozoal diseases,P01AC01,diloxanide,1
C0209210,IN,dolasetron,A04AA04,dolasetron,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AA,Serotonin (5HT3) antagonists,A04AA04,dolasetron,13
C0209211,IN,lanreotide,H01CB03,lanreotide,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CB,Somatostatin and analogues,H01CB03,lanreotide,31
C0209227,IN,famciclovir,J05AB09,famciclovir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,J05AB09,famciclovir,19
C0209227,IN,famciclovir,S01AD07,famciclovir,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AD,"Antivirals, ophthalmologic",S01AD07,famciclovir,19
C0209366,IN,cetrorelix,H01CC02,cetrorelix,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CC,Anti-gonadotropin-releasing hormones,H01CC02,cetrorelix,68
C0209475,,,J01DH05,biapenem,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DH,Carbapenems,J01DH05,biapenem,24
C0209738,IN,lamivudine,J05AF05,lamivudine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,J05AF05,lamivudine,1006
C0210380,,,N05AL07,levosulpiride,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AL,Benzamide antipsychotics,N05AL07,levosulpiride,1
C0210630,IN,filgrastim,L03AA02,filgrastim,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AA,Colony stimulating factors,L03AA02,filgrastim,1958
C0210657,IN,pemetrexed,L01BA04,pemetrexed,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BA,"Folic acid analogs, antimetabolites",L01BA04,pemetrexed,14
C0211011,IN,ziconotide,N02BG08,ziconotide,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BG,Other analgesics and antipyretics in ATC,N02BG08,ziconotide,2
C0211492,,,V09GA02,technetium (99mTc) tetrofosmin,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09G,CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,V09GA,Technetium (99mTc) compounds,V09GA02,technetium (99mTc) tetrofosmin,5
C0213404,IN,rufinamide,N03AF03,rufinamide,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AF,"Carboxamide derivatives, antiepileptics",N03AF03,rufinamide,72
C0215087,,,G04BX14,dapoxetine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BX,Other urologicals in ATC,G04BX14,dapoxetine,5
C0216231,IN,sargramostim,L03AA09,sargramostim,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AA,Colony stimulating factors,L03AA09,sargramostim,98
C0216278,IN,tinzaparin,B01AB10,tinzaparin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AB,Heparin group antithrombotic drugs,B01AB10,tinzaparin,22
C0216660,IN,zanamivir,J05AH01,zanamivir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AH,"Neuraminidase inhibitors, direct acting antivirals",J05AH01,zanamivir,152
C0216784,IN,valsartan,C09CA03,valsartan,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09C,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",C09CA,"Angiotensin II receptor blockers (ARBs), plain",C09CA03,valsartan,41
C0216971,PIN,colfosceril palmitate,R07AA01,colfosceril palmitate,R,RESPIRATORY SYSTEM DRUGS,R07,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07A,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07AA,Lung surfactants,R07AA01,colfosceril palmitate,34
C0218633,IN,molgramostim,L03AA03,molgramostim,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AA,Colony stimulating factors,L03AA03,molgramostim,691
C0218640,IN,lenograstim,L03AA10,lenograstim,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AA,Colony stimulating factors,L03AA10,lenograstim,42
C0218986,IN,aldesleukin,L03AC01,aldesleukin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AC,Interleukins,L03AC01,aldesleukin,11
C0220578,IN,palonosetron,A04AA05,palonosetron,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AA,Serotonin (5HT3) antagonists,A04AA05,palonosetron,22
C0242531,IN,vecuronium,M03AC03,vecuronium,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,"Other quaternary ammonium compounds in ATC, muscle relaxants, peripherally acting",M03AC03,vecuronium,344
C0243449,,,R06AX31,quifenadine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX31,quifenadine,1
C0243666,,,L01AD07,ranimustine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AD,"Nitrosoureas, antineoplastic alkylating agents",L01AD07,ranimustine,11
C0244404,IN,raloxifene,G03XC01,raloxifene,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03X,OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC,G03XC,Selective estrogen receptor modulators,G03XC01,raloxifene,8
C0244656,IN,fosphenytoin,N03AB05,fosphenytoin,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AB,"Hydantoin derivatives, antiepileptics",N03AB05,fosphenytoin,67
C0244672,PIN,fluorodopa F-18,V09IX05,fluorodopa (18F),V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09I,TUMOUR DETECTION RADIOPHARMACEUTICALS,V09IX,Other diagnostic radiopharmaceuticals for tumour detection in ATC,V09IX05,fluorodopa (18F),1
C0244713,IN,interferon beta-1b,L03AB08,interferon beta-1b,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AB,Interferons,L03AB08,interferon beta-1b,25
C0244748,,,L03AX02,roquinimex,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AX,Other immunostimulants in ATC,L03AX02,roquinimex,2
C0244821,IN,ropinirole,N04BC04,ropinirole,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04B,DOPAMINERGIC AGENTS,N04BC,Dopamine agonists,N04BC04,ropinirole,7
C0245109,IN,anakinra,L04AC03,anakinra,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC03,anakinra,658
C0245179,IN,tirilazad,N07XX01,tirilazad,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07X,OTHER NERVOUS SYSTEM DRUGS in ATC,N07XX,Other nervous system drugs in ATC,N07XX01,tirilazad,3
C0245514,IN,troglitazone,A10BG01,troglitazone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BG,"Thiazolidinediones, blood glucose lowering drugs",A10BG01,troglitazone,7
C0245561,IN,duloxetine,N06AX21,duloxetine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX21,duloxetine,52
C0246154,,,V08CA08,gadobenic acid,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08C,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,V08CA,Paramagnetic contrast media,V08CA08,gadobenic acid,36
C0246269,IN,icatibant,B06AC02,icatibant,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B06,OTHER HEMATOLOGICAL AGENTS in ATC,B06A,OTHER HEMATOLOGICAL AGENTS in ATC,B06AC,Drugs used in hereditary angioedema,B06AC02,icatibant,14
C0246415,IN,docetaxel,L01CD02,docetaxel,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01C,"PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, ANTINEOPLASTIC DRUGS",L01CD,"Taxanes, antineoplastic",L01CD02,docetaxel,93
C0246421,IN,letrozole,L02BG04,letrozole,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02B,HORMONE ANTAGONISTS AND RELATED AGENTS,L02BG,Aromatase inhibitors,L02BG04,letrozole,156
C0246584,,,J01DE03,cefozopran,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DE,Fourth-generation cephalosporins,J01DE03,cefozopran,35
C0246631,IN,remifentanil,N01AH06,remifentanil,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AH,Opioid anesthetics,N01AH06,remifentanil,718
C0246689,IN,repaglinide,A10BX02,repaglinide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins in ATC",A10BX02,repaglinide,13
C0246904,IN,levosimendan,C01CX08,levosimendan,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CX,Other cardiac stimulants in ATC,C01CX08,levosimendan,68
C0247025,IN,tirofiban,B01AC17,tirofiban,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC17,tirofiban,6
C0247194,IN,iloperidone,N05AX14,iloperidone,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AX,Other antipsychotics in ATC,N05AX14,iloperidone,2
C0248719,IN,telmisartan,C09CA07,telmisartan,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09C,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",C09CA,"Angiotensin II receptor blockers (ARBs), plain",C09CA07,telmisartan,15
C0249458,IN,valacyclovir,J05AB11,valaciclovir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,J05AB11,valaciclovir,117
C0249529,IN,febuxostat,M04AA03,febuxostat,M,MUSCULO-SKELETAL SYSTEM DRUGS,M04,ANTIGOUT PREPARATIONS,M04A,ANTIGOUT PREPARATIONS,M04AA,Preparations inhibiting uric acid production,M04AA03,febuxostat,4
C0249582,IN,paricalcitol,H05BX02,paricalcitol,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BX,Other anti-parathyroid agents in ATC,H05BX02,paricalcitol,10
C0251504,IN,zaleplon,N05CF03,zaleplon,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CF,Benzodiazepine related hypnotics and sedatives,N05CF03,zaleplon,8
C0252643,IN,bosentan,C02KX01,bosentan,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02K,OTHER ANTIHYPERTENSIVES in ATC,C02KX,Antihypertensives for pulmonary arterial hypertension,C02KX01,bosentan,160
C0252667,,,V09IX13,methionine (11C),V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09I,TUMOUR DETECTION RADIOPHARMACEUTICALS,V09IX,Other diagnostic radiopharmaceuticals for tumour detection in ATC,V09IX13,methionine (11C),30
C0253563,IN,eptifibatide,B01AC16,eptifibatide,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC16,eptifibatide,3
C0254119,IN,interferon beta-1a,L03AB07,interferon beta-1a,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AB,Interferons,L03AB07,interferon beta-1a,63
C0254211,,,J05AX13,umifenovir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX13,umifenovir,7
C0254215,IN,reviparin,B01AB08,reviparin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AB,Heparin group antithrombotic drugs,B01AB08,reviparin,3
C0256089,IN,quinagolide,G02CB04,quinagolide,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02C,OTHER GYNECOLOGICALS in ATC,G02CB,Prolactine inhibitors,G02CB04,quinagolide,10
C0256103,IN,reteplase,B01AD07,reteplase,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AD,"Enzymes, antithrombotic",B01AD07,reteplase,3
C0256552,,,N07CA04,acetylleucine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07C,ANTIVERTIGO PREPARATIONS,N07CA,Antivertigo preparations,N07CA04,acetylleucine,1
C0257190,IN,ivabradine,C01EB17,ivabradine,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01E,OTHER CARDIAC PREPARATIONS in ATC,C01EB,Other plain cardiac preparations in ATC,C01EB17,ivabradine,34
C0257343,IN,tamsulosin,G04CA02,tamsulosin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04C,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,G04CA,"Alpha-adrenoreceptor antagonists, benign prostatic hypertrophy",G04CA02,tamsulosin,21
C0257685,IN,zoledronic acid,M05BA08,zoledronic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonate drugs affecting bone structure and mineralization,M05BA08,zoledronic acid,144
C0259507,IN,danaparoid,B01AB09,danaparoid,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AB,Heparin group antithrombotic drugs,B01AB09,danaparoid,22
C0262964,IN,capreomycin,J04AB30,capreomycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AB,"Antibiotics, Antitubercular",J04AB30,capreomycin,12
C0262965,IN,chlormadinone,G03DB06,chlormadinone,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03D,PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03DB,"Pregnadien derivatives, progestogens",G03DB06,chlormadinone,17
C0281351,IN,uridine triacetate,A16AX13,uridine triacetate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX13,uridine triacetate,3
C0281666,IN,alitretinoin,D11AH04,alitretinoin,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AH,"Agents for dermatitis, excluding corticosteroids",D11AH04,alitretinoin,16
C0281666,IN,alitretinoin,L01XF02,alitretinoin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XF,Retinoids for cancer treatment,L01XF02,alitretinoin,16
C0282386,IN,levofloxacin,J01MA12,levofloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA12,levofloxacin,757
C0282386,IN,levofloxacin,S01AE05,levofloxacin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AE,"Fluoroquinolone antiinfectives, ophthalmologic",S01AE05,levofloxacin,757
C0284559,,,L04AA19,gusperimus,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AA,Selective immunosuppressants,L04AA19,gusperimus,13
C0284941,IN,acamprosate,N07BB03,acamprosate,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07B,DRUGS USED IN ADDICTIVE DISORDERS,N07BB,Drugs used in alcohol dependence,N07BB03,acamprosate,10
C0285590,IN,bicalutamide,L02BB03,bicalutamide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02B,HORMONE ANTAGONISTS AND RELATED AGENTS,L02BB,Anti-androgen hormone antagonists and related agents,L02BB03,bicalutamide,10
C0286079,IN,cidofovir,J05AB12,cidofovir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,J05AB12,cidofovir,206
C0286402,,,D10AF05,nadifloxacin,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AF,Antiinfectives for treatment of acne,D10AF05,nadifloxacin,4
C0286651,IN,atorvastatin,C10AA05,atorvastatin,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AA,"HMG CoA reductase inhibitors, plain lipid modifying drugs",C10AA05,atorvastatin,107
C0286738,IN,saquinavir,J05AE01,saquinavir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,"Protease inhibitors, direct acting antivirals",J05AE01,saquinavir,45
C0287041,IN,eprosartan,C09CA02,eprosartan,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09C,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",C09CA,"Angiotensin II receptor blockers (ARBs), plain",C09CA02,eprosartan,1
C0287573,IN,cefditoren,J01DD16,cefditoren,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DD,Third-generation cephalosporins,J01DD16,cefditoren,57
C0287721,IN,grepafloxacin,J01MA11,grepafloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA11,grepafloxacin,5
C0288165,IN,delavirdine,J05AG02,delavirdine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AG,Non-nucleoside reverse transcriptase inhibitors,J05AG02,delavirdine,7
C0288171,IN,irbesartan,C09CA04,irbesartan,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09C,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",C09CA,"Angiotensin II receptor blockers (ARBs), plain",C09CA04,irbesartan,23
C0288672,IN,abciximab,B01AC13,abciximab,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC13,abciximab,19
C0288792,IN,tazarotene,D05AX05,tazarotene,D,DERMATOLOGICALS,D05,ANTIPSORIATICS,D05A,ANTIPSORIATICS FOR TOPICAL USE,D05AX,Other antipsoriatics for topical use in ATC,D05AX05,tazarotene,41
C0289313,IN,rosiglitazone,A10BG02,rosiglitazone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BG,"Thiazolidinediones, blood glucose lowering drugs",A10BG02,rosiglitazone,66
C0290883,IN,anastrozole,L02BG03,anastrozole,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02B,HORMONE ANTAGONISTS AND RELATED AGENTS,L02BG,Aromatase inhibitors,L02BG03,anastrozole,60
C0291140,IN,imiglucerase,A16AB02,imiglucerase,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB02,imiglucerase,78
C0291772,IN,alosetron,A03AE01,alosetron,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AE,Serotonin receptor antagonists for functional gastrointestinal disorders,A03AE01,alosetron,2
C0292818,IN,ritonavir,J05AE03,ritonavir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,"Protease inhibitors, direct acting antivirals",J05AE03,ritonavir,558
C0293359,IN,insulin lispro,A10AB04,insulin lispro,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AB,"Insulins and analogues for injection, fast-acting",A10AB04,insulin lispro,95
C0293359,IN,insulin lispro,A10AC04,insulin lispro,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AC,"Insulins and analogues for injection, intermediate-acting",A10AC04,insulin lispro,95
C0293359,IN,insulin lispro,A10AD04,insulin lispro,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AD,"Insulins and analogues for injection used in Diabetes, intermediate- or long-acting combined with fast-acting",A10AD04,insulin lispro,95
C0296800,IN,fexofenadine,R06AX26,fexofenadine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX26,fexofenadine,60
C0296806,IN,iobitridol,V08AB11,iobitridol,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AB,"Watersoluble, nephrotropic, low osmolar X-ray contrast media",V08AB11,iobitridol,8
C0297635,IN,rizatriptan,N02CC04,rizatriptan,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CC,Selective serotonin (5HT1) agonists,N02CC04,rizatriptan,10
C0298067,IN,pirfenidone,L04AX05,pirfenidone,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AX,Other immunosuppressants in ATC,L04AX05,pirfenidone,10
C0298130,IN,montelukast,R03DC03,montelukast,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DC,Leukotriene receptor antagonists for obstructive airway diseases,R03DC03,montelukast,551
C0299792,IN,aripiprazole,N05AX12,aripiprazole,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AX,Other antipsychotics in ATC,N05AX12,aripiprazole,354
C0300205,IN,ulipristal,G03AD02,ulipristal,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03A,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,G03AD,Emergency contraceptive drugs,G03AD02,ulipristal,34
C0300205,IN,ulipristal,G03XB02,ulipristal,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03X,OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC,G03XB,"Progesterone receptor modulators, sex hormones and modulators of the genital system",G03XB02,ulipristal,34
C0301302,,,D01AE02,methylrosaniline,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AE,Other antifungals for topical use in ATC,D01AE02,methylrosaniline,90
C0301302,,,G01AX09,methylrosaniline,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AX,Other gynecological antiinfectives and antiseptics in ATC,G01AX09,methylrosaniline,90
C0301304,IN,phenylmercuric nitrate,D09AA04,phenylmercuric nitrate,D,DERMATOLOGICALS,D09,MEDICATED DRESSINGS,D09A,MEDICATED DRESSINGS,D09AA,Medicated dressings with antiinfectives,D09AA04,phenylmercuric nitrate,2
C0301366,IN,ecothiopate,S01EB03,ecothiopate,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EB,"Parasympathomimetics, antiglaucoma preparations and miotics",S01EB03,ecothiopate,5
C0301371,IN,diphemanil,A03AB15,diphemanil,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds for functional gastrointestinal disorders",A03AB15,diphemanil,11
C0301374,IN,methscopolamine,A03BB03,methylscopolamine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03B,"BELLADONNA AND DERIVATIVES CONTAINING DRUGS, PLAIN FOR FUNCTIONAL GASTROINTESTINAL DISORDERS",A03BB,"Belladonna alkaloids, semisynthetic, quaternary ammonium compounds for functional gastrointestinal disorders",A03BB03,methylscopolamine,7
C0301374,IN,methscopolamine,S01FA03,methylscopolamine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01F,MYDRIATICS AND CYCLOPLEGICS,S01FA,Anticholinergic mydriatics and cycloplegics,S01FA03,methylscopolamine,7
C0301375,,,A03AB04,penthienate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03A,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03AB,"Synthetic anticholinergics, quaternary ammonium compounds for functional gastrointestinal disorders",A03AB04,penthienate,1
C0301499,IN,ferrous carbonate,B03AA04,ferrous carbonate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03A,IRON ANTIANEMIC PREPARATIONS,B03AA,"Iron bivalent, oral antianemic preparations",B03AA04,ferrous carbonate,1
C0301503,IN,"rabies immune globulin, human",J06BB05,rabies immunoglobulin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,J06BB05,rabies immunoglobulin,26
C0301508,,,J07BL,Yellow fever vaccines,J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BL,Yellow fever vaccines,,,143
C0301508,,,J07BL01,"yellow fever, live attenuated",J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BL,Yellow fever vaccines,J07BL01,"yellow fever, live attenuated",143
C0301513,IN,human vaccinia immune globulin,J06BB07,vaccinia immunoglobulin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,J06BB07,vaccinia immunoglobulin,3
C0301527,IN,potassium gluconate,A12BA05,potassium gluconate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12B,POTASSIUM SUPPLEMENTS,A12BA,Potassium,A12BA05,potassium gluconate,1
C0304612,IN,diflorasone,D07AC10,diflorasone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC10,diflorasone,2
C0304866,,,A10AB02,insulin (beef),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AB,"Insulins and analogues for injection, fast-acting",A10AB02,insulin (beef),1
C0304866,,,A10AC02,insulin (beef),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AC,"Insulins and analogues for injection, intermediate-acting",A10AC02,insulin (beef),1
C0304866,,,A10AD02,insulin (beef),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AD,"Insulins and analogues for injection used in Diabetes, intermediate- or long-acting combined with fast-acting",A10AD02,insulin (beef),1
C0304866,,,A10AE02,insulin (beef),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",A10AE02,insulin (beef),1
C0304982,PIN,sodium iodide I131,V09FX03,sodium iodide (131I),V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09F,THYROID DIAGNOSTIC RADIOPHARMACEUTICALS,V09FX,Various thyroid diagnostic radiopharmaceuticals,V09FX03,sodium iodide (131I),630
C0304982,PIN,sodium iodide I131,V10XA01,sodium iodide (131I),V,VARIOUS DRUG CLASSES IN ATC,V10,THERAPEUTIC RADIOPHARMACEUTICALS,V10X,OTHER THERAPEUTIC RADIOPHARMACEUTICALS in ATC,V10XA,Iodine (131I) compounds,V10XA01,sodium iodide (131I),630
C0305040,PIN,thallous chloride Tl201,V09GX01,thallium (201Tl) chloride,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09G,CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,V09GX,Other cardiovascular system diagnostic radiopharmaceuticals in ATC,V09GX01,thallium (201Tl) chloride,1
C0305062,IN,"tetanus toxoid vaccine, inactivated",J07AM01,tetanus toxoid,J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AM,Tetanus vaccines,J07AM01,tetanus toxoid,2030
C0347993,IN,pyrethrum extract,P03AC01,pyrethrum,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03A,"ECTOPARASITICIDES, INCL. SCABICIDES",P03AC,"Pyrethrines, incl. synthetic compounds, ectoparasiticides, incl. scabicides",P03AC01,pyrethrum,410
C0352536,PIN,hydrocortisone butyrate,D07AB02,hydrocortisone butyrate,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AB,"Corticosteroids, moderately potent (group II)",D07AB02,hydrocortisone butyrate,12
C0356357,,,P02CX02,bephenium,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P02,ANTHELMINTICS,P02C,ANTINEMATODAL AGENTS,P02CX,Other antinematodals in ATC,P02CX02,bephenium,7
C0357059,IN,ferrous glycine sulfate,B03AA01,ferrous glycine sulfate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03A,IRON ANTIANEMIC PREPARATIONS,B03AA,"Iron bivalent, oral antianemic preparations",B03AA01,ferrous glycine sulfate,1
C0357084,IN,sodium ironedetate,B03AB03,sodium feredetate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03A,IRON ANTIANEMIC PREPARATIONS,B03AB,"Iron trivalent, oral antianemic preparations",B03AB03,sodium feredetate,10
C0358297,,,J07AC,Anthrax vaccines,J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AC,Anthrax vaccines,,,13
C0358321,,,J06BA,"Immunoglobulins, normal human",J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BA,"Immunoglobulins, normal human",,,1529
C0359156,PIN,rabbit anti-human T-lymphocyte globulin,L04AA04,antithymocyte immunoglobulin (rabbit),L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AA,Selective immunosuppressants,L04AA04,antithymocyte immunoglobulin (rabbit),307
C0360518,IN,clobetasone,D07AB01,clobetasone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AB,"Corticosteroids, moderately potent (group II)",D07AB01,clobetasone,19
C0360518,IN,clobetasone,S01BA09,clobetasone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BA,"Corticosteroid ophthalmologic antiinflammatory agents, plain",S01BA09,clobetasone,19
C0360534,IN,alclometasone,D07AB10,alclometasone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AB,"Corticosteroids, moderately potent (group II)",D07AB10,alclometasone,6
C0360534,IN,alclometasone,S01BA10,alclometasone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BA,"Corticosteroid ophthalmologic antiinflammatory agents, plain",S01BA10,alclometasone,6
C0360564,IN,mometasone,D07AC13,mometasone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AC,"Corticosteroids, potent (group III)",D07AC13,mometasone,52
C0360564,IN,mometasone,D07XC03,mometasone,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07X,"CORTICOSTEROIDS, OTHER COMBINATIONS",D07XC,"Corticosteroids, potent, other combinations",D07XC03,mometasone,52
C0360564,IN,mometasone,R01AD09,mometasone,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AD,Corticosteroid nasal preparations for topical use,R01AD09,mometasone,52
C0360564,IN,mometasone,R03BA07,mometasone,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03B,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS in ATC",R03BA,Glucocorticoid inhalants for obstructive airway disease,R03BA07,mometasone,52
C0376160,IN,zuclopenthixol,N05AF05,zuclopenthixol,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AF,"Thioxanthene derivatives, antipsychotic",N05AF05,zuclopenthixol,16
C0376637,IN,indinavir,J05AE02,indinavir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,"Protease inhibitors, direct acting antivirals",J05AE02,indinavir,94
C0376892,IN,polihexanide,D08AC05,polihexanide,D,DERMATOLOGICALS,D08,ANTISEPTICS AND DISINFECTANTS,D08A,ANTISEPTICS AND DISINFECTANTS,D08AC,Biguanides and amidines as antiseptics and disinfectants,D08AC05,polihexanide,9
C0376892,IN,polihexanide,S01AX24,polihexanide,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AX,Other antiinfectives in ATC,S01AX24,polihexanide,9
C0377223,IN,arginine glutamate,A05BA01,arginine glutamate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A05,BILE AND LIVER THERAPY DRUGS,A05B,"LIVER THERAPY, LIPOTROPICS",A05BA,Liver therapy drugs,A05BA01,arginine glutamate,1
C0377265,IN,levetiracetam,N03AX14,levetiracetam,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX14,levetiracetam,925
C0377349,PIN,sodium glycerophosphate,B05XA14,sodium glycerophosphate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA14,sodium glycerophosphate,9
C0378366,IN,desirudin,B01AE01,desirudin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AE,Direct thrombin inhibitors,B01AE01,desirudin,18
C0378466,IN,zafirlukast,R03DC01,zafirlukast,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DC,Leukotriene receptor antagonists for obstructive airway diseases,R03DC01,zafirlukast,44
C0378482,IN,rabeprazole,A02BC04,rabeprazole,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors for peptic ulcer and GORD,A02BC04,rabeprazole,23
C0378675,,,C08CA14,cilnidipine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,C08CA,Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects,C08CA14,cilnidipine,2
C0379135,IN,becaplermin,A01AD08,becaplermin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A01,STOMATOLOGICAL PREPARATIONS,A01A,STOMATOLOGICAL PREPARATIONS,A01AD,Other agents for local oral treatment in ATC,A01AD08,becaplermin,64
C0379135,IN,becaplermin,D03AX06,becaplermin,D,DERMATOLOGICALS,D03,PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS,D03A,CICATRIZANTS,D03AX,Other cicatrizants in ATC,D03AX06,becaplermin,64
C0379149,IN,temoporfin,L01XD05,temoporfin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XD,Sensitizers used in photodynamic/radiation therapy,L01XD05,temoporfin,1
C0379200,PIN,ibandronic acid,M05BA06,ibandronic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonate drugs affecting bone structure and mineralization,M05BA06,ibandronic acid,6
C0379881,IN,trovafloxacin,J01MA13,trovafloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA13,trovafloxacin,14
C0379955,PIN,indium In-111 pentetreotide,V09IB01,indium (111In) pentetreotide,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09I,TUMOUR DETECTION RADIOPHARMACEUTICALS,V09IB,Indium (111In) compounds,V09IB01,indium (111In) pentetreotide,18
C0380393,IN,ziprasidone,N05AE04,ziprasidone,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AE,"Indole derivatives, antipsychotic",N05AE04,ziprasidone,82
C0383429,IN,alemtuzumab,L04AG06,alemtuzumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AG,Monoclonal antibodies,L04AG06,alemtuzumab,282
C0387288,IN,verteporfin,S01LA01,verteporfin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01L,OCULAR VASCULAR DISORDER AGENTS,S01LA,Antineovascularisation agents,S01LA01,verteporfin,30
C0388638,,,L01XX57,plitidepsin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX57,plitidepsin,1
C0388753,IN,tolterodine,G04BD07,tolterodine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BD,Drugs for urinary frequency and incontinence,G04BD07,tolterodine,42
C0389169,IN,doripenem,J01DH04,doripenem,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DH,Carbapenems,J01DH04,doripenem,22
C0391001,IN,peginterferon alfa-2a,L03AB11,peginterferon alfa-2a,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AB,Interferons,L03AB11,peginterferon alfa-2a,39
C0393022,IN,rituximab,L01FA01,rituximab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FA,CD20 (Clusters of Differentiation 20) inhibitors,L01FA01,rituximab,1831
C0393080,IN,voriconazole,J02AC03,voriconazole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AC,Triazole and tetrazole derivatives,J02AC03,voriconazole,586
C0524639,IN,urofollitropin,G03GA04,urofollitropin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03G,GONADOTROPINS AND OTHER OVULATION STIMULANTS,G03GA,Gonadotropins,G03GA04,urofollitropin,8
C0525005,IN,nelfinavir,J05AE04,nelfinavir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,"Protease inhibitors, direct acting antivirals",J05AE04,nelfinavir,177
C0525079,IN,bendamustine,L01AA09,bendamustine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01A,ALKYLATING AGENTS,L01AA,Nitrogen mustard analogues,L01AA09,bendamustine,20
C0525227,IN,brimonidine,D11AX21,brimonidine,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AX,OTHER DERMATOLOGICAL PREPARATIONS IN ATC,D11AX21,brimonidine,37
C0525227,IN,brimonidine,S01EA05,brimonidine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EA,Sympathomimetics in glaucoma therapy,S01EA05,brimonidine,37
C0525227,IN,brimonidine,S01GA07,brimonidine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GA,Sympathomimetics used as decongestants,S01GA07,brimonidine,37
C0525678,IN,rasagiline,N04BD02,rasagiline,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04B,DOPAMINERGIC AGENTS,N04BD,"MAO B Inhibitors, dopaminergic anti-parkinson drugs",N04BD02,rasagiline,1
C0526058,,,R03DC02,pranlukast,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DC,Leukotriene receptor antagonists for obstructive airway diseases,R03DC02,pranlukast,20
C0526371,IN,midostaurin,L01EX10,midostaurin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX10,midostaurin,1
C0526399,IN,lercanidipine,C08CA13,lercanidipine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,C08CA,Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects,C08CA13,lercanidipine,4
C0526501,IN,mosapride,A03FA09,mosapride,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,A03FA09,mosapride,7
C0527129,,,J01MA17,prulifloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA17,prulifloxacin,2
C0527189,IN,olopatadine,R01AC08,olopatadine,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AC,"Antiallergic nasal preparations for topical use, excl. corticosteroids",R01AC08,olopatadine,41
C0527189,IN,olopatadine,S01GX09,olopatadine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GX,Other antiallergics in ATC,S01GX09,olopatadine,41
C0527316,IN,donepezil,N06DA02,donepezil,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06D,ANTI-DEMENTIA DRUGS,N06DA,Anticholinesterase anti-dementia drugs,N06DA02,donepezil,28
C0528023,IN,cerivastatin,C10AA06,cerivastatin,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AA,"HMG CoA reductase inhibitors, plain lipid modifying drugs",C10AA06,cerivastatin,3
C0528166,IN,zolmitriptan,N02CC03,zolmitriptan,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CC,Selective serotonin (5HT1) agonists,N02CC03,zolmitriptan,19
C0529793,IN,sildenafil,G04BE03,sildenafil,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BE,Drugs used in erectile dysfunction,G04BE03,sildenafil,461
C0530684,IN,ezogabine,N03AX21,retigabine,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX21,retigabine,8
C0531483,,,A03FA07,itopride,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,A03FA07,itopride,1
C0532578,,,A10BF03,voglibose,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BF,"Alpha glucosidase inhibitors, blood glucose lowering",A10BF03,voglibose,3
C0533545,IN,gemifloxacin,J01MA15,gemifloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA15,gemifloxacin,8
C0534301,,,R06AX28,rupatadine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX28,rupatadine,21
C0536004,IN,magnesium orotate,A12CC09,magnesium orotate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS in ATC,A12CC,"Magnesium supplements, alimentary tract and metabolism",A12CC09,magnesium orotate,2
C0536495,IN,moxifloxacin,J01MA14,moxifloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA14,moxifloxacin,182
C0536495,IN,moxifloxacin,S01AE07,moxifloxacin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AE,"Fluoroquinolone antiinfectives, ophthalmologic",S01AE07,moxifloxacin,182
C0537147,IN,tegaserod,A06AX06,tegaserod,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AX,Other drugs for constipation in ATC,A06AX06,tegaserod,8
C0537150,IN,ganaxolone,N03AX27,ganaxolone,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX27,ganaxolone,9
C0537270,IN,insulin detemir,A10AE05,insulin detemir,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",A10AE05,insulin detemir,63
C0537439,IN,enfuvirtide,J05AX07,enfuvirtide,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX07,enfuvirtide,20
C0537551,IN,pramlintide,A10BX05,pramlintide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins in ATC",A10BX05,pramlintide,9
C0537670,IN,oprelvekin,L03AC02,oprelvekin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AC,Interleukins,L03AC02,oprelvekin,60
C0537894,IN,caspofungin,J02AX04,caspofungin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AX,Other antimycotics for systemic use in ATC,J02AX04,caspofungin,219
C0538777,IN,ancestim,L03AA12,ancestim,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AA,Colony stimulating factors,L03AA12,ancestim,1
C0538927,IN,celecoxib,L01XX33,celecoxib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX33,celecoxib,99
C0538927,IN,celecoxib,M01AH01,celecoxib,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AH,Coxibs,M01AH01,celecoxib,99
C0540623,IN,naratriptan,N02CC02,naratriptan,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CC,Selective serotonin (5HT1) agonists,N02CC02,naratriptan,10
C0540694,PIN,adefovir dipivoxil,J05AF08,adefovir dipivoxil,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,J05AF08,adefovir dipivoxil,28
C0541153,,,J01DI03,faropenem,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DI,Other cephalosporins and penems in ATC,J01DI03,faropenem,13
C0541155,IN,colesevelam,C10AC04,colesevelam,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AC,Bile acid sequestrants,C10AC04,colesevelam,4
C0541315,IN,everolimus,L01EG02,everolimus,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EG,Mammalian target of rapamycin (mTOR) kinase inhibitors (L01EG),L01EG02,everolimus,266
C0541315,IN,everolimus,L04AH02,everolimus,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AH,Mammalian target of rapamycin (mTOR) kinase inhibitors (L04AH),L04AH02,everolimus,266
C0543448,IN,magnesium aspartate,A12CC05,magnesium aspartate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS in ATC,A12CC,"Magnesium supplements, alimentary tract and metabolism",A12CC05,magnesium aspartate,9
C0596004,IN,hyoscyamine,A03BA03,hyoscyamine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03B,"BELLADONNA AND DERIVATIVES CONTAINING DRUGS, PLAIN FOR FUNCTIONAL GASTROINTESTINAL DISORDERS",A03BA,"Belladonna alkaloids, tertiary amines for functional gastrointestinal disorders",A03BA03,hyoscyamine,1283
C0600370,IN,methacholine,V04CX03,methacholine,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CX,Other diagnostic agents in ATC,V04CX03,methacholine,1056
C0600489,IN,phenolphthalein,A06AB04,phenolphthalein,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,A06AB04,phenolphthalein,11
C0606070,IN,tocophersolan,A11HA08,tocofersolan,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A11,VITAMINS,A11H,OTHER PLAIN VITAMIN PREPARATIONS in ATC,A11HA,Other plain vitamin preparations in ATC,A11HA08,tocofersolan,3
C0614721,,,A12CC07,magnesium levulinate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A12,MINERAL SUPPLEMENTS,A12C,OTHER MINERAL SUPPLEMENTS in ATC,A12CC,"Magnesium supplements, alimentary tract and metabolism",A12CC07,magnesium levulinate,1
C0619323,,,N06AX15,pivagabine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX15,pivagabine,1
C0649350,IN,rivastigmine,N06DA03,rivastigmine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06D,ANTI-DEMENTIA DRUGS,N06DA,Anticholinesterase anti-dementia drugs,N06DA03,rivastigmine,12
C0650237,IN,clofezone,M01AA05,clofezone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AA,"Butylpyrazolidines, antiinflammatory and antirheumatic drugs",M01AA05,clofezone,23
C0650237,IN,clofezone,M02AA03,clofezone,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA03,clofezone,23
C0657912,IN,pregabalin,N02BF02,pregabalin,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BF,"Gabapentinoids, analgesics and antipyretics",N02BF02,pregabalin,93
C0662811,,,C09CA05,tasosartan,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09C,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",C09CA,"Angiotensin II receptor blockers (ARBs), plain",C09CA05,tasosartan,1
C0663182,IN,daclizumab,L04AC01,daclizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC01,daclizumab,113
C0663241,IN,linezolid,J01XX08,linezolid,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XX,Other antibacterials in ATC,J01XX08,linezolid,379
C0663655,IN,abacavir,J05AF06,abacavir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,J05AF06,abacavir,139
C0663733,IN,tipranavir,J05AE09,tipranavir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,"Protease inhibitors, direct acting antivirals",J05AE09,tipranavir,11
C0666513,IN,perflenapent,V08DA03,perflenapent,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08D,ULTRASOUND CONTRAST MEDIA,V08DA,Ultrasound contrast media,V08DA03,perflenapent,1
C0666743,IN,infliximab,L04AB02,infliximab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AB,Tumor necrosis factor alpha (TNF-alpha) inhibitors,L04AB02,infliximab,1342
C0668961,,,B01AE04,melagatran,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AE,Direct thrombin inhibitors,B01AE04,melagatran,3
C0671970,IN,capecitabine,L01BC06,capecitabine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BC,"Pyrimidine analogues, antineoplastic antimetabolites",L01BC06,capecitabine,35
C0672596,IN,palivizumab,J06BD01,palivizumab,J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BD,Antiviral monoclonal antibodies,J06BD01,palivizumab,559
C0672708,IN,vorinostat,L01XH01,vorinostat,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XH,Histone deacetylase (HDAC) inhibitors,L01XH01,vorinostat,35
C0673470,IN,istradefylline,N04CX01,istradefylline,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04C,OTHER ANTIPARKINSON DRUGS in ATC,N04CX,Other antiparkinson drugs in ATC,N04CX01,istradefylline,1
C0673966,IN,brinzolamide,S01EC04,brinzolamide,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EC,"Carbonic anhydrase inhibitors, antiglaucoma drugs and miotics",S01EC04,brinzolamide,11
C0674428,IN,efavirenz,J05AG03,efavirenz,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AG,Non-nucleoside reverse transcriptase inhibitors,J05AG03,efavirenz,458
C0676831,IN,basiliximab,L04AC02,basiliximab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC02,basiliximab,208
C0677667,IN,raltitrexed,L01BA03,raltitrexed,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BA,"Folic acid analogs, antimetabolites",L01BA03,raltitrexed,3
C0677829,IN,palifermin,V03AF08,palifermin,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AF,Detoxifying agents for antineoplastic treatment,V03AF08,palifermin,14
C0699817,IN,interferon alfa-n1,L03AB06,interferon alfa-n1,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AB,Interferons,L03AB06,interferon alfa-n1,7
C0700580,PIN,ipratropium bromide,R01AX03,ipratropium bromide,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AX,Other nasal preparations in ATC,R01AX03,ipratropium bromide,235
C0700580,PIN,ipratropium bromide,R03BB01,ipratropium bromide,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03B,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS in ATC",R03BB,Anticholinergics inhalants for obstructive airway diseases,R03BB01,ipratropium bromide,235
C0717537,IN,calcium acetate,V03AE07,calcium acetate,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AE,Drugs for treatment of hyperkalemia and hyperphosphatemia,V03AE07,calcium acetate,8
C0717550,IN,candesartan,C09CA06,candesartan,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09C,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",C09CA,"Angiotensin II receptor blockers (ARBs), plain",C09CA06,candesartan,21
C0717670,IN,denileukin diftitox,L01XX29,denileukin diftitox,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX29,denileukin diftitox,5
C0717758,IN,etanercept,L04AB01,etanercept,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AB,Tumor necrosis factor alpha (TNF-alpha) inhibitors,L04AB01,etanercept,576
C0718043,IN,sacrosidase,A16AB06,sacrosidase,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB06,sacrosidase,5
C0718050,IN,sevelamer,V03AE02,sevelamer,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AE,Drugs for treatment of hyperkalemia and hyperphosphatemia,V03AE02,sevelamer,33
C0724441,IN,yohimbine,G04BE04,yohimbine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BE,Drugs used in erectile dysfunction,G04BE04,yohimbine,19
C0728747,IN,trastuzumab,L01FD01,trastuzumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FD,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,L01FD01,trastuzumab,46
C0728810,,,V03AB29,cholinesterase,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB29,cholinesterase,155
C0732290,PIN,urea c-13,V04CX05,13C-urea,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CX,Other diagnostic agents in ATC,V04CX05,13C-urea,124
C0733397,IN,masoprocol,L01XX10,masoprocol,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX10,masoprocol,3
C0753183,,,C09AA14,temocapril,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09A,"ACE INHIBITORS, PLAIN",C09AA,"ACE inhibitors, plain",C09AA14,temocapril,3
C0753645,IN,gatifloxacin,J01MA16,gatifloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA16,gatifloxacin,66
C0753645,IN,gatifloxacin,S01AE06,gatifloxacin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AE,"Fluoroquinolone antiinfectives, ophthalmologic",S01AE06,gatifloxacin,66
C0753678,IN,paliperidone,N05AX13,paliperidone,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AX,Other antipsychotics in ATC,N05AX13,paliperidone,83
C0754011,IN,abiraterone,L02BX03,abiraterone,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02B,HORMONE ANTAGONISTS AND RELATED AGENTS,L02BX,Other hormone antagonists and related agents in ATC,L02BX03,abiraterone,1
C0754188,IN,amprenavir,J05AE05,amprenavir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,"Protease inhibitors, direct acting antivirals",J05AE05,amprenavir,23
C0754280,IN,flibanserin,G02CX02,flibanserin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02C,OTHER GYNECOLOGICALS in ATC,G02CX,Other gynecologicals in ATC,G02CX02,flibanserin,3
C0754647,IN,frovatriptan,N02CC07,frovatriptan,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CC,Selective serotonin (5HT1) agonists,N02CC07,frovatriptan,3
C0754659,IN,dutasteride,G04CB02,dutasteride,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04C,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,G04CB,Testosterone-5-alpha reductase inhibitors for benign prostatic hypertrophy,G04CB02,dutasteride,3
C0754820,IN,gadoversetamide,V08CA06,gadoversetamide,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08C,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,V08CA,Paramagnetic contrast media,V08CA06,gadoversetamide,3
C0757422,,,D03AX15,trafermin,D,DERMATOLOGICALS,D03,PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS,D03A,CICATRIZANTS,D03AX,Other cicatrizants in ATC,D03AX15,trafermin,2
C0759032,,,J05AX06,pleconaril,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX06,pleconaril,16
C0759933,IN,eletriptan,N02CC06,eletriptan,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CC,Selective serotonin (5HT1) agonists,N02CC06,eletriptan,3
C0762662,IN,rofecoxib,M01AH02,rofecoxib,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AH,Coxibs,M01AH02,rofecoxib,43
C0765273,IN,bexarotene,L01XF03,bexarotene,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XF,Retinoids for cancer treatment,L01XF03,bexarotene,8
C0766108,IN,clevidipine,C08CA16,clevidipine,C,CARDIOVASCULAR SYSTEM DRUGS,C08,CALCIUM CHANNEL BLOCKERS,C08C,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,C08CA,Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects,C08CA16,clevidipine,8
C0766326,IN,dronedarone,C01BD07,dronedarone,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BD,"Antiarrhythmics, class III",C01BD07,dronedarone,2
C0768119,IN,lanthanum carbonate,V03AE03,lanthanum carbonate,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AE,Drugs for treatment of hyperkalemia and hyperphosphatemia,V03AE03,lanthanum carbonate,5
C0770206,,,A10AB03,insulin (pork),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AB,"Insulins and analogues for injection, fast-acting",A10AB03,insulin (pork),52
C0770206,,,A10AC03,insulin (pork),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AC,"Insulins and analogues for injection, intermediate-acting",A10AC03,insulin (pork),52
C0770206,,,A10AD03,insulin (pork),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AD,"Insulins and analogues for injection used in Diabetes, intermediate- or long-acting combined with fast-acting",A10AD03,insulin (pork),52
C0770206,,,A10AE03,insulin (pork),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",A10AE03,insulin (pork),52
C0771311,PIN,alendronic acid,M05BA04,alendronic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonate drugs affecting bone structure and mineralization,M05BA04,alendronic acid,111
C0771795,,,V08CA02,gadoteric acid,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08C,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,V08CA,Paramagnetic contrast media,V08CA02,gadoteric acid,34
C0771950,IN,fluprednidene,D07AB07,fluprednidene,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07A,"CORTICOSTEROID DERMATOLOGICAL PREPARATIONS, PLAIN",D07AB,"Corticosteroids, moderately potent (group II)",D07AB07,fluprednidene,1
C0771950,IN,fluprednidene,D07XB03,fluprednidene,D,DERMATOLOGICALS,D07,"CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",D07X,"CORTICOSTEROIDS, OTHER COMBINATIONS",D07XB,"Corticosteroids, moderately potent, other combinations",D07XB03,fluprednidene,1
C0772051,IN,samarium Sm 153 lexidronam,V10BX02,samarium (153Sm) lexidronam,V,VARIOUS DRUG CLASSES IN ATC,V10,THERAPEUTIC RADIOPHARMACEUTICALS,V10B,PAIN PALLIATION (BONE SEEKING AGENTS),V10BX,Various pain palliation radiopharmaceuticals,V10BX02,samarium (153Sm) lexidronam,4
C0772089,IN,trospium,G04BD09,trospium,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BD,Drugs for urinary frequency and incontinence,G04BD09,trospium,4
C0772241,IN,levomethadone,N07BC05,levomethadone,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07B,DRUGS USED IN ADDICTIVE DISORDERS,N07BC,Drugs used in opioid dependence,N07BC05,levomethadone,1
C0772289,PIN,"corticotropin-releasing factor, human",V04CD04,corticorelin,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CD,pituitary function test diagnostic agents,V04CD04,corticorelin,534
C0772319,IN,unoprostone,S01EE02,unoprostone,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EE,"Prostaglandin analogues, antiglaucoma drugs and miotics",S01EE02,unoprostone,1
C0772321,IN,mangafodipir,V08CA05,mangafodipir,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08C,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,V08CA,Paramagnetic contrast media,V08CA05,mangafodipir,2
C0772364,IN,loteprednol,S01BA14,loteprednol,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BA,"Corticosteroid ophthalmologic antiinflammatory agents, plain",S01BA14,loteprednol,8
C0772394,IN,lepirudin,B01AE02,lepirudin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AE,Direct thrombin inhibitors,B01AE02,lepirudin,18
C0772505,IN,dexketoprofen,M01AE17,dexketoprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,"Propionic acid derivatives, antiinflammatory and antirheumatic products",M01AE17,dexketoprofen,7
C0772505,IN,dexketoprofen,M02AA27,dexketoprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA27,dexketoprofen,7
C0795635,IN,"insulin, regular, human",A10AB01,insulin (human),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AB,"Insulins and analogues for injection, fast-acting",A10AB01,insulin (human),357
C0795635,IN,"insulin, regular, human",A10AC01,insulin (human),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AC,"Insulins and analogues for injection, intermediate-acting",A10AC01,insulin (human),357
C0795635,IN,"insulin, regular, human",A10AD01,insulin (human),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AD,"Insulins and analogues for injection used in Diabetes, intermediate- or long-acting combined with fast-acting",A10AD01,insulin (human),357
C0795635,IN,"insulin, regular, human",A10AE01,insulin (human),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",A10AE01,insulin (human),357
C0795635,IN,"insulin, regular, human",A10AF01,insulin (human),A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AF,Insulins and analogues for inhalation,A10AF01,insulin (human),357
C0795661,,,J07BH01,"rota virus, live attenuated",J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BH,Rota virus diarrhea vaccines,J07BH01,"rota virus, live attenuated",1676
C0796392,IN,bevacizumab,L01FG01,bevacizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FG,VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitors,L01FG01,bevacizumab,817
C0796392,IN,bevacizumab,S01LA08,bevacizumab,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01L,OCULAR VASCULAR DISORDER AGENTS,S01LA,Antineovascularisation agents,S01LA08,bevacizumab,817
C0796545,IN,peginterferon alfa-2b,L03AB10,peginterferon alfa-2b,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AB,Interferons,L03AB10,peginterferon alfa-2b,11
C0851342,IN,magnesium silicate,A02AA05,magnesium silicate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02A,ANTACIDS,A02AA,antacids containing magnesium compounds,A02AA05,magnesium silicate,2
C0851344,IN,exemestane,L02BG06,exemestane,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02B,HORMONE ANTAGONISTS AND RELATED AGENTS,L02BG,Aromatase inhibitors,L02BG06,exemestane,3
C0872913,IN,tenecteplase,B01AD11,tenecteplase,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AD,"Enzymes, antithrombotic",B01AD11,tenecteplase,9
C0872916,PIN,xenon-133,V09EX03,xenon (133Xe) gas,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09E,RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,V09EX,Other respiratory system diagnostic radiopharmaceuticals in ATC,V09EX03,xenon (133Xe) gas,50
C0873118,IN,levobupivacaine,N01BB10,levobupivacaine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BB,Amide local anesthetics,N01BB10,levobupivacaine,2210
C0874161,IN,oseltamivir,J05AH02,oseltamivir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AH,"Neuraminidase inhibitors, direct acting antivirals",J05AH02,oseltamivir,804
C0877860,IN,felbinac,M02AA08,felbinac,M,MUSCULO-SKELETAL SYSTEM DRUGS,M02,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02A,TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,M02AA,"Antiinflammatory preparations, non-steroids for topical use",M02AA08,felbinac,3
C0878309,,,J01XE03,furazidin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XE,"Nitrofuran derivatives, antibacterials for systemic use",J01XE03,furazidin,2
C0879427,IN,panitumumab,L01FE02,panitumumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FE,EGFR (Epidermal Growth Factor Receptor) inhibitors,L01FE02,panitumumab,5
C0886584,IN,metyrosine,C02KB01,metirosine,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02K,OTHER ANTIHYPERTENSIVES in ATC,C02KB,"Tyrosine hydroxylase inhibitors, antihypertensives",C02KB01,metirosine,11
C0893383,PIN,gallium 67 citrate,V09HX01,gallium (67Ga) citrate,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09H,INFLAMMATION AND INFECTION DETECTION,V09HX,Other diagnostic radiopharmaceuticals for inflammation and infection detection in ATC,V09HX01,gallium (67Ga) citrate,34
C0893761,IN,lacosamide,N03AX18,lacosamide,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX18,lacosamide,137
C0903411,IN,tafenoquine,P01BA07,tafenoquine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BA,Aminoquinoline antimalarials,P01BA07,tafenoquine,14
C0903898,IN,nateglinide,A10BX03,nateglinide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins in ATC",A10BX03,nateglinide,4
C0904505,IN,mecasermin,H01AC03,mecasermin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,H01AC03,mecasermin,298
C0905464,,,C07AB14,landiolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AB,"Beta blocking agents, selective",C07AB14,landiolol,23
C0906166,,,A10BX08,mitiglinide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins in ATC",A10BX08,mitiglinide,2
C0907349,IN,nelarabine,L01BB07,nelarabine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BB,"Purine analogs, antimetabolites antineoplastic",L01BB07,nelarabine,25
C0907402,IN,insulin glargine,A10AE04,insulin glargine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",A10AE04,insulin glargine,134
C0907410,IN,telithromycin,J01FA15,telithromycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,J01FA15,telithromycin,32
C0907850,IN,ciclesonide,R01AD13,ciclesonide,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AD,Corticosteroid nasal preparations for topical use,R01AD13,ciclesonide,64
C0907850,IN,ciclesonide,R03BA08,ciclesonide,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03B,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS in ATC",R03BA,Glucocorticoid inhalants for obstructive airway disease,R03BA08,ciclesonide,64
C0908935,IN,desloratadine,R06AX27,desloratadine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX27,desloratadine,64
C0909381,IN,valganciclovir,J05AB14,valganciclovir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,J05AB14,valganciclovir,218
C0909839,IN,emtricitabine,J05AF09,emtricitabine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,J05AF09,emtricitabine,198
C0913246,IN,valdecoxib,M01AH03,valdecoxib,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AH,Coxibs,M01AH03,valdecoxib,9
C0913469,IN,pegvisomant,H01AX01,pegvisomant,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AX,Other anterior pituitary lobe hormones and analogues in ATC,H01AX01,pegvisomant,31
C0913506,IN,prucalopride,A06AX05,prucalopride,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AX,Other drugs for constipation in ATC,A06AX05,prucalopride,9
C0914729,IN,almotriptan,N02CC05,almotriptan,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CC,Selective serotonin (5HT1) agonists,N02CC05,almotriptan,6
C0915142,IN,parecoxib,M01AH04,parecoxib,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AH,Coxibs,M01AH04,parecoxib,17
C0916062,IN,bemiparin,B01AB12,bemiparin,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AB,Heparin group antithrombotic drugs,B01AB12,bemiparin,5
C0935916,IN,fulvestrant,L02BA03,fulvestrant,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02B,HORMONE ANTAGONISTS AND RELATED AGENTS,L02BA,Anti-estrogens,L02BA03,fulvestrant,3
C0935989,IN,imatinib,L01EA01,imatinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EA,BCR-ABL tyrosine kinase inhibitors,L01EA01,imatinib,607
C0936139,,,M05BX03,strontium ranelate,M,MUSCULO-SKELETAL SYSTEM DRUGS,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BX,Other drugs affecting bone structure and mineralization in ATC,M05BX03,strontium ranelate,1
C0936148,IN,posaconazole,J02AC04,posaconazole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AC,Triazole and tetrazole derivatives,J02AC04,posaconazole,175
C0936150,MIN,artemether / lumefantrine,P01BF01,artemether and lumefantrine,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BF,"Artemisinin and derivatives, combinations",P01BF01,artemether and lumefantrine,639
C0937846,IN,esomeprazole,A02BC05,esomeprazole,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors for peptic ulcer and GORD,A02BC05,esomeprazole,492
C0937916,IN,travoprost,S01EE04,travoprost,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EE,"Prostaglandin analogues, antiglaucoma drugs and miotics",S01EE04,travoprost,8
C0937917,IN,bimatoprost,S01EE03,bimatoprost,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EE,"Prostaglandin analogues, antiglaucoma drugs and miotics",S01EE03,bimatoprost,9
C0937932,IN,rasburicase,V03AF07,rasburicase,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AF,Detoxifying agents for antineoplastic treatment,V03AF07,rasburicase,80
C0937950,IN,darbepoetin alfa,B03XA02,darbepoetin alfa,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03X,OTHER ANTIANEMIC PREPARATIONS in ATC,B03XA,Other antianemic preparations in ATC,B03XA02,darbepoetin alfa,63
C0953467,IN,tacalcitol,D05AX04,tacalcitol,D,DERMATOLOGICALS,D05,ANTIPSORIATICS,D05A,ANTIPSORIATICS FOR TOPICAL USE,D05AX,Other antipsoriatics for topical use in ATC,D05AX04,tacalcitol,11
C0961209,IN,nepafenac,S01BC10,nepafenac,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01B,"ANTIINFLAMMATORY AGENTS, OPHTHALMOLOGIC",S01BC,"Antiinflammatory agents, non-steroidal, ophthalmologic",S01BC10,nepafenac,1
C0961485,IN,eplerenone,C03DA04,eplerenone,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03D,ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS,C03DA,Aldosterone antagonists,C03DA04,eplerenone,15
C0961965,IN,metreleptin,A16AA07,metreleptin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AA,Amino acids and derivatives,A16AA07,metreleptin,42
C0962517,IN,agalsidase alfa,A16AB03,agalsidase alfa,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB03,agalsidase alfa,69
C0962603,IN,alefacept,L04AA15,alefacept,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AA,Selective immunosuppressants,L04AA15,alefacept,12
C0963398,IN,tenofovir disoproxil,J05AF07,tenofovir disoproxil,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,J05AF07,tenofovir disoproxil,208
C0963839,,,G03XC03,lasofoxifene,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03X,OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC,G03XC,Selective estrogen receptor modulators,G03XC03,lasofoxifene,1
C0965129,IN,rosuvastatin,C10AA07,rosuvastatin,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AA,"HMG CoA reductase inhibitors, plain lipid modifying drugs",C10AA07,rosuvastatin,40
C0965618,IN,roflumilast,D05AX06,roflumilast,D,DERMATOLOGICALS,D05,ANTIPSORIATICS,D05A,ANTIPSORIATICS FOR TOPICAL USE,D05AX,Other antipsoriatics for topical use in ATC,D05AX06,roflumilast,12
C0965618,IN,roflumilast,R03DX07,roflumilast,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DX,Other systemic drugs for obstructive airway diseases in ATC,R03DX07,roflumilast,12
C0966107,IN,conivaptan,C03XA02,conivaptan,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03X,OTHER DIURETICS in ATC,C03XA,"Vasopressin antagonists, diuretics",C03XA02,conivaptan,5
C0966225,IN,omalizumab,R03DX05,omalizumab,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DX,Other systemic drugs for obstructive airway diseases in ATC,R03DX05,omalizumab,320
C0966370,,,B01AE05,ximelagatran,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AE,Direct thrombin inhibitors,B01AE05,ximelagatran,2
C0969324,IN,mepolizumab,R03DX09,mepolizumab,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DX,Other systemic drugs for obstructive airway diseases in ATC,R03DX09,mepolizumab,60
C0971023,IN,entecavir,J05AF10,entecavir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,J05AF10,entecavir,96
C0971579,IN,vardenafil,G04BE09,vardenafil,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BE,Drugs used in erectile dysfunction,G04BE09,vardenafil,2
C0971637,,,N06AX22,agomelatine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX22,agomelatine,5
C0972314,IN,etoricoxib,M01AH05,etoricoxib,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AH,Coxibs,M01AH05,etoricoxib,15
C0982025,IN,anti-inhibitor coagulant complex,B02BD01,"coagulation factor IX, II, VII and X in combination",B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BD,Blood coagulation factors,B02BD01,"coagulation factor IX, II, VII and X in combination",176
C0982025,IN,anti-inhibitor coagulant complex,B02BD03,factor VIII inhibitor bypassing activity,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BD,Blood coagulation factors,B02BD03,factor VIII inhibitor bypassing activity,176
C0982353,IN,potassium lactate,B05XA15,potassium lactate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B05,BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,B05X,I.V. SOLUTION ADDITIVES,B05XA,Electrolyte solutions,B05XA15,potassium lactate,8
C0995188,IN,cetuximab,L01FE01,cetuximab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FE,EGFR (Epidermal Growth Factor Receptor) inhibitors,L01FE01,cetuximab,15
C1096766,IN,cisatracurium,M03AC11,cisatracurium,M,MUSCULO-SKELETAL SYSTEM DRUGS,M03,MUSCLE RELAXANTS,M03A,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",M03AC,"Other quaternary ammonium compounds in ATC, muscle relaxants, peripherally acting",M03AC11,cisatracurium,61
C1096768,IN,meglumine antimoniate,P01CB01,meglumine antimonate,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01C,AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS,P01CB,Antimony compounds for treatment of leishmaniasis and trypanosomiasis,P01CB01,meglumine antimonate,267
C1098510,IN,fondaparinux,B01AX05,fondaparinux,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AX,Other antithrombotic agents in ATC,B01AX05,fondaparinux,26
C1099414,IN,pimecrolimus,D11AH02,pimecrolimus,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AH,"Agents for dermatitis, excluding corticosteroids",D11AH02,pimecrolimus,110
C1099456,IN,escitalopram,N06AB10,escitalopram,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AB,Selective serotonin reuptake inhibitors,N06AB10,escitalopram,290
C1099677,IN,solifenacin,G04BD08,solifenacin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BD,Drugs for urinary frequency and incontinence,G04BD08,solifenacin,24
C1101148,,,R06AX29,bilastine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AX,Other antihistamines for systemic use in ATC,R06AX29,bilastine,11
C1101148,,,S01GX13,bilastine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GX,Other antiallergics in ATC,S01GX13,bilastine,11
C1101425,,,C01EB02,camphora,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01E,OTHER CARDIAC PREPARATIONS in ATC,C01EB,Other plain cardiac preparations in ATC,C01EB02,camphora,47
C1101838,IN,pitavastatin,C10AA08,pitavastatin,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AA,"HMG CoA reductase inhibitors, plain lipid modifying drugs",C10AA08,pitavastatin,7
C1113707,IN,dimethicone,P03AX05,dimeticone,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03A,"ECTOPARASITICIDES, INCL. SCABICIDES",P03AX,"Other ectoparasiticides, incl. scabicides in ATC",P03AX05,dimeticone,22
C1120106,IN,ertapenem,J01DH03,ertapenem,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DH,Carbapenems,J01DH03,ertapenem,62
C1120110,IN,aliskiren,C09XA02,aliskiren,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09X,OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM in ATC,C09XA,Renin-inhibitors,C09XA02,aliskiren,9
C1120386,IN,micafungin,J02AX05,micafungin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AX,Other antimycotics for systemic use in ATC,J02AX05,micafungin,126
C1121849,IN,vandetanib,L01EX04,vandetanib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX04,vandetanib,26
C1121991,IN,cangrelor,B01AC25,cangrelor,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC25,cangrelor,3
C1122087,IN,adalimumab,L04AB04,adalimumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AB,Tumor necrosis factor alpha (TNF-alpha) inhibitors,L04AB04,adalimumab,634
C1122962,IN,gefitinib,L01EB01,gefitinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EB,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,L01EB01,gefitinib,23
C1134467,IN,methyl 5-aminolevulinate,L01XD03,methyl aminolevulinate,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XD,Sensitizers used in photodynamic/radiation therapy,L01XD03,methyl aminolevulinate,2
C1134659,IN,aflibercept,L01XX44,aflibercept,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX44,aflibercept,51
C1134659,IN,aflibercept,S01LA05,aflibercept,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01L,OCULAR VASCULAR DISORDER AGENTS,S01LA,Antineovascularisation agents,S01LA05,aflibercept,51
C1135132,IN,ixabepilone,L01DC04,ixabepilone,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01D,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,L01DC,Other cytotoxic antibiotics in ATC,L01DC04,ixabepilone,3
C1135135,IN,erlotinib,L01EB02,erlotinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EB,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,L01EB02,erlotinib,45
C1135662,IN,dornase alfa,R05CB13,dornase alfa (desoxyribonuclease),R,RESPIRATORY SYSTEM DRUGS,R05,COUGH AND COLD PREPARATIONS,R05C,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",R05CB,Mucolytics,R05CB13,dornase alfa (desoxyribonuclease),86
C1136262,PIN,technetium Tc 99m pertechnetate,V09FX01,technetium (99mTc) pertechnetate,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09F,THYROID DIAGNOSTIC RADIOPHARMACEUTICALS,V09FX,Various thyroid diagnostic radiopharmaceuticals,V09FX01,technetium (99mTc) pertechnetate,1
C1136535,IN,pegfilgrastim,L03AA13,pegfilgrastim,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AA,Colony stimulating factors,L03AA13,pegfilgrastim,30
C1137427,IN,agalsidase beta,A16AB04,agalsidase beta,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB04,agalsidase beta,22
C1138226,,,J05AX27,favipiravir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX27,favipiravir,27
C1142738,IN,anidulafungin,J02AX06,anidulafungin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AX,Other antimycotics for systemic use in ATC,J02AX06,anidulafungin,32
C1142933,,,A08AX01,rimonabant,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AX,Other antiobesity drugs in ATC,A08AX01,rimonabant,5
C1142934,IN,satraplatin,L01XA04,satraplatin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XA,"Platinum compounds, antineoplastic drugs",L01XA04,satraplatin,1
C1142985,IN,ezetimibe,C10AX09,ezetimibe,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AX,Other lipid modifying agents in ATC,C10AX09,ezetimibe,79
C1143018,IN,obeticholic acid,A05AA04,obeticholic acid,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A05,BILE AND LIVER THERAPY DRUGS,A05A,BILE THERAPY DRUGS,A05AA,Bile acids and derivatives for bile therapy,A05AA04,obeticholic acid,3
C1144149,IN,lenalidomide,L04AX04,lenalidomide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AX,Other immunosuppressants in ATC,L04AX04,lenalidomide,30
C1144403,IN,oritavancin,J01XA05,oritavancin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XA,Glycopeptide antibacterials,J01XA05,oritavancin,2
C1145610,PIN,cellulose sodium phosphate,V03AG01,sodium cellulose phosphate,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AG,Drugs for treatment of hypercalcemia,V03AG01,sodium cellulose phosphate,2
C1145759,IN,atazanavir,J05AE08,atazanavir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,"Protease inhibitors, direct acting antivirals",J05AE08,atazanavir,81
C1145760,IN,treprostinil,B01AC21,treprostinil,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC21,treprostinil,84
C1169997,IN,dexmethylphenidate,N06BA11,dexmethylphenidate,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BA,Centrally acting sympathomimetics,N06BA11,dexmethylphenidate,36
C1170000,IN,drotrecogin alfa,B01AD10,drotrecogin alfa (activated),B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AD,"Enzymes, antithrombotic",B01AD10,drotrecogin alfa (activated),345
C1172636,IN,dalbavancin,J01XA04,dalbavancin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XA,Glycopeptide antibacterials,J01XA04,dalbavancin,9
C1172734,IN,natalizumab,L04AG03,natalizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AG,Monoclonal antibodies,L04AG03,natalizumab,106
C1174893,IN,levocetirizine,R06AE09,levocetirizine,R,RESPIRATORY SYSTEM DRUGS,R06,ANTIHISTAMINES FOR SYSTEMIC USE,R06A,ANTIHISTAMINES FOR SYSTEMIC USE,R06AE,"Piperazine derivatives, systemic antihistamines",R06AE09,levocetirizine,45
C1174995,IN,efalizumab,L04AG02,efalizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AG,Monoclonal antibodies,L04AG02,efalizumab,7
C1176020,IN,sunitinib,L01EX01,sunitinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX01,sunitinib,52
C1176306,IN,aprepitant,A04AD12,aprepitant,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A04,ANTIEMETICS AND ANTINAUSEANTS,A04A,ANTIEMETICS AND ANTINAUSEANTS,A04AD,Other antiemetics in ATC,A04AD12,aprepitant,44
C1176308,IN,tolvaptan,C03XA01,tolvaptan,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03X,OTHER DIURETICS in ATC,C03XA,"Vasopressin antagonists, diuretics",C03XA01,tolvaptan,44
C1176309,IN,bortezomib,L01XG01,bortezomib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XG,"Proteasome inhibitors, antineoplastic agent",L01XG01,bortezomib,128
C1176315,IN,fosamprenavir,J05AE07,fosamprenavir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,"Protease inhibitors, direct acting antivirals",J05AE07,fosamprenavir,9
C1176316,IN,tadalafil,G04BE08,tadalafil,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BE,Drugs used in erectile dysfunction,G04BE08,tadalafil,55
C1176329,IN,ambrisentan,C02KX02,ambrisentan,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02K,OTHER ANTIHYPERTENSIVES in ATC,C02KX,Antihypertensives for pulmonary arterial hypertension,C02KX02,ambrisentan,17
C1176415,,,M01AH06,lumiracoxib,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AH,Coxibs,M01AH06,lumiracoxib,2
C1257385,IN,lonafarnib,A16AX20,lonafarnib,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX20,lonafarnib,10
C1260208,,,N07XX10,laquinimod,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07X,OTHER NERVOUS SYSTEM DRUGS in ATC,N07XX,Other nervous system drugs in ATC,N07XX10,laquinimod,1
C1260298,IN,tigecycline,J01AA12,tigecycline,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,Tetracycline antibiotics,J01AA,Tetracyclines,J01AA12,tigecycline,121
C1268876,IN,follitropin alfa,G03GA05,follitropin alfa,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03G,GONADOTROPINS AND OTHER OVULATION STIMULANTS,G03GA,Gonadotropins,G03GA05,follitropin alfa,4218
C1271607,IN,lutropin alfa,G03GA07,lutropin alfa,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03G,GONADOTROPINS AND OTHER OVULATION STIMULANTS,G03GA,Gonadotropins,G03GA07,lutropin alfa,2
C1302054,IN,laronidase,A16AB05,laronidase,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB05,laronidase,45
C1311070,IN,trabectedin,L01CX01,trabectedin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01C,"PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, ANTINEOPLASTIC DRUGS",L01CX,Other plant alkaloids and natural products in ATC,L01CX01,trabectedin,11
C1313052,IN,tasimelteon,N05CH03,tasimelteon,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CH,"Melatonin receptor agonists, hypnotics and sedatives",N05CH03,tasimelteon,2
C1313386,IN,"insulin glulisine, human",A10AB06,insulin glulisine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AB,"Insulins and analogues for injection, fast-acting",A10AB06,insulin glulisine,10
C1318649,IN,carglumic acid,A16AA05,carglumic acid,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AA,Amino acids and derivatives,A16AA05,carglumic acid,48
C1321596,IN,miglustat,A16AX06,miglustat,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX06,miglustat,89
C1322006,IN,difetarsone,P01AR02,difetarsone,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01A,AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,P01AR,"Arsenic compounds, for amoebiasis and other protozoal diseases",P01AR02,difetarsone,1
C1327841,IN,hexyl 5-aminolevulinate,V04CX06,hexaminolevulinate,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CX,Other diagnostic agents in ATC,V04CX06,hexaminolevulinate,2
C1328025,IN,pertuzumab,L01FD02,pertuzumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FD,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,L01FD02,pertuzumab,4
C1328071,IN,methoxy polyethylene glycol-epoetin beta,B03XA03,methoxy polyethylene glycol-epoetin beta,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03X,OTHER ANTIANEMIC PREPARATIONS in ATC,B03XA,Other antianemic preparations in ATC,B03XA03,methoxy polyethylene glycol-epoetin beta,4
C1337242,IN,cinacalcet,H05BX01,cinacalcet,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BX,Other anti-parathyroid agents in ATC,H05BX01,cinacalcet,60
C1367202,IN,ipilimumab,L01FX04,ipilimumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FX,Other monoclonal antibodies and antibody drug conjugates in ATC,L01FX04,ipilimumab,30
C1377670,IN,melitracen,N06AA14,melitracen,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AA,Non-selective monoamine reuptake inhibitors,N06AA14,melitracen,2
C1434792,IN,ibalizumab,J05AX23,ibalizumab,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX23,ibalizumab,1
C1434916,,,G01AX17,dapivirine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G01,GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,G01A,"ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",G01AX,Other gynecological antiinfectives and antiseptics in ATC,G01AX17,dapivirine,34
C1435444,IN,darunavir,J05AE10,darunavir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,"Protease inhibitors, direct acting antivirals",J05AE10,darunavir,80
C1436328,IN,eszopiclone,N05CF04,eszopiclone,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CF,Benzodiazepine related hypnotics and sedatives,N05CF04,eszopiclone,22
C1445578,,,M05BC01,dibotermin alfa,M,MUSCULO-SKELETAL SYSTEM DRUGS,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BC,Bone morphogenetic proteins,M05BC01,dibotermin alfa,91
C1445625,,,M05BC02,eptotermin alfa,M,MUSCULO-SKELETAL SYSTEM DRUGS,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BC,Bone morphogenetic proteins,M05BC02,eptotermin alfa,22
C1451502,IN,tafluprost,S01EE05,tafluprost,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EE,"Prostaglandin analogues, antiglaucoma drugs and miotics",S01EE05,tafluprost,1
C1451975,IN,arimoclomol,N07XX17,arimoclomol,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07X,OTHER NERVOUS SYSTEM DRUGS in ATC,N07XX,Other nervous system drugs in ATC,N07XX17,arimoclomol,1
C1453642,IN,telavancin,J01XA03,telavancin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XA,Glycopeptide antibacterials,J01XA03,telavancin,5
C1453933,IN,telbivudine,J05AF11,telbivudine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,J05AF11,telbivudine,79
C1455035,IN,degarelix,L02BX02,degarelix,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02B,HORMONE ANTAGONISTS AND RELATED AGENTS,L02BX,Other hormone antagonists and related agents in ATC,L02BX02,degarelix,3
C1455147,IN,dasatinib,L01EA02,dasatinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EA,BCR-ABL tyrosine kinase inhibitors,L01EA02,dasatinib,114
C1456408,IN,liraglutide,A10BJ02,liraglutide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,A10BJ02,liraglutide,49
C1456409,IN,etravirine,J05AG04,etravirine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AG,Non-nucleoside reverse transcriptase inhibitors,J05AG04,etravirine,45
C1506770,IN,lapatinib,L01EH01,lapatinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EH,Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors,L01EH01,lapatinib,10
C1507354,,,J01MA19,garenoxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA19,garenoxacin,5
C1508759,IN,maribavir,J05AX10,maribavir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX10,maribavir,6
C1516119,IN,sorafenib,L01EX02,sorafenib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX02,sorafenib,334
C1527027,IN,romidepsin,L01XH02,romidepsin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XH,Histone deacetylase (HDAC) inhibitors,L01XH02,romidepsin,1
C1530072,IN,vilazodone,N06AX24,vilazodone,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX24,vilazodone,12
C1530889,IN,teduglutide,A16AX08,teduglutide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX08,teduglutide,17
C1531015,IN,pegaptanib,S01LA03,pegaptanib,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01L,OCULAR VASCULAR DISORDER AGENTS,S01LA,Antineovascularisation agents,S01LA03,pegaptanib,11
C1533126,IN,milnacipran,N06AX17,milnacipran,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX17,milnacipran,4
C1533699,IN,gemtuzumab ozogamicin,L01FX02,gemtuzumab ozogamicin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FX,Other monoclonal antibodies and antibody drug conjugates in ATC,L01FX02,gemtuzumab ozogamicin,61
C1541483,IN,eculizumab,L04AJ01,eculizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AJ,Complement inhibitors,L04AJ01,eculizumab,369
C1541591,,,V10XA03,iodine (131I) omburtamab,V,VARIOUS DRUG CLASSES IN ATC,V10,THERAPEUTIC RADIOPHARMACEUTICALS,V10X,OTHER THERAPEUTIC RADIOPHARMACEUTICALS in ATC,V10XA,Iodine (131I) compounds,V10XA03,iodine (131I) omburtamab,1
C1565316,IN,ramelteon,N05CH02,ramelteon,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CH,"Melatonin receptor agonists, hypnotics and sedatives",N05CH02,ramelteon,10
C1565750,IN,sitagliptin,A10BH01,sitagliptin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering,A10BH01,sitagliptin,18
C1566537,IN,ranibizumab,S01LA04,ranibizumab,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01L,OCULAR VASCULAR DISORDER AGENTS,S01LA,Antineovascularisation agents,S01LA04,ranibizumab,210
C1566826,IN,rilpivirine,J05AG05,rilpivirine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AG,Non-nucleoside reverse transcriptase inhibitors,J05AG05,rilpivirine,43
C1567130,IN,inotuzumab ozogamicin,L01FB01,inotuzumab ozogamicin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FB,CD22 (Clusters of Differentiation 22) inhibitors,L01FB01,inotuzumab ozogamicin,23
C1569608,IN,varenicline,N07BA03,varenicline,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07B,DRUGS USED IN ADDICTIVE DISORDERS,N07BA,Drugs used in nicotine dependence,N07BA03,varenicline,22
C1569608,IN,varenicline,S01XA28,varenicline,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA28,varenicline,22
C1570906,IN,vildagliptin,A10BH02,vildagliptin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering,A10BH02,vildagliptin,2
C1571583,IN,dabigatran etexilate,B01AE07,dabigatran etexilate,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AE,Direct thrombin inhibitors,B01AE07,dabigatran etexilate,13
C1608295,IN,articaine,N01BB08,articaine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01B,LOCAL ANESTHETICS,N01BB,Amide local anesthetics,N01BB08,articaine,61
C1608841,IN,ustekinumab,L04AC05,ustekinumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC05,ustekinumab,117
C1609165,IN,tocilizumab,L04AC07,tocilizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC07,tocilizumab,306
C1609931,IN,siltuximab,L04AC11,siltuximab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC11,siltuximab,6
C1611088,IN,calcium carbimide,N07BB02,calcium carbimide,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07B,DRUGS USED IN ADDICTIVE DISORDERS,N07BB,Drugs used in alcohol dependence,N07BB02,calcium carbimide,1
C1611934,IN,saxagliptin,A10BH03,saxagliptin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering,A10BH03,saxagliptin,2
C1615657,IN,galsulfase,A16AB08,galsulfase,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB08,galsulfase,18
C1619629,IN,deferasirox,V03AC03,deferasirox,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AC,Iron chelating agents,V03AC03,deferasirox,246
C1619962,IN,belatacept,L04AA28,belatacept,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AA,Selective immunosuppressants,L04AA28,belatacept,13
C1619966,IN,abatacept,L04AA24,abatacept,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AA,Selective immunosuppressants,L04AA24,abatacept,129
C1620287,IN,prasugrel,B01AC22,prasugrel,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC22,prasugrel,10
C1622308,,,J01DI01,ceftobiprole medocaril,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DI,Other cephalosporins and penems in ATC,J01DI01,ceftobiprole medocaril,1
C1664205,IN,bedaquiline,J04AK05,bedaquiline,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AK,Other drugs for treatment of tuberculosis in ATC,J04AK05,bedaquiline,33
C1667052,IN,maraviroc,J05AX09,maraviroc,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX09,maraviroc,28
C1675326,IN,peramivir,J05AH03,peramivir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AH,"Neuraminidase inhibitors, direct acting antivirals",J05AH03,peramivir,43
C1678805,IN,apremilast,L04AA32,apremilast,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AA,Selective immunosuppressants,L04AA32,apremilast,7
C1684405,IN,lubiprostone,A06AX03,lubiprostone,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AX,Other drugs for constipation in ATC,A06AX03,lubiprostone,4
C1690432,IN,denosumab,M05BX04,denosumab,M,MUSCULO-SKELETAL SYSTEM DRUGS,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BX,Other drugs affecting bone structure and mineralization in ATC,M05BX04,denosumab,109
C1695579,IN,alglucosidase alfa,A16AB07,alglucosidase alfa,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB07,alglucosidase alfa,283
C1696547,IN,mecasermin rinfabate,H01AC05,mecasermin rinfabate,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,H01AC05,mecasermin rinfabate,6
C1698215,IN,regadenoson,C01EB21,regadenoson,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01E,OTHER CARDIAC PREPARATIONS in ATC,C01EB,Other plain cardiac preparations in ATC,C01EB21,regadenoson,9
C1698364,,,L01EK02,cediranib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EK,Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors,L01EK02,cediranib,8
C1698893,IN,gadofosveset,V08CA11,gadofosveset,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08C,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,V08CA,Paramagnetic contrast media,V08CA11,gadofosveset,11
C1699861,IN,brivaracetam,N03AX23,brivaracetam,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX23,brivaracetam,35
C1699926,IN,fingolimod,L04AE01,fingolimod,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AE,Sphingosine-1-phosphate (S1P) receptor modulators,L04AE01,fingolimod,70
C1700683,IN,rotigotine,N04BC09,rotigotine,N,NERVOUS SYSTEM DRUGS,N04,ANTI-PARKINSON DRUGS,N04B,DOPAMINERGIC AGENTS,N04BC,Dopamine agonists,N04BC09,rotigotine,5
C1700695,IN,sugammadex,V03AB35,sugammadex,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB35,sugammadex,82
C1700874,IN,axitinib,L01EK01,axitinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EK,Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors,L01EK01,axitinib,7
C1701455,IN,armodafinil,N06BA13,armodafinil,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BA,Centrally acting sympathomimetics,N06BA13,armodafinil,57
C1703334,IN,retapamulin,D06AX13,retapamulin,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AX,Other antibiotics for topical use in ATC,D06AX13,retapamulin,17
C1704271,,,C02KX03,sitaxentan,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02K,OTHER ANTIHYPERTENSIVES in ATC,C02KX,Antihypertensives for pulmonary arterial hypertension,C02KX03,sitaxentan,6
C1707080,IN,temsirolimus,L01EG01,temsirolimus,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EG,Mammalian target of rapamycin (mTOR) kinase inhibitors (L01EG),L01EG01,temsirolimus,25
C1718383,IN,teriflunomide,L04AK02,teriflunomide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AK,Dihydroorotate dehydrogenase (DHODH) inhibitors,L04AK02,teriflunomide,25
C1721268,,,C04AX33,clazosentan,C,CARDIOVASCULAR SYSTEM DRUGS,C04,PERIPHERAL VASODILATORS,C04A,PERIPHERAL VASODILATORS,C04AX,Other peripheral vasodilators in ATC,C04AX33,clazosentan,1
C1721300,IN,pralatrexate,L01BA05,pralatrexate,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01B,ANTIMETABOLITES,L01BA,"Folic acid analogs, antimetabolites",L01BA05,pralatrexate,1
C1721377,IN,nilotinib,L01EA03,nilotinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EA,BCR-ABL tyrosine kinase inhibitors,L01EA03,nilotinib,41
C1722260,IN,indacaterol,R03AC18,indacaterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC18,indacaterol,14
C1722267,IN,pimavanserin,N05AX17,pimavanserin,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AX,Other antipsychotics in ATC,N05AX17,pimavanserin,1
C1722685,IN,ecallantide,B06AC03,ecallantide,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B06,OTHER HEMATOLOGICAL AGENTS in ATC,B06A,OTHER HEMATOLOGICAL AGENTS in ATC,B06AC,Drugs used in hereditary angioedema,B06AC03,ecallantide,9
C1723401,IN,belimumab,L04AG04,belimumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AG,Monoclonal antibodies,L04AG04,belimumab,31
C1738934,IN,boceprevir,J05AP03,boceprevir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,J05AP03,boceprevir,4
C1739462,IN,idursulfase,A16AB09,idursulfase,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB09,idursulfase,107
C1739768,IN,rivaroxaban,B01AF01,rivaroxaban,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AF,Direct factor Xa inhibitors,B01AF01,rivaroxaban,81
C1742789,,,G04BE11,udenafil,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BE,Drugs used in erectile dysfunction,G04BE11,udenafil,6
C1744278,,,V09IX07,fluorocholine (18F),V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09I,TUMOUR DETECTION RADIOPHARMACEUTICALS,V09IX,Other diagnostic radiopharmaceuticals for tumour detection in ATC,V09IX07,fluorocholine (18F),2
C1831729,,,V09IX10,fluoroethyl-L-tyrosine (18F),V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09I,TUMOUR DETECTION RADIOPHARMACEUTICALS,V09IX,Other diagnostic radiopharmaceuticals for tumour detection in ATC,V09IX10,fluoroethyl-L-tyrosine (18F),4
C1831731,IN,bosutinib,L01EA04,bosutinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EA,BCR-ABL tyrosine kinase inhibitors,L01EA04,bosutinib,8
C1831796,IN,pazopanib,L01EX03,pazopanib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX03,pazopanib,27
C1831808,IN,apixaban,B01AF02,apixaban,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AF,Direct factor Xa inhibitors,B01AF02,apixaban,36
C1831905,IN,eltrombopag,B02BX05,eltrombopag,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BX,Other systemic hemostatics in ATC,B02BX05,eltrombopag,115
C1832021,IN,isavuconazole,J02AC05,isavuconazole,J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AC,Triazole and tetrazole derivatives,J02AC05,isavuconazole,21
C1832027,IN,ofatumumab,L01FA02,ofatumumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FA,CD20 (Clusters of Differentiation 20) inhibitors,L01FA02,ofatumumab,26
C1832027,IN,ofatumumab,L04AG12,ofatumumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AG,Monoclonal antibodies,L04AG12,ofatumumab,26
C1869620,IN,reslizumab,R03DX08,reslizumab,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DX,Other systemic drugs for obstructive airway diseases in ATC,R03DX08,reslizumab,17
C1870115,IN,silodosin,G04CA04,silodosin,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04C,DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,G04CA,"Alpha-adrenoreceptor antagonists, benign prostatic hypertrophy",G04CA04,silodosin,4
C1871526,IN,raltegravir,J05AJ01,raltegravir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AJ,"Integrase Inhibitors, antiinfectives for systematic use",J05AJ01,raltegravir,98
C1872109,IN,certolizumab pegol,L04AB05,certolizumab pegol,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AB,Tumor necrosis factor alpha (TNF-alpha) inhibitors,L04AB05,certolizumab pegol,45
C1872203,IN,pasireotide,H01CB05,pasireotide,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CB,Somatostatin and analogues,H01CB05,pasireotide,5
C1873633,IN,lisdexamfetamine,N06BA12,lisdexamfetamine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06B,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",N06BA,Centrally acting sympathomimetics,N06BA12,lisdexamfetamine,120
C1876200,IN,tesamorelin,H01AC06,tesamorelin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,H01AC06,tesamorelin,6
C1876229,IN,telaprevir,J05AP02,telaprevir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,J05AP02,telaprevir,7
C1880288,IN,desvenlafaxine,N06AX23,desvenlafaxine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX23,desvenlafaxine,31
C1882138,IN,ocrelizumab,L04AG08,ocrelizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AG,Monoclonal antibodies,L04AG08,ocrelizumab,15
C1948374,PIN,fluticasone furoate,R01AD12,fluticasone furoate,R,RESPIRATORY SYSTEM DRUGS,R01,NASAL PREPARATIONS,R01A,DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,R01AD,Corticosteroid nasal preparations for topical use,R01AD12,fluticasone furoate,66
C1948374,PIN,fluticasone furoate,R03BA09,fluticasone furoate,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03B,"OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS in ATC",R03BA,Glucocorticoid inhalants for obstructive airway disease,R03BA09,fluticasone furoate,66
C1955474,IN,plerixafor,L03AX16,plerixafor,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AX,Other immunostimulants in ATC,L03AX16,plerixafor,51
C1955479,,,S01XA33,diquafosol,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA33,diquafosol,2
C1956280,IN,luliconazole,D01AC18,luliconazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC18,luliconazole,2
C1958126,IN,alogliptin,A10BH04,alogliptin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering,A10BH04,alogliptin,5
C1958300,,,L01XK05,veliparib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XK,Poly (ADP-ribose) polymerase (PARP) inhibitors,L01XK05,veliparib,3
C1960121,IN,sinecatechins,D06BB12,sinecatechins,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,D06BB,"Antivirals, topical",D06BB12,sinecatechins,4
C1961852,IN,somatorelin,V04CD05,somatorelin,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CD,pituitary function test diagnostic agents,V04CD05,somatorelin,4
C1998098,IN,panobinostat,L01XH03,panobinostat,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XH,Histone deacetylase (HDAC) inhibitors,L01XH03,panobinostat,12
C1999375,IN,ticagrelor,B01AC24,ticagrelor,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC24,ticagrelor,15
C2000088,IN,asenapine,N05AH05,asenapine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AH,"Diazepines, oxazepines, thiazepines and oxepines antipsychotic drugs",N05AH05,asenapine,10
C2000145,IN,selexipag,B01AC27,selexipag,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC27,selexipag,21
C2000261,IN,linaclotide,A06AX04,linaclotide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AX,Other drugs for constipation in ATC,A06AX04,linaclotide,1
C2001271,IN,tapentadol,N02AX06,tapentadol,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02A,OPIOID ANALGESICS,N02AX,Other opioids in ATC,N02AX06,tapentadol,17
C2001525,IN,ceftaroline fosamil,J01DI02,ceftaroline fosamil,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DI,Other cephalosporins and penems in ATC,J01DI02,ceftaroline fosamil,37
C2001572,,,C01BG11,vernakalant,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01B,"ANTIARRHYTHMICS, CLASS I AND III",C01BG,"Other antiarrhythmics, class I and III in ATC",C01BG11,vernakalant,1
C2001856,IN,carfilzomib,L01XG02,carfilzomib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XG,"Proteasome inhibitors, antineoplastic agent",L01XG02,carfilzomib,7
C2003424,IN,lurasidone,N05AE05,lurasidone,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AE,"Indole derivatives, antipsychotic",N05AE05,lurasidone,25
C2316164,IN,olaparib,L01XK01,olaparib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XK,Poly (ADP-ribose) polymerase (PARP) inhibitors,L01XK01,olaparib,11
C2343589,IN,rilonacept,L04AC04,rilonacept,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC04,rilonacept,12
C2343853,IN,fesoterodine,G04BD11,fesoterodine,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BD,Drugs for urinary frequency and incontinence,G04BD11,fesoterodine,5
C2346801,IN,daratumumab,L01FC01,daratumumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FC,CD38 (Clusters of Differentiation 38) inhibitors,L01FC01,daratumumab,17
C2346819,,,N02BG12,tanezumab,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02B,OTHER ANALGESICS AND ANTIPYRETICS in ATC,N02BG,Other analgesics and antipyretics in ATC,N02BG12,tanezumab,2
C2346970,IN,bazedoxifene,G03XC02,bazedoxifene,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03X,OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC,G03XC,Selective estrogen receptor modulators,G03XC02,bazedoxifene,1
C2347624,IN,pomalidomide,L04AX06,pomalidomide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AX,Other immunosuppressants in ATC,L04AX06,pomalidomide,3
C2348241,IN,alcaftadine,S01GX11,alcaftadine,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01G,DECONGESTANTS AND ANTIALLERGICS,S01GX,Other antiallergics in ATC,S01GX11,alcaftadine,1
C2348248,IN,dexlansoprazole,A02BC06,dexlansoprazole,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors for peptic ulcer and GORD,A02BC06,dexlansoprazole,5
C2350866,IN,eribulin,L01XX41,eribulin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX41,eribulin,6
C2350948,IN,lorcaserin,A08AA11,lorcaserin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,A08AA11,lorcaserin,1
C2351038,IN,tremelimumab,L01FX20,tremelimumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FX,Other monoclonal antibodies and antibody drug conjugates in ATC,L01FX20,tremelimumab,2
C2351042,IN,besifloxacin,S01AE08,besifloxacin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AE,"Fluoroquinolone antiinfectives, ophthalmologic",S01AE08,besifloxacin,11
C2351398,,,L01EX06,masitinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX06,masitinib,1
C2353893,IN,golimumab,L04AB06,golimumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AB,Tumor necrosis factor alpha (TNF-alpha) inhibitors,L04AB06,golimumab,46
C2353951,IN,dapagliflozin,A10BK01,dapagliflozin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,A10BK01,dapagliflozin,15
C2364481,IN,romiplostim,B02BX04,romiplostim,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BX,Other systemic hemostatics in ATC,B02BX04,romiplostim,68
C2366367,PIN,C1 esterase inhibitor (human),B06AC01,"c1-inhibitor, plasma derived",B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B06,OTHER HEMATOLOGICAL AGENTS in ATC,B06A,OTHER HEMATOLOGICAL AGENTS in ATC,B06AC,Drugs used in hereditary angioedema,B06AC01,"c1-inhibitor, plasma derived",235
C2587184,PIN,"fibrinogen, human",B02BB01,"fibrinogen, human",B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BB,Fibrinogen containing hemostatics,B02BB01,"fibrinogen, human",2917
C2587204,IN,thyrotropin alfa,H01AB01,thyrotropin alfa,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AB,Thyrotropin Class in ATC,H01AB01,thyrotropin alfa,48
C2603873,,,L03AB12,albinterferon alfa-2b,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AB,Interferons,L03AB12,albinterferon alfa-2b,1
C2604598,IN,triheptanoin,A16AX17,triheptanoin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX17,triheptanoin,26
C2604635,IN,mipomersen,C10AX11,mipomersen,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AX,Other lipid modifying agents in ATC,C10AX11,mipomersen,4
C2605855,IN,simeprevir,J05AP05,simeprevir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,J05AP05,simeprevir,22
C2606556,IN,macitentan,C02KX04,macitentan,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02K,OTHER ANTIHYPERTENSIVES in ATC,C02KX,Antihypertensives for pulmonary arterial hypertension,C02KX04,macitentan,16
C2606637,IN,elvitegravir,J05AJ02,elvitegravir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AJ,"Integrase Inhibitors, antiinfectives for systematic use",J05AJ02,elvitegravir,24
C2607479,IN,albiglutide,A10BJ04,albiglutide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,A10BJ04,albiglutide,1
C2697961,IN,trametinib,L01EE01,trametinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EE,Mitogen-activated protein kinase (MEK) inhibitors,L01EE01,trametinib,68
C2698152,IN,olaratumab,L01FX10,olaratumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FX,Other monoclonal antibodies and antibody drug conjugates in ATC,L01FX10,olaratumab,2
C2698220,IN,migalastat,A16AX14,migalastat,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX14,migalastat,1
C2698291,PIN,azilsartan medoxomil,C09CA09,azilsartan medoxomil,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09C,"ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN",C09CA,"Angiotensin II receptor blockers (ARBs), plain",C09CA09,azilsartan medoxomil,4
C2698692,IN,idelalisib,L01EM01,idelalisib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EM,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,L01EM01,idelalisib,1
C2698764,IN,perampanel,N03AX22,perampanel,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX22,perampanel,131
C2699709,IN,calaspargase pegol,L01XX86,calaspargase pegol,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX86,calaspargase pegol,4
C2699902,,,J01DH06,tebipenem pivoxil,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DH,Carbapenems,J01DH06,tebipenem pivoxil,13
C2713007,,,L01EG03,ridaforolimus,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EG,Mammalian target of rapamycin (mTOR) kinase inhibitors (L01EG),L01EG03,ridaforolimus,4
C2713522,,,G03GA09,corifollitropin alfa,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03G,GONADOTROPINS AND OTHER OVULATION STIMULANTS,G03GA,Gonadotropins,G03GA09,corifollitropin alfa,29
C2713595,IN,tecovirimat,J05AX24,tecovirimat,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX24,tecovirimat,4
C2713599,,,J06BD02,motavizumab,J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BD,Antiviral monoclonal antibodies,J06BD02,motavizumab,9
C2714632,IN,elagolix,H01CC03,elagolix,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CC,Anti-gonadotropin-releasing hormones,H01CC03,elagolix,2
C2714681,,,M01AE14,dexibuprofen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M01,ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,M01A,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",M01AE,"Propionic acid derivatives, antiinflammatory and antirheumatic products",M01AE14,dexibuprofen,6
C2717021,IN,moxetumomab pasudotox,L01FB02,moxetumomab pasudotox,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FB,CD22 (Clusters of Differentiation 22) inhibitors,L01FB02,moxetumomab pasudotox,2
C2717174,IN,raxibacumab,J06BC02,raxibacumab,J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BC,Antibacterial monoclonal antibodies,J06BC02,raxibacumab,1
C2717561,IN,riociguat,C02KX05,riociguat,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02K,OTHER ANTIHYPERTENSIVES in ATC,C02KX,Antihypertensives for pulmonary arterial hypertension,C02KX05,riociguat,9
C2718773,IN,canakinumab,L04AC08,canakinumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC08,canakinumab,137
C2725260,IN,eslicarbazepine,N03AF04,eslicarbazepine,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AF,"Carboxamide derivatives, antiepileptics",N03AF04,eslicarbazepine,10
C2742502,IN,ramucirumab,L01FG02,ramucirumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FG,VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitors,L01FG02,ramucirumab,19
C2742503,IN,obinutuzumab,L01FA03,obinutuzumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FA,CD20 (Clusters of Differentiation 20) inhibitors,L01FA03,obinutuzumab,5
C2742797,IN,vedolizumab,L04AG05,vedolizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AG,Monoclonal antibodies,L04AG05,vedolizumab,89
C2743673,IN,teplizumab,A10XX01,teplizumab,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10X,OTHER DRUGS USED IN DIABETES in ATC,A10XX,Other drugs used in diabetes in ATC,A10XX01,teplizumab,10
C2743752,,,L01XH05,entinostat,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XH,Histone deacetylase (HDAC) inhibitors,L01XH05,entinostat,3
C2744440,IN,niraparib,L01XK02,niraparib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XK,Poly (ADP-ribose) polymerase (PARP) inhibitors,L01XK02,niraparib,1
C2744850,IN,tedizolid,J01XX11,tedizolid,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XX,Other antibacterials in ATC,J01XX11,tedizolid,9
C2745274,IN,tafamidis,N07XX08,tafamidis,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07X,OTHER NERVOUS SYSTEM DRUGS in ATC,N07XX,Other nervous system drugs in ATC,N07XX08,tafamidis,1
C2746063,IN,imetelstat,L01XX80,imetelstat,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX80,imetelstat,4
C2746078,IN,linagliptin,A10BH05,linagliptin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering,A10BH05,linagliptin,6
C2756957,PIN,"lymphocyte immune globulin, anti-thymocyte globulin, equine",L04AA03,antilymphocyte immunoglobulin (horse),L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AA,Selective immunosuppressants,L04AA03,antilymphocyte immunoglobulin (horse),32
C2825327,PIN,aceneuramic acid,M09AX05,aceneuramic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AX,Other drugs for disorders of the musculo-skeletal system in ATC,M09AX05,aceneuramic acid,1
C2825616,IN,esketamine,N01AX14,esketamine,N,NERVOUS SYSTEM DRUGS,N01,ANESTHETICS,N01A,"ANESTHETICS, GENERAL",N01AX,Other general anesthetics in ATC,N01AX14,esketamine,1664
C2825616,IN,esketamine,N06AX27,esketamine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX27,esketamine,1664
C2827093,IN,butylscopolamine,A03BB01,butylscopolamine,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03B,"BELLADONNA AND DERIVATIVES CONTAINING DRUGS, PLAIN FOR FUNCTIONAL GASTROINTESTINAL DISORDERS",A03BB,"Belladonna alkaloids, semisynthetic, quaternary ammonium compounds for functional gastrointestinal disorders",A03BB01,butylscopolamine,1
C2827241,IN,lomitapide,C10AX12,lomitapide,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AX,Other lipid modifying agents in ATC,C10AX12,lomitapide,13
C2828290,IN,delafloxacin,J01MA23,delafloxacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,"Fluoroquinolone antibacterials, systemic",J01MA23,delafloxacin,3
C2828299,,,P01BE05,artenimol,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P01,ANTIPROTOZOALS,P01B,ANTIMALARIALS,P01BE,"Artemisinin and derivatives, plain",P01BE05,artenimol,379
C2830183,IN,cabazitaxel,L01CD04,cabazitaxel,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01C,"PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS, ANTINEOPLASTIC DRUGS",L01CD,"Taxanes, antineoplastic",L01CD04,cabazitaxel,2
C2919267,IN,velaglucerase alfa,A16AB10,velaglucerase alfa,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB10,velaglucerase alfa,16
C2930041,MIN,ampicillin / sulbactam,J01CR04,sultamicillin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CR,"Combinations of penicillins, incl. beta-lactamase inhibitors",J01CR04,sultamicillin,42
C2930696,IN,tofacitinib,L04AF01,tofacitinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AF,Janus-associated kinase (JAK) inhibitors (L04AF),L04AF01,tofacitinib,57
C2930764,,,M09AX03,ataluren,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AX,Other drugs for disorders of the musculo-skeletal system in ATC,M09AX03,ataluren,19
C2930789,IN,nintedanib,L01EX09,nintedanib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX09,nintedanib,9
C2931926,IN,ruxolitinib,D11AH09,ruxolitinib,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AH,"Agents for dermatitis, excluding corticosteroids",D11AH09,ruxolitinib,95
C2931926,IN,ruxolitinib,L01EJ01,ruxolitinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EJ,Janus-associated kinase (JAK) inhibitors (L01EJ),L01EJ01,ruxolitinib,95
C2931958,,,J05AH04,laninamivir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AH,"Neuraminidase inhibitors, direct acting antivirals",J05AH04,laninamivir,40
C2932035,,,C01CX10,omecamtiv mecarbil,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01C,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,C01CX,Other cardiac stimulants in ATC,C01CX10,omecamtiv mecarbil,1
C2932486,,,L01XH06,tucidinostat,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XH,Histone deacetylase (HDAC) inhibitors,L01XH06,tucidinostat,4
C2934004,IN,fosdenopterin,A16AX19,fosdenopterin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX19,fosdenopterin,3
C2934193,IN,olodaterol,R03AC19,olodaterol,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03A,"ADRENERGICS, INHALANTS",R03AC,Selective beta-2-adrenoreceptor agonist inhalants,R03AC19,olodaterol,1
C2934701,IN,ponesimod,L04AE04,ponesimod,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AE,Sphingosine-1-phosphate (S1P) receptor modulators,L04AE04,ponesimod,2
C2935131,,,L01XH07,resminostat,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XH,Histone deacetylase (HDAC) inhibitors,L01XH07,resminostat,1
C2935436,PIN,ado-trastuzumab emtansine,L01FD03,trastuzumab emtansine,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FD,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,L01FD03,trastuzumab emtansine,3
C2936870,IN,cariprazine,N05AX15,cariprazine,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AX,Other antipsychotics in ATC,N05AX15,cariprazine,5
C2973446,IN,brentuximab vedotin,L01FX05,brentuximab vedotin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FX,Other monoclonal antibodies and antibody drug conjugates in ATC,L01FX05,brentuximab vedotin,57
C2973895,IN,lixisenatide,A10BJ03,lixisenatide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,A10BJ03,lixisenatide,2
C2974289,IN,crizotinib,L01ED01,crizotinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01ED,Anaplastic lymphoma kinase (ALK) inhibitors,L01ED01,crizotinib,66
C2974521,IN,vorapaxar,B01AC26,vorapaxar,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AC,Platelet aggregation inhibitors excl. heparin,B01AC26,vorapaxar,1
C2974540,IN,canagliflozin,A10BK02,canagliflozin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,A10BK02,canagliflozin,5
C2975395,,,L01XX78,navitoclax,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX78,navitoclax,3
C2975435,IN,edoxaban,B01AF03,edoxaban,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AF,Direct factor Xa inhibitors,B01AF03,edoxaban,17
C2976303,IN,sofosbuvir,J05AP08,sofosbuvir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,J05AP08,sofosbuvir,154
C2980074,IN,selumetinib,L01EE04,selumetinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EE,Mitogen-activated protein kinase (MEK) inhibitors,L01EE04,selumetinib,45
C2980091,IN,quizartinib,L01EX11,quizartinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX11,quizartinib,2
C2980094,IN,regorafenib,L01EX05,regorafenib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX05,regorafenib,27
C2981308,,,A10BH08,teneligliptin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BH,Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering,A10BH08,teneligliptin,2
C2981360,IN,lebrikizumab,D11AH10,lebrikizumab,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AH,"Agents for dermatitis, excluding corticosteroids",D11AH10,lebrikizumab,8
C2982078,IN,benralizumab,R03DX10,benralizumab,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DX,Other systemic drugs for obstructive airway diseases in ATC,R03DX10,benralizumab,24
C2983812,IN,mirabegron,G04BD12,mirabegron,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BD,Drugs for urinary frequency and incontinence,G04BD12,mirabegron,21
C2983838,IN,omadacycline,J01AA15,omadacycline,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,Tetracycline antibiotics,J01AA,Tetracyclines,J01AA15,omadacycline,2
C2983945,IN,ozenoxacin,D06AX14,ozenoxacin,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AX,Other antibiotics for topical use in ATC,D06AX14,ozenoxacin,10
C2986924,IN,lenvatinib,L01EX08,lenvatinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX08,lenvatinib,69
C2987417,IN,ponatinib,L01EA05,ponatinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EA,BCR-ABL tyrosine kinase inhibitors,L01EA05,ponatinib,13
C2987429,IN,teprotumumab,L04AG13,teprotumumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AG,Monoclonal antibodies,L04AG13,teprotumumab,1
C2987430,IN,dacomitinib,L01EB07,dacomitinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EB,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,L01EB07,dacomitinib,2
C2987603,IN,mogamulizumab,L01FX09,mogamulizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FX,Other monoclonal antibodies and antibody drug conjugates in ATC,L01FX09,mogamulizumab,2
C2987648,IN,afatinib,L01EB03,afatinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EB,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,L01EB03,afatinib,3
C2987670,IN,givinostat,M09AX14,givinostat,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AX,Other drugs for disorders of the musculo-skeletal system in ATC,M09AX14,givinostat,3
C2987716,IN,vismodegib,L01XJ01,vismodegib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XJ,Hedgehog pathway inhibitors,L01XJ01,vismodegib,8
C3177235,IN,cobicistat,V03AX03,cobicistat,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AX,Other therapeutic products in ATC,V03AX03,cobicistat,27
C3179470,IN,remimazolam,N05CD14,remimazolam,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CD,Benzodiazepine derivative hypnotics and sedatives,N05CD14,remimazolam,17
C3179535,IN,suvorexant,N05CJ01,suvorexant,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CJ,Orexin receptor antagonists,N05CJ01,suvorexant,3
C3179547,IN,secukinumab,L04AC10,secukinumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC10,secukinumab,32
C3179549,IN,dulaglutide,A10BJ05,dulaglutide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,A10BJ05,dulaglutide,5
C3181682,IN,cabozantinib,L01EX07,cabozantinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX07,cabozantinib,23
C3192263,IN,vemurafenib,L01EC01,vemurafenib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EC,B-Raf serine-threonine kinase (BRAF) inhibitors,L01EC01,vemurafenib,40
C3195420,PIN,C1 esterase inhibitor (recombinant),B06AC04,conestat alfa,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B06,OTHER HEMATOLOGICAL AGENTS in ATC,B06A,OTHER HEMATOLOGICAL AGENTS in ATC,B06AC,Drugs used in hereditary angioedema,B06AC04,conestat alfa,6
C3252090,IN,daclatasvir,J05AP07,daclatasvir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,J05AP07,daclatasvir,49
C3253985,IN,dolutegravir,J05AJ03,dolutegravir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AJ,"Integrase Inhibitors, antiinfectives for systematic use",J05AJ03,dolutegravir,163
C3254591,IN,infigratinib,L01EN03,infigratinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EN,Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors,L01EN03,infigratinib,1
C3264621,IN,ivacaftor,R07AX02,ivacaftor,R,RESPIRATORY SYSTEM DRUGS,R07,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07A,OTHER RESPIRATORY SYSTEM PRODUCTS in ATC,R07AX,Other respiratory system products in ATC,R07AX02,ivacaftor,218
C3272344,PIN,lutetium Lu 177 dotatate,V10XX04,lutetium (177Lu) oxodotreotide,V,VARIOUS DRUG CLASSES IN ATC,V10,THERAPEUTIC RADIOPHARMACEUTICALS,V10X,OTHER THERAPEUTIC RADIOPHARMACEUTICALS in ATC,V10XX,Various therapeutic radiopharmaceuticals,V10XX04,lutetium (177Lu) oxodotreotide,4
C3272698,IN,eliglustat,A16AX10,eliglustat,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX10,eliglustat,7
C3273401,IN,taliglucerase alfa,A16AB11,taliglucerase alfa,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB11,taliglucerase alfa,5
C3273754,IN,efinaconazole,D01AC19,efinaconazole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AC,"Imidazole and triazole derivatives, topical antifungals",D01AC19,efinaconazole,3
C3464497,IN,varicella-zoster virus vaccine live (Oka-Merck) strain,J07BK01,"varicella, live attenuated",J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BK,Varicella zoster vaccines,J07BK01,"varicella, live attenuated",1017
C3467876,IN,dabrafenib,L01EC02,dabrafenib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EC,B-Raf serine-threonine kinase (BRAF) inhibitors,L01EC02,dabrafenib,39
C3489483,,,V08CA10,gadoxetic acid,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08C,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,V08CA,Paramagnetic contrast media,V08CA10,gadoxetic acid,63
C3489575,IN,"sennosides, USP",A06AB06,senna glycosides,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AB,Contact laxatives,A06AB06,senna glycosides,38
C3489682,,,J04AK06,delamanid,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AK,Other drugs for treatment of tuberculosis in ATC,J04AK06,delamanid,21
C3489764,IN,ixekizumab,L04AC13,ixekizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC13,ixekizumab,9
C3490329,IN,glycerol phenylbutyrate,A16AX09,glycerol phenylbutyrate,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX09,glycerol phenylbutyrate,24
C3490348,IN,empagliflozin,A10BK03,empagliflozin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,A10BK03,empagliflozin,22
C3490795,IN,asfotase alfa,A16AB13,asfotase alfa,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB13,asfotase alfa,55
C3491162,IN,alirocumab,C10AX14,alirocumab,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AX,Other lipid modifying agents in ATC,C10AX14,alirocumab,6
C3491331,IN,brodalumab,L04AC12,brodalumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC12,brodalumab,2
C3491971,IN,insulin degludec,A10AE06,insulin degludec,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10A,INSULINS AND ANALOGUES,A10AE,"Insulins and analogues for injection, long-acting",A10AE06,insulin degludec,28
C3491974,IN,asunaprevir,J05AP06,asunaprevir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,J05AP06,asunaprevir,3
C3492889,,,A10BK05,ipragliflozin,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BK,Sodium-glucose co-transporter 2 (SGLT2) inhibitors,A10BK05,ipragliflozin,1
C3496793,IN,enzalutamide,L02BB04,enzalutamide,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02B,HORMONE ANTAGONISTS AND RELATED AGENTS,L02BB,Anti-androgen hormone antagonists and related agents,L02BB04,enzalutamide,3
C3501358,IN,ibrutinib,L01EL01,ibrutinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EL,Bruton's tyrosine kinase (BTK) inhibitors,L01EL01,ibrutinib,10
C3529352,IN,evolocumab,C10AX13,evolocumab,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AX,Other lipid modifying agents in ATC,C10AX13,evolocumab,16
C3529928,IN,pitolisant,N07XX11,pitolisant,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07X,OTHER NERVOUS SYSTEM DRUGS in ATC,N07XX,Other nervous system drugs in ATC,N07XX11,pitolisant,7
C3536832,IN,air,V03AN05,medical air,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AN,Medical gases,V03AN05,medical air,9
C3536876,,,N07BC03,levacetylmethadol,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07B,DRUGS USED IN ADDICTIVE DISORDERS,N07BC,Drugs used in opioid dependence,N07BC03,levacetylmethadol,1
C3539881,IN,gamma-interferon,L03AB03,interferon gamma,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AB,Interferons,L03AB03,interferon gamma,3533
C3541379,IN,lysozyme,D06BB07,lysozyme,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06B,CHEMOTHERAPEUTICS FOR TOPICAL USE,D06BB,"Antivirals, topical",D06BB07,lysozyme,549
C3541379,IN,lysozyme,J05AX02,lysozyme,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX02,lysozyme,549
C3555537,PIN,technetium Tc 99m tilmanocept,V09IA09,technetium (99mTc) tilmanocept,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09I,TUMOUR DETECTION RADIOPHARMACEUTICALS,V09IA,Technetium (99mTc) compounds,V09IA09,technetium (99mTc) tilmanocept,80
C3640098,PIN,edotreotide gallium ga-68,V09IX09,gallium (68Ga) edotreotide,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09I,TUMOUR DETECTION RADIOPHARMACEUTICALS,V09IX,Other diagnostic radiopharmaceuticals for tumour detection in ATC,V09IX09,gallium (68Ga) edotreotide,6
C3640212,IN,lipegfilgrastim,L03AA14,lipegfilgrastim,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AA,Colony stimulating factors,L03AA14,lipegfilgrastim,1
C3642427,IN,tavaborole,D01AE24,tavaborole,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AE,Other antifungals for topical use in ATC,D01AE24,tavaborole,2
C3652574,,,N06DX02,Ginkgo folium,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06D,ANTI-DEMENTIA DRUGS,N06DX,Other anti-dementia drugs in ATC,N06DX02,Ginkgo folium,36
C3652579,,,V09BA03,technetium (99mTc) pyrophosphate,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09B,SKELETON DIAGNOSTIC RADIOPHARMACEUTICALS,V09BA,Technetium (99mTc) compounds,V09BA03,technetium (99mTc) pyrophosphate,35
C3652583,,,V09BA01,technetium (99mTc) oxidronic acid,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09B,SKELETON DIAGNOSTIC RADIOPHARMACEUTICALS,V09BA,Technetium (99mTc) compounds,V09BA01,technetium (99mTc) oxidronic acid,1
C3652586,,,V09BA02,technetium (99mTc) medronic acid,V,VARIOUS DRUG CLASSES IN ATC,V09,DIAGNOSTIC RADIOPHARMACEUTICALS,V09B,SKELETON DIAGNOSTIC RADIOPHARMACEUTICALS,V09BA,Technetium (99mTc) compounds,V09BA02,technetium (99mTc) medronic acid,384
C3652663,,,V03AB24,digitalis antitoxin,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB24,digitalis antitoxin,7
C3652674,,,C07AB11,s-atenolol,C,CARDIOVASCULAR SYSTEM DRUGS,C07,beta-Adrenergic Blocking Agents,C07A,BETA BLOCKING AGENTS,C07AB,"Beta blocking agents, selective",C07AB11,s-atenolol,176
C3652694,,,D01AE10,ethyl hydroxybenzoate,D,DERMATOLOGICALS,D01,ANTIFUNGALS FOR DERMATOLOGICAL USE,D01A,ANTIFUNGALS FOR TOPICAL USE,D01AE,Other antifungals for topical use in ATC,D01AE10,ethyl hydroxybenzoate,61
C3652920,,,H05BA03,calcitonin (human synthetic),H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BA,Calcitonin preparations,H05BA03,calcitonin (human synthetic),21
C3652921,,,R03DA10,bufylline,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DA,"Xanthines, systemic for obstructive airway disease",R03DA10,bufylline,1
C3653088,,,P03AB51,"clofenotane, combinations",P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03A,"ECTOPARASITICIDES, INCL. SCABICIDES",P03AB,Chlorine containing product ectoparasiticides,P03AB51,"clofenotane, combinations",61
C3655918,,,J01FA16,solithromycin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,J01FA16,solithromycin,7
C3657270,IN,nivolumab,L01FF01,nivolumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FF,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,L01FF01,nivolumab,79
C3657824,IN,siponimod,L04AE03,siponimod,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AE,Sphingosine-1-phosphate (S1P) receptor modulators,L04AE03,siponimod,2
C3658667,IN,tralokinumab,D11AH07,tralokinumab,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AH,"Agents for dermatitis, excluding corticosteroids",D11AH07,tralokinumab,9
C3658706,IN,pembrolizumab,L01FF02,pembrolizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FF,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,L01FF02,pembrolizumab,39
C3659266,,,A06AX09,elobixibat,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AX,Other drugs for constipation in ATC,A06AX09,elobixibat,1
C3660913,,,J05AX21,pentanedioic acid imidazolyl ethanamide,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX21,pentanedioic acid imidazolyl ethanamide,2
C3660996,IN,dupilumab,D11AH05,dupilumab,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AH,"Agents for dermatitis, excluding corticosteroids",D11AH05,dupilumab,141
C3661282,IN,vortioxetine,N06AX26,vortioxetine,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX26,vortioxetine,9
C3661290,,,J05AP04,faldaprevir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,J05AP04,faldaprevir,2
C3661315,IN,rucaparib,L01XK03,rucaparib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XK,Poly (ADP-ribose) polymerase (PARP) inhibitors,L01XK03,rucaparib,1
C3696416,IN,sucroferric oxyhydroxide,V03AE05,sucroferric oxyhydroxide,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AE,Drugs for treatment of hyperkalemia and hyperphosphatemia,V03AE05,sucroferric oxyhydroxide,60
C3700393,,,C01DX21,serelaxin,C,CARDIOVASCULAR SYSTEM DRUGS,C01,CARDIAC THERAPY DRUGS,C01D,VASODILATORS USED IN CARDIAC DISEASES,C01DX,Other vasodilators used in cardiac diseases in ATC,C01DX21,serelaxin,4
C3700399,IN,naloxegol,A06AH03,naloxegol,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A06,DRUGS FOR CONSTIPATION,A06A,DRUGS FOR CONSTIPATION,A06AH,Peripheral opioid receptor antagonists,A06AH03,naloxegol,3
C3709760,PIN,coagulation factor XIII a-subunit (recombinant),B02BD11,catridecacog,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BD,Blood coagulation factors,B02BD11,catridecacog,229
C3713057,IN,caplacizumab,B01AX07,caplacizumab,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B01,ANTITHROMBOTIC AGENTS,B01A,ANTITHROMBOTIC AGENTS,B01AX,Other antithrombotic agents in ATC,B01AX07,caplacizumab,12
C3713860,IN,lifitegrast,S01XA25,lifitegrast,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA25,lifitegrast,1
C3713906,IN,etelcalcetide,H05BX04,etelcalcetide,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05B,ANTI-PARATHYROID AGENTS,H05BX,Other anti-parathyroid agents in ATC,H05BX04,etelcalcetide,3
C3713958,IN,tenofovir alafenamide,J05AF13,tenofovir alafenamide,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,J05AF13,tenofovir alafenamide,36
C3714572,PIN,pamidronic acid,M05BA03,pamidronic acid,M,MUSCULO-SKELETAL SYSTEM DRUGS,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BA,Bisphosphonate drugs affecting bone structure and mineralization,M05BA03,pamidronic acid,413
C3814772,IN,glycopyrronium,D11AA01,glycopyrronium,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AA,Antihidrotics,D11AA01,glycopyrronium,151
C3817397,IN,elosulfase alfa,A16AB12,elosulfase alfa,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB12,elosulfase alfa,45
C3818721,IN,ceritinib,L01ED02,ceritinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01ED,Anaplastic lymphoma kinase (ALK) inhibitors,L01ED02,ceritinib,8
C3848580,IN,peginterferon beta-1a,L03AB13,peginterferon beta-1a,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AB,Interferons,L03AB13,peginterferon beta-1a,2
C3852217,IN,guselkumab,L04AC16,guselkumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC16,guselkumab,1
C3852512,IN,dasabuvir,J05AP09,dasabuvir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,J05AP09,dasabuvir,20
C3852671,IN,selinexor,L01XX66,selinexor,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX66,selinexor,4
C3852841,IN,abemaciclib,L01EF03,abemaciclib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EF,Cyclin-dependent kinase (CDK) inhibitors,L01EF03,abemaciclib,2
C3852938,IN,letermovir,J05AX18,letermovir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX18,letermovir,16
C3853822,IN,palbociclib,L01EF01,palbociclib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EF,Cyclin-dependent kinase (CDK) inhibitors,L01EF01,palbociclib,7
C3853839,IN,blinatumomab,L01FX07,blinatumomab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FX,Other monoclonal antibodies and antibody drug conjugates in ATC,L01FX07,blinatumomab,91
C3853921,IN,alectinib,L01ED03,alectinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01ED,Anaplastic lymphoma kinase (ALK) inhibitors,L01ED03,alectinib,20
C3854019,IN,gentamicin,D06AX07,gentamicin,D,DERMATOLOGICALS,D06,ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,D06A,ANTIBIOTICS FOR TOPICAL USE,D06AX,Other antibiotics for topical use in ATC,D06AX07,gentamicin,2366
C3854019,IN,gentamicin,J01GB03,gentamicin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides in ATC,J01GB03,gentamicin,2366
C3854019,IN,gentamicin,S01AA11,gentamicin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01A,ANTIINFECTIVE OPHTHALMOLOGICS,S01AA,"Antibiotics, ophthalmologic",S01AA11,gentamicin,2366
C3854019,IN,gentamicin,S02AA14,gentamicin,S,SENSORY ORGAN DRUGS,S02,OTOLOGICALS,S02A,"ANTIINFECTIVE DRUGS, OTOLOGIC",S02AA,Antiinfectives,S02AA14,gentamicin,2366
C3854019,IN,gentamicin,S03AA06,gentamicin,S,SENSORY ORGAN DRUGS,S03,OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,S03A,"ANTIINFECTIVES, OPHTHALMOLOGIC AND OTOLOGIC",S03AA,Antiinfectives,S03AA06,gentamicin,2366
C3885063,IN,idarucizumab,V03AB37,idarucizumab,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB37,idarucizumab,2
C3885068,IN,semaglutide,A10BJ06,semaglutide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BJ,Glucagon-like peptide-1 (GLP-1) analogues,A10BJ06,semaglutide,9
C3885145,IN,sarilumab,L04AC14,sarilumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC14,sarilumab,4
C3885614,IN,brexpiprazole,N05AX16,brexpiprazole,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AX,Other antipsychotics in ATC,N05AX16,brexpiprazole,6
C3886460,IN,avatrombopag,B02BX08,avatrombopag,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BX,Other systemic hemostatics in ATC,B02BX08,avatrombopag,3
C3886496,,,M09AX04,drisapersen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AX,Other drugs for disorders of the musculo-skeletal system in ATC,M09AX04,drisapersen,7
C3886731,IN,sonidegib,L01XJ02,sonidegib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XJ,Hedgehog pathway inhibitors,L01XJ02,sonidegib,3
C3886763,IN,brincidofovir,J05AB17,brincidofovir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,J05AB17,brincidofovir,14
C3896936,IN,relugolix,L02BX04,relugolix,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02,ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L02B,HORMONE ANTAGONISTS AND RELATED AGENTS,L02BX,Other hormone antagonists and related agents in ATC,L02BX04,relugolix,1
C3896940,IN,gilteritinib,L01EX13,gilteritinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX13,gilteritinib,3
C3899947,IN,binimetinib,L01EE03,binimetinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EE,Mitogen-activated protein kinase (MEK) inhibitors,L01EE03,binimetinib,1
C4042342,IN,abaloparatide,H05AA04,abaloparatide,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H05,CALCIUM HOMEOSTASIS,H05A,PARATHYROID HORMONES AND ANALOGUES,H05AA,Parathyroid hormones and analogues,H05AA04,abaloparatide,1
C4042960,IN,talazoparib,L01XK04,talazoparib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XK,Poly (ADP-ribose) polymerase (PARP) inhibitors,L01XK04,talazoparib,3
C4043101,IN,aducanumab,N06DX03,aducanumab,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06D,ANTI-DEMENTIA DRUGS,N06DX,Other anti-dementia drugs in ATC,N06DX03,aducanumab,1
C4044947,IN,baricitinib,L04AF02,baricitinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AF,Janus-associated kinase (JAK) inhibitors (L04AF),L04AF02,baricitinib,27
C4045491,IN,doravirine,J05AG06,doravirine,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AG,Non-nucleoside reverse transcriptase inhibitors,J05AG06,doravirine,6
C4045494,IN,ribociclib,L01EF02,ribociclib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EF,Cyclin-dependent kinase (CDK) inhibitors,L01EF02,ribociclib,12
C4045501,,,S01EX07,ripasudil,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EX,Other antiglaucoma preparations in ATC,S01EX07,ripasudil,2
C4045511,IN,finerenone,C03DA05,finerenone,C,CARDIOVASCULAR SYSTEM DRUGS,C03,DIURETICS,C03D,ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS,C03DA,Aldosterone antagonists,C03DA05,finerenone,1
C4045824,IN,sodium zirconium cyclosilicate,V03AE10,sodium zirconium cyclosilicate,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AE,Drugs for treatment of hyperkalemia and hyperphosphatemia,V03AE10,sodium zirconium cyclosilicate,1
C4048265,IN,tetanus immune globulin,J06BB02,tetanus immunoglobulin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,J06BB02,tetanus immunoglobulin,15
C4049141,IN,copanlisib,L01EM02,copanlisib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EM,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,L01EM02,copanlisib,2
C4049146,IN,cobimetinib,L01EE02,cobimetinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EE,Mitogen-activated protein kinase (MEK) inhibitors,L01EE02,cobimetinib,3
C4050579,IN,sebelipase alfa,A16AB14,sebelipase alfa,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB14,sebelipase alfa,14
C4055109,IN,durvalumab,L01FF03,durvalumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FF,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,L01FF03,durvalumab,4
C4055417,IN,avelumab,L01FF04,avelumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FF,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,L01FF04,avelumab,4
C4055433,IN,atezolizumab,L01FF05,atezolizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FF,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,L01FF05,atezolizumab,48
C4055478,IN,alpelisib,L01EM03,alpelisib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EM,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,L01EM03,alpelisib,11
C4058811,IN,osimertinib,L01EB04,osimertinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EB,Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,L01EB04,osimertinib,3
C4078312,IN,acalabrutinib,L01EL02,acalabrutinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EL,Bruton's tyrosine kinase (BTK) inhibitors,L01EL02,acalabrutinib,1
C4078701,IN,valbenazine,N07XX13,valbenazine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07X,OTHER NERVOUS SYSTEM DRUGS in ATC,N07XX,Other nervous system drugs in ATC,N07XX13,valbenazine,1
C4079830,IN,venetoclax,L01XX52,venetoclax,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX52,venetoclax,23
C4079904,IN,andexanet alfa,V03AB38,andexanet alfa,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AB,Antidotes,V03AB38,andexanet alfa,2
C4080009,IN,vonoprazan,A02BC08,vonoprazan,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A02,DRUGS FOR ACID RELATED DISORDERS,A02B,DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),A02BC,Proton pump inhibitors for peptic ulcer and GORD,A02BC08,vonoprazan,7
C4080052,IN,elbasvir,J05AP10,elbasvir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,J05AP10,elbasvir,4
C4080053,IN,grazoprevir,J05AP11,grazoprevir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,J05AP11,grazoprevir,4
C4080091,IN,lorlatinib,L01ED05,lorlatinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01ED,Anaplastic lymphoma kinase (ALK) inhibitors,L01ED05,lorlatinib,6
C4082272,IN,arbekacin,J01GB12,arbekacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides in ATC,J01GB12,arbekacin,19
C4082771,,,V08AA02,metrizoic acid,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08A,"X-RAY CONTRAST MEDIA, IODINATED",V08AA,"Watersoluble, nephrotropic, high osmolar X-ray contrast media",V08AA02,metrizoic acid,15
C4086264,IN,entrectinib,L01EX14,entrectinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX14,entrectinib,12
C4086553,IN,luspatercept,B03XA06,luspatercept,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03X,OTHER ANTIANEMIC PREPARATIONS in ATC,B03XA,Other antianemic preparations in ATC,B03XA06,luspatercept,1
C4086895,IN,tazemetostat,L01XX72,tazemetostat,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX72,tazemetostat,3
C4277781,IN,deutetrabenazine,N07XX16,deutetrabenazine,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07X,OTHER NERVOUS SYSTEM DRUGS in ATC,N07XX,Other nervous system drugs in ATC,N07XX16,deutetrabenazine,5
C4278198,IN,olipudase alfa,A16AB25,olipudase alfa,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB25,olipudase alfa,3
C4278463,IN,emicizumab,B02BX06,emicizumab,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BX,Other systemic hemostatics in ATC,B02BX06,emicizumab,69
C4279595,IN,setmelanotide,A08AA12,setmelanotide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A08,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08A,"ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS",A08AA,Centrally acting antiobesity products,A08AA12,setmelanotide,8
C4279743,IN,vibegron,G04BD15,vibegron,G,GENITO URINARY SYSTEM AND SEX HORMONES,G04,UROLOGICALS,G04B,UROLOGICALS,G04BD,Drugs for urinary frequency and incontinence,G04BD15,vibegron,4
C4283710,IN,eteplirsen,M09AX06,eteplirsen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AX,Other drugs for disorders of the musculo-skeletal system in ATC,M09AX06,eteplirsen,12
C4287804,IN,pexidartinib,L01EX15,pexidartinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX15,pexidartinib,2
C4287815,IN,brigatinib,L01ED04,brigatinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01ED,Anaplastic lymphoma kinase (ALK) inhibitors,L01ED04,brigatinib,1
C4288415,,,L03AA17,pegteograstim,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AA,Colony stimulating factors,L03AA17,pegteograstim,1
C4291320,IN,bezlotoxumab,J06BC03,bezlotoxumab,J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BC,Antibacterial monoclonal antibodies,J06BC03,bezlotoxumab,1
C4301236,IN,nusinersen,M09AX07,nusinersen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AX,Other drugs for disorders of the musculo-skeletal system in ATC,M09AX07,nusinersen,223
C4301607,IN,burosumab,M05BX05,burosumab,M,MUSCULO-SKELETAL SYSTEM DRUGS,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BX,Other drugs affecting bone structure and mineralization in ATC,M05BX05,burosumab,47
C4301617,,,G03GA10,follitropin delta,G,GENITO URINARY SYSTEM AND SEX HORMONES,G03,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,G03G,GONADOTROPINS AND OTHER OVULATION STIMULANTS,G03GA,Gonadotropins,G03GA10,follitropin delta,4218
C4301781,IN,crisaborole,D11AH06,crisaborole,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AH,"Agents for dermatitis, excluding corticosteroids",D11AH06,crisaborole,24
C4305843,IN,lumateperone,N05AD10,lumateperone,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05A,ANTIPSYCHOTICS,N05AD,"Butyrophenone derivatives, antipsychotics",N05AD10,lumateperone,1
C4307388,IN,inclisiran,C10AX16,inclisiran,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AX,Other lipid modifying agents in ATC,C10AX16,inclisiran,2
C4309207,IN,lusutrombopag,B02BX07,lusutrombopag,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BX,Other systemic hemostatics in ATC,B02BX07,lusutrombopag,2
C4309999,,,J01XX13,gepotidacin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XX,Other antibacterials in ATC,J01XX13,gepotidacin,2
C4310385,IN,cabotegravir,J05AJ04,cabotegravir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AJ,"Integrase Inhibitors, antiinfectives for systematic use",J05AJ04,cabotegravir,13
C4310440,IN,pretomanid,J04AK08,pretomanid,J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AK,Other drugs for treatment of tuberculosis in ATC,J04AK08,pretomanid,3
C4310578,,,B03XA05,roxadustat,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03X,OTHER ANTIANEMIC PREPARATIONS in ATC,B03XA,Other antianemic preparations in ATC,B03XA05,roxadustat,1
C4317155,,,A03FA10,acotiamide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A03,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,A03F,PROPULSIVES,A03FA,Propulsives,A03FA10,acotiamide,1
C4330903,IN,osilodrostat,H02CA02,osilodrostat,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02C,ANTIADRENAL PREPARATIONS,H02CA,Anticorticosteroids,H02CA02,osilodrostat,2
C4475875,PIN,cerliponase alfa,A16AB17,cerliponase alfa,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB17,cerliponase alfa,16
C4482908,IN,lefamulin,J01XX12,lefamulin,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS in ATC,J01XX,Other antibacterials in ATC,J01XX12,lefamulin,1
C4489760,IN,sparsentan,C09XX01,sparsentan,C,CARDIOVASCULAR SYSTEM DRUGS,C09,AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,C09X,OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM in ATC,C09XX,Other agents acting on the renin-angiotensin system in ATC,C09XX01,sparsentan,1
C4505508,IN,lanadelumab,B06AC05,lanadelumab,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B06,OTHER HEMATOLOGICAL AGENTS in ATC,B06A,OTHER HEMATOLOGICAL AGENTS in ATC,B06AC,Drugs used in hereditary angioedema,B06AC05,lanadelumab,4
C4505511,IN,risankizumab,L04AC18,risankizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC18,risankizumab,1
C4505530,IN,nemolizumab,D11AH12,nemolizumab,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AH,"Agents for dermatitis, excluding corticosteroids",D11AH12,nemolizumab,4
C4507514,IN,avacopan,L04AJ05,avacopan,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AJ,Complement inhibitors,L04AJ05,avacopan,2
C4508522,IN,evinacumab,C10AX17,evinacumab,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AX,Other lipid modifying agents in ATC,C10AX17,evinacumab,7
C4508722,IN,asciminib,L01EA06,asciminib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EA,BCR-ABL tyrosine kinase inhibitors,L01EA06,asciminib,1
C4508936,IN,elafibranor,A05AX06,elafibranor,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A05,BILE AND LIVER THERAPY DRUGS,A05A,BILE THERAPY DRUGS,A05AX,Other drugs for bile therapy in ATC,A05AX06,elafibranor,1
C4519112,IN,velmanase alfa,A16AB15,velmanase alfa,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB15,velmanase alfa,8
C4519126,IN,rimegepant,N02CD06,rimegepant,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CD,Calcitonin gene-related peptide (CGRP) antagonists,N02CD06,rimegepant,2
C4519167,IN,tucatinib,L01EH03,tucatinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EH,Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors,L01EH03,tucatinib,2
C4519188,IN,daprodustat,B03XA07,daprodustat,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B03,ANTIANEMIC PREPARATIONS,B03X,OTHER ANTIANEMIC PREPARATIONS in ATC,B03XA,Other antianemic preparations in ATC,B03XA07,daprodustat,1
C4519199,IN,lasmiditan,N02CC08,lasmiditan,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CC,Selective serotonin (5HT1) agonists,N02CC08,lasmiditan,1
C4519213,IN,trifarotene,D10AD06,trifarotene,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AD,Retinoids for topical use in acne,D10AD06,trifarotene,5
C4519220,IN,fostemsavir,J05AX29,fostemsavir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX29,fostemsavir,1
C4519229,IN,pegvaliase,A16AB19,pegvaliase,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB19,pegvaliase,10
C4519258,IN,abametapir,P03AX07,abametapir,P,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",P03,"ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS",P03A,"ECTOPARASITICIDES, INCL. SCABICIDES",P03AX,"Other ectoparasiticides, incl. scabicides in ATC",P03AX07,abametapir,1
C4519269,IN,lemborexant,N05CJ02,lemborexant,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CJ,Orexin receptor antagonists,N05CJ02,lemborexant,3
C4519273,IN,glasdegib,L01XJ03,glasdegib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XJ,Hedgehog pathway inhibitors,L01XJ03,glasdegib,1
C4519277,IN,nirogacestat,L01XX81,nirogacestat,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX81,nirogacestat,1
C4519292,IN,sarecycline,J01AA14,sarecycline,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,Tetracycline antibiotics,J01AA,Tetracyclines,J01AA14,sarecycline,1
C4519324,,,L04AF05,itacitinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AF,Janus-associated kinase (JAK) inhibitors (L04AF),L04AF05,itacitinib,2
C4519428,IN,enasidenib,L01XM01,enasidenib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XM,"Isocitrate dehydrogenase (IDH) inhibitors, antineoplastic",L01XM01,enasidenib,2
C4519728,IN,vestronidase alfa,A16AB18,vestronidase alfa,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB18,vestronidase alfa,6
C4519734,IN,bimekizumab,L04AC21,bimekizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC21,bimekizumab,1
C4519739,IN,anifrolumab,L04AG11,anifrolumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AG,Monoclonal antibodies,L04AG11,anifrolumab,1
C4519744,IN,difelikefalin,V03AX04,difelikefalin,V,VARIOUS DRUG CLASSES IN ATC,V03,ALL OTHER THERAPEUTIC PRODUCTS,V03A,ALL OTHER THERAPEUTIC PRODUCTS,V03AX,Other therapeutic products in ATC,V03AX04,difelikefalin,1
C4519745,IN,vosoritide,M05BX07,vosoritide,M,MUSCULO-SKELETAL SYSTEM DRUGS,M05,DRUGS FOR TREATMENT OF BONE DISEASES,M05B,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,M05BX,Other drugs affecting bone structure and mineralization in ATC,M05BX07,vosoritide,11
C4524315,IN,larotrectinib,L01EX12,larotrectinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX12,larotrectinib,36
C4524703,IN,crizanlizumab,B06AX01,crizanlizumab,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B06,OTHER HEMATOLOGICAL AGENTS in ATC,B06A,OTHER HEMATOLOGICAL AGENTS in ATC,B06AX,Other hematological agents in ATC,B06AX01,crizanlizumab,6
C4535718,IN,netarsudil,S01EX05,netarsudil,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01E,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,S01EX,Other antiglaucoma preparations in ATC,S01EX05,netarsudil,7
C4541381,IN,tapinarof,D05AX07,tapinarof,D,DERMATOLOGICALS,D05,ANTIPSORIATICS,D05A,ANTIPSORIATICS FOR TOPICAL USE,D05AX,Other antipsoriatics for topical use in ATC,D05AX07,tapinarof,2
C4541383,IN,cenegermin,S01XA24,cenegermin,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA24,cenegermin,10
C4542165,IN,erenumab,N02CD01,erenumab,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CD,Calcitonin gene-related peptide (CGRP) antagonists,N02CD01,erenumab,6
C4542170,,,A16AB16,idursulfase beta,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB16,idursulfase beta,8
C4542175,IN,ropeginterferon alfa-2b,L03AB15,ropeginterferon alfa-2b,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AB,Interferons,L03AB15,ropeginterferon alfa-2b,1
C4547051,,,C10AB12,pemafibrate,C,CARDIOVASCULAR SYSTEM DRUGS,C10,LIPID MODIFYING AGENTS,C10A,"LIPID MODIFYING AGENTS, PLAIN",C10AB,"Fibrates, lipid modifying drugs, plain",C10AB12,pemafibrate,1
C4547202,IN,leniolisib,L03AX22,leniolisib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AX,Other immunostimulants in ATC,L03AX22,leniolisib,1
C4547455,IN,fezolinetant,G02CX06,fezolinetant,G,GENITO URINARY SYSTEM AND SEX HORMONES,G02,OTHER GYNECOLOGICALS in ATC,G02C,OTHER GYNECOLOGICALS in ATC,G02CX,Other gynecologicals in ATC,G02CX06,fezolinetant,1
C4548369,IN,cefiderocol,J01DI04,cefiderocol,J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS in ATC,J01DI,Other cephalosporins and penems in ATC,J01DI04,cefiderocol,6
C4548848,IN,brexanolone,N06AX29,brexanolone,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX29,brexanolone,55
C4549503,IN,fremanezumab,N02CD03,fremanezumab,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CD,Calcitonin gene-related peptide (CGRP) antagonists,N02CD03,fremanezumab,5
C4550124,IN,brolucizumab,S01LA06,brolucizumab,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01L,OCULAR VASCULAR DISORDER AGENTS,S01LA,Antineovascularisation agents,S01LA06,brolucizumab,4
C4550163,IN,tezepelumab,R03DX11,tezepelumab,R,RESPIRATORY SYSTEM DRUGS,R03,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,R03D,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC,R03DX,Other systemic drugs for obstructive airway diseases in ATC,R03DX11,tezepelumab,12
C4550350,IN,ravulizumab,L04AJ02,ravulizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AJ,Complement inhibitors,L04AJ02,ravulizumab,7
C4550368,IN,cenobamate,N03AX25,cenobamate,N,NERVOUS SYSTEM DRUGS,N03,ANTIEPILEPTICS,N03A,ANTIEPILEPTICS,N03AX,Other antiepileptics in ATC,N03AX25,cenobamate,3
C4688584,IN,givosiran,A16AX16,givosiran,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX16,givosiran,1
C4688747,IN,baloxavir marboxil,J05AX25,baloxavir marboxil,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX25,baloxavir marboxil,32
C4691336,,,V04CX09,patent blue,V,VARIOUS DRUG CLASSES IN ATC,V04,DIAGNOSTIC AGENTS,V04C,OTHER DIAGNOSTIC AGENTS in ATC,V04CX,Other diagnostic agents in ATC,V04CX09,patent blue,3
C4694272,IN,eptinezumab,N02CD05,eptinezumab,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CD,Calcitonin gene-related peptide (CGRP) antagonists,N02CD05,eptinezumab,1
C4694273,IN,galcanezumab,N02CD02,galcanezumab,N,NERVOUS SYSTEM DRUGS,N02,ANALGESICS,N02C,ANTIMIGRAINE PREPARATIONS,N02CD,Calcitonin gene-related peptide (CGRP) antagonists,N02CD02,galcanezumab,4
C4722567,,,L01FX06,dinutuximab beta,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FX,Other monoclonal antibodies and antibody drug conjugates in ATC,L01FX06,dinutuximab beta,46
C4723629,IN,voxelotor,B06AX03,voxelotor,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B06,OTHER HEMATOLOGICAL AGENTS in ATC,B06A,OTHER HEMATOLOGICAL AGENTS in ATC,B06AX,Other hematological agents in ATC,B06AX03,voxelotor,13
C4724814,,,A16AB24,pegzilarginase,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB24,pegzilarginase,2
C4726677,IN,remdesivir,J05AB16,remdesivir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,J05AB16,remdesivir,105
C4726717,IN,rozanolixizumab,L04AG16,rozanolixizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AG,Monoclonal antibodies,L04AG16,rozanolixizumab,3
C4726732,IN,satralizumab,L04AC19,satralizumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC19,satralizumab,2
C4726770,IN,somapacitan,H01AC07,somapacitan,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,H01AC07,somapacitan,12
C4726772,IN,somatrogon,H01AC08,somatrogon,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,H01AC08,somatrogon,8
C4726916,IN,trofinetide,N07XX24,trofinetide,N,NERVOUS SYSTEM DRUGS,N07,OTHER NERVOUS SYSTEM DRUGS in ATC,N07X,OTHER NERVOUS SYSTEM DRUGS in ATC,N07XX,Other nervous system drugs in ATC,N07XX24,trofinetide,4
C4726929,IN,upadacitinib,L04AF03,upadacitinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AF,Janus-associated kinase (JAK) inhibitors (L04AF),L04AF03,upadacitinib,20
C4726937,IN,valoctocogene roxaparvovec,B02BD15,valoctocogene roxaparvovec,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B02,ANTIHEMORRHAGICS,B02B,VITAMIN K AND OTHER HEMOSTATICS,B02BD,Blood coagulation factors,B02BD15,valoctocogene roxaparvovec,1
C4726940,IN,vamorolone,H02AB18,vamorolone,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H02,CORTICOSTEROIDS FOR SYSTEMIC USE,H02A,"CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",H02AB,"Glucocorticoids, Systemic",H02AB18,vamorolone,9
C4730996,IN,clascoterone,D10AX06,clascoterone,D,DERMATOLOGICALS,D10,ANTI-ACNE PREPARATIONS,D10A,ANTI-ACNE PREPARATIONS FOR TOPICAL USE,D10AX,Other anti-acne preparations for topical use in ATC,D10AX06,clascoterone,7
C4731737,IN,elapegademase,L03AX21,elapegademase,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L03,IMMUNOSTIMULANTS,L03A,IMMUNOSTIMULANTS,L03AX,Other immunostimulants in ATC,L03AX21,elapegademase,1
C4733494,IN,naxitamab,L01FX21,naxitamab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FX,Other monoclonal antibodies and antibody drug conjugates in ATC,L01FX21,naxitamab,7
C4740904,IN,emapalumab,L04AG09,emapalumab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AG,Monoclonal antibodies,L04AG09,emapalumab,9
C4743552,IN,avapritinib,L01EX18,avapritinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX18,avapritinib,2
C4746084,IN,tagraxofusp,L01XX67,tagraxofusp,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX67,tagraxofusp,3
C4763386,IN,toripalimab,L01FF13,toripalimab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FF,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,L01FF13,toripalimab,2
C5139676,IN,risdiplam,M09AX10,risdiplam,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AX,Other drugs for disorders of the musculo-skeletal system in ATC,M09AX10,risdiplam,25
C5139702,IN,danicopan,L04AJ09,danicopan,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AJ,Complement inhibitors,L04AJ09,danicopan,1
C5139725,,,L01XK06,pamiparib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XK,Poly (ADP-ribose) polymerase (PARP) inhibitors,L01XK06,pamiparib,1
C5139749,IN,ripretinib,L01EX19,ripretinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX19,ripretinib,1
C5139788,IN,abrocitinib,D11AH08,abrocitinib,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AH,"Agents for dermatitis, excluding corticosteroids",D11AH08,abrocitinib,7
C5139793,IN,casimersen,M09AX13,casimersen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AX,Other drugs for disorders of the musculo-skeletal system in ATC,M09AX13,casimersen,1
C5139804,IN,viltolarsen,M09AX12,viltolarsen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AX,Other drugs for disorders of the musculo-skeletal system in ATC,M09AX12,viltolarsen,2
C5139816,IN,aprocitentan,C02KN01,aprocitentan,C,CARDIOVASCULAR SYSTEM DRUGS,C02,ANTIHYPERTENSIVES,C02K,OTHER ANTIHYPERTENSIVES in ATC,C02KN,Other antihypertensives in ATC,C02KN01,aprocitentan,2
C5139845,IN,futibatinib,L01EN04,futibatinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EN,Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors,L01EN04,futibatinib,1
C5139868,IN,dasiglucagon,H04AA02,dasiglucagon,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H04,PANCREATIC HORMONES,H04A,GLYCOGENOLYTIC HORMONES,H04AA,Glycogenolytic hormones,H04AA02,dasiglucagon,3
C5139916,IN,tafasitamab,L01FX12,tafasitamab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FX,Other monoclonal antibodies and antibody drug conjugates in ATC,L01FX12,tafasitamab,1
C5139934,IN,tirzepatide,A10BX16,tirzepatide,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A10,DRUGS USED IN DIABETES,A10B,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",A10BX,"Other blood glucose lowering drugs, excl. insulins in ATC",A10BX16,tirzepatide,4
C5140028,IN,onasemnogene abeparvovec,M09AX09,onasemnogene abeparvovec,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AX,Other drugs for disorders of the musculo-skeletal system in ATC,M09AX09,onasemnogene abeparvovec,54
C5206403,IN,ibrexafungerp,J02AX07,ibrexafungerp,J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AX,Other antimycotics for systemic use in ATC,J02AX07,ibrexafungerp,1
C5222004,IN,golodirsen,M09AX08,golodirsen,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AX,Other drugs for disorders of the musculo-skeletal system in ATC,M09AX08,golodirsen,2
C5226639,IN,mitapivat,B06AX04,mitapivat,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B06,OTHER HEMATOLOGICAL AGENTS in ATC,B06A,OTHER HEMATOLOGICAL AGENTS in ATC,B06AX,Other hematological agents in ATC,B06AX04,mitapivat,2
C5226741,,,D11AH11,delgocitinib,D,DERMATOLOGICALS,D11,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11A,OTHER DERMATOLOGICAL PREPARATIONS in ATC,D11AH,"Agents for dermatitis, excluding corticosteroids",D11AH11,delgocitinib,3
C5226874,IN,pralsetinib,L01EX23,pralsetinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX23,pralsetinib,1
C5227411,IN,belantamab mafodotin,L01FX15,belantamab mafodotin,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01F,MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES,L01FX,Other monoclonal antibodies and antibody drug conjugates in ATC,L01FX15,belantamab mafodotin,1
C5227595,IN,zuranolone,N06AX31,zuranolone,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06A,ANTIDEPRESSANTS,N06AX,Other antidepressants in ATC,N06AX31,zuranolone,2
C5227711,IN,daridorexant,N05CJ03,daridorexant,N,NERVOUS SYSTEM DRUGS,N05,PSYCHOLEPTICS,N05C,HYPNOTICS AND SEDATIVES,N05CJ,Orexin receptor antagonists,N05CJ03,daridorexant,1
C5235396,IN,selpercatinib,L01EX22,selpercatinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01E,"PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",L01EX,Other protein kinase inhibitors in ATC,L01EX22,selpercatinib,5
C5235403,IN,linzagolix,H01CC04,linzagolix,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01C,HYPOTHALAMIC HORMONES,H01CC,Anti-gonadotropin-releasing hormones,H01CC04,linzagolix,2
C5237999,IN,donanemab,N06DX05,donanemab,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06D,ANTI-DEMENTIA DRUGS,N06DX,Other anti-dementia drugs in ATC,N06DX05,donanemab,1
C5238052,IN,odevixibat,A05AX05,odevixibat,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A05,BILE AND LIVER THERAPY DRUGS,A05A,BILE THERAPY DRUGS,A05AX,Other drugs for bile therapy in ATC,A05AX05,odevixibat,7
C5238067,,,B06AC07,garadacimab,B,BLOOD AND BLOOD FORMING ORGAN DRUGS,B06,OTHER HEMATOLOGICAL AGENTS in ATC,B06A,OTHER HEMATOLOGICAL AGENTS in ATC,B06AC,Drugs used in hereditary angioedema,B06AC07,garadacimab,1
C5238146,IN,spesolimab,L04AC22,spesolimab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC22,spesolimab,1
C5242453,IN,lecanemab,N06DX04,lecanemab,N,NERVOUS SYSTEM DRUGS,N06,PSYCHOANALEPTICS,N06D,ANTI-DEMENTIA DRUGS,N06DX,Other anti-dementia drugs in ATC,N06DX04,lecanemab,1
C5242456,,,A16AB27,pabinafusp alfa,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB27,pabinafusp alfa,1
C5244461,IN,lenacapavir,J05AX31,lenacapavir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals in ATC,J05AX31,lenacapavir,1
C5392287,IN,gadopiclenol,V08CA12,gadopiclenol,V,VARIOUS DRUG CLASSES IN ATC,V08,CONTRAST MEDIA,V08C,MAGNETIC RESONANCE IMAGING CONTRAST MEDIA,V08CA,Paramagnetic contrast media,V08CA12,gadopiclenol,2
C5392705,IN,vilobelimab,L04AJ10,vilobelimab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AJ,Complement inhibitors,L04AJ10,vilobelimab,2
C5418179,IN,belumosudil,L04AA48,belumosudil,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AA,Selective immunosuppressants,L04AA48,belumosudil,2
C5418188,IN,belzutifan,L01XX74,belzutifan,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX74,belzutifan,2
C5418250,IN,sotorasib,L01XX73,sotorasib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L01,ANTINEOPLASTIC AGENTS,L01X,OTHER ANTINEOPLASTIC AGENTS in ATC,L01XX,Other antineoplastic agents in ATC,L01XX73,sotorasib,1
C5418278,IN,ritlecitinib,L04AF08,ritlecitinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AF,Janus-associated kinase (JAK) inhibitors (L04AF),L04AF08,ritlecitinib,2
C5418318,IN,avalglucosidase alfa,A16AB22,avalglucosidase alfa,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB22,avalglucosidase alfa,5
C5418336,IN,crovalimab,L04AJ07,crovalimab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AJ,Complement inhibitors,L04AJ07,crovalimab,1
C5418443,IN,lumasiran,A16AX18,lumasiran,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX18,lumasiran,10
C5418478,IN,nirsevimab,J06BD08,nirsevimab,J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BD,Antiviral monoclonal antibodies,J06BD08,nirsevimab,20
C5419280,,,S01XA29,sepofarsen,S,SENSORY ORGAN DRUGS,S01,OPHTHALMOLOGICALS,S01X,OTHER OPHTHALMOLOGICALS IN ATC,S01XA,Other ophthalmologicals in ATC,S01XA29,sepofarsen,1
C5420393,,,L04AC25,levilimab,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AC,Interleukin inhibitors,L04AC25,levilimab,1
C5420928,IN,deucravacitinib,L04AF07,deucravacitinib,L,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,L04,IMMUNOSUPPRESSANTS,L04A,IMMUNOSUPPRESSANTS,L04AF,Janus-associated kinase (JAK) inhibitors (L04AF),L04AF07,deucravacitinib,1
C5421138,IN,cipaglucosidase alfa,A16AB23,cipaglucosidase alfa,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AB,Enzymes for ALIMENTARY TRACT AND METABOLISM,A16AB23,cipaglucosidase alfa,2
C5421356,IN,lonapegsomatropin,H01AC09,lonapegsomatropin,H,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",H01,PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,H01A,ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,H01AC,Somatropin and somatropin agonists,H01AC09,lonapegsomatropin,6
C5432268,,,J06BD06,regdanvimab,J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BD,Antiviral monoclonal antibodies,J06BD06,regdanvimab,2
C5432324,IN,ansuvimab,J06BD04,ansuvimab,J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BD,Antiviral monoclonal antibodies,J06BD04,ansuvimab,1
C5433947,IN,sotrovimab,J06BD05,sotrovimab,J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BD,Antiviral monoclonal antibodies,J06BD05,sotrovimab,18
C5435024,IN,molnupiravir,J05AB18,molnupiravir,J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,J05AB18,molnupiravir,2
C5446775,IN,nedosiran,A16AX25,nedosiran,A,ALIMENTARY TRACT AND METABOLISM DRUGS,A16,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16A,OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC,A16AX,Various alimentary tract and metabolism products,A16AX25,nedosiran,1
C5447557,IN,delandistrogene moxeparvovec,M09AX15,delandistrogene moxeparvovec,M,MUSCULO-SKELETAL SYSTEM DRUGS,M09,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09A,OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC,M09AX,Other drugs for disorders of the musculo-skeletal system in ATC,M09AX15,delandistrogene moxeparvovec,2
